<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Point‐of‐use fortification of foods with micronutrient powders containing iron in children of preschool and school‐age - De‐Regil, LM - 2017 | Cochrane Library</title> <meta content="Point‐of‐use fortification of foods with micronutrient powders containing iron in children of preschool and school‐age - De‐Regil, LM - 2017 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009666.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Point‐of‐use fortification of foods with micronutrient powders containing iron in children of preschool and school‐age - De‐Regil, LM - 2017 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009666.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD009666.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Point‐of‐use fortification of foods with micronutrient powders containing iron in children of preschool and school‐age" name="citation_title"/> <meta content="Luz Maria De‐Regil" name="citation_author"/> <meta content="Nutrition International" name="citation_author_institution"/> <meta content="lderegil@NutritionIntl.org" name="citation_author_email"/> <meta content="Maria Elena D Jefferds" name="citation_author"/> <meta content="Centers for Disease Control and Prevention" name="citation_author_institution"/> <meta content="Juan Pablo Peña‐Rosas" name="citation_author"/> <meta content="World Health Organization" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="11" name="citation_issue"/> <meta content="10.1002/14651858.CD009666.pub2" name="citation_doi"/> <meta content="2017" name="citation_date"/> <meta content="2017/11/23" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009666.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009666.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009666.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Anemia, Iron-Deficiency [blood, prevention &amp; control, *therapy]; Dietary Supplements; Edetic Acid [administration &amp; dosage]; Ferric Compounds [administration &amp; dosage]; Ferrous Compounds [administration &amp; dosage]; *Food, Fortified [adverse effects]; Iron [*administration &amp; dosage]; Micronutrients [*administration &amp; dosage, adverse effects]; Point-of-Care Systems; Powders; Trace Elements [administration &amp; dosage]; Vitamins [administration &amp; dosage]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009666.pub2&amp;doi=10.1002/14651858.CD009666.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009666.pub2&amp;doi=10.1002/14651858.CD009666.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009666.pub2&amp;doi=10.1002/14651858.CD009666.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009666.pub2&amp;doi=10.1002/14651858.CD009666.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009666.pub2&amp;doi=10.1002/14651858.CD009666.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009666.pub2&amp;doi=10.1002/14651858.CD009666.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009666.pub2&amp;doi=10.1002/14651858.CD009666.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009666.pub2&amp;doi=10.1002/14651858.CD009666.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009666.pub2&amp;doi=10.1002/14651858.CD009666.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009666.pub2&amp;doi=10.1002/14651858.CD009666.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009666.pub2&amp;doi=10.1002/14651858.CD009666.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009666.pub2&amp;doi=10.1002/14651858.CD009666.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009666.pub2&amp;doi=10.1002/14651858.CD009666.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009666.pub2&amp;doi=10.1002/14651858.CD009666.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009666.pub2&amp;doi=10.1002/14651858.CD009666.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009666.pub2&amp;doi=10.1002/14651858.CD009666.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009666.pub2&amp;doi=10.1002/14651858.CD009666.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009666.pub2&amp;doi=10.1002/14651858.CD009666.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009666.pub2&amp;doi=10.1002/14651858.CD009666.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009666.pub2&amp;doi=10.1002/14651858.CD009666.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009666.pub2&amp;doi=10.1002/14651858.CD009666.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009666.pub2&amp;doi=10.1002/14651858.CD009666.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009666.pub2&amp;doi=10.1002/14651858.CD009666.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="18M35a5z";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD009666\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD009666\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009666\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009666\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","fr","pl","fa","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD009666.pub2",title:"Point\\u2010of\\u2010use fortification of foods with micronutrient powders containing iron in children of preschool and school\\u2010age",firstPublishedDate:"Nov 23, 2017 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Developmental, Psychosocial and Learning Problems Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=18M35a5z&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009666.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009666.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD009666.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD009666.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009666.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD009666.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD009666.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD009666.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD009666.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD009666.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>5178 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD009666.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009666.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009666.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009666.pub2/full#CD009666-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009666.pub2/full#CD009666-sec-0146"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009666.pub2/full#CD009666-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009666.pub2/full#CD009666-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009666.pub2/full#CD009666-sec-0035"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009666.pub2/full#CD009666-sec-0036"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009666.pub2/full#CD009666-sec-0082"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009666.pub2/full#CD009666-sec-0140"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009666.pub2/appendices#CD009666-sec-0151"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/table_n/CD009666StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/table_n/CD009666StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009666.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009666.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009666.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009666.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009666.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD009666.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2017 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Point‐of‐use fortification of foods with micronutrient powders containing iron in children of preschool and school‐age </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009666.pub2/information#CD009666-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Luz Maria De‐Regil</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009666.pub2/information#CD009666-cr-0003">Maria Elena D Jefferds</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009666.pub2/information#CD009666-cr-0004">Juan Pablo Peña‐Rosas</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/information/en#CD009666-sec-0168">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 23 November 2017 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD009666.pub2">https://doi.org/10.1002/14651858.CD009666.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD009666-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009666-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009666-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009666-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD009666-abs-0002">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD009666-abs-0011">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD009666-abs-0001" lang="en"> <section id="CD009666-sec-0001"> <h3 class="title" id="CD009666-sec-0001">Background</h3> <p>Approximately 600 million children of preschool and school age are anaemic worldwide. It is estimated that at least half of the cases are due to iron deficiency. Point‐of‐use fortification of foods with micronutrient powders (MNP) has been proposed as a feasible intervention to prevent and treat anaemia. It refers to the addition of iron alone or in combination with other vitamins and minerals in powder form, to energy‐containing foods (excluding beverages) at home or in any other place where meals are to be consumed. MNPs can be added to foods either during or after cooking or immediately before consumption without the explicit purpose of improving the flavour or colour. </p> </section> <section id="CD009666-sec-0002"> <h3 class="title" id="CD009666-sec-0002">Objectives</h3> <p>To assess the effects of point‐of‐use fortification of foods with iron‐containing MNP alone, or in combination with other vitamins and minerals on nutrition, health and development among children at preschool (24 to 59 months) and school (five to 12 years) age, compared with no intervention, a placebo or iron‐containing supplements. </p> </section> <section id="CD009666-sec-0003"> <h3 class="title" id="CD009666-sec-0003">Search methods</h3> <p>In December 2016, we searched the following databases: CENTRAL, MEDLINE, Embase, BIOSIS, Science Citation Index, Social Science Citation Index, CINAHL, LILACS, IBECS, Popline and SciELO. We also searched two trials registers in April 2017, and contacted relevant organisations to identify ongoing and unpublished trials. </p> </section> <section id="CD009666-sec-0004"> <h3 class="title" id="CD009666-sec-0004">Selection criteria</h3> <p>Randomised controlled trials (RCTs) and quasi‐RCTs trials with either individual or cluster randomisation. Participants were children aged between 24 months and 12 years at the time of intervention. For trials with children outside this age range, we included studies where we were able to disaggregate the data for children aged 24 months to 12 years, or when more than half of the participants were within the requisite age range. We included trials with apparently healthy children; however, we included studies carried out in settings where anaemia and iron deficiency are prevalent, and thus participants may have had these conditions at baseline. </p> </section> <section id="CD009666-sec-0005"> <h3 class="title" id="CD009666-sec-0005">Data collection and analysis</h3> <p>Two review authors independently assessed the eligibility of trials against the inclusion criteria, extracted data from included trials, assessed the risk of bias of the included trials and graded the quality of the evidence. </p> </section> <section id="CD009666-sec-0006"> <h3 class="title" id="CD009666-sec-0006">Main results</h3> <p>We included 13 studies involving 5810 participants from Latin America, Africa and Asia. We excluded 38 studies and identified six ongoing/unpublished trials. All trials compared the provision of MNP for point‐of‐use fortification with no intervention or placebo. No trials compared the effects of MNP versus iron‐containing supplements (as drops, tablets or syrup). </p> <p>The sample sizes in the included trials ranged from 90 to 2193 participants. Six trials included participants younger than 59 months of age only, four included only children aged 60 months or older, and three trials included children both younger and older than 59 months of age. </p> <p>MNPs contained from two to 18 vitamins and minerals. The iron doses varied from 2.5 mg to 30 mg of elemental iron. Four trials reported giving 10 mg of elemental iron as sodium iron ethylenediaminetetraacetic acid (NaFeEDTA), chelated ferrous sulphate or microencapsulated ferrous fumarate. Three trials gave 12.5 mg of elemental iron as microencapsulated ferrous fumarate. Three trials gave 2.5 mg or 2.86 mg of elemental iron as NaFeEDTA. One trial gave 30 mg and one trial provided 14 mg of elemental iron as microencapsulated ferrous fumarate, while one trial gave 28 mg of iron as ferrous glycine phosphate. </p> <p>In comparison with receiving no intervention or a placebo, children receiving iron‐containing MNP for point‐of‐use fortification of foods had lower risk of anaemia prevalence ratio (PR) 0.66, 95% confidence interval (CI) 0.49 to 0.88, 10 trials, 2448 children; moderate‐quality evidence) and iron deficiency (PR 0.35, 95% CI 0.27 to 0.47, 5 trials, 1364 children; moderate‐quality evidence) and had higher haemoglobin (mean difference (MD) 3.37 g/L, 95% CI 0.94 to 5.80, 11 trials, 2746 children; low‐quality evidence). </p> <p>Only one trial with 115 children reported on all‐cause mortality (zero cases; low‐quality evidence). There was no effect on diarrhoea (risk ratio (RR) 0.97, 95% CI 0.53 to 1.78, 2 trials, 366 children; low‐quality evidence). </p> </section> <section id="CD009666-sec-0007"> <h3 class="title" id="CD009666-sec-0007">Authors' conclusions</h3> <p>Point‐of‐use fortification of foods with MNPs containing iron reduces anaemia and iron deficiency in preschool‐ and school‐age children. However, information on mortality, morbidity, developmental outcomes and adverse effects is still scarce. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD009666-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009666-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD009666-abs-0005">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD009666-abs-0008">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009666-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD009666-abs-0006">Français</a> </li> <li class="section-language"> <a class="" href="full/pl#CD009666-abs-0007">Polski</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD009666-abs-0012">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD009666-abs-0004" lang="en"> <h3>Powdered vitamins and minerals added to foods at the point‐of‐use reduces anaemia and iron deficiency in preschool‐ and school‐age children </h3> <p><b>Background to the question</b> </p> <p>Approximately one billion people worldwide are deficient in at least one vitamin or mineral (also known of micronutrients). Iron, vitamin A, zinc and iodine deficiencies are very frequent among children of preschool (aged 24 months to less than 5 years) and school age (5 to 12 years of age), limiting their health and daily physical performance. Anaemia, the condition in which red blood cells have limited capacity to carry oxygen, frequently results after prolonged iron deficiency. </p> <p>Point‐of‐use fortification with powdered vitamins and minerals has been proposed as a public health intervention to reduce micronutrient deficiencies in children. In this process, a powdered premix containing iron, and possibly other vitamins and minerals, is added to foods either during or after cooking, or immediately before consumption to improve their nutritious value but not their flavour or colour. In some cases, point‐of‐use fortification is also known as home fortification. </p> <p><b>Review question</b> </p> <p>What are the effects of point‐of‐use fortification of foods with iron‐containing micronutrient powders (MNP) alone, or in combination with other vitamins and minerals, on nutrition, health and development among children of preschool and school age (24 months to 12 years of age) compared with no intervention, a placebo (dummy pill) or regular iron‐containing supplements (as drops, tablets or syrup)? </p> <p><b>Study characteristics</b> </p> <p>This review included 13 trials with 5810 participants from Latin America, Africa and Asia. All trials compared the provision of MNP for point‐of‐use fortification with no intervention or placebo. Six trials included participants younger than 59 months of age only, four included only children aged 60 months of age or older, and three trials included children both younger and older than 59 months of age. MNPs contained from two to 18 vitamins and minerals. We searched existing clinical trials in December 2016 and ongoing trials in April 2017. We also contacted relevant institutions for additional information upon publication of the protocol and in April 2017. </p> <p><b>Key results</b> </p> <p>The review found that children receiving iron‐containing MNP for point‐of‐use fortification of foods were at significantly lower risk of having anaemia and iron deficiency and had higher haemoglobin concentrations. We did not find any positive or negative effect on diarrhoea or mortality, but the data on these two outcomes were very limited. </p> <p><b>Quality of the evidence</b> </p> <p>We rated the overall quality of the evidence for the provision of multiple MNP versus no intervention or placebo as moderate for anaemia, iron deficiency and adverse effects. We judged the evidence to be of low quality for haemoglobin, mortality and diarrhoea, and to be very low‐quality for ferritin. In general, the most common risk of bias in the studies was the lack of blinding for participants, personnel and outcome assessors. </p> <p><b>Authors' conclusions</b> </p> <p>Point‐of‐use fortification of foods with MNPs containing iron reduces anaemia and iron deficiency in preschool‐ and school‐age children and seems feasible for public health purposes. However, future research should aim to increase the body of evidence on mortality, morbidity, developmental outcomes and adverse effects. Due to the lack of trials, we were unable to determine at this time if this intervention has comparable effects to those observed with iron supplements (provided as drops, tablets or syrup). </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD009666-sec-0146" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD009666-sec-0146"></div> <h3 class="title" id="CD009666-sec-0147">Implications for practice</h3> <section id="CD009666-sec-0147"> <p>The findings of this review show that point‐of‐use fortification of foods with iron‐containing micronutrient powder (MNP) reduce anaemia and iron deficiency and improve haemoglobin concentrations among children aged 24 months to 12 years with mixed anaemia status (ranging from mild to severe public health problems) and primarily from low‐income populations. These findings are consistent across duration of supplementation. </p> <p>No trials compared point‐of‐use fortification of foods with iron‐containing MNP to iron supplementation, to iron and folic acid supplements or multiple micronutrient supplements. Thus, it is impossible to compare the relative efficacy, health effects or safety compared to these interventions. </p> <p>The trials included in this review provided MNP with diverse formulations ranging from two to 18 vitamins and minerals, iron doses, additional micronutrients composition and compounds. One expressed benefit of point‐of‐use fortification of foods with multiple MNP is that the formulation can be tailored to the target population's micronutrient intake gaps. While in theory this appears as a sensible approach, in many settings there is no current dietary intake or micronutrient status information in the population to tailor the formulation to a given country or community. In disadvantaged populations in low‐ and middle‐income countries, plant‐based diets with little access to animal source foods or fortified staple foods may be common. In addition to a limited dietary diversity, low bioavailability of vitamins and minerals in available staple foods due to dietary iron inhibitors (fibre, phytates, tannins), and poor vitamin and mineral content of the foods may contribute to the increased vulnerability to micronutrient malnutrition (<a href="./references#CD009666-bbs2-0080" title="Home Fortification Technical Advisory Group (HFTAG). Programmatic guidance brief on use of micronutrient powders (MNP) for home fortification. Geneva (Switzerland): Home Fortification Technical Advisory Group, 2011:1‐8. ">HFTAG 2011</a>). This has resulted in the pragmatic selection of formulations with about 15 vitamins and minerals to address multiple micronutrient deficiencies in addition to anaemia and iron deficiency in many projects being implemented. However, there are not enough studies to evaluate whether 15 vitamins and minerals (or any other grouping) is a more effective combination for health and functional outcomes for point‐of‐use fortification of foods with iron‐containing MNP. </p> <p>Some of the included trials reported the addition of the iron‐containing MNP before, during or after cooking, which might facilitate the incorporation of this intervention as part of school feeding programmes. For the trials conducted through institutional settings (schools, feeding centre), most trials added the product in the kitchen prior to serving the meals to the participants. Kitchen and other food service staff require training to add the product safely to the foods during meal preparation. The needed training, support and behaviour change interventions can vary considerably by context, particularly in settings where school feeding programmes are carried out by volunteers or parents as opposed to more skilled, professional, food service staff. The use of <i>multi‐serv</i> MNP packaging in institutional settings may lower the cost per dose compared to individual packaged doses, due to reduced packaging costs (<a href="./references#CD009666-bbs2-0080" title="Home Fortification Technical Advisory Group (HFTAG). Programmatic guidance brief on use of micronutrient powders (MNP) for home fortification. Geneva (Switzerland): Home Fortification Technical Advisory Group, 2011:1‐8. ">HFTAG 2011</a>), an important benefit for the implementation of point‐of‐use fortification of foods with iron‐containing MNP in larger scale. </p> <p>Integration of point‐of‐use fortification of foods with iron‐containing MNP into other programmes or sectors might improve the sustainability or feasibility to scale up when building on established or growing programme platforms, and could be an entry point for established co‐interventions in other public health initiatives. The opportunities for synergistically enhanced health and functional outcomes with integrated programmes are appealing but need to be documented as little evidence of these effects currently exists. It is important to monitor and understand effects, challenges and lessons learned when integrating point‐of‐use fortification of foods with iron‐containing MNP into multi‐sectorial programmes. </p> <p>All the trials included at least one arm with daily MNP intake (or daily while school was in session, typically five or six days a week for about 10 months of the year), and <a href="./references#CD009666-bbs2-0003" title="KounnavongS , SunaharaT , Mascie‐TaylorCG , HashizumeM , OkumuraJ , MojiK , et al. Effect of daily versus weekly home fortification with multiple micronutrient powder on haemoglobin concentration of young children in a rural area, Lao People's Democratic Republic: a randomised trial. Nutrition Journal2011;10(129):1‐11. [DOI: 10.1186/1475‐2891‐10‐129; PMC3266642; PUBMED: 22111770] ">Kounnavong 2011 (C)</a> and <a href="./references#CD009666-bbs2-0009" title="SharieffW , YinSA , WuM , YangQ , SchauerC , TomlinsonG , et al. Short‐term daily or weekly administration of micronutrient Sprinkles has high compliance and does not cause iron overload in Chinese schoolchildren: a cluster‐randomized trial. Public Health Nutrition2006;9(3):336‐44. [PUBMED: 16684385] ZlotkinS [pers comm] . Regards and question ‐ Sharieff 2006. Email to: JP Peña‐Rosas 2 November 2011. ">Sharieff 2006 (C)</a> each included intervention arms with either once or twice a week intake. There is also some interest in flexible regimens, where the MNP sachets are to be consumed at the preference of the individual or caretaker within a given period, with the caveat of not consuming more than one sachet a day. Based on programmatic experiences, some interest groups suggest that a reasonable and logistically feasible intake schedule is to consume one individual serving sachet two or three times a week (or every other day) (<a href="./references#CD009666-bbs2-0080" title="Home Fortification Technical Advisory Group (HFTAG). Programmatic guidance brief on use of micronutrient powders (MNP) for home fortification. Geneva (Switzerland): Home Fortification Technical Advisory Group, 2011:1‐8. ">HFTAG 2011</a>). Intermittent use can also be applied to institutional feeding programmes where the MNP is added a few days a week to the meals instead of daily. When recommending any intake schedule (daily, intermittent or flexible), it is important to suggest to participants that they develop a routine to help support the intake of all the individual MNP sachets. Further evaluation of these different intake regimens is needed. </p> </section> <h3 class="title" id="CD009666-sec-0148">Implications for research</h3> <section id="CD009666-sec-0148"> <p> <ul id="CD009666-list-0021"> <li> <p>It is necessary to generate evidence of the benefits that nutrients other than iron have on children's health and nutritional status, to justify the added value of powder formulations containing multiple micronutrients. </p> </li> <li> <p>Information on adverse effects is limited and frequently reported in an uneven manner. More data are needed to understand safety better and inform policy makers. It is hypothesised that MNP are safer than iron supplements, thus this is an important gap. </p> </li> <li> <p>Intake adherence data are also similarly limited and reported inconsistently; as one of the main rationales for this intervention is that it will result in higher intake adherence compared to iron supplementation, this is also a significant gap. </p> </li> <li> <p>In programmes that include point‐of‐use fortification of foods with MNP, a behaviour change intervention and communication strategy is a required intervention component when distributing individual MNP sachets directly to the participants, their families and caretakers (<a href="./references#CD009666-bbs2-0080" title="Home Fortification Technical Advisory Group (HFTAG). Programmatic guidance brief on use of micronutrient powders (MNP) for home fortification. Geneva (Switzerland): Home Fortification Technical Advisory Group, 2011:1‐8. ">HFTAG 2011</a>; <a href="./references#CD009666-bbs2-0110" title="TimmerA , IrizarryL , TrippK , Flores‐AyalaR , JefferdsME . Regional workshops to scale up home fortification to improve complementary feeding: collaboration between UNICEF, CDC and Partners. Sight and Life Special Supplement2013;Sept:42‐50. ">Timmer 2013</a>). Further research may be warranted to assess the relevance of behaviour change strategies targeted to either the children or families/caretakers in institutional feeding programmes where the involvement of children and families or caretakers on the use of MNP to the meal is not an individual decision (similar to what can occur with industrial fortification of staple foods in some contexts). The identification of potential implementation barriers may be required. </p> </li> <li> <p>Examining the integration of MNP into existing programme platforms to deliver MNP through daycares, ECD centres, school feeding and other feeding centre programmes, which might be lower cost, result in increased vitamin and mineral intake, and improved health and functional outcomes among children who regularly attend these institutions is an important research gap. </p> </li> <li> <p>Continued research to improve the bioavailability and absorption of iron and other micronutrients is needed, including the work already started with adding amylase and phytase reported in this review. Resolving sensory changes and organoleptic issues associated with amylase and phytase (e.g. food changed colour or consistency) are priorities. </p> </li> <li> <p>Additional important research gaps include understanding the efficacy and interactions of MNP in the context of high burdens of malaria, HIV and other diseases. </p> </li> <li> <p>Understanding the cost effectiveness of MNP interventions taking into consideration the entire intervention package, including the cost of the product, behaviour change intervention and communication and support, transportation, monitoring, training and refresher training, and how these costs vary across different delivery platforms and at increasing scale will provide useful guidance to the programmatic community, donors and other stakeholders when making investment decisions with scarce resources. </p> </li> </ul> </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD009666-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD009666-sec-0029"></div> <div class="table" id="CD009666-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Point‐of‐use fortification of foods with micronutrients powders (MNP) compared to no intervention or placebo in preschool and school‐age children</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Point‐of‐use fortification of foods with MNP compared to no intervention or placebo in preschool and school‐age children</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> preschool and school‐age children </p> <p><b>Setting:</b> all settings </p> <p><b>Intervention:</b> point‐of‐use fortification of foods with MNP </p> <p><b>Comparison:</b> no intervention or placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with no intervention or placebo</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with point‐of‐use fortification of foods with MNP</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Anaemia</b> (defined as haemoglobin &lt; 110 g/L for children aged 24‐59 months and &lt; 115 g/L for children aged 5‐11.9 years, adjusted by altitude where appropriate)* </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.66</b> <br/> (0.49 to 0.88) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2448<br/> (10 RCTs) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Included studies: <a href="./references#CD009666-bbs2-0001" title="InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Combined intensive nutrition education and micronutrient powder supplementation improved nutritional status of mildly wasted children on Nias Island, Indonesia. Asia Pacific Journal of Clinical Nutrition2012;21(3):361‐73. [PUBMED: 22705425] InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Improved nutrition knowledge and practice through intensive nutrition education: a study among caregivers of mildly wasted children on Nias Island, Indonesia. Food and Nutrition Bulletin2012;33(2):117‐27. [DOI: 10.1177/156482651203300205; PUBMED: 22908693] PurwestriRC , ScherbaumV , InayatiDA , WirawanNN , SuryantanJ , BloemMA , et al. Supplementary feeding with locally‐produced ready‐to‐use food (RUF) for mildly wasted children on Nias Island, Indonesia: comparison of daily and weekly programme outcomes. Asia Pacific Journal of Clinical Nutrition2012;21(3):374‐9. [PUBMED: 22705426] ScherbaumV [pers comm] . Your paper on MNP. Email to: LM De‐Regil 5 February 2013. ">Inayati 2012 (C)</a>; <a href="./references#CD009666-bbs2-0002" title="KemmerTM , OmerPS , Gidvani‐DiazVK , CoelloM . Acceptance and effect of ferrous fumarate containing micronutrient sprinkles on anemia, iron deficiency and anthropometrics in Honduran children. In: SilverbergDS editor(s). Anemia. Rijeka (Croatia): InTech, 2012. [DOI: 10.5772/30987] ">Kemmer 2012 (C)</a>; <a href="./references#CD009666-bbs2-0003" title="KounnavongS , SunaharaT , Mascie‐TaylorCG , HashizumeM , OkumuraJ , MojiK , et al. Effect of daily versus weekly home fortification with multiple micronutrient powder on haemoglobin concentration of young children in a rural area, Lao People's Democratic Republic: a randomised trial. Nutrition Journal2011;10(129):1‐11. [DOI: 10.1186/1475‐2891‐10‐129; PMC3266642; PUBMED: 22111770] ">Kounnavong 2011 (C)</a>; <a href="./references#CD009666-bbs2-0004" title="LundeenE [pers comm] . Kyrgyz Republic MNP data for children 24‐36 months. Email to: M Jefferds 3 November 2011. LundeenE , SchuethT , ToktobaevN , ZlotkinS , HyderSM , HouserR . Daily use of Sprinkles micronutrient powder for 2 months reduces anemia among children 6 to 36 months of age in the Kyrgyz Republic: a cluster‐randomized trial. Food and Nutrition Bulletin2010;31(3):446‐60. [DOI: 10.1177/156482651003100307; PUBMED: 20973465] ">Lundeen 2010 (C)</a>; <a href="./references#CD009666-bbs2-0005" title="Macharia‐MutieCW , MorettiD , Van denBrielN , OmusundiAM , MwangiAM , KokFJ , et al. Maize porridge enriched with a micronutrient powder containing low‐dose iron as NaFeEDTA but not amaranth grain flour reduces anemia and iron deficiency in Kenyan preschool children. Journal of Nutrition2012;142(9):1756‐63. [DOI: 10.3945/jn.112.157578; PUBMED: 22810982] Macharia‐MutieCW , OmusundiAM , MwaiJM , MwangiAM , BrouwerID . Simulation of the effect of maize porridge fortified with grain amaranth or micronutrient powder containing NaFeEDTA on iron intake and status in Kenyan children. Public Health Nutrition2013;16(9):1605‐13. [DOI: 10.1017/S1368980012005174; PUBMED: 23218415] ">Macharia‐Mutie 2012</a>; <a href="./references#CD009666-bbs2-0006" title="JerlingJ [pers comm] . Regards and question on Ogundale et al 2011 vir Cochrane review. Email to: JP Pena‐Rosas 3 November 2011. OgunladeAO , KrugerHS , JerlingJC , SmutsCM , CovicN , HanekomSM , et al. Point‐of‐use micronutrient fortification: lessons learned in implementing a preschool‐based pilot trial in South Africa. International Journal of Food Sciences and Nutrition2011;62(1):1‐16. [DOI: 10.3109/09637486.2010.495710; PUBMED: 20701549] ">Ogunlade 2011</a>; <a href="./references#CD009666-bbs2-0008" title="OseiAK , HouserRF , BulusuS , HamerDH . Acceptability of micronutrient fortified school meals by schoolchildren in rural Himalayan villages of India. Journal of Food Science2008;73(7):S354‐8. [DOI: 10.1111/j.1750‐3841.2008.00878.x; PUBMED: 18803728] OseiAK , RosenbergIH , HouserRF , BulusuS , MathewsM , HamerDH . Community‐level micronutrient fortification of school lunch meals improved vitamin A, folate, and iron status of schoolchildren in Himalayan villages of India. Journal of Nutrition2010;140(6):1146‐54. [DOI: 10.3945/jn.109.114751; PUBMED: 20410083] ">Osei 2008 (C)</a>; <a href="./references#CD009666-bbs2-0010" title="TroeschB [pers comm] . Regards and question on Troesch et al 2011. Email to: JP Peña‐Rosas 1 November 2011. TroeschB , vanStuijvenbergME , SmutsCM , KrugerHS , BiebingerR , HurrellRF , et al. A micronutrient powder with low doses of highly absorbable iron and zinc reduces iron and zinc deficiency and improves weight‐for‐age Z‐scores in South African children. Journal of Nutrition2011;141(2):237‐42. [DOI: 10.3945/jn.110.129247; PUBMED: 21178093] ">Troesch 2011b</a>; <a href="./references#CD009666-bbs2-0011" title="VarmaJL , DasS , SankarR , MannarMG , LevinsonFJ , HamerDH . Community‐level micronutrient fortification of a food supplement in India: a controlled trial in preschool children aged 36‐66 mo. American Journal of Clinical Nutrition2007;85(4):1127‐33. [PUBMED: 17413115] ">Varma 2007 (C)</a>; <a href="./references#CD009666-bbs2-0013" title="VinodkumarM , RajagopalanS . Efficacy of fortification of school meals with ferrous glycine phosphate and riboflavin against anemia and angular stomatitis in schoolchildren. Food and Nutrition Bulletin2009;30(3):260‐4. [DOI: 10.1177/156482650903000307; PUBMED: 19927606] ">Vinodkumar 2009 (C)</a>. </p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>375 per 1000</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>247 per 1000</b> <br/> (184 to 330) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Haemoglobin</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean haemoglobin score in control groups ranged from 103.50 g/L to 128.00 g/L</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean haemoglobin score in intervention groups was, on average, <b>3.37 g/L higher</b> (0.94 g/L higher to 5.80 g/L higher) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2746<br/> (11 RCTs) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Included studies: <a href="./references#CD009666-bbs2-0001" title="InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Combined intensive nutrition education and micronutrient powder supplementation improved nutritional status of mildly wasted children on Nias Island, Indonesia. Asia Pacific Journal of Clinical Nutrition2012;21(3):361‐73. [PUBMED: 22705425] InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Improved nutrition knowledge and practice through intensive nutrition education: a study among caregivers of mildly wasted children on Nias Island, Indonesia. Food and Nutrition Bulletin2012;33(2):117‐27. [DOI: 10.1177/156482651203300205; PUBMED: 22908693] PurwestriRC , ScherbaumV , InayatiDA , WirawanNN , SuryantanJ , BloemMA , et al. Supplementary feeding with locally‐produced ready‐to‐use food (RUF) for mildly wasted children on Nias Island, Indonesia: comparison of daily and weekly programme outcomes. Asia Pacific Journal of Clinical Nutrition2012;21(3):374‐9. [PUBMED: 22705426] ScherbaumV [pers comm] . Your paper on MNP. Email to: LM De‐Regil 5 February 2013. ">Inayati 2012 (C)</a>; <a href="./references#CD009666-bbs2-0002" title="KemmerTM , OmerPS , Gidvani‐DiazVK , CoelloM . Acceptance and effect of ferrous fumarate containing micronutrient sprinkles on anemia, iron deficiency and anthropometrics in Honduran children. In: SilverbergDS editor(s). Anemia. Rijeka (Croatia): InTech, 2012. [DOI: 10.5772/30987] ">Kemmer 2012 (C)</a>; <a href="./references#CD009666-bbs2-0003" title="KounnavongS , SunaharaT , Mascie‐TaylorCG , HashizumeM , OkumuraJ , MojiK , et al. Effect of daily versus weekly home fortification with multiple micronutrient powder on haemoglobin concentration of young children in a rural area, Lao People's Democratic Republic: a randomised trial. Nutrition Journal2011;10(129):1‐11. [DOI: 10.1186/1475‐2891‐10‐129; PMC3266642; PUBMED: 22111770] ">Kounnavong 2011 (C)</a>; <a href="./references#CD009666-bbs2-0004" title="LundeenE [pers comm] . Kyrgyz Republic MNP data for children 24‐36 months. Email to: M Jefferds 3 November 2011. LundeenE , SchuethT , ToktobaevN , ZlotkinS , HyderSM , HouserR . Daily use of Sprinkles micronutrient powder for 2 months reduces anemia among children 6 to 36 months of age in the Kyrgyz Republic: a cluster‐randomized trial. Food and Nutrition Bulletin2010;31(3):446‐60. [DOI: 10.1177/156482651003100307; PUBMED: 20973465] ">Lundeen 2010 (C)</a>; <a href="./references#CD009666-bbs2-0005" title="Macharia‐MutieCW , MorettiD , Van denBrielN , OmusundiAM , MwangiAM , KokFJ , et al. Maize porridge enriched with a micronutrient powder containing low‐dose iron as NaFeEDTA but not amaranth grain flour reduces anemia and iron deficiency in Kenyan preschool children. Journal of Nutrition2012;142(9):1756‐63. [DOI: 10.3945/jn.112.157578; PUBMED: 22810982] Macharia‐MutieCW , OmusundiAM , MwaiJM , MwangiAM , BrouwerID . Simulation of the effect of maize porridge fortified with grain amaranth or micronutrient powder containing NaFeEDTA on iron intake and status in Kenyan children. Public Health Nutrition2013;16(9):1605‐13. [DOI: 10.1017/S1368980012005174; PUBMED: 23218415] ">Macharia‐Mutie 2012</a>; <a href="./references#CD009666-bbs2-0006" title="JerlingJ [pers comm] . Regards and question on Ogundale et al 2011 vir Cochrane review. Email to: JP Pena‐Rosas 3 November 2011. OgunladeAO , KrugerHS , JerlingJC , SmutsCM , CovicN , HanekomSM , et al. Point‐of‐use micronutrient fortification: lessons learned in implementing a preschool‐based pilot trial in South Africa. International Journal of Food Sciences and Nutrition2011;62(1):1‐16. [DOI: 10.3109/09637486.2010.495710; PUBMED: 20701549] ">Ogunlade 2011</a>; <a href="./references#CD009666-bbs2-0008" title="OseiAK , HouserRF , BulusuS , HamerDH . Acceptability of micronutrient fortified school meals by schoolchildren in rural Himalayan villages of India. Journal of Food Science2008;73(7):S354‐8. [DOI: 10.1111/j.1750‐3841.2008.00878.x; PUBMED: 18803728] OseiAK , RosenbergIH , HouserRF , BulusuS , MathewsM , HamerDH . Community‐level micronutrient fortification of school lunch meals improved vitamin A, folate, and iron status of schoolchildren in Himalayan villages of India. Journal of Nutrition2010;140(6):1146‐54. [DOI: 10.3945/jn.109.114751; PUBMED: 20410083] ">Osei 2008 (C)</a>; <a href="./references#CD009666-bbs2-0009" title="SharieffW , YinSA , WuM , YangQ , SchauerC , TomlinsonG , et al. Short‐term daily or weekly administration of micronutrient Sprinkles has high compliance and does not cause iron overload in Chinese schoolchildren: a cluster‐randomized trial. Public Health Nutrition2006;9(3):336‐44. [PUBMED: 16684385] ZlotkinS [pers comm] . Regards and question ‐ Sharieff 2006. Email to: JP Peña‐Rosas 2 November 2011. ">Sharieff 2006 (C)</a>; <a href="./references#CD009666-bbs2-0011" title="VarmaJL , DasS , SankarR , MannarMG , LevinsonFJ , HamerDH . Community‐level micronutrient fortification of a food supplement in India: a controlled trial in preschool children aged 36‐66 mo. American Journal of Clinical Nutrition2007;85(4):1127‐33. [PUBMED: 17413115] ">Varma 2007 (C)</a>; <a href="./references#CD009666-bbs2-0012" title="VinodkumarM , RajagopalanS . Impact of a multiple‐micronutrient food supplement on the nutritional status of schoolchildren. Food and Nutrition Bulletin2006;27(3):203‐10. [DOI: 10.1177/156482650602700302; PUBMED: 17542110] ">Vinodkumar 2006 (C)</a>; <a href="./references#CD009666-bbs2-0013" title="VinodkumarM , RajagopalanS . Efficacy of fortification of school meals with ferrous glycine phosphate and riboflavin against anemia and angular stomatitis in schoolchildren. Food and Nutrition Bulletin2009;30(3):260‐4. [DOI: 10.1177/156482650903000307; PUBMED: 19927606] ">Vinodkumar 2009 (C)</a>. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Iron deficiency</b> (defined by using ferritin concentrations less than 15 µg/L) </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.35</b> <br/> (0.27 to 0.47) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1364<br/> (5 RCTs) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Included studies: <a href="./references#CD009666-bbs2-0005" title="Macharia‐MutieCW , MorettiD , Van denBrielN , OmusundiAM , MwangiAM , KokFJ , et al. Maize porridge enriched with a micronutrient powder containing low‐dose iron as NaFeEDTA but not amaranth grain flour reduces anemia and iron deficiency in Kenyan preschool children. Journal of Nutrition2012;142(9):1756‐63. [DOI: 10.3945/jn.112.157578; PUBMED: 22810982] Macharia‐MutieCW , OmusundiAM , MwaiJM , MwangiAM , BrouwerID . Simulation of the effect of maize porridge fortified with grain amaranth or micronutrient powder containing NaFeEDTA on iron intake and status in Kenyan children. Public Health Nutrition2013;16(9):1605‐13. [DOI: 10.1017/S1368980012005174; PUBMED: 23218415] ">Macharia‐Mutie 2012</a>; <a href="./references#CD009666-bbs2-0008" title="OseiAK , HouserRF , BulusuS , HamerDH . Acceptability of micronutrient fortified school meals by schoolchildren in rural Himalayan villages of India. Journal of Food Science2008;73(7):S354‐8. [DOI: 10.1111/j.1750‐3841.2008.00878.x; PUBMED: 18803728] OseiAK , RosenbergIH , HouserRF , BulusuS , MathewsM , HamerDH . Community‐level micronutrient fortification of school lunch meals improved vitamin A, folate, and iron status of schoolchildren in Himalayan villages of India. Journal of Nutrition2010;140(6):1146‐54. [DOI: 10.3945/jn.109.114751; PUBMED: 20410083] ">Osei 2008 (C)</a>; <a href="./references#CD009666-bbs2-0009" title="SharieffW , YinSA , WuM , YangQ , SchauerC , TomlinsonG , et al. Short‐term daily or weekly administration of micronutrient Sprinkles has high compliance and does not cause iron overload in Chinese schoolchildren: a cluster‐randomized trial. Public Health Nutrition2006;9(3):336‐44. [PUBMED: 16684385] ZlotkinS [pers comm] . Regards and question ‐ Sharieff 2006. Email to: JP Peña‐Rosas 2 November 2011. ">Sharieff 2006 (C)</a>; <a href="./references#CD009666-bbs2-0010" title="TroeschB [pers comm] . Regards and question on Troesch et al 2011. Email to: JP Peña‐Rosas 1 November 2011. TroeschB , vanStuijvenbergME , SmutsCM , KrugerHS , BiebingerR , HurrellRF , et al. A micronutrient powder with low doses of highly absorbable iron and zinc reduces iron and zinc deficiency and improves weight‐for‐age Z‐scores in South African children. Journal of Nutrition2011;141(2):237‐42. [DOI: 10.3945/jn.110.129247; PUBMED: 21178093] ">Troesch 2011b</a>; <a href="./references#CD009666-bbs2-0011" title="VarmaJL , DasS , SankarR , MannarMG , LevinsonFJ , HamerDH . Community‐level micronutrient fortification of a food supplement in India: a controlled trial in preschool children aged 36‐66 mo. American Journal of Clinical Nutrition2007;85(4):1127‐33. [PUBMED: 17413115] ">Varma 2007 (C)</a>. </p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>220 per 1000</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>77 per 1000</b> <br/> (59 to 104) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Ferritin</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The standardised mean ferritin score in intervention groups was, on average, <b>0.42 μg/L higher</b> (4.36 μg/L lower to 5.19 μg/L higher) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1066<br/> (3 RCTs) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>d,e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Included studies: <a href="./references#CD009666-bbs2-0008" title="OseiAK , HouserRF , BulusuS , HamerDH . Acceptability of micronutrient fortified school meals by schoolchildren in rural Himalayan villages of India. Journal of Food Science2008;73(7):S354‐8. [DOI: 10.1111/j.1750‐3841.2008.00878.x; PUBMED: 18803728] OseiAK , RosenbergIH , HouserRF , BulusuS , MathewsM , HamerDH . Community‐level micronutrient fortification of school lunch meals improved vitamin A, folate, and iron status of schoolchildren in Himalayan villages of India. Journal of Nutrition2010;140(6):1146‐54. [DOI: 10.3945/jn.109.114751; PUBMED: 20410083] ">Osei 2008 (C)</a>; <a href="./references#CD009666-bbs2-0009" title="SharieffW , YinSA , WuM , YangQ , SchauerC , TomlinsonG , et al. Short‐term daily or weekly administration of micronutrient Sprinkles has high compliance and does not cause iron overload in Chinese schoolchildren: a cluster‐randomized trial. Public Health Nutrition2006;9(3):336‐44. [PUBMED: 16684385] ZlotkinS [pers comm] . Regards and question ‐ Sharieff 2006. Email to: JP Peña‐Rosas 2 November 2011. ">Sharieff 2006 (C)</a>; <a href="./references#CD009666-bbs2-0011" title="VarmaJL , DasS , SankarR , MannarMG , LevinsonFJ , HamerDH . Community‐level micronutrient fortification of a food supplement in India: a controlled trial in preschool children aged 36‐66 mo. American Journal of Clinical Nutrition2007;85(4):1127‐33. [PUBMED: 17413115] ">Varma 2007 (C)</a>. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>All‐cause mortality</b> (number of deaths during trial) </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Not estimable</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>115<br/> (1 RCT) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>f</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Included study: <a href="./references#CD009666-bbs2-0001" title="InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Combined intensive nutrition education and micronutrient powder supplementation improved nutritional status of mildly wasted children on Nias Island, Indonesia. Asia Pacific Journal of Clinical Nutrition2012;21(3):361‐73. [PUBMED: 22705425] InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Improved nutrition knowledge and practice through intensive nutrition education: a study among caregivers of mildly wasted children on Nias Island, Indonesia. Food and Nutrition Bulletin2012;33(2):117‐27. [DOI: 10.1177/156482651203300205; PUBMED: 22908693] PurwestriRC , ScherbaumV , InayatiDA , WirawanNN , SuryantanJ , BloemMA , et al. Supplementary feeding with locally‐produced ready‐to‐use food (RUF) for mildly wasted children on Nias Island, Indonesia: comparison of daily and weekly programme outcomes. Asia Pacific Journal of Clinical Nutrition2012;21(3):374‐9. [PUBMED: 22705426] ScherbaumV [pers comm] . Your paper on MNP. Email to: LM De‐Regil 5 February 2013. ">Inayati 2012 (C)</a>. </p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b> <br/> (0 to 0) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Diarrhoea</b> (≥ 3 liquid stools per day) </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.97</b> <br/> (0.53 to 1.78) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>366<br/> (2 RCTs) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>g</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Included studies: <a href="./references#CD009666-bbs2-0001" title="InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Combined intensive nutrition education and micronutrient powder supplementation improved nutritional status of mildly wasted children on Nias Island, Indonesia. Asia Pacific Journal of Clinical Nutrition2012;21(3):361‐73. [PUBMED: 22705425] InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Improved nutrition knowledge and practice through intensive nutrition education: a study among caregivers of mildly wasted children on Nias Island, Indonesia. Food and Nutrition Bulletin2012;33(2):117‐27. [DOI: 10.1177/156482651203300205; PUBMED: 22908693] PurwestriRC , ScherbaumV , InayatiDA , WirawanNN , SuryantanJ , BloemMA , et al. Supplementary feeding with locally‐produced ready‐to‐use food (RUF) for mildly wasted children on Nias Island, Indonesia: comparison of daily and weekly programme outcomes. Asia Pacific Journal of Clinical Nutrition2012;21(3):374‐9. [PUBMED: 22705426] ScherbaumV [pers comm] . Your paper on MNP. Email to: LM De‐Regil 5 February 2013. ">Inayati 2012 (C)</a>; <a href="./references#CD009666-bbs2-0008" title="OseiAK , HouserRF , BulusuS , HamerDH . Acceptability of micronutrient fortified school meals by schoolchildren in rural Himalayan villages of India. Journal of Food Science2008;73(7):S354‐8. [DOI: 10.1111/j.1750‐3841.2008.00878.x; PUBMED: 18803728] OseiAK , RosenbergIH , HouserRF , BulusuS , MathewsM , HamerDH . Community‐level micronutrient fortification of school lunch meals improved vitamin A, folate, and iron status of schoolchildren in Himalayan villages of India. Journal of Nutrition2010;140(6):1146‐54. [DOI: 10.3945/jn.109.114751; PUBMED: 20410083] ">Osei 2008 (C)</a>. </p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>96 per 1000</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>93 per 1000</b> <br/> (51 to 170) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse effects</b> (any, as defined by trialists) </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.09</b> <br/> (0.16 to 7.42) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>90<br/> (1 RCT) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Included study: <a href="./references#CD009666-bbs2-0007" title="OrozcoJ , VargasC , RojasML , HerreraAM , MontoyaL , SánchezJG , et al. The effect of powdered micronutrients on the hematologic values and nutritional status of healthy preschoolers. Medellín, 2013 [Efecto de los micronutrientes en polvo en el estado nutricional y en los valores hemáticos de preescolares sanos. Medellín, 2013]. Revista Facultad Nacional de Salud Pública2015;33(2):161‐70. [DOI: 10.17533/udea.rfnsp.v33n2a03] ">Orozco 2015 (C)</a>. </p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>43 per 1000</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>46 per 1000</b> <br/> (7 to 316) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>MD: m</b> ean difference; <b>MNP:</b> micronutrient powder; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Most studies had no blinding. High heterogeneity (72%) with most studies showing a positive effect of MNP.<br/> <sup>b</sup>Most studies had no blinding. High heterogeneity (93%) with most studies showing a positive effect of MNP.<br/> <sup>c</sup>Most studies had no blinding. No heterogeneity with most studies showing a positive effect of MNP.<br/> <sup>d</sup>All the studies had no or unclear blinding.<br/> <sup>e</sup>100% heterogeneity with most inconsistency in direction of effect.<br/> <sup>f</sup>Only one low‐risk trial reported all‐cause mortality.<br/> <sup>g</sup>Two low‐risk trials reported diarrhoea. No heterogeneity with both studies showing no difference between intervention and comparison group. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD009666-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD009666-sec-0030"></div> <section id="CD009666-sec-0031"> <h3 class="title" id="CD009666-sec-0031">Description of the condition</h3> <p>Vitamin and mineral deficiencies are highly prevalent among children of preschool (usually 24 to 59 months of age) and school‐age (five to 12 years of age), limiting their health and daily physical performance. In addition to anaemia, frequently reported micronutrient deficiencies in these age groups are those of iron, vitamin A, zinc and iodine. </p> <p>Anaemia is a condition characterised by a reduction in the body's oxygen‐carrying capacity. It is estimated that over 1.6 billion people, or a quarter of the world's population, are anaemic. The prevalence of anaemia globally is 43% (range 38% to 47%) in children aged six to 59 months (<a href="./references#CD009666-bbs2-0105" title="StevensGA , FinucaneMM , De‐RegilLM , PaciorekCJ , FlaxmanSR , BrancaF , et al. Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non‐pregnant women for 1995‐2011: a systematic analysis of population ‐ representative data. Lancet Global Health2013;1(1):e16‐25. [10.1016/S2214‐109X(13)70001‐9; PMC4547326] ">Stevens 2013</a>). Most anaemia occurs in low‐ and middle‐income countries (<a href="./references#CD009666-bbs2-0125" title="World Health Organization. The Global Prevalence of Anaemia in 2011. Geneva (Switzerland): World Health Organization, 2015. ">WHO 2015b</a>). Causes of anaemia include iron, folate, vitamin B<sub>12</sub> and vitamin A deficiencies; chronic inflammation; parasitic infestations and inherited blood disorders (<a href="./references#CD009666-bbs2-0087" title="JimenezC , LeetsI , PucheR , AnzolaE , MontillaR , ParraC , et al. A single dose of vitamin A improves haemoglobin concentration, retinol status and phagocytic function of neutrophils in preschool children. British Journal of Nutrition2010;103(6):798‐802. [DOI: 10.1017/S0007114509992765; PUBMED: 20003622] ">Jimenez 2010</a>; <a href="./references#CD009666-bbs2-0116" title="World Health Organization. Iron Deficiency Anaemia Assessment Prevention and Control: a Guide for Programme Managers. Geneva (Switzerland): World Health Organization, 2001:132. ">WHO 2001</a>). The proportion of all anaemia amenable to iron is estimated to be 42% in children (<a href="./references#CD009666-bbs2-0125" title="World Health Organization. The Global Prevalence of Anaemia in 2011. Geneva (Switzerland): World Health Organization, 2015. ">WHO 2015b</a>). The proportions of severe anaemia amenable to iron is estimated to be 50% for children (<a href="./references#CD009666-bbs2-0105" title="StevensGA , FinucaneMM , De‐RegilLM , PaciorekCJ , FlaxmanSR , BrancaF , et al. Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non‐pregnant women for 1995‐2011: a systematic analysis of population ‐ representative data. Lancet Global Health2013;1(1):e16‐25. [10.1016/S2214‐109X(13)70001‐9; PMC4547326] ">Stevens 2013</a>). It is assumed to be higher (about 60%) in malaria‐free areas (<a href="./references#CD009666-bbs2-0100" title="RastogiR , MathersCD . Global burden of iron deficiency anaemia in the year 2000. www.who.int/healthinfo/statistics/bod_irondeficiencyanaemia.pdf (accessed 27 July 2010). ">Rastogi 2002</a>; <a href="./references#CD009666-bbs2-0107" title="StoltzfusRJ , MullanyL , BlackRE . Iron deficiency anaemia. In: EzzatiM , LopezAD , RodgersA , MurrayCLJ editor(s). Comparative Quantification of Health Risks: Global and Regional Burden of Disease. Geneva (Switzerland): World Health Organization, 2004:163‐209. ">Stoltzfus 2004</a>; <a href="./references#CD009666-bbs2-0118" title="World Health Organization. Global health risks: mortality and burden of disease attributable to selected major risks. Geneva (Switzerland): World Health Organization, 2009. ">WHO 2009</a>). Iron deficiency can be caused by chronic poor dietary iron intake (in quantity and quality), together with increased iron requirements resulting from growth and from losses due to intestinal parasitic infestations and menstruation in postmenarchal girls (<a href="./references#CD009666-bbs2-0116" title="World Health Organization. Iron Deficiency Anaemia Assessment Prevention and Control: a Guide for Programme Managers. Geneva (Switzerland): World Health Organization, 2001:132. ">WHO 2001</a>). Anaemia in children is diagnosed when the haemoglobin (Hb) concentration in the blood is below a predefined cut‐off value, which varies with age and the residential elevation (<a href="./references#CD009666-bbs2-0120" title="World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System. Geneva (Switzerland): World Health Organization, 2011. ">WHO 2011a</a>). Iron deficiency anaemia is diagnosed by the combined presence of anaemia and iron deficiency, measured by ferritin or any other biomarker of iron status such as serum transferrin receptors or zinc protoporphyrin (<a href="./references#CD009666-bbs2-0121" title="World Health Organization. Serum ferritin concentrations for the assessment of iron status and iron deficiency in populations. Vitamin and Mineral Nutrition Information System. Geneva (Switzerland): World Health Organization, 2011. ">WHO 2011b</a>). </p> <p>Iron deficiency anaemia in children of preschool and school‐age is associated with considerable morbidity. This condition appears to be associated with potentially irreversible impairment of cognitive development in preschool‐age children and with reduced learning and educational performance in school‐age children (<a href="./references#CD009666-bbs2-0092" title="LozoffB . Iron deficiency and child development. Food and Nutrition Bulletin2007;28(Suppl 4):S560‐71. [DOI: 10.1177/15648265070284S409; PUBMED: 18297894] ">Lozoff 2007</a>). Iron deficiency has been estimated to contribute to 0.2% of deaths in children under five years of age, and every year approximately 2.2 million years are lost due to iron‐induced disability worldwide (measured in disability‐adjusted life years (DALYs), a measure of overall disease burden, expressed as the number of years lost due to ill‐health, disability or early death) (<a href="./references#CD009666-bbs2-0065" title="BlackRE , AllenLH , BhuttaZA , CaulfieldLE , DeOnisM , EzzatiM , et al. Maternal and child undernutrition: global and regional exposures and health consequences. Lancet2008;371(9608):243‐60. [DOI: 10.1016/S0140‐6736(07)61690‐0; PUBMED: 18207566] ">Black 2008</a>; <a href="./references#CD009666-bbs2-0107" title="StoltzfusRJ , MullanyL , BlackRE . Iron deficiency anaemia. In: EzzatiM , LopezAD , RodgersA , MurrayCLJ editor(s). Comparative Quantification of Health Risks: Global and Regional Burden of Disease. Geneva (Switzerland): World Health Organization, 2004:163‐209. ">Stoltzfus 2004</a>; <a href="./references#CD009666-bbs2-0118" title="World Health Organization. Global health risks: mortality and burden of disease attributable to selected major risks. Geneva (Switzerland): World Health Organization, 2009. ">WHO 2009</a>). </p> <p>Vitamin A is an essential nutrient that comprises a group of unsaturated organic compounds such as retinol, retinal and retinoic acid. Provitamin A carotenoids, which are produced in plants, are also a primary dietary source of vitamin A (<a href="./references#CD009666-bbs2-0109" title="TanumihardjoSA , RussellRM , StephensenCB , GannonBM , CraftNE , HaskellMJ , et al. Biomarkers of nutrition for development (BOND) ‐ vitamin A review. Journal of Nutrition2016;146(9):1816S‐48S. [DOI: 10.3945/jn.115.229708; PMC4997277; PUBMED: 27511929] ">Tanumihardjo 2016</a>). When the intake, absorption or utilisation of vitamin A or provitamin A carotenoids is inadequate, vitamin A deficiency can occur. Vitamin A deficiency disorders include xerophthalmia and increased risk of death from infectious diseases, especially among preschool children (<a href="./references#CD009666-bbs2-0109" title="TanumihardjoSA , RussellRM , StephensenCB , GannonBM , CraftNE , HaskellMJ , et al. Biomarkers of nutrition for development (BOND) ‐ vitamin A review. Journal of Nutrition2016;146(9):1816S‐48S. [DOI: 10.3945/jn.115.229708; PMC4997277; PUBMED: 27511929] ">Tanumihardjo 2016</a>). Vitamin A deficiency is a risk factor for blindness and for mortality from measles and diarrhoea in children (<a href="./references#CD009666-bbs2-0106" title="StevensGA , BennettJE , HennocqQ , LuY , De‐RegilLM , RogersL , et al. Trends and mortality effects of vitamin A deficiency in children in 138 low‐income and middle‐income countries between 1991 and 2013: a pooled analysis of population‐based surveys. Lancet Global Health2015;3(9):e528‐36. [DOI: 10.1016/S2214‐109X(15)00039‐X; PUBMED: 26275329] ">Stevens 2015</a>). In 2013, the prevalence of vitamin A deficiency was 29% in children, mostly from in low‐ and middle‐income countries (<a href="./references#CD009666-bbs2-0106" title="StevensGA , BennettJE , HennocqQ , LuY , De‐RegilLM , RogersL , et al. Trends and mortality effects of vitamin A deficiency in children in 138 low‐income and middle‐income countries between 1991 and 2013: a pooled analysis of population‐based surveys. Lancet Global Health2015;3(9):e528‐36. [DOI: 10.1016/S2214‐109X(15)00039‐X; PUBMED: 26275329] ">Stevens 2015</a>). </p> <p>Zinc deficiency affects overall body metabolism and can be associated with poor growth, stunting and wasting; increased infections and the appearance of skin lesions. In countries where zinc intakes are inadequate, zinc deficiency may present as poor physical growth, impaired immune competence, reproductive dysfunction and sub optimal neurobehavioral development. This can increase risk of child morbidity and mortality, and preterm births (<a href="./references#CD009666-bbs2-0067" title="BrownKH , PeersonJM , BakerSK , HessSY . Preventive zinc supplementation among infants, preschoolers, and older prepubertal children. Food and Nutrition Bulletin2009;30(Suppl 1):S12‐40. ">Brown 2009</a>; <a href="./references#CD009666-bbs2-0088" title="KingJC , BrownKH , GibsonRS , KrebsNF , LoweNM , et al. Biomarkers of Nutrition for Development (BOND) ‐ zinc review. Journal of Nutrition2016;146(4):858S‐885S. [DOI: 10.3945/jn.115.220079; PMC4807640; PUBMED: 26962190] ">King 2016</a>). Some authors have estimated that zinc deficiency is responsible for about 4% of child mortality (<a href="./references#CD009666-bbs2-0065" title="BlackRE , AllenLH , BhuttaZA , CaulfieldLE , DeOnisM , EzzatiM , et al. Maternal and child undernutrition: global and regional exposures and health consequences. Lancet2008;371(9608):243‐60. [DOI: 10.1016/S0140‐6736(07)61690‐0; PUBMED: 18207566] ">Black 2008</a>), and that supplementing children with this nutrient may help reduce deaths related to diarrhoea and pneumonia (<a href="./references#CD009666-bbs2-0130" title="YakoobMY , TheodoratouE , JabeenA , ImdadA , EiseleTP , FergusonJ , et al. Preventive zinc supplementation in developing countries: impact on mortality and morbidity due to diarrhea, pneumonia and malaria. BMC Public Health2011;11(Suppl 3):S23. [DOI: 10.1186/1471‐2458‐11‐S3‐S23; PMC3231897; PUBMED: 21501441] ">Yakoob 2011</a>). It is estimated that 29.8% (95% CI 29.4% to 30.1%) of school‐age children (approximately 241 million) have insufficient iodine intakes. </p> <p>Iodine deficiency affects more than one‐third of school‐age children worldwide and results in developmental delays and other health problems (<a href="./references#CD009666-bbs2-0059" title="AnderssonM , KarumbunathanV , ZimmermannMB . Global iodine status in 2011 and trends over the past decade. Journal of Nutrition2012;142(4):744‐50. [DOI: 10.3945/jn.111.149393; PUBMED: 22378324] ">Andersson 2012</a>). Vitamin D deficiency and folate insufficiency may also be a concern during childhood. </p> <p>Folic acid, another form of which is known as folate, is one of the B vitamins. Inadequate folate intake is the main cause of folate deficiency. The use of antifolate drugs used in treatment and prophylaxis for <i>Pneumocystis jirovecii</i> pneumonia, malaria and toxoplasmosis selectively inhibit folate's actions in microbial organisms such as bacteria, protozoa and fungi. In some low‐ and middle‐income countries, malabsorptive conditions, such as tropical sprue, can also cause folate deficiency. Although essential throughout life, folate is particularly critical during early stages of human development. Folate deficiency may result in megaloblastic anaemia in which low numbers of large red blood cells occur (<a href="./references#CD009666-bbs2-0060" title="BaileyLB , StoverPJ , McNultyH , FenechMF , GregoryJF3rd , MillsJL , et al. Biomarkers of nutrition for development‐folate review. Journal of Nutrition2015;145(7):1636S‐80S. [DOI: 10.3945/jn.114.206599; PMC4478945; PUBMED: 26451605] ">Bailey 2015</a>). Among other micronutrients, current micronutrient powders (MNP) formulations generally include folic acid and there is ongoing debate on risks and benefits of the provision of supplemental folic acid through point‐of‐use fortification, especially in children living in sub‐Saharan Africa where malaria is endemic (<a href="./references#CD009666-bbs2-0089" title="KupkaR . The role of folate in malaria ‐ implications for home fortification programmes among children aged 6‐59 months. Maternal &amp; Child Nutrition2015;11(Suppl 4):1‐15. [DOI: 10.1111/mcn.12102; PUBMED: 26756732] ">Kupka 2015</a>). </p> <p>Vitamin D has a key role in bone metabolism (<a href="./references#CD009666-bbs2-0128" title="WinzenbergT , PowellS , ShawKA , JonesG . Effects of vitamin D supplementation on bone density in healthy children: systematic review and meta‐analysis. BMJ2011;342:c7254. [PMC3026600; PUBMED: 21266418] ">Winzenberg 2011</a>), while adequate folate and folic acid intake is particularly important for pubescent girls who are capable of reproduction, as poor maternal folate status around the time of conception increases the risk of neural tube and other defects at birth (<a href="./references#CD009666-bbs2-0096" title="MulinareJ , CorderoJF , EricksonJD , BerryRJ . Periconceptional use of multivitamins and the occurrence of neural tube defects. JAMA1988;260(21):3141‐5. [PUBMED: 3184392] ">Mulinare 1988</a>). Unfortunately, to date, there are insufficient data to estimate the global magnitude of inadequate folate or vitamin D status among any populations, including children. </p> <p>In low‐income countries, some nutritional risk factors increase the incidence or severity of infectious diseases and contribute to a high number of deaths and loss of healthy years. Micronutrient deficiencies (iron, vitamin A and zinc), in combination with childhood underweight and sub optimal breastfeeding, cause 7% of deaths and 10% of total disease burden (<a href="./references#CD009666-bbs2-0118" title="World Health Organization. Global health risks: mortality and burden of disease attributable to selected major risks. Geneva (Switzerland): World Health Organization, 2009. ">WHO 2009</a>). In 2010, globally, an estimated 27% (171 million) of children younger than five years of age were stunted and 16% (104 million) were underweight. Africa and Asia have more severe burdens of undernutrition, but the problem persists in some Latin American countries (<a href="./references#CD009666-bbs2-0093" title="LutterCK , DaelmansBM , DeOnisM , KothariMT , RuelMT , ArimondM , et al. Undernutrition, poor feeding practices, and low coverage of key nutrition interventions. Pediatrics2011;128(6):1418‐27. [DOI: 10.1542/peds.2011‐1392; PUBMED: 22065267] ">Lutter 2011</a>). Underweight and undernutrition particularly increase child death and disability. Due to overlapping effects, these risk factors are responsible for an estimated 3.9 million deaths (35% of total deaths) and 33% of total DALYs in children younger than five years of age. Their combined contribution to specific causes of death is highest for diarrhoeal diseases (73%) and close to 50% for pneumonia, measles and severe neonatal infections (<a href="./references#CD009666-bbs2-0118" title="World Health Organization. Global health risks: mortality and burden of disease attributable to selected major risks. Geneva (Switzerland): World Health Organization, 2009. ">WHO 2009</a>). </p> </section> <section id="CD009666-sec-0032"> <h3 class="title" id="CD009666-sec-0032">Description of the intervention</h3> <p>Public health strategies to address micronutrient malnutrition include prevention of parasitic infestations and other infections; dietary diversification to improve the consumption of foods with highly absorbable vitamins and minerals; industrial fortification of staple foods; provision of supplementary foods; and provision of supplements in the form of liquids, pills and tablets (<a href="http://archie.cochrane.org/sections/documents/view?version=52942960543188449936100526124005%26format=REVMAN#REF-Bhutta-2008" target="_blank">Bhutta 2008</a>), with the latter being a widespread intervention. </p> <p>There are few essential nutrition actions for preschool‐ and school‐age children (<a href="./references#CD009666-bbs2-0123" title="World Health Organization. Essential nutrition actions: improving maternal, newborn, infant and young child health and nutrition. Geneva (Switzerland): World Health Organization, 2013. ">WHO 2013</a>). The World Health Organization (WHO) recommends a supplemental provision of 2 mg of elemental iron per kilogram bodyweight per day for three months in children less than six years of age born at term. Children of school‐age and older should receive 30 mg of iron and 250 μg (0.25 mg) of folic acid daily for three months, particularly in populations where anaemia prevalence is greater than 40% (<a href="./references#CD009666-bbs2-0116" title="World Health Organization. Iron Deficiency Anaemia Assessment Prevention and Control: a Guide for Programme Managers. Geneva (Switzerland): World Health Organization, 2001:132. ">WHO 2001</a>). The intermittent use of iron supplements is also recommended as a public health strategy for these age groups in settings where anaemia prevalence is higher than 20% (<a href="./references#CD009666-bbs2-0122" title="World Health Organization. Guideline: intermittent iron supplementation in preschool and school‐age children. Geneva (Switzerland): World Health Organization, 2011. ">WHO 2011c</a>). Both supplementation regimens have proven to be effective in reducing the risk of having anaemia and iron deficiency (<a href="./references#CD009666-bbs2-0072" title="De‐RegilLM , JefferdsMED , SylvetskyAC , DowswellT . Intermittent iron supplementation for improving nutrition and development in children under 12 years of age. Cochrane Database of Systematic Reviews2011, Issue 12. [DOI: 10.1002/14651858.CD009085.pub2] ">De‐Regil 2011a</a>; <a href="./references#CD009666-bbs2-0077" title="GeraT , SachdevHP , NestelP , SachdevSS . Effect of iron supplementation on haemoglobin response in children: systematic review of randomised controlled trials. Journal of Pediatric Gastroenterology and Nutrition2007;44(4):468‐86. [DOI: 10.1097/01.mpg.0000243440.85452.38; PUBMED: 17414146] ">Gera 2007</a>). Though the current recommendations only include iron alone or with folic acid, it has been suggested that administration of additional micronutrients may prevent or reverse anaemia derived from other nutritional deficiencies (<a href="./references#CD009666-bbs2-0064" title="BhuttaZA , AhmedT , BlackRE , CousensS , DeweyK , GiuglianiE , et al. Maternal and Child Undernutrition Study Group. What works? interventions for maternal and child undernutrition and survival. Lancet2008;371(9610):417‐40. [DOI: 10.1016/S0140‐6736(07)61693‐6; PUBMED: 18206226] ">Bhutta 2008</a>), and also have positive effects on length or height and weight, serum zinc, serum retinol and motor development (<a href="./references#CD009666-bbs2-0058" title="AllenLH , PeersonJM , OlneyDK . Provision of multiple rather than two or fewer micronutrients more effectively improves growth and other outcomes in micronutrient‐deficient children and adults. Journal of Nutrition2009;139(5):1022‐30. [DOI: 10.3945/jn.107.086199; PUBMED: 19321586] ">Allen 2009</a>). However, the long regimen duration, bad taste of liquid iron drops and syrups, adverse effects associated with daily iron supplementation (e.g. gastrointestinal discomfort, constipation and teeth staining with drops or syrups) and the limited implementation of large‐scale, intermittent iron supplementation programmes have triggered the development of new approaches to provide iron and other nutrients. </p> <p>Point‐of‐use fortification of foods with MNP has been proposed as an alternative to oral supplements and industrially fortified foods to provide micronutrients to different age groups (<a href="./references#CD009666-bbs2-0048" title="ZlotkinS , ArthurP , AntwiKY , YeungG . Treatment of anemia with microencapsulated ferrous fumarate plus ascorbic acid supplied as sprinkles to complementary (weaning) foods. American Journal of Clinical Nutrition2001;74(6):791‐5. [PUBMED: 11722961] ">Zlotkin 2001</a>; <a href="./references#CD009666-bbs2-0131" title="ZlotkinSH , SchauerC , ChristofidesA , SharieffW , TondeurMC , HyderSM . Micronutrient sprinkles to control childhood anaemia. PLoS Medicine2005;2(1):e1. [DOI: 10.1371/journal.pmed.0020001; PMC545194] ">Zlotkin 2005</a>) and is currently recommended by the World Health Organization for infants, young children and children aged 2–12 years living in populations where anaemia is a public health problem (<a href="./references#CD009666-bbs2-0126" title="World Health Organization. WHO guideline: Use of multiple micronutrient powders for point‐of‐use fortification of foods consumed by infants and young children aged 6–23 months and children aged 2–12 years. Geneva: World Health Organization, 2016. ">WHO 2016</a>). It refers to the addition of vitamins and minerals in powder form to energy‐containing foods at home or in any other place where meals are to be consumed, such as schools, nurseries and refugee camps. MNPs can be added to foods either during or after cooking, or immediately before consumption without the explicit purpose of improving the flavour or colour. In some cases, point‐of‐use fortification is also known as home fortification. </p> <p>Point‐of‐use fortification with MNP can be described as a hybrid intervention between industrial fortification of staple foods or condiments and targeted vitamin and mineral supplementation. The uniqueness of this intervention results from the mixture of advantages and disadvantages inherited from both parent interventions. Point‐of‐use fortification is similar to industrial fortification of staple foods because the vitamins and minerals are added to meals or condiments regularly consumed and usually does not require additional changes to dietary intake behaviours. Point‐of‐use fortification entails the fortification of foods immediately before consumption at home or at another point of use such as schools or child‐care facilities, and there is no long‐term interaction between micronutrients and the food that can diminish their shelf life. In industrial fortification, conversely, micronutrients are added to staple foods or condiments during industrial processing and are more prone to the potential undesirable chemical interactions over time that affect the food sensory properties as well as the bioavailability of some micronutrients (<a href="./references#CD009666-bbs2-0127" title="World Health Organization, Food , Agricultural Organization of the UnitedNations . Guidelines on food fortification with micronutrients. Geneva (Switzerland): WHO, 2006. ">WHO/FAO 2006</a>). </p> <p>Like micronutrient supplementation, point‐of‐use fortification with MNP is targeted to specific populations so that the number and quantity of micronutrients can be tailored to meet the target groups' needs without increasing the risk of overload among other population groups. Also typical of vitamin and mineral supplementation, point‐of‐use fortification allows for flexibility in the provision regimen (e.g. daily, intermittently) (<a href="./references#CD009666-bbs2-0086" title="HyderSM , HaseenF , RahmanM , TondeurM , ZlotkinSH . Effect of daily versus once‐weekly home fortification with micronutrient Sprinkles on hemoglobin and iron status among young children in rural Bangladesh. Food and Nutrition Bulletin2007;28(2):156‐64. [DOI: 10.1177/156482650702800204; PUBMED: 24683674] ">Hyder 2007</a>), and can be adapted according to the selected delivery channel (e.g. health or school systems or social protection programmes) or context. </p> <p>Both micronutrient supplementation and point‐of‐use fortification of foods with MNP require active participation from the target population to achieve and sustain high coverage and regular and appropriate use, with the possible exception being the use of MNP in institutional settings, where the powder is added to the meals prior to serving them to the participants, and a lesser degree of 'active participation' may potentially be expected of participants in some settings. However, in comparison to supplementation, the addition of MNP to foods or meals may result in a higher acceptance and use among children and care‐takers as a result of the lower number of adverse effects (<a href="./references#CD009666-bbs2-0131" title="ZlotkinSH , SchauerC , ChristofidesA , SharieffW , TondeurMC , HyderSM . Micronutrient sprinkles to control childhood anaemia. PLoS Medicine2005;2(1):e1. [DOI: 10.1371/journal.pmed.0020001; PMC545194] ">Zlotkin 2005</a>), and tastelessness of the product when prepared correctly. It is still unclear whether the absorption of MNP mimics that of supplements or that of industrial fortification of staple foods. </p> <p>Point‐of‐use fortification of foods with MNP containing at least iron, vitamin A and zinc is recommended to improve iron status and reduce anaemia among infants and children aged six to 23 months of age (<a href="./references#CD009666-bbs2-0126" title="World Health Organization. WHO guideline: Use of multiple micronutrient powders for point‐of‐use fortification of foods consumed by infants and young children aged 6–23 months and children aged 2–12 years. Geneva: World Health Organization, 2016. ">WHO 2016</a>). </p> </section> <section id="CD009666-sec-0033"> <h3 class="title" id="CD009666-sec-0033">How the intervention might work</h3> <p>MNPs were initially conceived as a way to deliver a novel iron compound, encapsulated ferrous fumarate, an iron salt covered by a thin lipid layer aimed at preventing the interaction of iron with foods. The encapsulation minimises changes caused by iron to the taste or colour in the food to which it is added (<a href="./references#CD009666-bbs2-0091" title="LiyanageC , ZlotkinS . Bioavailability of iron from micro‐encapsulated iron sprinkle supplement. Food and Nutrition Bulletin2002;23(Suppl 3):133‐7. [PUBMED: 12362781] ">Liyanage 2002</a>). Other iron compounds have also been tested. Micronised ferric pyrophosphate has produced a similar haematological response in children aged six to 23 months in comparison to encapsulated ferrous fumarate (<a href="./references#CD009666-bbs2-0068" title="ChristofidesA , AsanteKP , SchauerC , SharieffW , Owusu‐AgyeiS , ZlotkinS . Multi‐micronutrient sprinkles including a low dose of iron provided as microencapsulated ferrous fumarate improves haematologic indices in anaemic children: a randomized clinical trial. Maternal and Child Nutrition2006;2(3):169‐80. ">Christofides 2006</a>; <a href="./references#CD009666-bbs2-0023" title="HirveS , BhaveS , BavdekarA , NaikS , PanditA , SchauerC , et al. Low dose 'Sprinkles' ‐ an innovative approach to treat iron deficiency anemia in infants and young children. Indian Pediatrics2007;44(2):91‐100. [PUBMED: 17351300] ">Hirve 2007</a>). More recently, sodium iron ethylenediaminetetraacetic acid (NaFeEDTA) has been proposed as a more efficacious fortificant that, given in a low dose, could produce similar effects on Hb as those observed with ferrous sulphate among school‐age children, particularly when added to cereal‐based foods that are rich in inhibitors of iron absorption (<a href="./references#CD009666-bbs2-0111" title="TroeschB , VanStuijvenbergME , SmutsCM , KrugerHS , BiebingerR , HurrellRF , et al. A micronutrient powder with low doses of highly absorbable iron and zinc reduces iron and zinc deficiency and improves weight‐for‐age Z‐scores in South African children. Journal of Nutrition2011;141(2):237‐42. [DOI: 10.3945/jn.110.129247; PUBMED: 21178093] ">Troesch 2011a</a>). Independently of the source, the iron is frequently accompanied with other micronutrients such as zinc, vitamin A, vitamin C, vitamin D or folic acid, and in some cases, MNP formulations may include up to 15 vitamins and minerals. These formulations are currently developed by various manufacturers (<a href="./references#CD009666-bbs2-0070" title="DePeeS , KraemerK , van denBrielT , BoyE , GrassetC , Moench‐PfannerR , et al. World Food Programme, Sprinkles Global Health Initiative. Quality criteria for micronutrient powder products: report of a meeting organized by the World Food Programme and Sprinkles Global Health Initiative. Food and Nutrition Bulletin2008;29(3):232‐41. [DOI: 10.1177/156482650802900309; PUBMED: 18947036] ">De Pee 2008</a>; <a href="./references#CD009666-bbs2-0071" title="DePeeS , BloemMW . Current and potential role of specially formulated foods and food supplements for preventing malnutrition among 6‐ to 23‐month‐old children and for treating moderate malnutrition among 6‐ to 59‐month‐old children. Food and Nutrition Bulletin2009;30(Suppl 3):S434‐63. [DOI: 10.1177/15648265090303S305; PUBMED: 19998866] ">De Pee 2009</a>). From the packaging perspective, MNP were initially delivered in single‐dose sachets, which are lightweight and relatively simple to store and transport, and allow easier dosage control (<a href="./references#CD009666-bbs2-0070" title="DePeeS , KraemerK , van denBrielT , BoyE , GrassetC , Moench‐PfannerR , et al. World Food Programme, Sprinkles Global Health Initiative. Quality criteria for micronutrient powder products: report of a meeting organized by the World Food Programme and Sprinkles Global Health Initiative. Food and Nutrition Bulletin2008;29(3):232‐41. [DOI: 10.1177/156482650802900309; PUBMED: 18947036] ">De Pee 2008</a>; <a href="./references#CD009666-bbs2-0103" title="Sprinkles Global Health Initiative. Micronutrient Sprinkles for use in infants and young children: guidelines on recommendations for use and program monitoring and evaluation. www.sghi.org/resource_centre/GuidelinesGen2008.pdf (accessed on 10 September 2010). ">SGHI 2008</a>); although the disposal of non‐degradable sachets has raised some environmental concerns. Currently, the package of the MNP has been broadened to the use of bulk, multi‐serving packages from which powders are added over the meals by using measuring spoons. </p> <p>The use of MNP by infants and young children aged six to 23 months has been reported to reduce the risk of anaemia and iron deficiency in settings where anaemia prevalence is higher than 20%; an effect apparently similar to that achieved by oral iron and folic acid supplements (<a href="./references#CD009666-bbs2-0073" title="De‐RegilLM , SuchdevPS , VistGE , WalleserS , Peña‐RosasJP . Home fortification of foods with multiple micronutrient powders for health and nutrition in children under two years of age. Cochrane Database of Systematic Reviews2011, Issue 9. [DOI: 10.1002/14651858.CD008959.pub2] ">De‐Regil 2011b</a>; <a href="./references#CD009666-bbs2-0075" title="DeweyKG , Adu‐AfarwuahS . Systematic review of the efficacy and effectiveness of complementary feeding interventions in developing countries. Maternal &amp; Child Nutrition2008;4(Suppl 1):24‐85. [DOI: 10.1111/j.1740‐8709.2007.00124.x; PUBMED: 18289157] ">Dewey 2008</a>). Although most of the trials have examined the provision of MNP on a daily basis, other trials suggest that providing this intervention in a flexible or intermittent regimen, and hence a lower overall monthly dose, produces the similar haematological response as daily use of MNP (<a href="./references#CD009666-bbs2-0086" title="HyderSM , HaseenF , RahmanM , TondeurM , ZlotkinSH . Effect of daily versus once‐weekly home fortification with micronutrient Sprinkles on hemoglobin and iron status among young children in rural Bangladesh. Food and Nutrition Bulletin2007;28(2):156‐64. [DOI: 10.1177/156482650702800204; PUBMED: 24683674] ">Hyder 2007</a>; <a href="./references#CD009666-bbs2-0025" title="IpH , HyderSM , HaseenF , RahmanM , ZlotkinSH . Improved adherence and anaemia cure rates with flexible administration of micronutrient Sprinkles: a new public health approach to anaemia control. European Journal of Clinical Nutrition2009;63(2):165‐72. [DOI: 10.1038/sj.ejcn.1602917; PUBMED: 17895911] ">Ip 2009</a>; <a href="./references#CD009666-bbs2-0104" title="SharieffW , BhuttaZ , SchauerC , TomlinsonG , ZlotkinS . Micronutrients (including zinc) reduce diarrhoea in children: the Pakistan Sprinkles Diarrhoea Study. Archives of Disease in Childhood2006;91(7):573‐9. [DOI: 10.1136/adc.2005.086199] ">Sharieff 2006</a>). The intermittent provision of iron was proposed in the 1990s as a feasible public health strategy to supplement children's and women's diets and to reduce anaemia, as it is supposed to maximise absorption by provision of iron in synchrony with the turnover of the mucosal cells (<a href="./references#CD009666-bbs2-0062" title="BeatonGH , McCabeGP . Efficacy of intermittent iron supplementation in the control of iron deficiency anaemia in developing countries. The Micronutrient Initiative. Ottawa (Canada): The Micronutrient Initiative, 1999. ">Beaton 1999</a>; <a href="./references#CD009666-bbs2-0063" title="BergerJ , AguayoVM , TéllezW , LujánC , TraissacP , San MiguelJL . Weekly iron supplementation is as effective as 5 day per week iron supplementation in Bolivian school children living at high altitude. European Journal of Clinical Nutrition1997;51(6):381‐6. [PUBMED: 9192196] ">Berger 1997</a>; <a href="./references#CD009666-bbs2-0114" title="ViteriFE . Iron supplementation for the control of iron deficiency in populations at risk. Nutrition Reviews1997;55(6):195‐209. [PUBMED: 9279056] ">Viteri 1997</a>). </p> <p>An important consideration when providing supplemental iron to children is the presence of malaria because the malaria parasite requires iron for growth, mainly circulating‐free iron (<a href="./references#CD009666-bbs2-0097" title="OkebeJU , YahavD , ShbitaR , PaulM . Oral iron supplements for children in malaria‐endemic areas. Cochrane Database of Systematic Reviews2011, Issue 10. [DOI: 10.1002/14651858.CD006589.pub3] ">Okebe 2011</a>). Approximately 40% of the world population is exposed to the parasite, and it is endemic in over 100 countries (<a href="./references#CD009666-bbs2-0118" title="World Health Organization. Global health risks: mortality and burden of disease attributable to selected major risks. Geneva (Switzerland): World Health Organization, 2009. ">WHO 2009</a>; <a href="./references#CD009666-bbs2-0119" title="World Health Organization. Malaria. In: PoumerolG , Wilder‐SmithA editor(s). Malaria. International Travel and Health. Situation as on 1 January 2010. Geneva (Switzerland): World Health Organization, 2010. ">WHO 2010a</a>). There were an estimated 839,000 malaria deaths worldwide in 2015 (uncertainty interval, 653,000 to 1.1 million). Of the estimated deaths, most occur in the WHO African Region (88%), followed by the WHO South‐East Asia Region (10%) and the WHO Eastern Mediterranean Region (2%) (<a href="./references#CD009666-bbs2-0124" title="World Health Organization. World Malaria Report 2015. Geneva (Switzerland): World Health Organization, 2015. ">WHO 2015a</a>). Nonetheless, large reductions in the number of malaria cases and deaths have been documented between 2000 and 2015. Of all the complications associated with malaria, severe anaemia is the most common and causes the highest number of malaria‐related deaths. Although the mechanisms by which additional iron can benefit the parasite are far from clear (<a href="./references#CD009666-bbs2-0099" title="PrenticeAM , GhattasH , DohertyC , CoxSE . Iron metabolism and malaria. Food and Nutrition Bulletin2007;28(Suppl 4):S524‐39. [DOI: 10.1177/15648265070284S406; PUBMED: 18297891] ">Prentice 2007</a>), it has been hypothesised that the provision of iron along with foods or low doses of iron, either as encapsulated ferrous fumarate or NaFeEDTA, might help to prevent anaemia at the time of infection if it reduces the quantity of free iron (non‐transferrin‐bound iron) available to the parasite (<a href="./references#CD009666-bbs2-0085" title="HurrellR . Iron and malaria: absorption, efficacy and safety. International Journal of Vitamin Nutrition Research2010;80(4‐5):279‐92. [DOI: 10.1024/0300‐9831/a000035; PUBMED: 21462111] ">Hurrell 2010</a>). </p> <p>In addition to malaria, another safety concern related to the use of MNPs is their possible effect on diarrhoea. One systematic review reported a slight, significant increase in the incidence of diarrhoea with MNP intake, with no significant increases in recurrent diarrhoea or upper respiratory infection (<a href="./references#CD009666-bbs2-0102" title="SalamRA , MacPhailC , DasJK , BhuttaZA . Effectiveness of micronutrient powders (MNP) in women and children. BMC Public Health2013;13 Suppl 3:S22. [DOI: 10.1186/1471‐2458‐13‐S3‐S22] ">Salam 2013</a>). Some trials have reported an increase in the number of diarrhoeal episodes after initiating the intervention, followed by a decrease in the frequency of liquid stools after few days (<a href="./references#CD009666-bbs2-0073" title="De‐RegilLM , SuchdevPS , VistGE , WalleserS , Peña‐RosasJP . Home fortification of foods with multiple micronutrient powders for health and nutrition in children under two years of age. Cochrane Database of Systematic Reviews2011, Issue 9. [DOI: 10.1002/14651858.CD008959.pub2] ">De‐Regil 2011b</a>). As a preventive measure, some organisations have advocated the widespread distribution of information on the prompt detection and treatment of diarrhoea (<a href="./references#CD009666-bbs2-0115" title="World Food Programme/DSM. Dealing with diarrhoea in children in refugee, emergency and development situations in the context of micronutrient powder use. Technical Brief2010; Vol. 1:3. ">WFP/DSM 2010</a>). Despite these possible caveats, the use of MNP has been considered by some scientists as one of the most cost‐effective strategies to prevent vitamin and mineral malnutrition (<a href="./references#CD009666-bbs2-0084" title="HortonS , ShekarM , McDonaldC , MahalA , Krystene‐BrooksJ . Scaling up Nutrition. What will it cost?. Washington (DC): The International Bank for Reconstruction and Development/The World Bank, 2010. ">Horton 2010</a>). </p> </section> <section id="CD009666-sec-0034"> <h3 class="title" id="CD009666-sec-0034">Why it is important to do this review</h3> <p>The use of MNP for home or point‐of‐use fortification of complementary foods among infants and young children aged six to 23 months of age has been shown to be effective in reducing anaemia and iron deficiency in young children (<a href="./references#CD009666-bbs2-0073" title="De‐RegilLM , SuchdevPS , VistGE , WalleserS , Peña‐RosasJP . Home fortification of foods with multiple micronutrient powders for health and nutrition in children under two years of age. Cochrane Database of Systematic Reviews2011, Issue 9. [DOI: 10.1002/14651858.CD008959.pub2] ">De‐Regil 2011b</a>). The initial success of this intervention has encouraged its use in other vulnerable populations, such as children of preschool (usually 24 months to less than 5 years of age) and school‐age (usually five to 12 years of age), as the distribution of MNP can potentially build on and enhance existing school‐feeding programmes in addition to other existing community‐based platforms. In 2012 to 2013, the World Food Programme (WFP) was in the process of planning or implementing MNP programmes to reach approximately 1.5 million school‐age children by adding MNP to school lunches (<a href="./references#CD009666-bbs2-0094" title="MartiniE . Providing micronutrient powder (MNP) through school feeding to improve health and nutritional status of school children. Presentation at the UNICEF/CDC Regional Workshop on improving the nutritional quality of complementary foods for children 6‐23 months through home fortification in Central and Eastern Europe and Middle East and North Africa; 2013 May 29; Antalya, Turkey2013. ">Martini 2013</a>). Overall, MNP interventions have been pilot‐tested in all regions of the world for various population groups, but most often for children aged six to 23 months or six to 59 months; in 2013, 61 MNP projects were being implemented in 43 countries, and there were 16 national‐scale MNP programmes (<a href="./references#CD009666-bbs2-0112" title="UNICEF . Nutridash 2013: Global report of the pilot year. UNICEF2014. ">UNICEF 2014</a>). Projects distributing MNP in 2013 reported that they projected to reach more than 14 million participants in 2014 (<a href="./references#CD009666-bbs2-0112" title="UNICEF . Nutridash 2013: Global report of the pilot year. UNICEF2014. ">UNICEF 2014</a>). Likewise, it is also important to assess any adverse effects and potential adverse effects on health with this intervention in this age group. </p> <p>To date, there is no systematic assessment of the effects of MNP provision among preschool‐ and school‐aged children to inform policy‐making. </p> <p>This review will complement the findings of other systematic reviews, which explored the effects of point‐of‐use fortification with multiple MNP in children younger than two years of age (<a href="./references#CD009666-bbs2-0073" title="De‐RegilLM , SuchdevPS , VistGE , WalleserS , Peña‐RosasJP . Home fortification of foods with multiple micronutrient powders for health and nutrition in children under two years of age. Cochrane Database of Systematic Reviews2011, Issue 9. [DOI: 10.1002/14651858.CD008959.pub2] ">De‐Regil 2011b</a>) and among pregnant women (<a href="./references#CD009666-bbs2-0108" title="SuchdevPS , Peña‐RosasJP , De‐Regil . Multiple micronutrient powders for home (point‐of‐use) fortification of foods in pregnant women. Cochrane Database of Systematic Reviews2015, Issue 6. [DOI: 10.1002/14651858.CD011158.pub2] ">Suchdev 2015</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD009666-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD009666-sec-0035"></div> <p>To assess the effects of point‐of‐use fortification of foods with iron‐containing MNP alone, or in combination with other vitamins and minerals on nutrition, health and development among children at preschool (24 to 59 months) and school (five to 12 years) age, compared with no intervention, a placebo or iron‐containing supplements. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD009666-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD009666-sec-0036"></div> <section id="CD009666-sec-0037"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD009666-sec-0038"> <h4 class="title">Types of studies</h4> <p>Randomised controlled trials (RCTs) and quasi‐RCTs with randomisation at either individual or cluster level. Quasi‐RCTs are trials that use systematic methods to allocate participants to treatment groups such as alternation, assignment based on date of birth or case record number (<a href="./references#CD009666-bbs2-0090" title="LefebvreC , ManheimerE , GlanvilleJ . Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Lefebvre 2011</a>). We found no RCTs that met our inclusion criteria (<a href="#CD009666-sec-0037">Criteria for considering studies for this review</a>). We included no other types of evidence (e.g. cohort or case‐control studies) in this review, but we considered such evidence in the <a href="#CD009666-sec-0140">Discussion</a>, where relevant. </p> </section> <section id="CD009666-sec-0039"> <h4 class="title">Types of participants</h4> <p>We included trials aimed at children aged 24 months (two years) to 59 months (less than five years of age) and five to 12 years of age at the time of receiving the intervention with the MNP. We did not include trials specifically targeting hospitalised children with clinical conditions, HIV‐associated infections or enterally fed children. </p> <p>We defined school age as that between five and 12 years of age. Although many children do not attend schools, these ages are compulsory school years in most settings, providing with it an entry point to address the nutritional needs of this age group (<a href="./references#CD009666-bbs2-0069" title="Commission on Ending Childhood Obesity. Report of the Commission on Ending Childhood Obesity. Geneva (Switzerland): World Health Organization, 2016. ">Commission on Ending Childhood Obesity 2016</a>). We acknowledge the overlap between this age range and the one used for adolescent age, 10 to 19 years of age (<a href="./references#CD009666-bbs2-0117" title="World Health Organization. Strategic directions for improving the health and development of children and adolescents. Geneva (Switzerland): World Health Organization, 2003. ">WHO 2003</a>), and made a pragmatic decision based on the most suitable delivery platform. </p> <p>We included trials carried out in settings where anaemia and iron deficiency were prevalent; thus participants could be anaemic or not. We also included trials for which the results for children aged between 24 and less than five years of age and five to 12 years of age could be extracted separately, or in which more than half of the participants fulfilled this criterion (we performed a <a href="#CD009666-sec-0081">Sensitivity analysis</a> if marginal decisions were made). </p> </section> <section id="CD009666-sec-0040"> <h4 class="title">Types of interventions</h4> <p>Interventions involved the provision of MNP for point‐of‐use fortification given at any dose, frequency and duration. The comparison groups included no intervention, placebo or usual supplementation. Specifically, we assessed the evidence on the following comparisons. </p> <p> <ul id="CD009666-list-0001"> <li> <p>Point‐of‐use fortification of foods with MNP versus no intervention or placebo.</p> </li> <li> <p>Point‐of‐use fortification of foods with MNP versus iron‐only supplement.</p> </li> <li> <p>Point‐of‐use fortification of foods with MNP versus iron and folic acid supplements.</p> </li> <li> <p>Point‐of‐use fortification of foods with MNP versus same micronutrients in supplements.</p> </li> </ul> </p> <p>We included interventions that combined MNP with co‐interventions, such as education, vitamin A supplementation programmes, zinc for the treatment of diarrhoea or other approaches, but only if the co‐interventions were the same in both the intervention and comparison groups. We excluded trials examining supplementary food‐based interventions (lipid‐based supplements, chewable tablets, fortified complementary foods and other industrially fortified foods). </p> </section> <section id="CD009666-sec-0041"> <h4 class="title">Types of outcome measures</h4> <section id="CD009666-sec-0042"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD009666-list-0002"> <li> <p>Anaemia (defined as Hb lower than 110 g/L for children aged 24 to 59 months and lower than 115 g/L for children aged five to 11.9 years, adjusted by altitude where appropriate).* </p> </li> <li> <p>Hb (in grams per litre).*</p> </li> <li> <p>Iron deficiency (defined by using ferritin concentrations less than 15 µg/L).*</p> </li> <li> <p>Ferritin (in micrograms per litre).*</p> </li> <li> <p>All‐cause mortality (number of deaths during the trial).*</p> </li> <li> <p>Diarrhoea (three liquid stools or more per day).*</p> </li> <li> <p>Adverse effects (any, as defined by trialists).</p> </li> </ul> </p> <p>We considered outcomes marked by an asterisk (*) as critical for decision making by a panel of experts and included them in the 'Summary of findings' tables (<a href="./references#CD009666-bbs2-0079" title="GuyattGH , OxmanAD , KunzR , AtkinsD , BrozekJ , VistG , et al. GRADE guidelines: 2. Framing the question and deciding on important outcomes. Journal of Clinical Epidemiology2011;64(4):395‐400. [DOI: 10.1016/j.jclinepi.2010.09.012; PUBMED: 21194891] ">Guyatt 2011</a>; <a href="./references#CD009666-bbs2-0098" title="Peña‐RosasJP , De‐RegilLM , RogersLM , BopardikarA , PanissetU . Translating research into action: WHO evidence‐informed guidelines for safe and effective micronutrient interventions. Journal of Nutrition2012;142(1):197‐204S. [DOI: 10.3945/jn.111.138834; PUBMED: 22113868] ">Peña‐Rosas 2012</a>). </p> </section> <section id="CD009666-sec-0043"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD009666-list-0003"> <li> <p>Iron deficiency anaemia (defined by the presence of anaemia plus iron deficiency, diagnosed with an indicator of iron status as selected by trialists). </p> </li> <li> <p>Cognitive development and school performance (as defined by trialists).</p> </li> <li> <p>Motor development and physical capacity (as defined by trialists).</p> </li> <li> <p>All‐cause morbidity (number of participants with at least one episode of any disease during the trial). </p> </li> <li> <p>Acute respiratory infection (as defined by trialists; e.g. pneumonia, bronchiolitis or bronchitis). </p> </li> <li> <p>Growth (height‐for‐age Z‐score (HAZ)).</p> </li> <li> <p>Growth (weight‐for‐age Z‐score (WAZ)).</p> </li> <li> <p>Growth (weight‐for‐height Z‐score (WHZ)).</p> </li> <li> <p>Adherence (percentage of children who consumed more than 70% of the expected doses over the intervention period). </p> </li> <li> <p>Red blood cell folate (in milligrams per decilitre).</p> </li> <li> <p>Serum/plasma retinol (in millimoles per litre).</p> </li> <li> <p>Serum/plasma zinc concentrations (in millimoles per litre).</p> </li> </ul> </p> <p>We intended to group the outcomes by time points as follows, if these follow‐up data were reported for the above outcomes: immediately postintervention, one to six months postintervention, and seven to 12 months postintervention. </p> </section> </section> </section> <section id="CD009666-sec-0044"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD009666-sec-0045"> <h4 class="title">Electronic searches</h4> <p>We searched the electronic databases and trial registers listed below in December 2016 and April 2017. MNP formulations were introduced after 2000, therefore, we limited the searches by publication year from 2000 onwards. There were no language limits. </p> <p> <ul id="CD009666-list-0004"> <li> <p>Cochrane Central Register of Controlled Trials CRSO (CENTRAL; searched 7 December 2016). </p> </li> <li> <p>MEDLINE Ovid (2000 to 6 December 2016).</p> </li> <li> <p>Embase Ovid (2000 to 6 December 2016).</p> </li> <li> <p>BIOSIS ISI (2000 to 6 December 2016).</p> </li> <li> <p>Social Citation Index Web of Science (SCI; 2000 to 7 December 2016).</p> </li> <li> <p>Social Science Citation Index Web of Science (SSCI; 2000 to 7 December 2016).</p> </li> <li> <p>CINAHL Plus EBSCOhost (Cumulative Index to Nursing and Allied Health Literature; 2000 to 7 December 2016). </p> </li> <li> <p>LILACS (Latin American and Caribbean Health Science Information database; <a href="http://lilacs.bvsalud.org/en/" target="_blank">lilacs.bvsalud.org/en</a>; 2000 to 15 December 2016). </p> </li> <li> <p>IBECS (<a href="http://ibecs.isciii.es/" target="_blank">ibecs.isciii.es</a>; 2000 to 15 December 2016). </p> </li> <li> <p>POPLINE (<a href="http://www.popline.org/" target="_blank">www.popline.org</a>; 2000 to 15 December 2016). </p> </li> <li> <p>SciELO (Scientific Library Online; <a href="http://www.scielo.br/" target="_blank">www.scielo.br</a>; 2000 to 15 December 2016). </p> </li> <li> <p>ClinicalTrials.gov (<a href="https://clinicaltrials.gov/" target="_blank">clinicaltrials.gov</a>; searched 19 April 2017). </p> </li> <li> <p>WHO International Clinical Trials Registry Platform (ICTRP; <a href="http://www.who.int/ictrp/en/" target="_blank">www.who.int/ictrp/en</a>; searched 13 April 2017). </p> </li> </ul> </p> </section> <section id="CD009666-sec-0046"> <h4 class="title">Searching other resources</h4> <p>We contacted authors and known experts for assistance in identifying ongoing studies or unpublished data on 21 June 2014 and again on 19 April 2017. We also contacted the regional offices of WHO; the WHO Departments of Nutrition for Health and Development, Division of Nutrition, Physical Activity, and Obesity of the Centers for Disease Control and Prevention (CDC); the United Nations Children's Fund (UNICEF); the WFP; Nutrition International (formerly Micronutrient Initiative); Helen Keller International (HKI); Home Fortification Technical Advisory Group (HF‐TAG); the Global Alliance for Improved Nutrition (GAIN); the US Agency for International Development; and Sight and Life. </p> </section> </section> <section id="CD009666-sec-0047"> <h3 class="title" id="CD009666-sec-0047">Data collection and analysis</h3> <section id="CD009666-sec-0048"> <h4 class="title">Selection of studies</h4> <p>Two review authors (LD‐R and MJ) independently screened all titles and abstracts retrieved by the electronic searches for eligibility. One review author (LD‐R) searched the additional sources. Each review author independently assessed two‐thirds of the full‐text reports for inclusion according to the above criteria (<a href="#CD009666-sec-0037">Criteria for considering studies for this review</a>); we assessed each paper in duplicate, resolving any disagreements through discussion. </p> <p>If trials were published only as abstracts, or study reports contained little information on methods, we attempted to contact the authors to obtain further details of study design and results. </p> <p>We recorded our decisions in a study flow diagram (<a href="./references#CD009666-bbs2-0095" title="MoherD , LiberatiA , TetzlaffJ , AltmanDG , The PRISMA Group. Preferred reporting items for systematic reviews and meta‐analyses: the PRISMA statement. PLoS Medicine2009;6(7):e1000097. [DOI: 10.1371/journal.pmed1000097] ">Moher 2009</a>). </p> </section> <section id="CD009666-sec-0049"> <h4 class="title">Data extraction and management</h4> <p>For eligible trials, two review authors (MJ and JP‐R) independently extracted data using a form designed for this review. The data collection form was adapted from a similar review in a different population group (<a href="./references#CD009666-bbs2-0073" title="De‐RegilLM , SuchdevPS , VistGE , WalleserS , Peña‐RosasJP . Home fortification of foods with multiple micronutrient powders for health and nutrition in children under two years of age. Cochrane Database of Systematic Reviews2011, Issue 9. [DOI: 10.1002/14651858.CD008959.pub2] ">De‐Regil 2011b</a>), and piloted by MJ and JP‐R on two included studies, before finalised for use in this review. MJ extracted data from half of the trials and JP‐R extracted data from the other half. LD‐R extracted data from all the trials. LD‐R entered data into Review Manager 5 (<a href="./references#CD009666-bbs2-0101" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>), and the review author who extracted the data in duplicate checked LD‐R's data entry for accuracy. We resolved any discrepancies through discussion and documented the process. </p> <p>We completed the data collection form electronically and recorded information on the following. </p> <section id="CD009666-sec-0050"> <h5 class="title">Trial methods</h5> <p> <ul id="CD009666-list-0005"> <li> <p>Study design.</p> </li> <li> <p>Unit and method of allocation.</p> </li> <li> <p>Method of sequence generation.</p> </li> <li> <p>Masking of participants, personnel and outcome assessors.</p> </li> </ul> </p> </section> <section id="CD009666-sec-0051"> <h5 class="title">Participants</h5> <p> <ul id="CD009666-list-0006"> <li> <p>Location of the study.</p> </li> <li> <p>Sample size.</p> </li> <li> <p>Age.</p> </li> <li> <p>Sex.</p> </li> <li> <p>Socioeconomic status (as defined by trialists and where such information was available).</p> </li> <li> <p>Baseline prevalence of anaemia.</p> </li> <li> <p>Baseline prevalence of soil helminths.</p> </li> <li> <p>Baseline malaria prevalence.</p> </li> <li> <p>Inclusion and exclusion criteria.</p> </li> </ul> </p> </section> <section id="CD009666-sec-0052"> <h5 class="title">Intervention</h5> <p> <ul id="CD009666-list-0007"> <li> <p>Dose.</p> </li> <li> <p>Type of iron compound.</p> </li> <li> <p>Provision of MNP regimen.</p> </li> <li> <p>Duration of the intervention.</p> </li> <li> <p>Cointervention.</p> </li> </ul> </p> </section> <section id="CD009666-sec-0053"> <h5 class="title">Comparison group</h5> <p> <ul id="CD009666-list-0008"> <li> <p>No intervention.</p> </li> <li> <p>Placebo.</p> </li> <li> <p>Provision of iron supplements.</p> </li> </ul> </p> </section> <section id="CD009666-sec-0054"> <h5 class="title">Outcomes</h5> <p> <ul id="CD009666-list-0009"> <li> <p>Primary and secondary outcomes outlined under <a href="#CD009666-sec-0041">Types of outcome measures</a>. </p> </li> <li> <p>Exclusion of participants after randomisation and proportion of losses at follow‐up.</p> </li> </ul> </p> <p>We recorded both prespecified and non‐prespecified outcomes, although we did not use the latter to underpin the conclusions of the review. </p> <p>When information regarding any of the trials was unclear, we attempted to contact authors of the original reports to provide further details. If there was insufficient information for us to be able to assess risk of bias, we categorised trials as awaiting assessment, until further information is published or made available to us. </p> </section> </section> <section id="CD009666-sec-0055"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (LD‐R and MJ) independently assessed the risk of bias of each study using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD009666-bbs2-0081" title="HigginsJPT , AltmanDG , SterneJAC . Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011a</a>). Both review authors assigned each study a rating of low, high or unclear risk of bias, for the following domains: random sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, incomplete outcome data, selective reporting and other potential sources of bias; we also assessed the overall risk of bias. We resolved any disagreement by discussion or by involving a third review author (JP‐R). </p> <section id="CD009666-sec-0056"> <h5 class="title">Random sequence generation (checking for selection bias)</h5> <p>We described the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it produced comparable groups. </p> <p> <ul id="CD009666-list-0010"> <li> <p>Low risk of bias: any truly random process; for example, random number table, computer random number generator. </p> </li> <li> <p>High risk of bias: any non‐random process; for example, odd or even date of birth, hospital or clinic record number. </p> </li> <li> <p>Unclear risk of bias: insufficient information to permit judgement of low or high risk of bias. </p> </li> </ul> </p> </section> <section id="CD009666-sec-0057"> <h5 class="title">Allocation concealment (checking for possible selection bias)</h5> <p>We described the method used to conceal the allocation sequence in sufficient detail to determine whether intervention allocations could have been foreseen in advance of, or during, enrolment. </p> <p> <ul id="CD009666-list-0011"> <li> <p>Low risk of bias: for example, telephone or central randomisation; consecutively numbered, sealed, opaque envelopes. </p> </li> <li> <p>High risk of bias: open random allocation, unsealed or non‐opaque envelopes.</p> </li> <li> <p>Unclear risk of bias: insufficient information to permit judgement of low or high risk of bias. </p> </li> </ul> </p> </section> <section id="CD009666-sec-0058"> <h5 class="title">Blinding of participants and personnel (checking for possible performance bias)</h5> <p>We described all measures used, if any, to blind study participants and personnel from knowledge of which intervention a participant received. </p> <p> <ul id="CD009666-list-0012"> <li> <p>Low risk of bias: neither participants nor personnel giving the intervention were aware of the intervention. </p> </li> <li> <p>High risk of bias: either participants or personnel were aware of the intervention.</p> </li> <li> <p>Unclear risk of bias: insufficient information to permit judgement of low or high risk of bias. </p> </li> </ul> </p> </section> <section id="CD009666-sec-0059"> <h5 class="title">Blinding of outcome assessment (checking for possible detection bias)</h5> <p>We described all measures used, if any, to blind outcome assessors from knowledge as to which intervention a participant received. </p> <p> <ul id="CD009666-list-0013"> <li> <p>Low risk of bias: blinding of outcomes, which is unlikely to have been broken.</p> </li> <li> <p>High risk of bias: for example, no blinding of outcome assessment where measurement is likely to be influenced by lack of blinding, or where blinding could have been broken. </p> </li> <li> <p>Unclear risk of bias: insufficient information to permit judgement of low or high risk of bias. </p> </li> </ul> </p> </section> <section id="CD009666-sec-0060"> <h5 class="title">Incomplete outcome data (checking for possible attrition bias through withdrawals, dropouts, protocol deviations) </h5> <p>We assessed outcomes in each included study as follows.</p> <p> <ul id="CD009666-list-0014"> <li> <p>Low risk of bias: either there were no missing outcome data or the missing outcome data were unlikely to bias the results based on the following considerations: study authors provided transparent documentation of participant flow throughout the study, the proportion of missing data was similar in the intervention and control groups, the reasons for missing data were provided and balanced across intervention and control groups, the reasons for missing data were not likely to bias the results (for example, moving house). </p> </li> <li> <p>High risk of bias: missing outcome data were likely to bias the results. Trials also received this rating if an 'as‐treated (per protocol)' analysis was performed with substantial differences between the intervention received and that assigned at randomisation, or if potentially inappropriate methods for imputation had been used. </p> </li> <li> <p>Unclear risk of bias: insufficient information to permit judgement of low or high risk of bias. </p> </li> </ul> </p> </section> <section id="CD009666-sec-0061"> <h5 class="title">Selective reporting (checking for possible reporting bias)</h5> <p>We stated how the possibility of selective outcome reporting was examined and what was found. </p> <p> <ul id="CD009666-list-0015"> <li> <p>Low risk of bias: where it was clear that all the study's prespecified outcomes and all expected outcomes of interest to the review were reported. </p> </li> <li> <p>High risk of bias: where not all the study's prespecified outcomes were reported, one or more reported primary outcomes were not prespecified, outcomes of interest were reported incompletely and so could not be used, the study failed to include results of a key outcome that would have been expected to have been reported. </p> </li> <li> <p>Unclear risk of bias: insufficient information to permit judgement of low or high risk of bias. </p> </li> </ul> </p> </section> <section id="CD009666-sec-0062"> <h5 class="title">Other bias (checking for other potential sources of bias not covered by the domains above) </h5> <p>We assessed if the study was free of other potential bias as follows.</p> <p> <ul id="CD009666-list-0016"> <li> <p>Low risk of bias: where there was similarity between the outcome measure at baseline, similarity between potential confounding variables at baseline, or adequate protection of study arms against contamination. </p> </li> <li> <p>High risk of bias: where there was no similarity between outcome measure at baseline, similarity between potential confounding variables at baseline or adequate protection of study arms against contamination. </p> </li> <li> <p>Unclear risk of bias: insufficient information to permit judgement of low or high risk of bias. </p> </li> </ul> </p> </section> <section id="CD009666-sec-0063"> <h5 class="title">Overall risk of bias</h5> <p>We summarised the overall risk of bias at two levels: within trials (across domains) and across trials. </p> <section id="CD009666-sec-0064"> <h6 class="title">Overall risk of bias within trials</h6> <p>For the assessment within trials, we assessed the likely magnitude and direction of the bias in each of the 'Risk of bias' domains and whether we considered they were likely to impact on the findings. We considered trials at high risk of bias if they had poor or unclear allocation concealment and either inadequate blinding of both participants and personnel or high/imbalanced losses to follow‐up. We explored the impact of the level of bias through a <a href="#CD009666-sec-0081">Sensitivity analysis</a>. </p> </section> <section id="CD009666-sec-0065"> <h6 class="title">Overall risk of bias between trials</h6> <p>For the assessment across trials, we set out the main findings of the review in the 'Summary of findings' table, prepared using GRADEpro software (<a href="./references#CD009666-bbs2-0078" title="McMaster University (developed by Evidence Prime). GRADEpro GDT. Version accessed 14 August 2017. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015. ">GRADEpro GDT 2015</a>). We listed the primary outcomes for each comparison, with estimates of relative effects, along with the number of participants and trials contributing data for those outcomes. For each individual outcome, we assessed the quality of the evidence using the GRADE approach (<a href="./references#CD009666-bbs2-0061" title="BalshemH , HelfandM , SchünemannHJ , OxmanAD , KunzR , BrozekJ , et al. GRADE guidelines: 3. Rating the quality of evidence. Journal of Clinical Epidemiology2011;64(4):401‐6. [DOI: 10.1016/j.jclinepi.2010.07.015; PUBMED: 21208779] ">Balshem 2011</a>), which involved consideration of within‐study risk of bias (methodological quality), directness of evidence, heterogeneity, precision of effect estimates and risk of publication bias, and resulted in one out of four levels of quality (high, moderate, low or very low). This assessment was limited only to the trials included in this review. </p> </section> </section> </section> <section id="CD009666-sec-0066"> <h4 class="title">Measures of treatment effect</h4> <section id="CD009666-sec-0067"> <h5 class="title">Dichotomous data</h5> <p>For dichotomous data, we presented results as prevalence ratio (PR) or risk ratio (RR) with 95% confidence intervals (95% CI). </p> </section> <section id="CD009666-sec-0068"> <h5 class="title">Continuous data</h5> <p>For continuous data, we used the mean difference (MD) with 95% CI if outcomes were measured in the same way between trials. </p> <p>We used the standardised mean difference (SMD) with 95% CI to combine trials that measured the same outcome but used different measurement methods. </p> </section> <section id="CD009666-sec-0069"> <h5 class="title">Rates</h5> <p>For rates, if they represented events that could have occurred more than once per participant, we reported the rate difference using the methodologies described in <a href="./references#CD009666-bbs2-0074" title="DeeksJJ , HigginsJPT , AltmanDG . Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Deeks 2011</a>. </p> </section> </section> <section id="CD009666-sec-0070"> <h4 class="title">Unit of analysis issues</h4> <section id="CD009666-sec-0071"> <h5 class="title">Cluster‐randomised trials</h5> <p>Where we identified both cluster‐randomised trials and individually randomised trials reporting data for the same outcome, we considered that it was reasonable to combine the results from both if there was little heterogeneity between the study designs, and the interaction between the effect of intervention and the choice of randomisation unit was considered unlikely. </p> <p>Cluster‐randomised trials are labelled with a '(C)'. <a href="./references#CD009666-bbs2-0001" title="InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Combined intensive nutrition education and micronutrient powder supplementation improved nutritional status of mildly wasted children on Nias Island, Indonesia. Asia Pacific Journal of Clinical Nutrition2012;21(3):361‐73. [PUBMED: 22705425] InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Improved nutrition knowledge and practice through intensive nutrition education: a study among caregivers of mildly wasted children on Nias Island, Indonesia. Food and Nutrition Bulletin2012;33(2):117‐27. [DOI: 10.1177/156482651203300205; PUBMED: 22908693] PurwestriRC , ScherbaumV , InayatiDA , WirawanNN , SuryantanJ , BloemMA , et al. Supplementary feeding with locally‐produced ready‐to‐use food (RUF) for mildly wasted children on Nias Island, Indonesia: comparison of daily and weekly programme outcomes. Asia Pacific Journal of Clinical Nutrition2012;21(3):374‐9. [PUBMED: 22705426] ScherbaumV [pers comm] . Your paper on MNP. Email to: LM De‐Regil 5 February 2013. ">Inayati 2012 (C)</a> took into account the clustering effect by using a mixed‐effects model. </p> <p>Where possible, we estimated the intra cluster correlation coefficient (ICC) from trials' original data sets and reported the design effect. On the basis of this information, we used the methods set out in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> to calculate the adjusted sample sizes (<a href="./references#CD009666-bbs2-0082" title="HigginsJPT , DeeksJJ , AltmanDG . Chapter 16: Special topics in statistics. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011b</a>). We estimated the ICC from original data provided by <a href="./references#CD009666-bbs2-0004" title="LundeenE [pers comm] . Kyrgyz Republic MNP data for children 24‐36 months. Email to: M Jefferds 3 November 2011. LundeenE , SchuethT , ToktobaevN , ZlotkinS , HyderSM , HouserR . Daily use of Sprinkles micronutrient powder for 2 months reduces anemia among children 6 to 36 months of age in the Kyrgyz Republic: a cluster‐randomized trial. Food and Nutrition Bulletin2010;31(3):446‐60. [DOI: 10.1177/156482651003100307; PUBMED: 20973465] ">Lundeen 2010 (C)</a> and imputed the ICC in seven other trials (<a href="./references#CD009666-bbs2-0002" title="KemmerTM , OmerPS , Gidvani‐DiazVK , CoelloM . Acceptance and effect of ferrous fumarate containing micronutrient sprinkles on anemia, iron deficiency and anthropometrics in Honduran children. In: SilverbergDS editor(s). Anemia. Rijeka (Croatia): InTech, 2012. [DOI: 10.5772/30987] ">Kemmer 2012 (C)</a>; <a href="./references#CD009666-bbs2-0003" title="KounnavongS , SunaharaT , Mascie‐TaylorCG , HashizumeM , OkumuraJ , MojiK , et al. Effect of daily versus weekly home fortification with multiple micronutrient powder on haemoglobin concentration of young children in a rural area, Lao People's Democratic Republic: a randomised trial. Nutrition Journal2011;10(129):1‐11. [DOI: 10.1186/1475‐2891‐10‐129; PMC3266642; PUBMED: 22111770] ">Kounnavong 2011 (C)</a>; <a href="./references#CD009666-bbs2-0008" title="OseiAK , HouserRF , BulusuS , HamerDH . Acceptability of micronutrient fortified school meals by schoolchildren in rural Himalayan villages of India. Journal of Food Science2008;73(7):S354‐8. [DOI: 10.1111/j.1750‐3841.2008.00878.x; PUBMED: 18803728] OseiAK , RosenbergIH , HouserRF , BulusuS , MathewsM , HamerDH . Community‐level micronutrient fortification of school lunch meals improved vitamin A, folate, and iron status of schoolchildren in Himalayan villages of India. Journal of Nutrition2010;140(6):1146‐54. [DOI: 10.3945/jn.109.114751; PUBMED: 20410083] ">Osei 2008 (C)</a>; <a href="./references#CD009666-bbs2-0009" title="SharieffW , YinSA , WuM , YangQ , SchauerC , TomlinsonG , et al. Short‐term daily or weekly administration of micronutrient Sprinkles has high compliance and does not cause iron overload in Chinese schoolchildren: a cluster‐randomized trial. Public Health Nutrition2006;9(3):336‐44. [PUBMED: 16684385] ZlotkinS [pers comm] . Regards and question ‐ Sharieff 2006. Email to: JP Peña‐Rosas 2 November 2011. ">Sharieff 2006 (C)</a>; <a href="./references#CD009666-bbs2-0011" title="VarmaJL , DasS , SankarR , MannarMG , LevinsonFJ , HamerDH . Community‐level micronutrient fortification of a food supplement in India: a controlled trial in preschool children aged 36‐66 mo. American Journal of Clinical Nutrition2007;85(4):1127‐33. [PUBMED: 17413115] ">Varma 2007 (C)</a>; <a href="./references#CD009666-bbs2-0012" title="VinodkumarM , RajagopalanS . Impact of a multiple‐micronutrient food supplement on the nutritional status of schoolchildren. Food and Nutrition Bulletin2006;27(3):203‐10. [DOI: 10.1177/156482650602700302; PUBMED: 17542110] ">Vinodkumar 2006 (C)</a>; <a href="./references#CD009666-bbs2-0013" title="VinodkumarM , RajagopalanS . Efficacy of fortification of school meals with ferrous glycine phosphate and riboflavin against anemia and angular stomatitis in schoolchildren. Food and Nutrition Bulletin2009;30(3):260‐4. [DOI: 10.1177/156482650903000307; PUBMED: 19927606] ">Vinodkumar 2009 (C)</a>), and then calculated each trial's effective sample size. </p> </section> <section id="CD009666-sec-0072"> <h5 class="title">Trials with more than two treatment groups</h5> <p>For trials with more than two intervention groups (multi‐arm trials), we included the directly relevant arms only. If we identified trials with various relevant arms, we combined the groups into a single, pair‐wise comparison (<a href="./references#CD009666-bbs2-0082" title="HigginsJPT , DeeksJJ , AltmanDG . Chapter 16: Special topics in statistics. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011b</a>), and included the disaggregated data in the corresponding subgroup category. If the control group was shared by two or more study arms, we divided the control group (events and total population) equally by the number of relevant subgroup categories to avoid double counting the participants. We noted the details in the <a href="./references#CD009666-sec-0174" title="">Characteristics of included studies</a> tables. </p> <p>Two trials included additional arms in the comparisons as they provided weekly and daily regimens (<a href="./references#CD009666-bbs2-0003" title="KounnavongS , SunaharaT , Mascie‐TaylorCG , HashizumeM , OkumuraJ , MojiK , et al. Effect of daily versus weekly home fortification with multiple micronutrient powder on haemoglobin concentration of young children in a rural area, Lao People's Democratic Republic: a randomised trial. Nutrition Journal2011;10(129):1‐11. [DOI: 10.1186/1475‐2891‐10‐129; PMC3266642; PUBMED: 22111770] ">Kounnavong 2011 (C)</a>; <a href="./references#CD009666-bbs2-0009" title="SharieffW , YinSA , WuM , YangQ , SchauerC , TomlinsonG , et al. Short‐term daily or weekly administration of micronutrient Sprinkles has high compliance and does not cause iron overload in Chinese schoolchildren: a cluster‐randomized trial. Public Health Nutrition2006;9(3):336‐44. [PUBMED: 16684385] ZlotkinS [pers comm] . Regards and question ‐ Sharieff 2006. Email to: JP Peña‐Rosas 2 November 2011. ">Sharieff 2006 (C)</a>). </p> </section> <section id="CD009666-sec-0073"> <h5 class="title">Cross‐over trials</h5> <p>There were no cross‐over trials that met our inclusion criteria (<a href="#CD009666-sec-0037">Criteria for considering studies for this review</a>). See <a href="#CD009666-tbl-0002">Table 1</a> and our protocol (<a href="./references#CD009666-bbs2-0132" title="De‐RegilLM , JefferdsMED , Peña‐RosasJP . Point‐of‐use fortification of foods with micronutrient powders containing iron in children of preschool and school age. Cochrane Database of Systematic Reviews2012, Issue 2. [DOI: 10.1002/14651858.CD009666] ">De‐Regil 2012</a>), for methods for managing cross‐over trials archived for use in future updates of this review. </p> <div class="table" id="CD009666-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Unused methods archived for use in future updates of this review</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Method</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Approach</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unit of analysis issues</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cross‐over trials</b> </p> <p>We planned to only include the first period of a randomised cross‐over trial prior to the washout period or to a change in the sequence of treatments. We planned to treat them as parallel randomised controlled trials. </p> </td> </tr> </tbody> </table> </div> </section> </section> <section id="CD009666-sec-0074"> <h4 class="title">Dealing with missing data</h4> <section id="CD009666-sec-0075"> <h5 class="title">Missing participants</h5> <p>We noted dropout for each included study. We noted attrition on the 'Risk of bias' form and included it in the 'Risk of bias' summary. We conducted analysis on an available‐case analysis basis: we included data from those participants whose results were known. We considered attrition as a potential source of heterogeneity. </p> <p>We attempted to include all participants randomised to each group in the analyses. We contacted the authors and asked them to provide additional information and we performed an available‐case analysis and discussed the extent to which the missing data could alter the results or conclusions (or both) of the review. We noted in the <a href="#CD009666-sec-0083">Description of studies</a> when authors provided additional information. </p> </section> <section id="CD009666-sec-0076"> <h5 class="title">Missing data</h5> <p>Where key data (e.g. standard deviations (SD)) were missing from the report, we attempted to contact the corresponding authors (or other authors if necessary) of the included trials to request the unreported data. If this information was not achievable, we did not impute it and noted that the study did not provide data for that particular outcome. </p> </section> </section> <section id="CD009666-sec-0077"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed methodological heterogeneity by examining the methodological characteristics and risk of bias of the trials, and clinical heterogeneity by examining the similarity between the types of participants, interventions and outcomes. </p> <p>For statistical heterogeneity, we examined the forest plots from meta‐analyses to look for heterogeneity among trials and used the I<sup>2</sup> statistic, Tau<sup>2</sup> and Chi<sup>2</sup> test to quantify the level of heterogeneity among the trials in each analysis. If we identified moderate or substantial heterogeneity, we explored it by prespecified subgroup analysis (see <a href="#CD009666-sec-0080">Subgroup analysis and investigation of heterogeneity</a>). We considered an I<sup>2</sup> statistic greater than 50% to indicate substantial heterogeneity. We advise caution in the interpretation of analyses with high degrees of heterogeneity. </p> </section> <section id="CD009666-sec-0078"> <h4 class="title">Assessment of reporting biases</h4> <p>Where we suspected reporting bias (see 'Selective reporting bias' under <a href="#CD009666-sec-0055">Assessment of risk of bias in included studies</a>), we attempted to contact study authors, asking them to provide missing outcome data. Where this was not possible, and the missing data were thought to introduce serious bias, we explored the impact of including such trials in the overall assessment of results by conducting a sensitivity analysis (see <a href="#CD009666-sec-0081">Sensitivity analysis</a>).  </p> <p>If more than 10 trials contributed data to the primary outcomes, we presented a funnel plot to evaluate asymmetry, and hence a possible indication of publication bias for primary outcomes. Any identified asymmetry could be due to publication bias, but could also be attributable to a real relationship between trial size and effect size (e.g. larger trials may have poorer participant supervision and thus compliance to supplementation, which may, in turn, influence effect size). In such a case, we included, in the <a href="#CD009666-sec-0140">Discussion</a>, a section on the possible causes of the observed asymmetry, including descriptions of reported compliance in the larger trials as compared with smaller trials. </p> </section> <section id="CD009666-sec-0079"> <h4 class="title">Data synthesis</h4> <p>We conducted a meta‐analysis to obtain an overall estimate of the effect of the treatment when more than one study had examined similar interventions using similar methods, been conducted in similar populations and measured similar (comparable) outcomes. </p> <p>We accounted for heterogeneity using a random‐effects meta‐analysis for combining data, as we anticipated that there may be natural heterogeneity between trials attributable to the different doses, durations, populations and implementation or delivery strategies. We carried out the meta‐analysis using the inverse‐variance statistical method for continuous variables and the Mantel‐Haenszel statistical method for dichotomous variables (<a href="./references#CD009666-bbs2-0101" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). </p> <p>We did not combine outcomes expressed as continuous or dichotomous measures.</p> </section> <section id="CD009666-sec-0080"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Where data were available, we carried out the following subgroup analyses:</p> <p> <ul id="CD009666-list-0017"> <li> <p>anaemic status of participants at the start of intervention (anaemia defined as Hb values less than 110 g/L or less than 115 g/L, adjusted by altitude if appropriate): anaemic, non‐anaemic, mixed/unknown; </p> </li> <li> <p>age of children at the start of the intervention: 24 to 59 months, five to 12 years;</p> </li> <li> <p>refugee status: yes, no;</p> </li> <li> <p>malaria status of the study site at the time of the trial: yes, no, not reported;</p> </li> <li> <p>frequency: daily, weekly, flexible;</p> </li> <li> <p>duration of intervention: less than three months, three months or more;</p> </li> <li> <p>iron content of product: 12.5 mg or less, more than 12.5 mg;</p> </li> <li> <p>type of iron compound: as reported by the trialists; and</p> </li> <li> <p>number of nutrients accompanying iron: one to four, five to nine, 10 or more.</p> </li> </ul> </p> <p>We conducted the following, post hoc subgroup analysis:</p> <p> <ul id="CD009666-list-0018"> <li> <p>micronutrient composition: iron alone, at least iron plus vitamin A plus zinc, other combinations without bundling iron plus vitamin A plus zinc. </p> </li> </ul> </p> <p>We used only the primary outcomes in the subgroup analysis (<a href="#CD009666-sec-0042">Primary outcomes</a>). We did not conduct subgroup analyses for outcomes with three or fewer trials. We explored the forest plots visually and identified where CI did not overlap to identify differences between subgroup categories. We also formally investigated differences between two or more subgroups (<a href="./references#CD009666-bbs2-0066" title="BorensteinM , HedgesLV , HigginsJPT , RothsteinHR . Introduction to Meta‐Analysis. Oxford (UK): John Wiley &amp; Sons, 2009. ">Borenstein 2009</a>). </p> </section> <section id="CD009666-sec-0081"> <h4 class="title">Sensitivity analysis</h4> <p>We carried out a sensitivity analysis to explore:</p> <p> <ul id="CD009666-list-0019"> <li> <p>the effects of removing trials at high risk of bias (trials with poor or unclear allocation concealment and blinding on either domain (i.e. both participants and personnel) or high/imbalanced loss to follow‐up) from the analysis; </p> </li> <li> <p>the effects of different ICC values for cluster trials (where these were included, see <a href="#CD009666-sec-0070">Unit of analysis issues</a>); and </p> </li> <li> <p>trials with mixed populations in which marginal decisions were made (i.e. when trials included populations with an age range broader than that of our inclusion criterion: <a href="#CD009666-sec-0037">Criteria for considering studies for this review</a>). </p> </li> </ul> </p> <p>We conducted the following, post‐hoc sensitivity analysis:</p> <p> <ul id="CD009666-list-0020"> <li> <p>the effects of combining studies comparing the intervention versus no intervention or placebo. </p> </li> </ul> </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD009666-sec-0082" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD009666-sec-0082"></div> <section id="CD009666-sec-0083"> <h3 class="title">Description of studies</h3> <section id="CD009666-sec-0084"> <h4 class="title">Results of the search</h4> <p><a href="#CD009666-fig-0001">Figure 1</a> depicts the process for assessing and selecting trials for inclusion in this review. The search strategy identified 12,437 records for possible inclusion and 10,477 were available after duplicate records were removed. We assessed 81 full‐text reports corresponding to 57 studies for eligibility. We included 13 trials (17 reports) in the review, excluded 38 trials (57 reports) with reasons (<a href="./references#CD009666-sec-0175" title="">Characteristics of excluded studies</a> table), and identified six ongoing or unpublished trials (<a href="./references#CD009666-bbs2-0052" title="ACTRN12616001245482 . Food fortification powder for improving micronutrient status in underweight and overweight/obese primary school children [The effect of a multiple micronutrient powder for point‐of‐use fortification of foods on the micronutrient status of underweight and overweight/obese primary school children in Vietnam ‐ a randomised controlled trial]. apps.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12616001245482 Date first registered: 6 September 2016. ">ACTRN12616001245482</a>; <a href="./references#CD009666-bbs2-0053" title="NCT01917032 . Effect of home‐fortification with micronutrient powder sprinkles in hematologic and nutritional status in preschool children in Medellín: a randomized clinical trial. clinicaltrials.gov/show/NCT01917032 Date first received: 2 August 2013. ">NCT01917032</a>; <a href="./references#CD009666-bbs2-0054" title="NCT02280330 . Iodine intake &amp; status of preschoolers given micronutrient powder for 6 months. clinicaltrials.gov/ct2/show/NCT02280330 Date first received: 27 October 2014. ">NCT02280330</a>; <a href="./references#CD009666-bbs2-0055" title="NCT02302729 . Early child development and nutrition in Guatemala. clinicaltrials.gov/ct2/show/study/NCT02302729 Date first received: 31 October 2014. ">NCT02302729</a>; <a href="./references#CD009666-bbs2-0056" title="KureishyS , KhanGN , ArrifS , AshrafK , CespedesA , HabibMA , et al. A mixed methods study to assess the effectiveness of food‐based interventions to prevent stunting among children under‐five years in Districts Thatta and Sujawal, Sindh Province, Pakistan: study protocol. BMC Public Health2017;17(1):1‐6. [DOI: 10.1186/s12889‐016‐3976‐y; PUBMED: 28056945] NCT02422953 . Effectiveness of food/nutrient based interventions to prevent stunting among children under five in Thatta and Sajawal districts, Sindh province, Pakistan. clinicaltrials.gov/ct2/show/record/NCT02422953 Date first received: 15 April 2015. ">NCT02422953</a>; <a href="./references#CD009666-bbs2-0057" title="PACTR201607001693286 . The efficacy of multiple micronutrient powder supplementation in children under five years in Arusha District. apps.who.int/trialsearch/Trial2.aspx?TrialID=PACTR201607001693286 Date first registered: 24 June 2016. ">PACTR201607001693286</a>). </p> <div class="figure" id="CD009666-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD009666-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD009666-sec-0085"> <h4 class="title">Included studies</h4> <p>We included 13 trials with 5810 participants. All included trials contributed data to the review but some trials randomised participants to intervention arms that were not relevant to the comparisons we assessed. We have indicated in the <a href="./references#CD009666-sec-0174" title="">Characteristics of included studies</a> tables if we did not include any randomised arms in the analyses. Nine out of 12 trials were randomised at cluster level (labelled with a '(C)'), and for them, we have only included the estimated effective sample size in the analysis, after adjusting the data to account for the clustering effect. </p> <p>In addition to the published papers, abstracts and reports identified by the search, one trial author provided us with the original data sets, for us to analyse the results for children aged 24 months and older only (<a href="./references#CD009666-bbs2-0004" title="LundeenE [pers comm] . Kyrgyz Republic MNP data for children 24‐36 months. Email to: M Jefferds 3 November 2011. LundeenE , SchuethT , ToktobaevN , ZlotkinS , HyderSM , HouserR . Daily use of Sprinkles micronutrient powder for 2 months reduces anemia among children 6 to 36 months of age in the Kyrgyz Republic: a cluster‐randomized trial. Food and Nutrition Bulletin2010;31(3):446‐60. [DOI: 10.1177/156482651003100307; PUBMED: 20973465] ">Lundeen 2010 (C)</a>. Additionally, we obtained additional information on the studies for various included studies (<a href="./references#CD009666-bbs2-0001" title="InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Combined intensive nutrition education and micronutrient powder supplementation improved nutritional status of mildly wasted children on Nias Island, Indonesia. Asia Pacific Journal of Clinical Nutrition2012;21(3):361‐73. [PUBMED: 22705425] InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Improved nutrition knowledge and practice through intensive nutrition education: a study among caregivers of mildly wasted children on Nias Island, Indonesia. Food and Nutrition Bulletin2012;33(2):117‐27. [DOI: 10.1177/156482651203300205; PUBMED: 22908693] PurwestriRC , ScherbaumV , InayatiDA , WirawanNN , SuryantanJ , BloemMA , et al. Supplementary feeding with locally‐produced ready‐to‐use food (RUF) for mildly wasted children on Nias Island, Indonesia: comparison of daily and weekly programme outcomes. Asia Pacific Journal of Clinical Nutrition2012;21(3):374‐9. [PUBMED: 22705426] ScherbaumV [pers comm] . Your paper on MNP. Email to: LM De‐Regil 5 February 2013. ">Inayati 2012 (C)</a>; <a href="./references#CD009666-bbs2-0004" title="LundeenE [pers comm] . Kyrgyz Republic MNP data for children 24‐36 months. Email to: M Jefferds 3 November 2011. LundeenE , SchuethT , ToktobaevN , ZlotkinS , HyderSM , HouserR . Daily use of Sprinkles micronutrient powder for 2 months reduces anemia among children 6 to 36 months of age in the Kyrgyz Republic: a cluster‐randomized trial. Food and Nutrition Bulletin2010;31(3):446‐60. [DOI: 10.1177/156482651003100307; PUBMED: 20973465] ">Lundeen 2010 (C)</a>; <a href="./references#CD009666-bbs2-0006" title="JerlingJ [pers comm] . Regards and question on Ogundale et al 2011 vir Cochrane review. Email to: JP Pena‐Rosas 3 November 2011. OgunladeAO , KrugerHS , JerlingJC , SmutsCM , CovicN , HanekomSM , et al. Point‐of‐use micronutrient fortification: lessons learned in implementing a preschool‐based pilot trial in South Africa. International Journal of Food Sciences and Nutrition2011;62(1):1‐16. [DOI: 10.3109/09637486.2010.495710; PUBMED: 20701549] ">Ogunlade 2011</a>; <a href="./references#CD009666-bbs2-0009" title="SharieffW , YinSA , WuM , YangQ , SchauerC , TomlinsonG , et al. Short‐term daily or weekly administration of micronutrient Sprinkles has high compliance and does not cause iron overload in Chinese schoolchildren: a cluster‐randomized trial. Public Health Nutrition2006;9(3):336‐44. [PUBMED: 16684385] ZlotkinS [pers comm] . Regards and question ‐ Sharieff 2006. Email to: JP Peña‐Rosas 2 November 2011. ">Sharieff 2006 (C)</a>; <a href="./references#CD009666-bbs2-0010" title="TroeschB [pers comm] . Regards and question on Troesch et al 2011. Email to: JP Peña‐Rosas 1 November 2011. TroeschB , vanStuijvenbergME , SmutsCM , KrugerHS , BiebingerR , HurrellRF , et al. A micronutrient powder with low doses of highly absorbable iron and zinc reduces iron and zinc deficiency and improves weight‐for‐age Z‐scores in South African children. Journal of Nutrition2011;141(2):237‐42. [DOI: 10.3945/jn.110.129247; PUBMED: 21178093] ">Troesch 2011b</a>), and obtained useful information for the description of the study or the 'Risk of bias' assessment. This is presented in the <a href="./references#CD009666-sec-0174" title="">Characteristics of included studies</a> table. </p> <section id="CD009666-sec-0086"> <h5 class="title">Settings</h5> <p>All 13 trials were published after 2005, with four taking place in India (<a href="./references#CD009666-bbs2-0008" title="OseiAK , HouserRF , BulusuS , HamerDH . Acceptability of micronutrient fortified school meals by schoolchildren in rural Himalayan villages of India. Journal of Food Science2008;73(7):S354‐8. [DOI: 10.1111/j.1750‐3841.2008.00878.x; PUBMED: 18803728] OseiAK , RosenbergIH , HouserRF , BulusuS , MathewsM , HamerDH . Community‐level micronutrient fortification of school lunch meals improved vitamin A, folate, and iron status of schoolchildren in Himalayan villages of India. Journal of Nutrition2010;140(6):1146‐54. [DOI: 10.3945/jn.109.114751; PUBMED: 20410083] ">Osei 2008 (C)</a>; <a href="./references#CD009666-bbs2-0011" title="VarmaJL , DasS , SankarR , MannarMG , LevinsonFJ , HamerDH . Community‐level micronutrient fortification of a food supplement in India: a controlled trial in preschool children aged 36‐66 mo. American Journal of Clinical Nutrition2007;85(4):1127‐33. [PUBMED: 17413115] ">Varma 2007 (C)</a>; <a href="./references#CD009666-bbs2-0012" title="VinodkumarM , RajagopalanS . Impact of a multiple‐micronutrient food supplement on the nutritional status of schoolchildren. Food and Nutrition Bulletin2006;27(3):203‐10. [DOI: 10.1177/156482650602700302; PUBMED: 17542110] ">Vinodkumar 2006 (C)</a>; <a href="./references#CD009666-bbs2-0013" title="VinodkumarM , RajagopalanS . Efficacy of fortification of school meals with ferrous glycine phosphate and riboflavin against anemia and angular stomatitis in schoolchildren. Food and Nutrition Bulletin2009;30(3):260‐4. [DOI: 10.1177/156482650903000307; PUBMED: 19927606] ">Vinodkumar 2009 (C)</a>) and four in other parts of Asia: Indonesia (<a href="./references#CD009666-bbs2-0001" title="InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Combined intensive nutrition education and micronutrient powder supplementation improved nutritional status of mildly wasted children on Nias Island, Indonesia. Asia Pacific Journal of Clinical Nutrition2012;21(3):361‐73. [PUBMED: 22705425] InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Improved nutrition knowledge and practice through intensive nutrition education: a study among caregivers of mildly wasted children on Nias Island, Indonesia. Food and Nutrition Bulletin2012;33(2):117‐27. [DOI: 10.1177/156482651203300205; PUBMED: 22908693] PurwestriRC , ScherbaumV , InayatiDA , WirawanNN , SuryantanJ , BloemMA , et al. Supplementary feeding with locally‐produced ready‐to‐use food (RUF) for mildly wasted children on Nias Island, Indonesia: comparison of daily and weekly programme outcomes. Asia Pacific Journal of Clinical Nutrition2012;21(3):374‐9. [PUBMED: 22705426] ScherbaumV [pers comm] . Your paper on MNP. Email to: LM De‐Regil 5 February 2013. ">Inayati 2012 (C)</a>), Lao People's Democratic Republic (<a href="./references#CD009666-bbs2-0003" title="KounnavongS , SunaharaT , Mascie‐TaylorCG , HashizumeM , OkumuraJ , MojiK , et al. Effect of daily versus weekly home fortification with multiple micronutrient powder on haemoglobin concentration of young children in a rural area, Lao People's Democratic Republic: a randomised trial. Nutrition Journal2011;10(129):1‐11. [DOI: 10.1186/1475‐2891‐10‐129; PMC3266642; PUBMED: 22111770] ">Kounnavong 2011 (C)</a>), Kyrgyz Republic (<a href="./references#CD009666-bbs2-0004" title="LundeenE [pers comm] . Kyrgyz Republic MNP data for children 24‐36 months. Email to: M Jefferds 3 November 2011. LundeenE , SchuethT , ToktobaevN , ZlotkinS , HyderSM , HouserR . Daily use of Sprinkles micronutrient powder for 2 months reduces anemia among children 6 to 36 months of age in the Kyrgyz Republic: a cluster‐randomized trial. Food and Nutrition Bulletin2010;31(3):446‐60. [DOI: 10.1177/156482651003100307; PUBMED: 20973465] ">Lundeen 2010 (C)</a>), and China (<a href="./references#CD009666-bbs2-0009" title="SharieffW , YinSA , WuM , YangQ , SchauerC , TomlinsonG , et al. Short‐term daily or weekly administration of micronutrient Sprinkles has high compliance and does not cause iron overload in Chinese schoolchildren: a cluster‐randomized trial. Public Health Nutrition2006;9(3):336‐44. [PUBMED: 16684385] ZlotkinS [pers comm] . Regards and question ‐ Sharieff 2006. Email to: JP Peña‐Rosas 2 November 2011. ">Sharieff 2006 (C)</a>). Two trials each were carried out in South Africa (<a href="./references#CD009666-bbs2-0006" title="JerlingJ [pers comm] . Regards and question on Ogundale et al 2011 vir Cochrane review. Email to: JP Pena‐Rosas 3 November 2011. OgunladeAO , KrugerHS , JerlingJC , SmutsCM , CovicN , HanekomSM , et al. Point‐of‐use micronutrient fortification: lessons learned in implementing a preschool‐based pilot trial in South Africa. International Journal of Food Sciences and Nutrition2011;62(1):1‐16. [DOI: 10.3109/09637486.2010.495710; PUBMED: 20701549] ">Ogunlade 2011</a>; <a href="./references#CD009666-bbs2-0010" title="TroeschB [pers comm] . Regards and question on Troesch et al 2011. Email to: JP Peña‐Rosas 1 November 2011. TroeschB , vanStuijvenbergME , SmutsCM , KrugerHS , BiebingerR , HurrellRF , et al. A micronutrient powder with low doses of highly absorbable iron and zinc reduces iron and zinc deficiency and improves weight‐for‐age Z‐scores in South African children. Journal of Nutrition2011;141(2):237‐42. [DOI: 10.3945/jn.110.129247; PUBMED: 21178093] ">Troesch 2011b</a>) and Kenya (<a href="./references#CD009666-bbs2-0005" title="Macharia‐MutieCW , MorettiD , Van denBrielN , OmusundiAM , MwangiAM , KokFJ , et al. Maize porridge enriched with a micronutrient powder containing low‐dose iron as NaFeEDTA but not amaranth grain flour reduces anemia and iron deficiency in Kenyan preschool children. Journal of Nutrition2012;142(9):1756‐63. [DOI: 10.3945/jn.112.157578; PUBMED: 22810982] Macharia‐MutieCW , OmusundiAM , MwaiJM , MwangiAM , BrouwerID . Simulation of the effect of maize porridge fortified with grain amaranth or micronutrient powder containing NaFeEDTA on iron intake and status in Kenyan children. Public Health Nutrition2013;16(9):1605‐13. [DOI: 10.1017/S1368980012005174; PUBMED: 23218415] ">Macharia‐Mutie 2012</a>), while one study each was conducted in Honduras (<a href="./references#CD009666-bbs2-0002" title="KemmerTM , OmerPS , Gidvani‐DiazVK , CoelloM . Acceptance and effect of ferrous fumarate containing micronutrient sprinkles on anemia, iron deficiency and anthropometrics in Honduran children. In: SilverbergDS editor(s). Anemia. Rijeka (Croatia): InTech, 2012. [DOI: 10.5772/30987] ">Kemmer 2012 (C)</a>) and Colombia (<a href="./references#CD009666-bbs2-0007" title="OrozcoJ , VargasC , RojasML , HerreraAM , MontoyaL , SánchezJG , et al. The effect of powdered micronutrients on the hematologic values and nutritional status of healthy preschoolers. Medellín, 2013 [Efecto de los micronutrientes en polvo en el estado nutricional y en los valores hemáticos de preescolares sanos. Medellín, 2013]. Revista Facultad Nacional de Salud Pública2015;33(2):161‐70. [DOI: 10.17533/udea.rfnsp.v33n2a03] ">Orozco 2015 (C)</a>). </p> <p>Nine trials took place in institutional settings with eight occurring in schools (<a href="./references#CD009666-bbs2-0006" title="JerlingJ [pers comm] . Regards and question on Ogundale et al 2011 vir Cochrane review. Email to: JP Pena‐Rosas 3 November 2011. OgunladeAO , KrugerHS , JerlingJC , SmutsCM , CovicN , HanekomSM , et al. Point‐of‐use micronutrient fortification: lessons learned in implementing a preschool‐based pilot trial in South Africa. International Journal of Food Sciences and Nutrition2011;62(1):1‐16. [DOI: 10.3109/09637486.2010.495710; PUBMED: 20701549] ">Ogunlade 2011</a>; <a href="./references#CD009666-bbs2-0007" title="OrozcoJ , VargasC , RojasML , HerreraAM , MontoyaL , SánchezJG , et al. The effect of powdered micronutrients on the hematologic values and nutritional status of healthy preschoolers. Medellín, 2013 [Efecto de los micronutrientes en polvo en el estado nutricional y en los valores hemáticos de preescolares sanos. Medellín, 2013]. Revista Facultad Nacional de Salud Pública2015;33(2):161‐70. [DOI: 10.17533/udea.rfnsp.v33n2a03] ">Orozco 2015 (C)</a>; <a href="./references#CD009666-bbs2-0008" title="OseiAK , HouserRF , BulusuS , HamerDH . Acceptability of micronutrient fortified school meals by schoolchildren in rural Himalayan villages of India. Journal of Food Science2008;73(7):S354‐8. [DOI: 10.1111/j.1750‐3841.2008.00878.x; PUBMED: 18803728] OseiAK , RosenbergIH , HouserRF , BulusuS , MathewsM , HamerDH . Community‐level micronutrient fortification of school lunch meals improved vitamin A, folate, and iron status of schoolchildren in Himalayan villages of India. Journal of Nutrition2010;140(6):1146‐54. [DOI: 10.3945/jn.109.114751; PUBMED: 20410083] ">Osei 2008 (C)</a>; <a href="./references#CD009666-bbs2-0009" title="SharieffW , YinSA , WuM , YangQ , SchauerC , TomlinsonG , et al. Short‐term daily or weekly administration of micronutrient Sprinkles has high compliance and does not cause iron overload in Chinese schoolchildren: a cluster‐randomized trial. Public Health Nutrition2006;9(3):336‐44. [PUBMED: 16684385] ZlotkinS [pers comm] . Regards and question ‐ Sharieff 2006. Email to: JP Peña‐Rosas 2 November 2011. ">Sharieff 2006 (C)</a>; <a href="./references#CD009666-bbs2-0010" title="TroeschB [pers comm] . Regards and question on Troesch et al 2011. Email to: JP Peña‐Rosas 1 November 2011. TroeschB , vanStuijvenbergME , SmutsCM , KrugerHS , BiebingerR , HurrellRF , et al. A micronutrient powder with low doses of highly absorbable iron and zinc reduces iron and zinc deficiency and improves weight‐for‐age Z‐scores in South African children. Journal of Nutrition2011;141(2):237‐42. [DOI: 10.3945/jn.110.129247; PUBMED: 21178093] ">Troesch 2011b</a>; <a href="./references#CD009666-bbs2-0011" title="VarmaJL , DasS , SankarR , MannarMG , LevinsonFJ , HamerDH . Community‐level micronutrient fortification of a food supplement in India: a controlled trial in preschool children aged 36‐66 mo. American Journal of Clinical Nutrition2007;85(4):1127‐33. [PUBMED: 17413115] ">Varma 2007 (C)</a>; <a href="./references#CD009666-bbs2-0012" title="VinodkumarM , RajagopalanS . Impact of a multiple‐micronutrient food supplement on the nutritional status of schoolchildren. Food and Nutrition Bulletin2006;27(3):203‐10. [DOI: 10.1177/156482650602700302; PUBMED: 17542110] ">Vinodkumar 2006 (C)</a>; <a href="./references#CD009666-bbs2-0013" title="VinodkumarM , RajagopalanS . Efficacy of fortification of school meals with ferrous glycine phosphate and riboflavin against anemia and angular stomatitis in schoolchildren. Food and Nutrition Bulletin2009;30(3):260‐4. [DOI: 10.1177/156482650903000307; PUBMED: 19927606] ">Vinodkumar 2009 (C)</a>) and one in a feeding centre (<a href="./references#CD009666-bbs2-0005" title="Macharia‐MutieCW , MorettiD , Van denBrielN , OmusundiAM , MwangiAM , KokFJ , et al. Maize porridge enriched with a micronutrient powder containing low‐dose iron as NaFeEDTA but not amaranth grain flour reduces anemia and iron deficiency in Kenyan preschool children. Journal of Nutrition2012;142(9):1756‐63. [DOI: 10.3945/jn.112.157578; PUBMED: 22810982] Macharia‐MutieCW , OmusundiAM , MwaiJM , MwangiAM , BrouwerID . Simulation of the effect of maize porridge fortified with grain amaranth or micronutrient powder containing NaFeEDTA on iron intake and status in Kenyan children. Public Health Nutrition2013;16(9):1605‐13. [DOI: 10.1017/S1368980012005174; PUBMED: 23218415] ">Macharia‐Mutie 2012</a>). The remaining trials took place in communities. </p> <p>Three trials reported to be conducted in areas where malaria is endemic (<a href="./references#CD009666-bbs2-0003" title="KounnavongS , SunaharaT , Mascie‐TaylorCG , HashizumeM , OkumuraJ , MojiK , et al. Effect of daily versus weekly home fortification with multiple micronutrient powder on haemoglobin concentration of young children in a rural area, Lao People's Democratic Republic: a randomised trial. Nutrition Journal2011;10(129):1‐11. [DOI: 10.1186/1475‐2891‐10‐129; PMC3266642; PUBMED: 22111770] ">Kounnavong 2011 (C)</a>; <a href="./references#CD009666-bbs2-0005" title="Macharia‐MutieCW , MorettiD , Van denBrielN , OmusundiAM , MwangiAM , KokFJ , et al. Maize porridge enriched with a micronutrient powder containing low‐dose iron as NaFeEDTA but not amaranth grain flour reduces anemia and iron deficiency in Kenyan preschool children. Journal of Nutrition2012;142(9):1756‐63. [DOI: 10.3945/jn.112.157578; PUBMED: 22810982] Macharia‐MutieCW , OmusundiAM , MwaiJM , MwangiAM , BrouwerID . Simulation of the effect of maize porridge fortified with grain amaranth or micronutrient powder containing NaFeEDTA on iron intake and status in Kenyan children. Public Health Nutrition2013;16(9):1605‐13. [DOI: 10.1017/S1368980012005174; PUBMED: 23218415] ">Macharia‐Mutie 2012</a>; <a href="./references#CD009666-bbs2-0011" title="VarmaJL , DasS , SankarR , MannarMG , LevinsonFJ , HamerDH . Community‐level micronutrient fortification of a food supplement in India: a controlled trial in preschool children aged 36‐66 mo. American Journal of Clinical Nutrition2007;85(4):1127‐33. [PUBMED: 17413115] ">Varma 2007 (C)</a>). </p> <p>We have indicated in the <a href="./references#CD009666-sec-0174" title="">Characteristics of included studies</a> table the reported baseline prevalence of anaemia, which varied substantially across the trials that provided this information (range 7.3% to 92% among the nine trials reporting these data that did not exclude participants with anaemia). </p> </section> <section id="CD009666-sec-0087"> <h5 class="title">Participants</h5> <p>Among the 13 trials, the sample sizes ranged between 90 and 2193 participants, and included children from six months up to 15 years of age. Six trials only included children up to 59 months of age (<a href="./references#CD009666-bbs2-0001" title="InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Combined intensive nutrition education and micronutrient powder supplementation improved nutritional status of mildly wasted children on Nias Island, Indonesia. Asia Pacific Journal of Clinical Nutrition2012;21(3):361‐73. [PUBMED: 22705425] InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Improved nutrition knowledge and practice through intensive nutrition education: a study among caregivers of mildly wasted children on Nias Island, Indonesia. Food and Nutrition Bulletin2012;33(2):117‐27. [DOI: 10.1177/156482651203300205; PUBMED: 22908693] PurwestriRC , ScherbaumV , InayatiDA , WirawanNN , SuryantanJ , BloemMA , et al. Supplementary feeding with locally‐produced ready‐to‐use food (RUF) for mildly wasted children on Nias Island, Indonesia: comparison of daily and weekly programme outcomes. Asia Pacific Journal of Clinical Nutrition2012;21(3):374‐9. [PUBMED: 22705426] ScherbaumV [pers comm] . Your paper on MNP. Email to: LM De‐Regil 5 February 2013. ">Inayati 2012 (C)</a>; <a href="./references#CD009666-bbs2-0002" title="KemmerTM , OmerPS , Gidvani‐DiazVK , CoelloM . Acceptance and effect of ferrous fumarate containing micronutrient sprinkles on anemia, iron deficiency and anthropometrics in Honduran children. In: SilverbergDS editor(s). Anemia. Rijeka (Croatia): InTech, 2012. [DOI: 10.5772/30987] ">Kemmer 2012 (C)</a>; <a href="./references#CD009666-bbs2-0003" title="KounnavongS , SunaharaT , Mascie‐TaylorCG , HashizumeM , OkumuraJ , MojiK , et al. Effect of daily versus weekly home fortification with multiple micronutrient powder on haemoglobin concentration of young children in a rural area, Lao People's Democratic Republic: a randomised trial. Nutrition Journal2011;10(129):1‐11. [DOI: 10.1186/1475‐2891‐10‐129; PMC3266642; PUBMED: 22111770] ">Kounnavong 2011 (C)</a>; <a href="./references#CD009666-bbs2-0004" title="LundeenE [pers comm] . Kyrgyz Republic MNP data for children 24‐36 months. Email to: M Jefferds 3 November 2011. LundeenE , SchuethT , ToktobaevN , ZlotkinS , HyderSM , HouserR . Daily use of Sprinkles micronutrient powder for 2 months reduces anemia among children 6 to 36 months of age in the Kyrgyz Republic: a cluster‐randomized trial. Food and Nutrition Bulletin2010;31(3):446‐60. [DOI: 10.1177/156482651003100307; PUBMED: 20973465] ">Lundeen 2010 (C)</a>; <a href="./references#CD009666-bbs2-0005" title="Macharia‐MutieCW , MorettiD , Van denBrielN , OmusundiAM , MwangiAM , KokFJ , et al. Maize porridge enriched with a micronutrient powder containing low‐dose iron as NaFeEDTA but not amaranth grain flour reduces anemia and iron deficiency in Kenyan preschool children. Journal of Nutrition2012;142(9):1756‐63. [DOI: 10.3945/jn.112.157578; PUBMED: 22810982] Macharia‐MutieCW , OmusundiAM , MwaiJM , MwangiAM , BrouwerID . Simulation of the effect of maize porridge fortified with grain amaranth or micronutrient powder containing NaFeEDTA on iron intake and status in Kenyan children. Public Health Nutrition2013;16(9):1605‐13. [DOI: 10.1017/S1368980012005174; PUBMED: 23218415] ">Macharia‐Mutie 2012</a>; <a href="./references#CD009666-bbs2-0007" title="OrozcoJ , VargasC , RojasML , HerreraAM , MontoyaL , SánchezJG , et al. The effect of powdered micronutrients on the hematologic values and nutritional status of healthy preschoolers. Medellín, 2013 [Efecto de los micronutrientes en polvo en el estado nutricional y en los valores hemáticos de preescolares sanos. Medellín, 2013]. Revista Facultad Nacional de Salud Pública2015;33(2):161‐70. [DOI: 10.17533/udea.rfnsp.v33n2a03] ">Orozco 2015 (C)</a>), while four trials included only children aged five years or older (<a href="./references#CD009666-bbs2-0008" title="OseiAK , HouserRF , BulusuS , HamerDH . Acceptability of micronutrient fortified school meals by schoolchildren in rural Himalayan villages of India. Journal of Food Science2008;73(7):S354‐8. [DOI: 10.1111/j.1750‐3841.2008.00878.x; PUBMED: 18803728] OseiAK , RosenbergIH , HouserRF , BulusuS , MathewsM , HamerDH . Community‐level micronutrient fortification of school lunch meals improved vitamin A, folate, and iron status of schoolchildren in Himalayan villages of India. Journal of Nutrition2010;140(6):1146‐54. [DOI: 10.3945/jn.109.114751; PUBMED: 20410083] ">Osei 2008 (C)</a>; <a href="./references#CD009666-bbs2-0010" title="TroeschB [pers comm] . Regards and question on Troesch et al 2011. Email to: JP Peña‐Rosas 1 November 2011. TroeschB , vanStuijvenbergME , SmutsCM , KrugerHS , BiebingerR , HurrellRF , et al. A micronutrient powder with low doses of highly absorbable iron and zinc reduces iron and zinc deficiency and improves weight‐for‐age Z‐scores in South African children. Journal of Nutrition2011;141(2):237‐42. [DOI: 10.3945/jn.110.129247; PUBMED: 21178093] ">Troesch 2011b</a>; <a href="./references#CD009666-bbs2-0012" title="VinodkumarM , RajagopalanS . Impact of a multiple‐micronutrient food supplement on the nutritional status of schoolchildren. Food and Nutrition Bulletin2006;27(3):203‐10. [DOI: 10.1177/156482650602700302; PUBMED: 17542110] ">Vinodkumar 2006 (C)</a>; <a href="./references#CD009666-bbs2-0013" title="VinodkumarM , RajagopalanS . Efficacy of fortification of school meals with ferrous glycine phosphate and riboflavin against anemia and angular stomatitis in schoolchildren. Food and Nutrition Bulletin2009;30(3):260‐4. [DOI: 10.1177/156482650903000307; PUBMED: 19927606] ">Vinodkumar 2009 (C)</a>), and three trials included children both younger and older than 59 months of age (<a href="./references#CD009666-bbs2-0006" title="JerlingJ [pers comm] . Regards and question on Ogundale et al 2011 vir Cochrane review. Email to: JP Pena‐Rosas 3 November 2011. OgunladeAO , KrugerHS , JerlingJC , SmutsCM , CovicN , HanekomSM , et al. Point‐of‐use micronutrient fortification: lessons learned in implementing a preschool‐based pilot trial in South Africa. International Journal of Food Sciences and Nutrition2011;62(1):1‐16. [DOI: 10.3109/09637486.2010.495710; PUBMED: 20701549] ">Ogunlade 2011</a>; <a href="./references#CD009666-bbs2-0009" title="SharieffW , YinSA , WuM , YangQ , SchauerC , TomlinsonG , et al. Short‐term daily or weekly administration of micronutrient Sprinkles has high compliance and does not cause iron overload in Chinese schoolchildren: a cluster‐randomized trial. Public Health Nutrition2006;9(3):336‐44. [PUBMED: 16684385] ZlotkinS [pers comm] . Regards and question ‐ Sharieff 2006. Email to: JP Peña‐Rosas 2 November 2011. ">Sharieff 2006 (C)</a>; <a href="./references#CD009666-bbs2-0011" title="VarmaJL , DasS , SankarR , MannarMG , LevinsonFJ , HamerDH . Community‐level micronutrient fortification of a food supplement in India: a controlled trial in preschool children aged 36‐66 mo. American Journal of Clinical Nutrition2007;85(4):1127‐33. [PUBMED: 17413115] ">Varma 2007 (C)</a>). Eleven trials included boys and girls; two trials did not report the sex of the participants (<a href="./references#CD009666-bbs2-0012" title="VinodkumarM , RajagopalanS . Impact of a multiple‐micronutrient food supplement on the nutritional status of schoolchildren. Food and Nutrition Bulletin2006;27(3):203‐10. [DOI: 10.1177/156482650602700302; PUBMED: 17542110] ">Vinodkumar 2006 (C)</a>; <a href="./references#CD009666-bbs2-0013" title="VinodkumarM , RajagopalanS . Efficacy of fortification of school meals with ferrous glycine phosphate and riboflavin against anemia and angular stomatitis in schoolchildren. Food and Nutrition Bulletin2009;30(3):260‐4. [DOI: 10.1177/156482650903000307; PUBMED: 19927606] ">Vinodkumar 2009 (C)</a>). </p> <p>Seven trials excluded children with low Hb values (cut‐offs varied and ranged from 70 g/L to 110 g/L or lower) (<a href="./references#CD009666-bbs2-0003" title="KounnavongS , SunaharaT , Mascie‐TaylorCG , HashizumeM , OkumuraJ , MojiK , et al. Effect of daily versus weekly home fortification with multiple micronutrient powder on haemoglobin concentration of young children in a rural area, Lao People's Democratic Republic: a randomised trial. Nutrition Journal2011;10(129):1‐11. [DOI: 10.1186/1475‐2891‐10‐129; PMC3266642; PUBMED: 22111770] ">Kounnavong 2011 (C)</a>; <a href="./references#CD009666-bbs2-0004" title="LundeenE [pers comm] . Kyrgyz Republic MNP data for children 24‐36 months. Email to: M Jefferds 3 November 2011. LundeenE , SchuethT , ToktobaevN , ZlotkinS , HyderSM , HouserR . Daily use of Sprinkles micronutrient powder for 2 months reduces anemia among children 6 to 36 months of age in the Kyrgyz Republic: a cluster‐randomized trial. Food and Nutrition Bulletin2010;31(3):446‐60. [DOI: 10.1177/156482651003100307; PUBMED: 20973465] ">Lundeen 2010 (C)</a>; <a href="./references#CD009666-bbs2-0007" title="OrozcoJ , VargasC , RojasML , HerreraAM , MontoyaL , SánchezJG , et al. The effect of powdered micronutrients on the hematologic values and nutritional status of healthy preschoolers. Medellín, 2013 [Efecto de los micronutrientes en polvo en el estado nutricional y en los valores hemáticos de preescolares sanos. Medellín, 2013]. Revista Facultad Nacional de Salud Pública2015;33(2):161‐70. [DOI: 10.17533/udea.rfnsp.v33n2a03] ">Orozco 2015 (C)</a>; <a href="./references#CD009666-bbs2-0010" title="TroeschB [pers comm] . Regards and question on Troesch et al 2011. Email to: JP Peña‐Rosas 1 November 2011. TroeschB , vanStuijvenbergME , SmutsCM , KrugerHS , BiebingerR , HurrellRF , et al. A micronutrient powder with low doses of highly absorbable iron and zinc reduces iron and zinc deficiency and improves weight‐for‐age Z‐scores in South African children. Journal of Nutrition2011;141(2):237‐42. [DOI: 10.3945/jn.110.129247; PUBMED: 21178093] ">Troesch 2011b</a>; <a href="./references#CD009666-bbs2-0011" title="VarmaJL , DasS , SankarR , MannarMG , LevinsonFJ , HamerDH . Community‐level micronutrient fortification of a food supplement in India: a controlled trial in preschool children aged 36‐66 mo. American Journal of Clinical Nutrition2007;85(4):1127‐33. [PUBMED: 17413115] ">Varma 2007 (C)</a>; <a href="./references#CD009666-bbs2-0012" title="VinodkumarM , RajagopalanS . Impact of a multiple‐micronutrient food supplement on the nutritional status of schoolchildren. Food and Nutrition Bulletin2006;27(3):203‐10. [DOI: 10.1177/156482650602700302; PUBMED: 17542110] ">Vinodkumar 2006 (C)</a>; <a href="./references#CD009666-bbs2-0013" title="VinodkumarM , RajagopalanS . Efficacy of fortification of school meals with ferrous glycine phosphate and riboflavin against anemia and angular stomatitis in schoolchildren. Food and Nutrition Bulletin2009;30(3):260‐4. [DOI: 10.1177/156482650903000307; PUBMED: 19927606] ">Vinodkumar 2009 (C)</a>), while the study in Honduras included only non‐anaemic children (<a href="./references#CD009666-bbs2-0002" title="KemmerTM , OmerPS , Gidvani‐DiazVK , CoelloM . Acceptance and effect of ferrous fumarate containing micronutrient sprinkles on anemia, iron deficiency and anthropometrics in Honduran children. In: SilverbergDS editor(s). Anemia. Rijeka (Croatia): InTech, 2012. [DOI: 10.5772/30987] ">Kemmer 2012 (C)</a>). Overall, the participants in these trials came from low‐ and middle‐income populations, with the authors of seven trials reporting that participants were of low socioeconomic status (<a href="./references#CD009666-bbs2-0001" title="InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Combined intensive nutrition education and micronutrient powder supplementation improved nutritional status of mildly wasted children on Nias Island, Indonesia. Asia Pacific Journal of Clinical Nutrition2012;21(3):361‐73. [PUBMED: 22705425] InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Improved nutrition knowledge and practice through intensive nutrition education: a study among caregivers of mildly wasted children on Nias Island, Indonesia. Food and Nutrition Bulletin2012;33(2):117‐27. [DOI: 10.1177/156482651203300205; PUBMED: 22908693] PurwestriRC , ScherbaumV , InayatiDA , WirawanNN , SuryantanJ , BloemMA , et al. Supplementary feeding with locally‐produced ready‐to‐use food (RUF) for mildly wasted children on Nias Island, Indonesia: comparison of daily and weekly programme outcomes. Asia Pacific Journal of Clinical Nutrition2012;21(3):374‐9. [PUBMED: 22705426] ScherbaumV [pers comm] . Your paper on MNP. Email to: LM De‐Regil 5 February 2013. ">Inayati 2012 (C)</a>; <a href="./references#CD009666-bbs2-0004" title="LundeenE [pers comm] . Kyrgyz Republic MNP data for children 24‐36 months. Email to: M Jefferds 3 November 2011. LundeenE , SchuethT , ToktobaevN , ZlotkinS , HyderSM , HouserR . Daily use of Sprinkles micronutrient powder for 2 months reduces anemia among children 6 to 36 months of age in the Kyrgyz Republic: a cluster‐randomized trial. Food and Nutrition Bulletin2010;31(3):446‐60. [DOI: 10.1177/156482651003100307; PUBMED: 20973465] ">Lundeen 2010 (C)</a>; <a href="./references#CD009666-bbs2-0006" title="JerlingJ [pers comm] . Regards and question on Ogundale et al 2011 vir Cochrane review. Email to: JP Pena‐Rosas 3 November 2011. OgunladeAO , KrugerHS , JerlingJC , SmutsCM , CovicN , HanekomSM , et al. Point‐of‐use micronutrient fortification: lessons learned in implementing a preschool‐based pilot trial in South Africa. International Journal of Food Sciences and Nutrition2011;62(1):1‐16. [DOI: 10.3109/09637486.2010.495710; PUBMED: 20701549] ">Ogunlade 2011</a>; <a href="./references#CD009666-bbs2-0007" title="OrozcoJ , VargasC , RojasML , HerreraAM , MontoyaL , SánchezJG , et al. The effect of powdered micronutrients on the hematologic values and nutritional status of healthy preschoolers. Medellín, 2013 [Efecto de los micronutrientes en polvo en el estado nutricional y en los valores hemáticos de preescolares sanos. Medellín, 2013]. Revista Facultad Nacional de Salud Pública2015;33(2):161‐70. [DOI: 10.17533/udea.rfnsp.v33n2a03] ">Orozco 2015 (C)</a>; <a href="./references#CD009666-bbs2-0010" title="TroeschB [pers comm] . Regards and question on Troesch et al 2011. Email to: JP Peña‐Rosas 1 November 2011. TroeschB , vanStuijvenbergME , SmutsCM , KrugerHS , BiebingerR , HurrellRF , et al. A micronutrient powder with low doses of highly absorbable iron and zinc reduces iron and zinc deficiency and improves weight‐for‐age Z‐scores in South African children. Journal of Nutrition2011;141(2):237‐42. [DOI: 10.3945/jn.110.129247; PUBMED: 21178093] ">Troesch 2011b</a>; <a href="./references#CD009666-bbs2-0012" title="VinodkumarM , RajagopalanS . Impact of a multiple‐micronutrient food supplement on the nutritional status of schoolchildren. Food and Nutrition Bulletin2006;27(3):203‐10. [DOI: 10.1177/156482650602700302; PUBMED: 17542110] ">Vinodkumar 2006 (C)</a>; <a href="./references#CD009666-bbs2-0013" title="VinodkumarM , RajagopalanS . Efficacy of fortification of school meals with ferrous glycine phosphate and riboflavin against anemia and angular stomatitis in schoolchildren. Food and Nutrition Bulletin2009;30(3):260‐4. [DOI: 10.1177/156482650903000307; PUBMED: 19927606] ">Vinodkumar 2009 (C)</a>), and three trials describing the participants as living in rural agricultural communities (<a href="./references#CD009666-bbs2-0002" title="KemmerTM , OmerPS , Gidvani‐DiazVK , CoelloM . Acceptance and effect of ferrous fumarate containing micronutrient sprinkles on anemia, iron deficiency and anthropometrics in Honduran children. In: SilverbergDS editor(s). Anemia. Rijeka (Croatia): InTech, 2012. [DOI: 10.5772/30987] ">Kemmer 2012 (C)</a>; <a href="./references#CD009666-bbs2-0005" title="Macharia‐MutieCW , MorettiD , Van denBrielN , OmusundiAM , MwangiAM , KokFJ , et al. Maize porridge enriched with a micronutrient powder containing low‐dose iron as NaFeEDTA but not amaranth grain flour reduces anemia and iron deficiency in Kenyan preschool children. Journal of Nutrition2012;142(9):1756‐63. [DOI: 10.3945/jn.112.157578; PUBMED: 22810982] Macharia‐MutieCW , OmusundiAM , MwaiJM , MwangiAM , BrouwerID . Simulation of the effect of maize porridge fortified with grain amaranth or micronutrient powder containing NaFeEDTA on iron intake and status in Kenyan children. Public Health Nutrition2013;16(9):1605‐13. [DOI: 10.1017/S1368980012005174; PUBMED: 23218415] ">Macharia‐Mutie 2012</a>; <a href="./references#CD009666-bbs2-0008" title="OseiAK , HouserRF , BulusuS , HamerDH . Acceptability of micronutrient fortified school meals by schoolchildren in rural Himalayan villages of India. Journal of Food Science2008;73(7):S354‐8. [DOI: 10.1111/j.1750‐3841.2008.00878.x; PUBMED: 18803728] OseiAK , RosenbergIH , HouserRF , BulusuS , MathewsM , HamerDH . Community‐level micronutrient fortification of school lunch meals improved vitamin A, folate, and iron status of schoolchildren in Himalayan villages of India. Journal of Nutrition2010;140(6):1146‐54. [DOI: 10.3945/jn.109.114751; PUBMED: 20410083] ">Osei 2008 (C)</a>). In two trials, the authors mentioned that some (<a href="./references#CD009666-bbs2-0003" title="KounnavongS , SunaharaT , Mascie‐TaylorCG , HashizumeM , OkumuraJ , MojiK , et al. Effect of daily versus weekly home fortification with multiple micronutrient powder on haemoglobin concentration of young children in a rural area, Lao People's Democratic Republic: a randomised trial. Nutrition Journal2011;10(129):1‐11. [DOI: 10.1186/1475‐2891‐10‐129; PMC3266642; PUBMED: 22111770] ">Kounnavong 2011 (C)</a>) or all (<a href="./references#CD009666-bbs2-0009" title="SharieffW , YinSA , WuM , YangQ , SchauerC , TomlinsonG , et al. Short‐term daily or weekly administration of micronutrient Sprinkles has high compliance and does not cause iron overload in Chinese schoolchildren: a cluster‐randomized trial. Public Health Nutrition2006;9(3):336‐44. [PUBMED: 16684385] ZlotkinS [pers comm] . Regards and question ‐ Sharieff 2006. Email to: JP Peña‐Rosas 2 November 2011. ">Sharieff 2006 (C)</a>) participants were relatively wealthy, based on household characteristics such as being able to pay school fees or having electricity, an improved water source and a latrine. </p> </section> <section id="CD009666-sec-0088"> <h5 class="title">Comparisons</h5> <p>All included trials compared the provision of MNP versus no intervention or placebo and are therefore included in comparison 1. None of the trials contributed data to any other comparison. </p> </section> <section id="CD009666-sec-0089"> <h5 class="title">Micronutrient powder composition, iron dose and regimen</h5> <p>As described in the <a href="./references#CD009666-sec-0174" title="">Characteristics of included studies</a> tables, there was little consistency in MNP composition across most trials. Three trials reported a formulation of 14 vitamins and minerals (<a href="./references#CD009666-bbs2-0001" title="InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Combined intensive nutrition education and micronutrient powder supplementation improved nutritional status of mildly wasted children on Nias Island, Indonesia. Asia Pacific Journal of Clinical Nutrition2012;21(3):361‐73. [PUBMED: 22705425] InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Improved nutrition knowledge and practice through intensive nutrition education: a study among caregivers of mildly wasted children on Nias Island, Indonesia. Food and Nutrition Bulletin2012;33(2):117‐27. [DOI: 10.1177/156482651203300205; PUBMED: 22908693] PurwestriRC , ScherbaumV , InayatiDA , WirawanNN , SuryantanJ , BloemMA , et al. Supplementary feeding with locally‐produced ready‐to‐use food (RUF) for mildly wasted children on Nias Island, Indonesia: comparison of daily and weekly programme outcomes. Asia Pacific Journal of Clinical Nutrition2012;21(3):374‐9. [PUBMED: 22705426] ScherbaumV [pers comm] . Your paper on MNP. Email to: LM De‐Regil 5 February 2013. ">Inayati 2012 (C)</a>; <a href="./references#CD009666-bbs2-0007" title="OrozcoJ , VargasC , RojasML , HerreraAM , MontoyaL , SánchezJG , et al. The effect of powdered micronutrients on the hematologic values and nutritional status of healthy preschoolers. Medellín, 2013 [Efecto de los micronutrientes en polvo en el estado nutricional y en los valores hemáticos de preescolares sanos. Medellín, 2013]. Revista Facultad Nacional de Salud Pública2015;33(2):161‐70. [DOI: 10.17533/udea.rfnsp.v33n2a03] ">Orozco 2015 (C)</a>; <a href="./references#CD009666-bbs2-0008" title="OseiAK , HouserRF , BulusuS , HamerDH . Acceptability of micronutrient fortified school meals by schoolchildren in rural Himalayan villages of India. Journal of Food Science2008;73(7):S354‐8. [DOI: 10.1111/j.1750‐3841.2008.00878.x; PUBMED: 18803728] OseiAK , RosenbergIH , HouserRF , BulusuS , MathewsM , HamerDH . Community‐level micronutrient fortification of school lunch meals improved vitamin A, folate, and iron status of schoolchildren in Himalayan villages of India. Journal of Nutrition2010;140(6):1146‐54. [DOI: 10.3945/jn.109.114751; PUBMED: 20410083] ">Osei 2008 (C)</a>), two trials reported a formulation with six vitamins and minerals (<a href="./references#CD009666-bbs2-0002" title="KemmerTM , OmerPS , Gidvani‐DiazVK , CoelloM . Acceptance and effect of ferrous fumarate containing micronutrient sprinkles on anemia, iron deficiency and anthropometrics in Honduran children. In: SilverbergDS editor(s). Anemia. Rijeka (Croatia): InTech, 2012. [DOI: 10.5772/30987] ">Kemmer 2012 (C)</a>; <a href="./references#CD009666-bbs2-0009" title="SharieffW , YinSA , WuM , YangQ , SchauerC , TomlinsonG , et al. Short‐term daily or weekly administration of micronutrient Sprinkles has high compliance and does not cause iron overload in Chinese schoolchildren: a cluster‐randomized trial. Public Health Nutrition2006;9(3):336‐44. [PUBMED: 16684385] ZlotkinS [pers comm] . Regards and question ‐ Sharieff 2006. Email to: JP Peña‐Rosas 2 November 2011. ">Sharieff 2006 (C)</a>), and each of the remaining trials reported a different formulation (range of two to 18 vitamin and minerals). </p> <p>The iron dose and type of iron compound also varied across trials. Four trials reported giving 10 mg of elemental iron either as NaFeEDTA (<a href="./references#CD009666-bbs2-0008" title="OseiAK , HouserRF , BulusuS , HamerDH . Acceptability of micronutrient fortified school meals by schoolchildren in rural Himalayan villages of India. Journal of Food Science2008;73(7):S354‐8. [DOI: 10.1111/j.1750‐3841.2008.00878.x; PUBMED: 18803728] OseiAK , RosenbergIH , HouserRF , BulusuS , MathewsM , HamerDH . Community‐level micronutrient fortification of school lunch meals improved vitamin A, folate, and iron status of schoolchildren in Himalayan villages of India. Journal of Nutrition2010;140(6):1146‐54. [DOI: 10.3945/jn.109.114751; PUBMED: 20410083] ">Osei 2008 (C)</a>), chelated ferrous sulphate (<a href="./references#CD009666-bbs2-0012" title="VinodkumarM , RajagopalanS . Impact of a multiple‐micronutrient food supplement on the nutritional status of schoolchildren. Food and Nutrition Bulletin2006;27(3):203‐10. [DOI: 10.1177/156482650602700302; PUBMED: 17542110] ">Vinodkumar 2006 (C)</a>), or microencapsulated ferrous fumarate (<a href="./references#CD009666-bbs2-0001" title="InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Combined intensive nutrition education and micronutrient powder supplementation improved nutritional status of mildly wasted children on Nias Island, Indonesia. Asia Pacific Journal of Clinical Nutrition2012;21(3):361‐73. [PUBMED: 22705425] InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Improved nutrition knowledge and practice through intensive nutrition education: a study among caregivers of mildly wasted children on Nias Island, Indonesia. Food and Nutrition Bulletin2012;33(2):117‐27. [DOI: 10.1177/156482651203300205; PUBMED: 22908693] PurwestriRC , ScherbaumV , InayatiDA , WirawanNN , SuryantanJ , BloemMA , et al. Supplementary feeding with locally‐produced ready‐to‐use food (RUF) for mildly wasted children on Nias Island, Indonesia: comparison of daily and weekly programme outcomes. Asia Pacific Journal of Clinical Nutrition2012;21(3):374‐9. [PUBMED: 22705426] ScherbaumV [pers comm] . Your paper on MNP. Email to: LM De‐Regil 5 February 2013. ">Inayati 2012 (C)</a>; <a href="./references#CD009666-bbs2-0003" title="KounnavongS , SunaharaT , Mascie‐TaylorCG , HashizumeM , OkumuraJ , MojiK , et al. Effect of daily versus weekly home fortification with multiple micronutrient powder on haemoglobin concentration of young children in a rural area, Lao People's Democratic Republic: a randomised trial. Nutrition Journal2011;10(129):1‐11. [DOI: 10.1186/1475‐2891‐10‐129; PMC3266642; PUBMED: 22111770] ">Kounnavong 2011 (C)</a>). Three trials gave 12.5 mg of elemental iron as microencapsulated ferrous fumarate (<a href="./references#CD009666-bbs2-0002" title="KemmerTM , OmerPS , Gidvani‐DiazVK , CoelloM . Acceptance and effect of ferrous fumarate containing micronutrient sprinkles on anemia, iron deficiency and anthropometrics in Honduran children. In: SilverbergDS editor(s). Anemia. Rijeka (Croatia): InTech, 2012. [DOI: 10.5772/30987] ">Kemmer 2012 (C)</a>; <a href="./references#CD009666-bbs2-0004" title="LundeenE [pers comm] . Kyrgyz Republic MNP data for children 24‐36 months. Email to: M Jefferds 3 November 2011. LundeenE , SchuethT , ToktobaevN , ZlotkinS , HyderSM , HouserR . Daily use of Sprinkles micronutrient powder for 2 months reduces anemia among children 6 to 36 months of age in the Kyrgyz Republic: a cluster‐randomized trial. Food and Nutrition Bulletin2010;31(3):446‐60. [DOI: 10.1177/156482651003100307; PUBMED: 20973465] ">Lundeen 2010 (C)</a>; <a href="./references#CD009666-bbs2-0007" title="OrozcoJ , VargasC , RojasML , HerreraAM , MontoyaL , SánchezJG , et al. The effect of powdered micronutrients on the hematologic values and nutritional status of healthy preschoolers. Medellín, 2013 [Efecto de los micronutrientes en polvo en el estado nutricional y en los valores hemáticos de preescolares sanos. Medellín, 2013]. Revista Facultad Nacional de Salud Pública2015;33(2):161‐70. [DOI: 10.17533/udea.rfnsp.v33n2a03] ">Orozco 2015 (C)</a>). Three trials gave 2.5 mg of elemental iron (<a href="./references#CD009666-bbs2-0005" title="Macharia‐MutieCW , MorettiD , Van denBrielN , OmusundiAM , MwangiAM , KokFJ , et al. Maize porridge enriched with a micronutrient powder containing low‐dose iron as NaFeEDTA but not amaranth grain flour reduces anemia and iron deficiency in Kenyan preschool children. Journal of Nutrition2012;142(9):1756‐63. [DOI: 10.3945/jn.112.157578; PUBMED: 22810982] Macharia‐MutieCW , OmusundiAM , MwaiJM , MwangiAM , BrouwerID . Simulation of the effect of maize porridge fortified with grain amaranth or micronutrient powder containing NaFeEDTA on iron intake and status in Kenyan children. Public Health Nutrition2013;16(9):1605‐13. [DOI: 10.1017/S1368980012005174; PUBMED: 23218415] ">Macharia‐Mutie 2012</a>; <a href="./references#CD009666-bbs2-0010" title="TroeschB [pers comm] . Regards and question on Troesch et al 2011. Email to: JP Peña‐Rosas 1 November 2011. TroeschB , vanStuijvenbergME , SmutsCM , KrugerHS , BiebingerR , HurrellRF , et al. A micronutrient powder with low doses of highly absorbable iron and zinc reduces iron and zinc deficiency and improves weight‐for‐age Z‐scores in South African children. Journal of Nutrition2011;141(2):237‐42. [DOI: 10.3945/jn.110.129247; PUBMED: 21178093] ">Troesch 2011b</a>) or 2.86 mg of elemental iron (<a href="./references#CD009666-bbs2-0006" title="JerlingJ [pers comm] . Regards and question on Ogundale et al 2011 vir Cochrane review. Email to: JP Pena‐Rosas 3 November 2011. OgunladeAO , KrugerHS , JerlingJC , SmutsCM , CovicN , HanekomSM , et al. Point‐of‐use micronutrient fortification: lessons learned in implementing a preschool‐based pilot trial in South Africa. International Journal of Food Sciences and Nutrition2011;62(1):1‐16. [DOI: 10.3109/09637486.2010.495710; PUBMED: 20701549] ">Ogunlade 2011</a>) as NaFeEDTA. Two trials gave 30 mg of elemental iron (<a href="./references#CD009666-bbs2-0009" title="SharieffW , YinSA , WuM , YangQ , SchauerC , TomlinsonG , et al. Short‐term daily or weekly administration of micronutrient Sprinkles has high compliance and does not cause iron overload in Chinese schoolchildren: a cluster‐randomized trial. Public Health Nutrition2006;9(3):336‐44. [PUBMED: 16684385] ZlotkinS [pers comm] . Regards and question ‐ Sharieff 2006. Email to: JP Peña‐Rosas 2 November 2011. ">Sharieff 2006 (C)</a>) or 14 mg of elemental iron (<a href="./references#CD009666-bbs2-0011" title="VarmaJL , DasS , SankarR , MannarMG , LevinsonFJ , HamerDH . Community‐level micronutrient fortification of a food supplement in India: a controlled trial in preschool children aged 36‐66 mo. American Journal of Clinical Nutrition2007;85(4):1127‐33. [PUBMED: 17413115] ">Varma 2007 (C)</a>) as microencapsulated ferrous fumarate, while one trial gave 28 mg of elemental iron as ferrous glycine phosphate (<a href="./references#CD009666-bbs2-0013" title="VinodkumarM , RajagopalanS . Efficacy of fortification of school meals with ferrous glycine phosphate and riboflavin against anemia and angular stomatitis in schoolchildren. Food and Nutrition Bulletin2009;30(3):260‐4. [DOI: 10.1177/156482650903000307; PUBMED: 19927606] ">Vinodkumar 2009 (C)</a>). Overall, seven trials used encapsulated ferrous fumarate (<a href="./references#CD009666-bbs2-0001" title="InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Combined intensive nutrition education and micronutrient powder supplementation improved nutritional status of mildly wasted children on Nias Island, Indonesia. Asia Pacific Journal of Clinical Nutrition2012;21(3):361‐73. [PUBMED: 22705425] InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Improved nutrition knowledge and practice through intensive nutrition education: a study among caregivers of mildly wasted children on Nias Island, Indonesia. Food and Nutrition Bulletin2012;33(2):117‐27. [DOI: 10.1177/156482651203300205; PUBMED: 22908693] PurwestriRC , ScherbaumV , InayatiDA , WirawanNN , SuryantanJ , BloemMA , et al. Supplementary feeding with locally‐produced ready‐to‐use food (RUF) for mildly wasted children on Nias Island, Indonesia: comparison of daily and weekly programme outcomes. Asia Pacific Journal of Clinical Nutrition2012;21(3):374‐9. [PUBMED: 22705426] ScherbaumV [pers comm] . Your paper on MNP. Email to: LM De‐Regil 5 February 2013. ">Inayati 2012 (C)</a>; <a href="./references#CD009666-bbs2-0002" title="KemmerTM , OmerPS , Gidvani‐DiazVK , CoelloM . Acceptance and effect of ferrous fumarate containing micronutrient sprinkles on anemia, iron deficiency and anthropometrics in Honduran children. In: SilverbergDS editor(s). Anemia. Rijeka (Croatia): InTech, 2012. [DOI: 10.5772/30987] ">Kemmer 2012 (C)</a>; <a href="./references#CD009666-bbs2-0003" title="KounnavongS , SunaharaT , Mascie‐TaylorCG , HashizumeM , OkumuraJ , MojiK , et al. Effect of daily versus weekly home fortification with multiple micronutrient powder on haemoglobin concentration of young children in a rural area, Lao People's Democratic Republic: a randomised trial. Nutrition Journal2011;10(129):1‐11. [DOI: 10.1186/1475‐2891‐10‐129; PMC3266642; PUBMED: 22111770] ">Kounnavong 2011 (C)</a>; <a href="./references#CD009666-bbs2-0004" title="LundeenE [pers comm] . Kyrgyz Republic MNP data for children 24‐36 months. Email to: M Jefferds 3 November 2011. LundeenE , SchuethT , ToktobaevN , ZlotkinS , HyderSM , HouserR . Daily use of Sprinkles micronutrient powder for 2 months reduces anemia among children 6 to 36 months of age in the Kyrgyz Republic: a cluster‐randomized trial. Food and Nutrition Bulletin2010;31(3):446‐60. [DOI: 10.1177/156482651003100307; PUBMED: 20973465] ">Lundeen 2010 (C)</a>, <a href="./references#CD009666-bbs2-0007" title="OrozcoJ , VargasC , RojasML , HerreraAM , MontoyaL , SánchezJG , et al. The effect of powdered micronutrients on the hematologic values and nutritional status of healthy preschoolers. Medellín, 2013 [Efecto de los micronutrientes en polvo en el estado nutricional y en los valores hemáticos de preescolares sanos. Medellín, 2013]. Revista Facultad Nacional de Salud Pública2015;33(2):161‐70. [DOI: 10.17533/udea.rfnsp.v33n2a03] ">Orozco 2015 (C)</a>, <a href="./references#CD009666-bbs2-0009" title="SharieffW , YinSA , WuM , YangQ , SchauerC , TomlinsonG , et al. Short‐term daily or weekly administration of micronutrient Sprinkles has high compliance and does not cause iron overload in Chinese schoolchildren: a cluster‐randomized trial. Public Health Nutrition2006;9(3):336‐44. [PUBMED: 16684385] ZlotkinS [pers comm] . Regards and question ‐ Sharieff 2006. Email to: JP Peña‐Rosas 2 November 2011. ">Sharieff 2006 (C)</a>, <a href="./references#CD009666-bbs2-0011" title="VarmaJL , DasS , SankarR , MannarMG , LevinsonFJ , HamerDH . Community‐level micronutrient fortification of a food supplement in India: a controlled trial in preschool children aged 36‐66 mo. American Journal of Clinical Nutrition2007;85(4):1127‐33. [PUBMED: 17413115] ">Varma 2007 (C)</a>); four trials used iron as ferric sodium ethylenediaminetetraacetate (NaFeEDTA) (<a href="./references#CD009666-bbs2-0005" title="Macharia‐MutieCW , MorettiD , Van denBrielN , OmusundiAM , MwangiAM , KokFJ , et al. Maize porridge enriched with a micronutrient powder containing low‐dose iron as NaFeEDTA but not amaranth grain flour reduces anemia and iron deficiency in Kenyan preschool children. Journal of Nutrition2012;142(9):1756‐63. [DOI: 10.3945/jn.112.157578; PUBMED: 22810982] Macharia‐MutieCW , OmusundiAM , MwaiJM , MwangiAM , BrouwerID . Simulation of the effect of maize porridge fortified with grain amaranth or micronutrient powder containing NaFeEDTA on iron intake and status in Kenyan children. Public Health Nutrition2013;16(9):1605‐13. [DOI: 10.1017/S1368980012005174; PUBMED: 23218415] ">Macharia‐Mutie 2012</a>; <a href="./references#CD009666-bbs2-0006" title="JerlingJ [pers comm] . Regards and question on Ogundale et al 2011 vir Cochrane review. Email to: JP Pena‐Rosas 3 November 2011. OgunladeAO , KrugerHS , JerlingJC , SmutsCM , CovicN , HanekomSM , et al. Point‐of‐use micronutrient fortification: lessons learned in implementing a preschool‐based pilot trial in South Africa. International Journal of Food Sciences and Nutrition2011;62(1):1‐16. [DOI: 10.3109/09637486.2010.495710; PUBMED: 20701549] ">Ogunlade 2011</a>, <a href="./references#CD009666-bbs2-0008" title="OseiAK , HouserRF , BulusuS , HamerDH . Acceptability of micronutrient fortified school meals by schoolchildren in rural Himalayan villages of India. Journal of Food Science2008;73(7):S354‐8. [DOI: 10.1111/j.1750‐3841.2008.00878.x; PUBMED: 18803728] OseiAK , RosenbergIH , HouserRF , BulusuS , MathewsM , HamerDH . Community‐level micronutrient fortification of school lunch meals improved vitamin A, folate, and iron status of schoolchildren in Himalayan villages of India. Journal of Nutrition2010;140(6):1146‐54. [DOI: 10.3945/jn.109.114751; PUBMED: 20410083] ">Osei 2008 (C)</a>, <a href="./references#CD009666-bbs2-0010" title="TroeschB [pers comm] . Regards and question on Troesch et al 2011. Email to: JP Peña‐Rosas 1 November 2011. TroeschB , vanStuijvenbergME , SmutsCM , KrugerHS , BiebingerR , HurrellRF , et al. A micronutrient powder with low doses of highly absorbable iron and zinc reduces iron and zinc deficiency and improves weight‐for‐age Z‐scores in South African children. Journal of Nutrition2011;141(2):237‐42. [DOI: 10.3945/jn.110.129247; PUBMED: 21178093] ">Troesch 2011b</a>), one trial used chelated ferrous sulphate (<a href="./references#CD009666-bbs2-0012" title="VinodkumarM , RajagopalanS . Impact of a multiple‐micronutrient food supplement on the nutritional status of schoolchildren. Food and Nutrition Bulletin2006;27(3):203‐10. [DOI: 10.1177/156482650602700302; PUBMED: 17542110] ">Vinodkumar 2006 (C)</a>), one trial used ferrous glycine phosphate (<a href="./references#CD009666-bbs2-0013" title="VinodkumarM , RajagopalanS . Efficacy of fortification of school meals with ferrous glycine phosphate and riboflavin against anemia and angular stomatitis in schoolchildren. Food and Nutrition Bulletin2009;30(3):260‐4. [DOI: 10.1177/156482650903000307; PUBMED: 19927606] ">Vinodkumar 2009 (C)</a>). </p> <p>All trials included daily provision of MNP in at least one arm of the study. However, for seven trials carried out in school settings, daily was defined variably as five or six times a week when school was in session (<a href="./references#CD009666-bbs2-0006" title="JerlingJ [pers comm] . Regards and question on Ogundale et al 2011 vir Cochrane review. Email to: JP Pena‐Rosas 3 November 2011. OgunladeAO , KrugerHS , JerlingJC , SmutsCM , CovicN , HanekomSM , et al. Point‐of‐use micronutrient fortification: lessons learned in implementing a preschool‐based pilot trial in South Africa. International Journal of Food Sciences and Nutrition2011;62(1):1‐16. [DOI: 10.3109/09637486.2010.495710; PUBMED: 20701549] ">Ogunlade 2011</a>; <a href="./references#CD009666-bbs2-0007" title="OrozcoJ , VargasC , RojasML , HerreraAM , MontoyaL , SánchezJG , et al. The effect of powdered micronutrients on the hematologic values and nutritional status of healthy preschoolers. Medellín, 2013 [Efecto de los micronutrientes en polvo en el estado nutricional y en los valores hemáticos de preescolares sanos. Medellín, 2013]. Revista Facultad Nacional de Salud Pública2015;33(2):161‐70. [DOI: 10.17533/udea.rfnsp.v33n2a03] ">Orozco 2015 (C)</a>; <a href="./references#CD009666-bbs2-0008" title="OseiAK , HouserRF , BulusuS , HamerDH . Acceptability of micronutrient fortified school meals by schoolchildren in rural Himalayan villages of India. Journal of Food Science2008;73(7):S354‐8. [DOI: 10.1111/j.1750‐3841.2008.00878.x; PUBMED: 18803728] OseiAK , RosenbergIH , HouserRF , BulusuS , MathewsM , HamerDH . Community‐level micronutrient fortification of school lunch meals improved vitamin A, folate, and iron status of schoolchildren in Himalayan villages of India. Journal of Nutrition2010;140(6):1146‐54. [DOI: 10.3945/jn.109.114751; PUBMED: 20410083] ">Osei 2008 (C)</a>; <a href="./references#CD009666-bbs2-0009" title="SharieffW , YinSA , WuM , YangQ , SchauerC , TomlinsonG , et al. Short‐term daily or weekly administration of micronutrient Sprinkles has high compliance and does not cause iron overload in Chinese schoolchildren: a cluster‐randomized trial. Public Health Nutrition2006;9(3):336‐44. [PUBMED: 16684385] ZlotkinS [pers comm] . Regards and question ‐ Sharieff 2006. Email to: JP Peña‐Rosas 2 November 2011. ">Sharieff 2006 (C)</a>; <a href="./references#CD009666-bbs2-0010" title="TroeschB [pers comm] . Regards and question on Troesch et al 2011. Email to: JP Peña‐Rosas 1 November 2011. TroeschB , vanStuijvenbergME , SmutsCM , KrugerHS , BiebingerR , HurrellRF , et al. A micronutrient powder with low doses of highly absorbable iron and zinc reduces iron and zinc deficiency and improves weight‐for‐age Z‐scores in South African children. Journal of Nutrition2011;141(2):237‐42. [DOI: 10.3945/jn.110.129247; PUBMED: 21178093] ">Troesch 2011b</a>; <a href="./references#CD009666-bbs2-0011" title="VarmaJL , DasS , SankarR , MannarMG , LevinsonFJ , HamerDH . Community‐level micronutrient fortification of a food supplement in India: a controlled trial in preschool children aged 36‐66 mo. American Journal of Clinical Nutrition2007;85(4):1127‐33. [PUBMED: 17413115] ">Varma 2007 (C)</a>; <a href="./references#CD009666-bbs2-0013" title="VinodkumarM , RajagopalanS . Efficacy of fortification of school meals with ferrous glycine phosphate and riboflavin against anemia and angular stomatitis in schoolchildren. Food and Nutrition Bulletin2009;30(3):260‐4. [DOI: 10.1177/156482650903000307; PUBMED: 19927606] ">Vinodkumar 2009 (C)</a>). Two trials also included arms with intermittent use, providing MNPs either once or twice a week (<a href="./references#CD009666-bbs2-0003" title="KounnavongS , SunaharaT , Mascie‐TaylorCG , HashizumeM , OkumuraJ , MojiK , et al. Effect of daily versus weekly home fortification with multiple micronutrient powder on haemoglobin concentration of young children in a rural area, Lao People's Democratic Republic: a randomised trial. Nutrition Journal2011;10(129):1‐11. [DOI: 10.1186/1475‐2891‐10‐129; PMC3266642; PUBMED: 22111770] ">Kounnavong 2011 (C)</a>; <a href="./references#CD009666-bbs2-0009" title="SharieffW , YinSA , WuM , YangQ , SchauerC , TomlinsonG , et al. Short‐term daily or weekly administration of micronutrient Sprinkles has high compliance and does not cause iron overload in Chinese schoolchildren: a cluster‐randomized trial. Public Health Nutrition2006;9(3):336‐44. [PUBMED: 16684385] ZlotkinS [pers comm] . Regards and question ‐ Sharieff 2006. Email to: JP Peña‐Rosas 2 November 2011. ">Sharieff 2006 (C)</a>). The study duration ranged from eight weeks to 12 months, with four trials reporting a duration of 23 or 24 weeks (six months) (<a href="./references#CD009666-bbs2-0003" title="KounnavongS , SunaharaT , Mascie‐TaylorCG , HashizumeM , OkumuraJ , MojiK , et al. Effect of daily versus weekly home fortification with multiple micronutrient powder on haemoglobin concentration of young children in a rural area, Lao People's Democratic Republic: a randomised trial. Nutrition Journal2011;10(129):1‐11. [DOI: 10.1186/1475‐2891‐10‐129; PMC3266642; PUBMED: 22111770] ">Kounnavong 2011 (C)</a>; <a href="./references#CD009666-bbs2-0010" title="TroeschB [pers comm] . Regards and question on Troesch et al 2011. Email to: JP Peña‐Rosas 1 November 2011. TroeschB , vanStuijvenbergME , SmutsCM , KrugerHS , BiebingerR , HurrellRF , et al. A micronutrient powder with low doses of highly absorbable iron and zinc reduces iron and zinc deficiency and improves weight‐for‐age Z‐scores in South African children. Journal of Nutrition2011;141(2):237‐42. [DOI: 10.3945/jn.110.129247; PUBMED: 21178093] ">Troesch 2011b</a>; <a href="./references#CD009666-bbs2-0011" title="VarmaJL , DasS , SankarR , MannarMG , LevinsonFJ , HamerDH . Community‐level micronutrient fortification of a food supplement in India: a controlled trial in preschool children aged 36‐66 mo. American Journal of Clinical Nutrition2007;85(4):1127‐33. [PUBMED: 17413115] ">Varma 2007 (C)</a>; <a href="./references#CD009666-bbs2-0013" title="VinodkumarM , RajagopalanS . Efficacy of fortification of school meals with ferrous glycine phosphate and riboflavin against anemia and angular stomatitis in schoolchildren. Food and Nutrition Bulletin2009;30(3):260‐4. [DOI: 10.1177/156482650903000307; PUBMED: 19927606] ">Vinodkumar 2009 (C)</a>), and two trials reporting a duration of four months (<a href="./references#CD009666-bbs2-0002" title="KemmerTM , OmerPS , Gidvani‐DiazVK , CoelloM . Acceptance and effect of ferrous fumarate containing micronutrient sprinkles on anemia, iron deficiency and anthropometrics in Honduran children. In: SilverbergDS editor(s). Anemia. Rijeka (Croatia): InTech, 2012. [DOI: 10.5772/30987] ">Kemmer 2012 (C)</a>; <a href="./references#CD009666-bbs2-0005" title="Macharia‐MutieCW , MorettiD , Van denBrielN , OmusundiAM , MwangiAM , KokFJ , et al. Maize porridge enriched with a micronutrient powder containing low‐dose iron as NaFeEDTA but not amaranth grain flour reduces anemia and iron deficiency in Kenyan preschool children. Journal of Nutrition2012;142(9):1756‐63. [DOI: 10.3945/jn.112.157578; PUBMED: 22810982] Macharia‐MutieCW , OmusundiAM , MwaiJM , MwangiAM , BrouwerID . Simulation of the effect of maize porridge fortified with grain amaranth or micronutrient powder containing NaFeEDTA on iron intake and status in Kenyan children. Public Health Nutrition2013;16(9):1605‐13. [DOI: 10.1017/S1368980012005174; PUBMED: 23218415] ">Macharia‐Mutie 2012</a>), with the remaining trials each reporting a different duration. For one trial, duration varied for each participant depending on whether they achieved a WHZ score of ‐1.0 or greater during the intervention period and were discharged (<a href="./references#CD009666-bbs2-0001" title="InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Combined intensive nutrition education and micronutrient powder supplementation improved nutritional status of mildly wasted children on Nias Island, Indonesia. Asia Pacific Journal of Clinical Nutrition2012;21(3):361‐73. [PUBMED: 22705425] InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Improved nutrition knowledge and practice through intensive nutrition education: a study among caregivers of mildly wasted children on Nias Island, Indonesia. Food and Nutrition Bulletin2012;33(2):117‐27. [DOI: 10.1177/156482651203300205; PUBMED: 22908693] PurwestriRC , ScherbaumV , InayatiDA , WirawanNN , SuryantanJ , BloemMA , et al. Supplementary feeding with locally‐produced ready‐to‐use food (RUF) for mildly wasted children on Nias Island, Indonesia: comparison of daily and weekly programme outcomes. Asia Pacific Journal of Clinical Nutrition2012;21(3):374‐9. [PUBMED: 22705426] ScherbaumV [pers comm] . Your paper on MNP. Email to: LM De‐Regil 5 February 2013. ">Inayati 2012 (C)</a>). The most common co‐intervention was antihelminthic treatment, reported by nine trials (<a href="./references#CD009666-bbs2-0002" title="KemmerTM , OmerPS , Gidvani‐DiazVK , CoelloM . Acceptance and effect of ferrous fumarate containing micronutrient sprinkles on anemia, iron deficiency and anthropometrics in Honduran children. In: SilverbergDS editor(s). Anemia. Rijeka (Croatia): InTech, 2012. [DOI: 10.5772/30987] ">Kemmer 2012 (C)</a>; <a href="./references#CD009666-bbs2-0003" title="KounnavongS , SunaharaT , Mascie‐TaylorCG , HashizumeM , OkumuraJ , MojiK , et al. Effect of daily versus weekly home fortification with multiple micronutrient powder on haemoglobin concentration of young children in a rural area, Lao People's Democratic Republic: a randomised trial. Nutrition Journal2011;10(129):1‐11. [DOI: 10.1186/1475‐2891‐10‐129; PMC3266642; PUBMED: 22111770] ">Kounnavong 2011 (C)</a>; <a href="./references#CD009666-bbs2-0005" title="Macharia‐MutieCW , MorettiD , Van denBrielN , OmusundiAM , MwangiAM , KokFJ , et al. Maize porridge enriched with a micronutrient powder containing low‐dose iron as NaFeEDTA but not amaranth grain flour reduces anemia and iron deficiency in Kenyan preschool children. Journal of Nutrition2012;142(9):1756‐63. [DOI: 10.3945/jn.112.157578; PUBMED: 22810982] Macharia‐MutieCW , OmusundiAM , MwaiJM , MwangiAM , BrouwerID . Simulation of the effect of maize porridge fortified with grain amaranth or micronutrient powder containing NaFeEDTA on iron intake and status in Kenyan children. Public Health Nutrition2013;16(9):1605‐13. [DOI: 10.1017/S1368980012005174; PUBMED: 23218415] ">Macharia‐Mutie 2012</a>; <a href="./references#CD009666-bbs2-0006" title="JerlingJ [pers comm] . Regards and question on Ogundale et al 2011 vir Cochrane review. Email to: JP Pena‐Rosas 3 November 2011. OgunladeAO , KrugerHS , JerlingJC , SmutsCM , CovicN , HanekomSM , et al. Point‐of‐use micronutrient fortification: lessons learned in implementing a preschool‐based pilot trial in South Africa. International Journal of Food Sciences and Nutrition2011;62(1):1‐16. [DOI: 10.3109/09637486.2010.495710; PUBMED: 20701549] ">Ogunlade 2011</a>; <a href="./references#CD009666-bbs2-0007" title="OrozcoJ , VargasC , RojasML , HerreraAM , MontoyaL , SánchezJG , et al. The effect of powdered micronutrients on the hematologic values and nutritional status of healthy preschoolers. Medellín, 2013 [Efecto de los micronutrientes en polvo en el estado nutricional y en los valores hemáticos de preescolares sanos. Medellín, 2013]. Revista Facultad Nacional de Salud Pública2015;33(2):161‐70. [DOI: 10.17533/udea.rfnsp.v33n2a03] ">Orozco 2015 (C)</a>; <a href="./references#CD009666-bbs2-0008" title="OseiAK , HouserRF , BulusuS , HamerDH . Acceptability of micronutrient fortified school meals by schoolchildren in rural Himalayan villages of India. Journal of Food Science2008;73(7):S354‐8. [DOI: 10.1111/j.1750‐3841.2008.00878.x; PUBMED: 18803728] OseiAK , RosenbergIH , HouserRF , BulusuS , MathewsM , HamerDH . Community‐level micronutrient fortification of school lunch meals improved vitamin A, folate, and iron status of schoolchildren in Himalayan villages of India. Journal of Nutrition2010;140(6):1146‐54. [DOI: 10.3945/jn.109.114751; PUBMED: 20410083] ">Osei 2008 (C)</a>; <a href="./references#CD009666-bbs2-0010" title="TroeschB [pers comm] . Regards and question on Troesch et al 2011. Email to: JP Peña‐Rosas 1 November 2011. TroeschB , vanStuijvenbergME , SmutsCM , KrugerHS , BiebingerR , HurrellRF , et al. A micronutrient powder with low doses of highly absorbable iron and zinc reduces iron and zinc deficiency and improves weight‐for‐age Z‐scores in South African children. Journal of Nutrition2011;141(2):237‐42. [DOI: 10.3945/jn.110.129247; PUBMED: 21178093] ">Troesch 2011b</a>; <a href="./references#CD009666-bbs2-0012" title="VinodkumarM , RajagopalanS . Impact of a multiple‐micronutrient food supplement on the nutritional status of schoolchildren. Food and Nutrition Bulletin2006;27(3):203‐10. [DOI: 10.1177/156482650602700302; PUBMED: 17542110] ">Vinodkumar 2006 (C)</a>; <a href="./references#CD009666-bbs2-0013" title="VinodkumarM , RajagopalanS . Efficacy of fortification of school meals with ferrous glycine phosphate and riboflavin against anemia and angular stomatitis in schoolchildren. Food and Nutrition Bulletin2009;30(3):260‐4. [DOI: 10.1177/156482650903000307; PUBMED: 19927606] ">Vinodkumar 2009 (C)</a>). One trial also gave vitamin A supplementation (<a href="./references#CD009666-bbs2-0003" title="KounnavongS , SunaharaT , Mascie‐TaylorCG , HashizumeM , OkumuraJ , MojiK , et al. Effect of daily versus weekly home fortification with multiple micronutrient powder on haemoglobin concentration of young children in a rural area, Lao People's Democratic Republic: a randomised trial. Nutrition Journal2011;10(129):1‐11. [DOI: 10.1186/1475‐2891‐10‐129; PMC3266642; PUBMED: 22111770] ">Kounnavong 2011 (C)</a>), and one trial also provided a sweet or juice after carrying out assessments (<a href="./references#CD009666-bbs2-0008" title="OseiAK , HouserRF , BulusuS , HamerDH . Acceptability of micronutrient fortified school meals by schoolchildren in rural Himalayan villages of India. Journal of Food Science2008;73(7):S354‐8. [DOI: 10.1111/j.1750‐3841.2008.00878.x; PUBMED: 18803728] OseiAK , RosenbergIH , HouserRF , BulusuS , MathewsM , HamerDH . Community‐level micronutrient fortification of school lunch meals improved vitamin A, folate, and iron status of schoolchildren in Himalayan villages of India. Journal of Nutrition2010;140(6):1146‐54. [DOI: 10.3945/jn.109.114751; PUBMED: 20410083] ">Osei 2008 (C)</a>). </p> </section> </section> <section id="CD009666-sec-0090"> <h4 class="title">Excluded studies</h4> <p>We excluded 38 studies (57 reports and two personal communications). The age of the participants was outside the scope of this review in 21 trials (<a href="./references#CD009666-bbs2-0014" title="AboudFE , AkhterS . A cluster‐randomized evaluation of a responsive stimulation and feeding intervention in Bangladesh. Pediatrics2011;127(5):e1191‐7. [DOI: 10.1542/peds.2010‐2160; PUBMED: 21502222] AboudFE , MooreAC , AkhterS . Effectiveness of a community‐based responsive feeding programme in rural Bangladesh: a cluster randomized field trial. Maternal and Child Nutrition2008;4(4):275‐86. [DOI: 10.1111/j.1740‐8709.2008.00146.x; PUBMED: 18811792] AboudFE , ShafiqueS , AkhterS . A responsive feeding intervention increases children’s self‐feeding and maternal responsiveness but not weight gain. Journal of Nutrition2009;139(9):1738‐43. [DOI: 10.3945/jn.109.104885; PUBMED: 19587124] ">Aboud 2011</a>; <a href="./references#CD009666-bbs2-0015" title="AhmedP , MahmoodA , AzizS , AzimW . Comparison of response between food supplemented with powdered iron and iron in syrup form for iron deficiency anemia. Journal of the College of Physicians and Surgeons Pakistan2003;13(7):402‐4. [DOI: 07.2003/JCPSP.402404; PUBMED: 12887843] ">Ahmed 2003</a>; <a href="./references#CD009666-bbs2-0021" title="GeltmanPL , HironakaLK , MehtaSD , PadillaP , RodriguesP , MeyersAF , et al. Iron supplementation of low‐income infants: a randomized clinical trial of adherence with ferrous fumarate sprinkles versus ferrous sulfate drops. Journal of Pediatrics2009;154(5):738‐43. ">Geltman 2009</a>; <a href="./references#CD009666-bbs2-0023" title="HirveS , BhaveS , BavdekarA , NaikS , PanditA , SchauerC , et al. Low dose 'Sprinkles' ‐ an innovative approach to treat iron deficiency anemia in infants and young children. Indian Pediatrics2007;44(2):91‐100. [PUBMED: 17351300] ">Hirve 2007</a>; <a href="./references#CD009666-bbs2-0025" title="IpH , HyderSM , HaseenF , RahmanM , ZlotkinSH . Improved adherence and anaemia cure rates with flexible administration of micronutrient Sprinkles: a new public health approach to anaemia control. European Journal of Clinical Nutrition2009;63(2):165‐72. [DOI: 10.1038/sj.ejcn.1602917; PUBMED: 17895911] ">Ip 2009</a>; <a href="./references#CD009666-bbs2-0026" title="JackSJ , OuK , CheaM , ChhinL , DevenishR , DunbarM , et al. Effect of micronutrient sprinkles on reducing anemia: a cluster‐randomized effectiveness trial. Archives of Pediatrics &amp; Adolescent Medicine2012;166(9):842‐50. [DOI: 10.1001/archpediatrics.2012.1003; PUBMED: 22801933] ">Jack 2012</a>; <a href="./references#CD009666-bbs2-0027" title="Barth‐JaeggiT , MorettiD , KvalsvigJ , HoldingPA , NjengaJ , MwangiA , et al. In‐home fortification with 2.5 mg iron as NaFeEDTA does not reduce anaemia but increases weight gain: a randomised controlled trial in Kenyan infants. Maternal &amp; Child Nutrition2015;11(Suppl 4):151‐62. [DOI: 10.1111/mcn.12163; PUBMED: 25420455] JaeggiT , KortmanGA , MorettiD , ChassardC , HoldingP , DostalA , et al. Iron fortification adversely affects the gut microbiome, increases pathogen abundance and induces intestinal inflammation in Kenyan infants. Gut2015;64(5):731‐42. [DOI: 10.1136/gutjnl‐2014‐307720; PUBMED: 25143342] ZimmermannM , KvalsvigJ . Changes in microbiota and iron status after iron fortification of complementary foods. clinicaltrials.gov/ct2/show/NCT01111864 Date first received: 23 April 2010. ">Jaeggi 2015</a>; <a href="./references#CD009666-bbs2-0028" title="KhanWU , ShafiqueS , ShikderH , ShakurYA , SellenDW , ChowdhuryJS , et al. Home fortification with calcium reduces Hb response to iron among anaemic Bangladeshi infants consuming a new multi‐micronutrient powder formulation. Public Health Nutrition2014; Vol. 17, issue 7:1578‐86. [DOI: 10.1017/S1368980013001742; PUBMED: 23816321] ">Khan 2014</a>; <a href="./references#CD009666-bbs2-0031" title="LoechlCU , MenonP , ArimondM , RuelMT , PeltoG , HabichtJP , et al. Using programme theory to assess the feasibility of delivering micronutrient Sprinkles through a food‐assisted maternal and child health and nutrition programme in rural Haiti. Maternal and Child Nutrition2009;5(1):33‐48. [DOI: 10.1111/j.1740‐8709.2008.00154.x; PUBMED: 19161543] MenonP , RuelMT , LoechlCU , ArimondM , HabichtJP , PeltoG , et al. Micronutrient Sprinkles reduce anemia among 9‐ to 24‐mo‐old children when delivered through an integrated health and nutrition program in rural Haiti. Journal of Nutrition2007;137(4):1023‐30. [PUBMED: 17374671] ">Menon 2007</a>; <a href="./references#CD009666-bbs2-0033" title="AburtoNJ , Ramirez‐ZeaM , NeufeldLM , Flores‐AyalaR . The effect of nutritional supplementation on physical activity and exploratory behavior of Mexican infants aged 8‐12 months. European Journal of Clinical Nutrition2010;64(6):644‐51. [DOI: 10.1038/ejcn.2010.52; PUBMED: 20354559] ColcheroA , NeufeldLM . Cost estimations of different types of micronutrient supplements for children and pregnant women (poster presentation). FASEB Journal2008; Vol. 22:Abstract 678.21. García‐GuerraA , NeufeldLM , DomínguezCP , García‐FeregrinoR , Hernández‐CabreraA . Effect of three supplements with identical micronutrient content on anemia in Mexican children (poster presentation). FASEB Journal2008; Vol. 22:Abstract 677.5. ">Neufeld 2008</a>; <a href="./references#CD009666-bbs2-0038" title="SamadpourK , LongKZ , HayatbakhshR , MarksGC . Randomised comparison of the effects of Sprinkles and Foodlets with the currently recommended supplement (Drops) on micronutrient status and growth in Iranian children. European Journal of Clinical Nutrition2011;65(12):1287‐94. [DOI: 10.1038/ejcn.2011.124; PUBMED: 21750564] ">Samadpour 2011</a>; <a href="./references#CD009666-bbs2-0041" title="SmutsCM , DhansayMA , FaberM , vanStuijvenbergME , SwanevelderS , GrossR , et al. Efficacy of multiple micronutrient supplementation for improving anemia, micronutrient status, and growth in South African infants. Journal of Nutrition2005;135(3):653‐9S. [PUBMED: 15735110] ">Smuts 2005</a>; <a href="./references#CD009666-bbs2-0042" title="SoofiS , CousensS , IqbalSP , AkhundT , KhanJ , AhmedI , et al. Effect of provision of daily zinc and iron with several micronutrients on growth and morbidity among young children in Pakistan: a cluster‐randomised trial. Lancet2013;382(9886):29‐40. [DOI: 10.1016/S0140‐6736(13)60437‐7; PUBMED: 23602230] ">Soofi 2013</a>; <a href="./references#CD009666-bbs2-0043" title="Centers for Disease Control and Prevention. Baseline data from the Nyando Integrated Child Health and Education Project ‐ Kenya, 2007. Morbidity and Mortality Weekly Report2007;56(42):1109‐13. JefferdsME , OgangeL , OwuorM , CruzK , PersonB , ObureA , et al. Formative research exploring acceptability, utilization, and promotion in order to develop a micronutrient powder (Sprinkles) intervention among Luo families in western Kenya. Food and Nutrition Bulletin2010;31(2 Suppl):S179‐85. [DOI: 10.1177/15648265100312S210; PUBMED: 20715602] SuchdevPS , RuthLJ , WoodruffBA , MbakayaC , MandavaU , Flores‐AyalaR , et al. Selling Sprinkles micronutrient powder reduces anemia, iron deficiency, and vitamin A deficiency in young children in Western Kenya: a cluster‐randomized controlled trial. American Journal of Clinical Nutrition2012;95(5):1223‐30. [DOI: 10.3945/ajcn.111.030072; PMC4697950; PUBMED: 22492366] SuchdevPS , ShahA , JefferdsME , EleveldA , PatelM , SteinAD , et al. Sustainability of market‐based community distribution of Sprinkles in western Kenya. Maternal and Child Nutrition2013;9 Suppl 1:78‐88. [DOI: 10.1111/j.1740‐8709.2012.00450.x; PUBMED: 23167586] ">Suchdev 2007 (C)</a>; <a href="./references#CD009666-bbs2-0044" title="NCT02073149 . Safe and efficacious iron for children in Kenya (SEICK) [Comparison of home fortification with two iron formulations in Kenyan children protected against malaria by artemisinin‐based combination therapy: a placebo‐controlled non‐inferiority trial]. clinicaltrials.gov/ct2/show/record/NCT02073149 Date first received: 25 February 2014. TeshomeEM , Andang'oPEA , OsotiV , TerwelSR , OtienoW , DemirAY , et al. Daily home fortification with iron as ferrous fumarate versus NaFeEDTA: a randomised, placebo‐controlled, non‐inferiority trial in Kenyan children. BMC Medicine2017;15:89. [doi.org/10.1186/s12916‐017‐0839‐z; PUBMED: 28449690 ] ">Teshome 2017</a>; <a href="./references#CD009666-bbs2-0045" title="TroeschB . Optimized micronutrient powder containing low levels of highly bioavailable iron and zinc together with EDTA, phytase and ascorbic acid improves the nutritional status of children. Sight and Life Magazine2010, issue 3:9‐14. TroeschB , EgliI , ZederC , HurrellRF , dePeeS , ZimmermannMB . Optimization of a phytase‐containing micronutrient powder with low amounts of highly bioavailable iron for in‐home fortification of complementary foods. American Journal of Clinical Nutrition2009;89(2):539‐44. [DOI: 10.3945/ajcn.2008.27026; PUBMED: 19106242] ">Troesch 2009</a>; <a href="./references#CD009666-bbs2-0047" title="Wijaya‐ErhardtM , ErhardtJG , UntoroJ , KaryadiE , WibowoL , GrossR . Effects of daily or weekly multiple‐micronutrient and iron foodlike tablets on body iron stores of Indonesian infants aged 6‐12 mo: a double‐blind, randomized, placebo‐controlled trial. American Journal of Clinical Nutrition2007;86(6):1680‐6. [PUBMED: 18065586] ">Wijaya‐Erhardt 2007</a>; <a href="./references#CD009666-bbs2-0048" title="ZlotkinS , ArthurP , AntwiKY , YeungG . Treatment of anemia with microencapsulated ferrous fumarate plus ascorbic acid supplied as sprinkles to complementary (weaning) foods. American Journal of Clinical Nutrition2001;74(6):791‐5. [PUBMED: 11722961] ">Zlotkin 2001</a>; <a href="./references#CD009666-bbs2-0049" title="ZlotkinS , AntwiKY , SchauerC , YeungG . Use of microencapsulated iron (II) fumarate sprinkles to prevent recurrence of anaemia in infants and young children at high risk. Bulletin of the World Health Organization2003;81(2):108‐15. [PMC2572396; PUBMED: 12756979] ">Zlotkin 2003a</a>; <a href="./references#CD009666-bbs2-0050" title="ZlotkinS , ArthurP , SchauerC , AntwiKY , YeungG , PiekarzA . Home‐fortification with iron and zinc Sprinkles of iron Sprinkles alone successfully treats anemia in infants and young children. Journal of Nutrition2003;133(4):1075‐80. [PUBMED: 12672922] ">Zlotkin 2003b</a>; <a href="./references#CD009666-bbs2-0051" title="ZlotkinS , NewtonS , AimoneAM , AzindowI , Amenga‐EtegoS , TchumK , et al. Effect of iron fortification on malaria incidence in infants and young children in Ghana: a randomized trial. JAMA2013;310(9):938‐47. [DOI: 10.1001/jama.2013.277129; PUBMED: 24002280] ">Zlotkin 2013</a>). In 18 trials, the participants were less than 24 months old (<a href="./references#CD009666-bbs2-0014" title="AboudFE , AkhterS . A cluster‐randomized evaluation of a responsive stimulation and feeding intervention in Bangladesh. Pediatrics2011;127(5):e1191‐7. [DOI: 10.1542/peds.2010‐2160; PUBMED: 21502222] AboudFE , MooreAC , AkhterS . Effectiveness of a community‐based responsive feeding programme in rural Bangladesh: a cluster randomized field trial. Maternal and Child Nutrition2008;4(4):275‐86. [DOI: 10.1111/j.1740‐8709.2008.00146.x; PUBMED: 18811792] AboudFE , ShafiqueS , AkhterS . A responsive feeding intervention increases children’s self‐feeding and maternal responsiveness but not weight gain. Journal of Nutrition2009;139(9):1738‐43. [DOI: 10.3945/jn.109.104885; PUBMED: 19587124] ">Aboud 2011</a>; <a href="./references#CD009666-bbs2-0021" title="GeltmanPL , HironakaLK , MehtaSD , PadillaP , RodriguesP , MeyersAF , et al. Iron supplementation of low‐income infants: a randomized clinical trial of adherence with ferrous fumarate sprinkles versus ferrous sulfate drops. Journal of Pediatrics2009;154(5):738‐43. ">Geltman 2009</a>; <a href="./references#CD009666-bbs2-0023" title="HirveS , BhaveS , BavdekarA , NaikS , PanditA , SchauerC , et al. Low dose 'Sprinkles' ‐ an innovative approach to treat iron deficiency anemia in infants and young children. Indian Pediatrics2007;44(2):91‐100. [PUBMED: 17351300] ">Hirve 2007</a>; <a href="./references#CD009666-bbs2-0025" title="IpH , HyderSM , HaseenF , RahmanM , ZlotkinSH . Improved adherence and anaemia cure rates with flexible administration of micronutrient Sprinkles: a new public health approach to anaemia control. European Journal of Clinical Nutrition2009;63(2):165‐72. [DOI: 10.1038/sj.ejcn.1602917; PUBMED: 17895911] ">Ip 2009</a>; <a href="./references#CD009666-bbs2-0026" title="JackSJ , OuK , CheaM , ChhinL , DevenishR , DunbarM , et al. Effect of micronutrient sprinkles on reducing anemia: a cluster‐randomized effectiveness trial. Archives of Pediatrics &amp; Adolescent Medicine2012;166(9):842‐50. [DOI: 10.1001/archpediatrics.2012.1003; PUBMED: 22801933] ">Jack 2012</a>; <a href="./references#CD009666-bbs2-0027" title="Barth‐JaeggiT , MorettiD , KvalsvigJ , HoldingPA , NjengaJ , MwangiA , et al. In‐home fortification with 2.5 mg iron as NaFeEDTA does not reduce anaemia but increases weight gain: a randomised controlled trial in Kenyan infants. Maternal &amp; Child Nutrition2015;11(Suppl 4):151‐62. [DOI: 10.1111/mcn.12163; PUBMED: 25420455] JaeggiT , KortmanGA , MorettiD , ChassardC , HoldingP , DostalA , et al. Iron fortification adversely affects the gut microbiome, increases pathogen abundance and induces intestinal inflammation in Kenyan infants. Gut2015;64(5):731‐42. [DOI: 10.1136/gutjnl‐2014‐307720; PUBMED: 25143342] ZimmermannM , KvalsvigJ . Changes in microbiota and iron status after iron fortification of complementary foods. clinicaltrials.gov/ct2/show/NCT01111864 Date first received: 23 April 2010. ">Jaeggi 2015</a>; <a href="./references#CD009666-bbs2-0028" title="KhanWU , ShafiqueS , ShikderH , ShakurYA , SellenDW , ChowdhuryJS , et al. Home fortification with calcium reduces Hb response to iron among anaemic Bangladeshi infants consuming a new multi‐micronutrient powder formulation. Public Health Nutrition2014; Vol. 17, issue 7:1578‐86. [DOI: 10.1017/S1368980013001742; PUBMED: 23816321] ">Khan 2014</a>; <a href="./references#CD009666-bbs2-0031" title="LoechlCU , MenonP , ArimondM , RuelMT , PeltoG , HabichtJP , et al. Using programme theory to assess the feasibility of delivering micronutrient Sprinkles through a food‐assisted maternal and child health and nutrition programme in rural Haiti. Maternal and Child Nutrition2009;5(1):33‐48. [DOI: 10.1111/j.1740‐8709.2008.00154.x; PUBMED: 19161543] MenonP , RuelMT , LoechlCU , ArimondM , HabichtJP , PeltoG , et al. Micronutrient Sprinkles reduce anemia among 9‐ to 24‐mo‐old children when delivered through an integrated health and nutrition program in rural Haiti. Journal of Nutrition2007;137(4):1023‐30. [PUBMED: 17374671] ">Menon 2007</a>; <a href="./references#CD009666-bbs2-0033" title="AburtoNJ , Ramirez‐ZeaM , NeufeldLM , Flores‐AyalaR . The effect of nutritional supplementation on physical activity and exploratory behavior of Mexican infants aged 8‐12 months. European Journal of Clinical Nutrition2010;64(6):644‐51. [DOI: 10.1038/ejcn.2010.52; PUBMED: 20354559] ColcheroA , NeufeldLM . Cost estimations of different types of micronutrient supplements for children and pregnant women (poster presentation). FASEB Journal2008; Vol. 22:Abstract 678.21. García‐GuerraA , NeufeldLM , DomínguezCP , García‐FeregrinoR , Hernández‐CabreraA . Effect of three supplements with identical micronutrient content on anemia in Mexican children (poster presentation). FASEB Journal2008; Vol. 22:Abstract 677.5. ">Neufeld 2008</a>; <a href="./references#CD009666-bbs2-0038" title="SamadpourK , LongKZ , HayatbakhshR , MarksGC . Randomised comparison of the effects of Sprinkles and Foodlets with the currently recommended supplement (Drops) on micronutrient status and growth in Iranian children. European Journal of Clinical Nutrition2011;65(12):1287‐94. [DOI: 10.1038/ejcn.2011.124; PUBMED: 21750564] ">Samadpour 2011</a>; <a href="./references#CD009666-bbs2-0041" title="SmutsCM , DhansayMA , FaberM , vanStuijvenbergME , SwanevelderS , GrossR , et al. Efficacy of multiple micronutrient supplementation for improving anemia, micronutrient status, and growth in South African infants. Journal of Nutrition2005;135(3):653‐9S. [PUBMED: 15735110] ">Smuts 2005</a>; <a href="./references#CD009666-bbs2-0042" title="SoofiS , CousensS , IqbalSP , AkhundT , KhanJ , AhmedI , et al. Effect of provision of daily zinc and iron with several micronutrients on growth and morbidity among young children in Pakistan: a cluster‐randomised trial. Lancet2013;382(9886):29‐40. [DOI: 10.1016/S0140‐6736(13)60437‐7; PUBMED: 23602230] ">Soofi 2013</a>; <a href="./references#CD009666-bbs2-0043" title="Centers for Disease Control and Prevention. Baseline data from the Nyando Integrated Child Health and Education Project ‐ Kenya, 2007. Morbidity and Mortality Weekly Report2007;56(42):1109‐13. JefferdsME , OgangeL , OwuorM , CruzK , PersonB , ObureA , et al. Formative research exploring acceptability, utilization, and promotion in order to develop a micronutrient powder (Sprinkles) intervention among Luo families in western Kenya. Food and Nutrition Bulletin2010;31(2 Suppl):S179‐85. [DOI: 10.1177/15648265100312S210; PUBMED: 20715602] SuchdevPS , RuthLJ , WoodruffBA , MbakayaC , MandavaU , Flores‐AyalaR , et al. Selling Sprinkles micronutrient powder reduces anemia, iron deficiency, and vitamin A deficiency in young children in Western Kenya: a cluster‐randomized controlled trial. American Journal of Clinical Nutrition2012;95(5):1223‐30. [DOI: 10.3945/ajcn.111.030072; PMC4697950; PUBMED: 22492366] SuchdevPS , ShahA , JefferdsME , EleveldA , PatelM , SteinAD , et al. Sustainability of market‐based community distribution of Sprinkles in western Kenya. Maternal and Child Nutrition2013;9 Suppl 1:78‐88. [DOI: 10.1111/j.1740‐8709.2012.00450.x; PUBMED: 23167586] ">Suchdev 2007 (C)</a>; <a href="./references#CD009666-bbs2-0047" title="Wijaya‐ErhardtM , ErhardtJG , UntoroJ , KaryadiE , WibowoL , GrossR . Effects of daily or weekly multiple‐micronutrient and iron foodlike tablets on body iron stores of Indonesian infants aged 6‐12 mo: a double‐blind, randomized, placebo‐controlled trial. American Journal of Clinical Nutrition2007;86(6):1680‐6. [PUBMED: 18065586] ">Wijaya‐Erhardt 2007</a>; <a href="./references#CD009666-bbs2-0048" title="ZlotkinS , ArthurP , AntwiKY , YeungG . Treatment of anemia with microencapsulated ferrous fumarate plus ascorbic acid supplied as sprinkles to complementary (weaning) foods. American Journal of Clinical Nutrition2001;74(6):791‐5. [PUBMED: 11722961] ">Zlotkin 2001</a>; <a href="./references#CD009666-bbs2-0049" title="ZlotkinS , AntwiKY , SchauerC , YeungG . Use of microencapsulated iron (II) fumarate sprinkles to prevent recurrence of anaemia in infants and young children at high risk. Bulletin of the World Health Organization2003;81(2):108‐15. [PMC2572396; PUBMED: 12756979] ">Zlotkin 2003a</a>; <a href="./references#CD009666-bbs2-0050" title="ZlotkinS , ArthurP , SchauerC , AntwiKY , YeungG , PiekarzA . Home‐fortification with iron and zinc Sprinkles of iron Sprinkles alone successfully treats anemia in infants and young children. Journal of Nutrition2003;133(4):1075‐80. [PUBMED: 12672922] ">Zlotkin 2003b</a>; <a href="./references#CD009666-bbs2-0051" title="ZlotkinS , NewtonS , AimoneAM , AzindowI , Amenga‐EtegoS , TchumK , et al. Effect of iron fortification on malaria incidence in infants and young children in Ghana: a randomized trial. JAMA2013;310(9):938‐47. [DOI: 10.1001/jama.2013.277129; PUBMED: 24002280] ">Zlotkin 2013</a>). In two trials, children were aged 12 to 59 months but 51% of the participants were aged between 12 and 23 months (<a href="./references#CD009666-bbs2-0015" title="AhmedP , MahmoodA , AzizS , AzimW . Comparison of response between food supplemented with powdered iron and iron in syrup form for iron deficiency anemia. Journal of the College of Physicians and Surgeons Pakistan2003;13(7):402‐4. [DOI: 07.2003/JCPSP.402404; PUBMED: 12887843] ">Ahmed 2003</a>; <a href="./references#CD009666-bbs2-0044" title="NCT02073149 . Safe and efficacious iron for children in Kenya (SEICK) [Comparison of home fortification with two iron formulations in Kenyan children protected against malaria by artemisinin‐based combination therapy: a placebo‐controlled non‐inferiority trial]. clinicaltrials.gov/ct2/show/record/NCT02073149 Date first received: 25 February 2014. TeshomeEM , Andang'oPEA , OsotiV , TerwelSR , OtienoW , DemirAY , et al. Daily home fortification with iron as ferrous fumarate versus NaFeEDTA: a randomised, placebo‐controlled, non‐inferiority trial in Kenyan children. BMC Medicine2017;15:89. [doi.org/10.1186/s12916‐017‐0839‐z; PUBMED: 28449690 ] ">Teshome 2017</a>). One trial was conducted on healthy, non‐pregnant, non‐lactating young women (<a href="./references#CD009666-bbs2-0045" title="TroeschB . Optimized micronutrient powder containing low levels of highly bioavailable iron and zinc together with EDTA, phytase and ascorbic acid improves the nutritional status of children. Sight and Life Magazine2010, issue 3:9‐14. TroeschB , EgliI , ZederC , HurrellRF , dePeeS , ZimmermannMB . Optimization of a phytase‐containing micronutrient powder with low amounts of highly bioavailable iron for in‐home fortification of complementary foods. American Journal of Clinical Nutrition2009;89(2):539‐44. [DOI: 10.3945/ajcn.2008.27026; PUBMED: 19106242] ">Troesch 2009</a>). </p> <p>In eight trials, the interventions did not evaluate MNP‐containing iron. One trial evaluated the effect of iron drops and not powders for point‐of‐use fortification (<a href="./references#CD009666-bbs2-0017" title="BagniUV , BaiãoMR , SouzaMM , LuizRR , VeigaGV . Effect of weekly rice fortification with iron on anaemia prevalence and haemoglobin concentration among children attending public daycare centres in Rio de Janeiro, Brazil [Efeito da fortificaçao semanel do arroz com ferro quelato sobre a frequencia de anemia e concentraçao de hemoglobina em crianças de creches municipais de Rio de Janeiro, Brasil]. Cadernos de Saude Publica2009;25(2):291‐302. [PUBMED: 19219236] ">Bagni 2009 (C)</a>), while two trials involved a fortified condiment or seasoning in powder form and not a MNP for point‐of‐use fortification (<a href="./references#CD009666-bbs2-0018" title="ChenK , LiTY , ChenL , QuP , LiuYX . Effects of vitamin A, vitamin A plus iron and multiple micronutrient‐fortified seasoning powder on preschool children in a suburb of Chongqing, China. Journal of Nutritional Science and Vitaminology2008;54(6):440‐7. [PUBMED: 19155581] ChenK , ZhangX , LiTY , ChenL , WeiXP , QuP , et al. Effect of vitamin A, vitamin A plus iron and multiple micronutrient‐fortified seasoning powder on infectious morbidity of preschool children. Nutrition2011;27(4):428‐34. [DOI: 10.1016/j.nut.2010.04.004; PUBMED: 20605698] Dr Chen [percomm] . Regards and question on study: effect of vitamin A, vitamin A plus iron and multiple micronutrient‐fortified seasoning powder on infectious morbidity of preschool children. Email to: JP Pena‐Rosas 1 November 2011. ">Chen 2008</a>; <a href="./references#CD009666-bbs2-0030" title="MangerMS , McKenzieJE , WinichagoonP , GrayA , ChavasitV , PongcharoenT , et al. A micronutrient‐fortified seasoning powder reduces morbidity and improves short‐term cognitive function, but has no effect on anthropometric measures in primary school children in northeast Thailand: a randomized controlled trial. American Journal of Clinical Nutrition2008;87(6):1715‐22. [PUBMED: 18541560] WinichagoonP , McKenzieJE , ChavasitV , PongcharoenT , GowachirapantS , BoonpradermA , et al. A multimicronutrient‐fortified seasoning powder enhances the hemoglobin, zinc, and iodine status of primary school children in North East Thailand: a randomized controlled trial of efficacy. Journal of Nutrition2006;136(6):1617‐23. [PUBMED: 16702330] ">Manger 2008</a>). Three trials evaluated the effects of zinc and placebo tablets dissolved in freshly prepared fruit juice and administered to the children every day (<a href="./references#CD009666-bbs2-0029" title="KikafundaJK , WalkerAF , AllanEF , TumwineJK . Effect of zinc supplementation on growth and body composition of Ugandan preschool children: a randomized, controlled, intervention trial. American Journal of Clinical Nutrition1998;68(6):1261‐6. [PUBMED: 9846856] ">Kikafunda 1998</a>); the effects of four powdered fortificants added to a base powder containing protein 8 g, sugar 12 g and maltodextrin 4 g to be dissolved in 100 mL of a soy‐based fruit drink (<a href="./references#CD009666-bbs2-0034" title="OsendarpSJ , BaghurstKI , BryanJ , CalvaresiE , HughesD , HussainiM , et al. Effect of a 12‐mo micronutrient intervention on learning and memory in well‐nourished and marginally nourished school‐aged children: 2 parallel, randomized, placebo‐controlled studies in Australia and Indonesia. American Journal of Clinical Nutrition2007;86(4):1082‐93. [PUBMED: 17921387] ">Osendarp 2007</a>); or the effects of synthetic β‐carotene powder added to rice (<a href="./references#CD009666-bbs2-0046" title="Vuong leT , DuekerSR , MurphySP . Plasma beta‐carotene and retinol concentrations of children increase after a 30‐d supplementation with the fruit Momordica cochinchinensis (gac). American Journal of Clinical Nutrition2002;75(5):872‐9. [PUBMED: 11976161] ">Vuong 2002</a>). Two trials were of ineligible interventions (<a href="./references#CD009666-bbs2-0032" title="FrongilloEA , NguyenPH , SahaKK , SanghviT , AfsanaK , HagueR , et al. Large‐scale behavior‐change initiative for infant and young child feeding advanced language and motor development in a cluster‐randomized program evaluation in Bangladesh. Journal of Nutrition2017;147(2):256‐63. [DOI: 10.3945/jn.116.240861; PUBMED: 28031374] MenonP , NguyenPH , SahaKK , KhaledA , KennedyA , TranLM , et al. Impacts on breastfeeding practices of at‐scale strategies that combine intensive interpersonal counseling, mass media, and community mobilization: results of cluster‐randomized program evaluations in Bangladesh and Viet Nam. PLoS Medicine2016;13(10):e1002159. [DOI: 10.1371/journal.pmed.1002159; PUBMED: 27780198] MenonP , NguyenPH , SahaKK , KhaledA , SanghviT , BakerJ , et al. Combining intensive counseling by frontline workers with a nationwide mass media campaign has large differential impacts on complementary feeding practices but not on child growth: results of a cluster‐randomized program evaluation in Bangladesh. Journal of Nutrition2016;146(10):2075‐84. [DOI: 10.3945/jn.116.232314; PUBMED: 27581575] MenonP , RawatR . Impact of behavior change communications and market‐based approach to delivering micronutrient powders on stunting, infant feeding practices and anemia in Bangladesh. clinicaltrials.gov/ct2/show/NCT01678716 Date first received: 29 August 2012. ">Menon 2016</a>; <a href="./references#CD009666-bbs2-0037" title="RimH , KimS , SimB , GangH , KimH , KimY , et al. Effect of iron fortification of nursery complementary food on iron status of infants in the DPR Korea. Asia Pacific Journal of Clinical Nutrition2008;17(2):264‐9. [PUBMED: 18586646] ">Rim 2008</a>). From these, one study assessed the effects of behaviour‐change interventions in Bangladesh, where half of the sample were offered MNP sachets containing iron, folic acid, zinc, and vitamins A and C for sale to mothers (<a href="./references#CD009666-bbs2-0032" title="FrongilloEA , NguyenPH , SahaKK , SanghviT , AfsanaK , HagueR , et al. Large‐scale behavior‐change initiative for infant and young child feeding advanced language and motor development in a cluster‐randomized program evaluation in Bangladesh. Journal of Nutrition2017;147(2):256‐63. [DOI: 10.3945/jn.116.240861; PUBMED: 28031374] MenonP , NguyenPH , SahaKK , KhaledA , KennedyA , TranLM , et al. Impacts on breastfeeding practices of at‐scale strategies that combine intensive interpersonal counseling, mass media, and community mobilization: results of cluster‐randomized program evaluations in Bangladesh and Viet Nam. PLoS Medicine2016;13(10):e1002159. [DOI: 10.1371/journal.pmed.1002159; PUBMED: 27780198] MenonP , NguyenPH , SahaKK , KhaledA , SanghviT , BakerJ , et al. Combining intensive counseling by frontline workers with a nationwide mass media campaign has large differential impacts on complementary feeding practices but not on child growth: results of a cluster‐randomized program evaluation in Bangladesh. Journal of Nutrition2016;146(10):2075‐84. [DOI: 10.3945/jn.116.232314; PUBMED: 27581575] MenonP , RawatR . Impact of behavior change communications and market‐based approach to delivering micronutrient powders on stunting, infant feeding practices and anemia in Bangladesh. clinicaltrials.gov/ct2/show/NCT01678716 Date first received: 29 August 2012. ">Menon 2016</a>). </p> <p>Six studies had types of study design other than RCT (<a href="./references#CD009666-bbs2-0016" title="AngdembeMR , ChoudhuryN , HaqueMR , AhmedT . Adherence to multiple micronutrient powder among young children in rural Bangladesh: a cross‐sectional study. BMC Public Health2015;15(440):1‐10. [DOI: 10.1186/s12889‐015‐1752‐z; PMC4424501; PUBMED: 25925874] ">Angdembe 2015</a>; <a href="./references#CD009666-bbs2-0019" title="ClarkeSE , SackoM , RoschnikN , DickoY , DiarraS , TheraP , et al. Seasonal malaria chemoprevention combined with micronutrient supplementation delivered through community preschools: findings from a cluster randomized trial in Mali. Tropical Medicine &amp; International Health2015;20(Suppl 1):25‐6. ">Clarke 2015</a>; <a href="./references#CD009666-bbs2-0020" title="DePeeS , Moench‐PfannerR , MartiniE , ZlotkinSH , Darnton‐HillI , BloemMW . Home fortification in emergency response and transition programming: experiences in Aceh and Nias, Indonesia. Food and Nutrition Bulletin2007;28(2):189‐97. [DOI: 10.1177/156482650702800208; PUBMED: 24683678] ">De Pee 2007</a>; <a href="./references#CD009666-bbs2-0024" title="Huamán‐EspinoL , AparcoJP , Nuñez‐RoblesE , GonzálesE , PillacaJ , Mayta‐TristánP . Consumption of chispitas® multimicronutrient supplements and anemia in 6–35‐month‐old children: cross‐cut study in the context of a populational health intervention in Apurimac, Peru [Consumo de suplementos con multimicronutrientes Chispitas® y anemia en niños de 6 a 35 meses: estudio transversal en el contexto de una intervención poblacional en Apurímac, Perú]. Revista Peruana de Medicina Experimental y Salud Publica2012;29(3):314‐23. [PUBMED: 23085791] MunaycoCV , Ulloa‐ReaME , Medina‐OsisJ , Lozano‐RevollarCR , TejadaV , Castro‐SalazarC , et al. Evaluation of the impact of multiple micronutrient powders on children anemia in three Andean regions in Peru [Evaluación del impacto de los multimicronutrientes en polvo sobre la anemia infantil en tres regiones andinas del Perú]. Revista Peruana de Medicina Experimental y Salud Publica2013;30(2):229‐34. [PUBMED: 23949507] ">Huamán‐Espino 2012</a>; <a href="./references#CD009666-bbs2-0035" title="PaganiniD , UyogaMA , ZimmermannMB . Iron fortification of foods for infants and children in low‐income countries: effects on the gut microbiome, gut inflammation, and diarrhea. Nutrients2016;8(8):1‐11. [DOI: 10.3390/nu8080494; PMC4997407; PUBMED: 27529276] ">Paganini 2016</a>; <a href="./references#CD009666-bbs2-0036" title="RahJH , dePeeS , KraemerK , SteigerG , BloemMW , SpiegelP , et al. Program experience with micronutrient powders and current evidence. Journal of Nutrition2012;142(1):191‐6S. [DOI: 10.3945/jn.111.140004; PUBMED: 22131547] ">Rah 2012</a>). One trial described the post‐tsunami experience with distribution of <i>Vitalita</i> sprinkles in Aceh and Nias, Indonesia, and did not have a control group (<a href="./references#CD009666-bbs2-0020" title="DePeeS , Moench‐PfannerR , MartiniE , ZlotkinSH , Darnton‐HillI , BloemMW . Home fortification in emergency response and transition programming: experiences in Aceh and Nias, Indonesia. Food and Nutrition Bulletin2007;28(2):189‐97. [DOI: 10.1177/156482650702800208; PUBMED: 24683678] ">De Pee 2007</a>), and two involved cross‐sectional surveys (<a href="./references#CD009666-bbs2-0016" title="AngdembeMR , ChoudhuryN , HaqueMR , AhmedT . Adherence to multiple micronutrient powder among young children in rural Bangladesh: a cross‐sectional study. BMC Public Health2015;15(440):1‐10. [DOI: 10.1186/s12889‐015‐1752‐z; PMC4424501; PUBMED: 25925874] ">Angdembe 2015</a>; <a href="./references#CD009666-bbs2-0019" title="ClarkeSE , SackoM , RoschnikN , DickoY , DiarraS , TheraP , et al. Seasonal malaria chemoprevention combined with micronutrient supplementation delivered through community preschools: findings from a cluster randomized trial in Mali. Tropical Medicine &amp; International Health2015;20(Suppl 1):25‐6. ">Clarke 2015</a>). One of these references was a literature review of the effects of iron‐fortified foods, including in‐home iron fortification of complementary foods using MNP in gut microbiome (<a href="./references#CD009666-bbs2-0035" title="PaganiniD , UyogaMA , ZimmermannMB . Iron fortification of foods for infants and children in low‐income countries: effects on the gut microbiome, gut inflammation, and diarrhea. Nutrients2016;8(8):1‐11. [DOI: 10.3390/nu8080494; PMC4997407; PUBMED: 27529276] ">Paganini 2016</a>). </p> <p>One registered study aimed to find out whether adding a small quantity of powdered beef liver to day‐care meals of Brazilian preschool children from Salvador for 12 months could prevent anaemia and micronutrient deficiencies, and improve their growth, health and development in the same way (or better), than adding a small quantity of MNP (Sprinkles) (<a href="./references#CD009666-bbs2-0022" title="GibsonR . Fortifying day‐care meals with desiccated beef liver or micronutrient sprinkles to combat anaemia and micronutrient deficiencies in Brazillian pre‐school children. www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12610000646044 Date first registered: 9 August 2010. GibsonR [pers comm] . Regards and question. Email to: JP Peña‐Rosas 9 February 2017. ">Gibson 2010</a>). However, the study was not conducted because the baseline micronutrient survey data showed no evidence of micronutrient deficiencies among the preschool‐age children. </p> <p>Two studies had ineligible comparison types (<a href="./references#CD009666-bbs2-0039" title="NCT00967551 . The impact of the use of zinc supplementation and other micronutrients on the occurrence of diarrhea diseases and respiratory infections in children of daycare centers. clinicaltrials.gov/show/NCT00967551 Date first received: 27 August 2009. SampaioDL , MattosAP , RibeiroTC , LeiteME , ColeCR , Costa‐RibeiroHJr . Zinc and other micronutrients supplementation through the use of sprinkles: impact on the occurrence of diarrhoea and respiratory infections in institutionalized children [Suplementação de zinco e outros micronutrientes através do uso de sprinkles: impacto na ocorrência de doença diarreica e infecções respiratórias em crianças institucionalizadas]. Jornal de Pediatria2013;89(3):286‐93. [DOI: 10.1016/j.jped.2012.11.004; PUBMED: 23664200] ">Sampaio 2013</a>; <a href="./references#CD009666-bbs2-0040" title="Selva SuárezLN , Ochoa AlonsoAA . Actions for prevention and control of iron‐deficiency anemia in up to five‐years old children [Acciones para la prevención y control de la anemia por deficiencia de hierro en niños hasta cinco años]. Revista Cubana de Salud Pública2011;37(3):200‐6. [DOI: 10.1590/S0864‐34662011000300003] ">Selva Suárez 2011</a>). </p> <p>See the <a href="./references#CD009666-sec-0175" title="">Characteristics of excluded studies</a> table for a detailed description of the trials and the reasons for their exclusion. </p> <section id="CD009666-sec-0091"> <h5 class="title">Ongoing studies</h5> <p>We identified six ongoing studies (<a href="./references#CD009666-bbs2-0052" title="ACTRN12616001245482 . Food fortification powder for improving micronutrient status in underweight and overweight/obese primary school children [The effect of a multiple micronutrient powder for point‐of‐use fortification of foods on the micronutrient status of underweight and overweight/obese primary school children in Vietnam ‐ a randomised controlled trial]. apps.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12616001245482 Date first registered: 6 September 2016. ">ACTRN12616001245482</a>; <a href="./references#CD009666-bbs2-0053" title="NCT01917032 . Effect of home‐fortification with micronutrient powder sprinkles in hematologic and nutritional status in preschool children in Medellín: a randomized clinical trial. clinicaltrials.gov/show/NCT01917032 Date first received: 2 August 2013. ">NCT01917032</a>; <a href="./references#CD009666-bbs2-0054" title="NCT02280330 . Iodine intake &amp; status of preschoolers given micronutrient powder for 6 months. clinicaltrials.gov/ct2/show/NCT02280330 Date first received: 27 October 2014. ">NCT02280330</a>; <a href="./references#CD009666-bbs2-0055" title="NCT02302729 . Early child development and nutrition in Guatemala. clinicaltrials.gov/ct2/show/study/NCT02302729 Date first received: 31 October 2014. ">NCT02302729</a>; <a href="./references#CD009666-bbs2-0056" title="KureishyS , KhanGN , ArrifS , AshrafK , CespedesA , HabibMA , et al. A mixed methods study to assess the effectiveness of food‐based interventions to prevent stunting among children under‐five years in Districts Thatta and Sujawal, Sindh Province, Pakistan: study protocol. BMC Public Health2017;17(1):1‐6. [DOI: 10.1186/s12889‐016‐3976‐y; PUBMED: 28056945] NCT02422953 . Effectiveness of food/nutrient based interventions to prevent stunting among children under five in Thatta and Sajawal districts, Sindh province, Pakistan. clinicaltrials.gov/ct2/show/record/NCT02422953 Date first received: 15 April 2015. ">NCT02422953</a>; <a href="./references#CD009666-bbs2-0057" title="PACTR201607001693286 . The efficacy of multiple micronutrient powder supplementation in children under five years in Arusha District. apps.who.int/trialsearch/Trial2.aspx?TrialID=PACTR201607001693286 Date first registered: 24 June 2016. ">PACTR201607001693286</a>). The studies are being conducted in Colombia (<a href="./references#CD009666-bbs2-0053" title="NCT01917032 . Effect of home‐fortification with micronutrient powder sprinkles in hematologic and nutritional status in preschool children in Medellín: a randomized clinical trial. clinicaltrials.gov/show/NCT01917032 Date first received: 2 August 2013. ">NCT01917032</a>), Guatemala (<a href="./references#CD009666-bbs2-0055" title="NCT02302729 . Early child development and nutrition in Guatemala. clinicaltrials.gov/ct2/show/study/NCT02302729 Date first received: 31 October 2014. ">NCT02302729</a>), Pakistan (<a href="./references#CD009666-bbs2-0056" title="KureishyS , KhanGN , ArrifS , AshrafK , CespedesA , HabibMA , et al. A mixed methods study to assess the effectiveness of food‐based interventions to prevent stunting among children under‐five years in Districts Thatta and Sujawal, Sindh Province, Pakistan: study protocol. BMC Public Health2017;17(1):1‐6. [DOI: 10.1186/s12889‐016‐3976‐y; PUBMED: 28056945] NCT02422953 . Effectiveness of food/nutrient based interventions to prevent stunting among children under five in Thatta and Sajawal districts, Sindh province, Pakistan. clinicaltrials.gov/ct2/show/record/NCT02422953 Date first received: 15 April 2015. ">NCT02422953</a>), Philippines (<a href="./references#CD009666-bbs2-0054" title="NCT02280330 . Iodine intake &amp; status of preschoolers given micronutrient powder for 6 months. clinicaltrials.gov/ct2/show/NCT02280330 Date first received: 27 October 2014. ">NCT02280330</a>), Tanzania (<a href="./references#CD009666-bbs2-0057" title="PACTR201607001693286 . The efficacy of multiple micronutrient powder supplementation in children under five years in Arusha District. apps.who.int/trialsearch/Trial2.aspx?TrialID=PACTR201607001693286 Date first registered: 24 June 2016. ">PACTR201607001693286</a>), and Vietnam (<a href="./references#CD009666-bbs2-0052" title="ACTRN12616001245482 . Food fortification powder for improving micronutrient status in underweight and overweight/obese primary school children [The effect of a multiple micronutrient powder for point‐of‐use fortification of foods on the micronutrient status of underweight and overweight/obese primary school children in Vietnam ‐ a randomised controlled trial]. apps.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12616001245482 Date first registered: 6 September 2016. ">ACTRN12616001245482</a>). Most studies are being conducted in children of different age ranges: six to 12 months of age and preschool‐age children (36 to 48 months of age) (<a href="./references#CD009666-bbs2-0055" title="NCT02302729 . Early child development and nutrition in Guatemala. clinicaltrials.gov/ct2/show/study/NCT02302729 Date first received: 31 October 2014. ">NCT02302729</a>); healthy boys and girls aged four to six years (<a href="./references#CD009666-bbs2-0054" title="NCT02280330 . Iodine intake &amp; status of preschoolers given micronutrient powder for 6 months. clinicaltrials.gov/ct2/show/NCT02280330 Date first received: 27 October 2014. ">NCT02280330</a>), children aged six to 59 months with moderate anaemia (Hb concentration 70 g/L to 100 g/L) (<a href="./references#CD009666-bbs2-0057" title="PACTR201607001693286 . The efficacy of multiple micronutrient powder supplementation in children under five years in Arusha District. apps.who.int/trialsearch/Trial2.aspx?TrialID=PACTR201607001693286 Date first registered: 24 June 2016. ">PACTR201607001693286</a>), non‐anaemic children aged five to 59 months (<a href="./references#CD009666-bbs2-0053" title="NCT01917032 . Effect of home‐fortification with micronutrient powder sprinkles in hematologic and nutritional status in preschool children in Medellín: a randomized clinical trial. clinicaltrials.gov/show/NCT01917032 Date first received: 2 August 2013. ">NCT01917032</a>), and healthy primary school boys and girls aged six to nine years (<a href="./references#CD009666-bbs2-0052" title="ACTRN12616001245482 . Food fortification powder for improving micronutrient status in underweight and overweight/obese primary school children [The effect of a multiple micronutrient powder for point‐of‐use fortification of foods on the micronutrient status of underweight and overweight/obese primary school children in Vietnam ‐ a randomised controlled trial]. apps.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12616001245482 Date first registered: 6 September 2016. ">ACTRN12616001245482</a>). One study is on pregnant women, lactating mothers and children aged six to 59 months (<a href="./references#CD009666-bbs2-0056" title="KureishyS , KhanGN , ArrifS , AshrafK , CespedesA , HabibMA , et al. A mixed methods study to assess the effectiveness of food‐based interventions to prevent stunting among children under‐five years in Districts Thatta and Sujawal, Sindh Province, Pakistan: study protocol. BMC Public Health2017;17(1):1‐6. [DOI: 10.1186/s12889‐016‐3976‐y; PUBMED: 28056945] NCT02422953 . Effectiveness of food/nutrient based interventions to prevent stunting among children under five in Thatta and Sajawal districts, Sindh province, Pakistan. clinicaltrials.gov/ct2/show/record/NCT02422953 Date first received: 15 April 2015. ">NCT02422953</a>). See <a href="./references#CD009666-sec-0176" title="">Characteristics of ongoing studies</a> table for details. </p> </section> </section> </section> <section id="CD009666-sec-0092"> <h3 class="title">Risk of bias in included studies</h3> <p>Overall, study methods were not well described in many of the included trials. However, we contacted all study authors and obtained a very high response rate: 83.3% of study authors provided additional information that improved the quality of our assessment (see <a href="#CD009666-fig-0002">Figure 2</a> and <a href="#CD009666-fig-0003">Figure 3</a>). All provided clarifications are noted in the <a href="./references#CD009666-sec-0174" title="">Characteristics of included studies</a> table. </p> <div class="figure" id="CD009666-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included trials." data-id="CD009666-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included trials. </p> </div> </div> </div> <div class="figure" id="CD009666-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD009666-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <p>In total, we judged nine out of 13 studies at low risk of bias (<a href="./references#CD009666-bbs2-0001" title="InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Combined intensive nutrition education and micronutrient powder supplementation improved nutritional status of mildly wasted children on Nias Island, Indonesia. Asia Pacific Journal of Clinical Nutrition2012;21(3):361‐73. [PUBMED: 22705425] InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Improved nutrition knowledge and practice through intensive nutrition education: a study among caregivers of mildly wasted children on Nias Island, Indonesia. Food and Nutrition Bulletin2012;33(2):117‐27. [DOI: 10.1177/156482651203300205; PUBMED: 22908693] PurwestriRC , ScherbaumV , InayatiDA , WirawanNN , SuryantanJ , BloemMA , et al. Supplementary feeding with locally‐produced ready‐to‐use food (RUF) for mildly wasted children on Nias Island, Indonesia: comparison of daily and weekly programme outcomes. Asia Pacific Journal of Clinical Nutrition2012;21(3):374‐9. [PUBMED: 22705426] ScherbaumV [pers comm] . Your paper on MNP. Email to: LM De‐Regil 5 February 2013. ">Inayati 2012 (C)</a>; <a href="./references#CD009666-bbs2-0003" title="KounnavongS , SunaharaT , Mascie‐TaylorCG , HashizumeM , OkumuraJ , MojiK , et al. Effect of daily versus weekly home fortification with multiple micronutrient powder on haemoglobin concentration of young children in a rural area, Lao People's Democratic Republic: a randomised trial. Nutrition Journal2011;10(129):1‐11. [DOI: 10.1186/1475‐2891‐10‐129; PMC3266642; PUBMED: 22111770] ">Kounnavong 2011 (C)</a>; <a href="./references#CD009666-bbs2-0004" title="LundeenE [pers comm] . Kyrgyz Republic MNP data for children 24‐36 months. Email to: M Jefferds 3 November 2011. LundeenE , SchuethT , ToktobaevN , ZlotkinS , HyderSM , HouserR . Daily use of Sprinkles micronutrient powder for 2 months reduces anemia among children 6 to 36 months of age in the Kyrgyz Republic: a cluster‐randomized trial. Food and Nutrition Bulletin2010;31(3):446‐60. [DOI: 10.1177/156482651003100307; PUBMED: 20973465] ">Lundeen 2010 (C)</a>; <a href="./references#CD009666-bbs2-0005" title="Macharia‐MutieCW , MorettiD , Van denBrielN , OmusundiAM , MwangiAM , KokFJ , et al. Maize porridge enriched with a micronutrient powder containing low‐dose iron as NaFeEDTA but not amaranth grain flour reduces anemia and iron deficiency in Kenyan preschool children. Journal of Nutrition2012;142(9):1756‐63. [DOI: 10.3945/jn.112.157578; PUBMED: 22810982] Macharia‐MutieCW , OmusundiAM , MwaiJM , MwangiAM , BrouwerID . Simulation of the effect of maize porridge fortified with grain amaranth or micronutrient powder containing NaFeEDTA on iron intake and status in Kenyan children. Public Health Nutrition2013;16(9):1605‐13. [DOI: 10.1017/S1368980012005174; PUBMED: 23218415] ">Macharia‐Mutie 2012</a>; <a href="./references#CD009666-bbs2-0006" title="JerlingJ [pers comm] . Regards and question on Ogundale et al 2011 vir Cochrane review. Email to: JP Pena‐Rosas 3 November 2011. OgunladeAO , KrugerHS , JerlingJC , SmutsCM , CovicN , HanekomSM , et al. Point‐of‐use micronutrient fortification: lessons learned in implementing a preschool‐based pilot trial in South Africa. International Journal of Food Sciences and Nutrition2011;62(1):1‐16. [DOI: 10.3109/09637486.2010.495710; PUBMED: 20701549] ">Ogunlade 2011</a>; <a href="./references#CD009666-bbs2-0007" title="OrozcoJ , VargasC , RojasML , HerreraAM , MontoyaL , SánchezJG , et al. The effect of powdered micronutrients on the hematologic values and nutritional status of healthy preschoolers. Medellín, 2013 [Efecto de los micronutrientes en polvo en el estado nutricional y en los valores hemáticos de preescolares sanos. Medellín, 2013]. Revista Facultad Nacional de Salud Pública2015;33(2):161‐70. [DOI: 10.17533/udea.rfnsp.v33n2a03] ">Orozco 2015 (C)</a>; <a href="./references#CD009666-bbs2-0008" title="OseiAK , HouserRF , BulusuS , HamerDH . Acceptability of micronutrient fortified school meals by schoolchildren in rural Himalayan villages of India. Journal of Food Science2008;73(7):S354‐8. [DOI: 10.1111/j.1750‐3841.2008.00878.x; PUBMED: 18803728] OseiAK , RosenbergIH , HouserRF , BulusuS , MathewsM , HamerDH . Community‐level micronutrient fortification of school lunch meals improved vitamin A, folate, and iron status of schoolchildren in Himalayan villages of India. Journal of Nutrition2010;140(6):1146‐54. [DOI: 10.3945/jn.109.114751; PUBMED: 20410083] ">Osei 2008 (C)</a>; <a href="./references#CD009666-bbs2-0011" title="VarmaJL , DasS , SankarR , MannarMG , LevinsonFJ , HamerDH . Community‐level micronutrient fortification of a food supplement in India: a controlled trial in preschool children aged 36‐66 mo. American Journal of Clinical Nutrition2007;85(4):1127‐33. [PUBMED: 17413115] ">Varma 2007 (C)</a>; <a href="./references#CD009666-bbs2-0012" title="VinodkumarM , RajagopalanS . Impact of a multiple‐micronutrient food supplement on the nutritional status of schoolchildren. Food and Nutrition Bulletin2006;27(3):203‐10. [DOI: 10.1177/156482650602700302; PUBMED: 17542110] ">Vinodkumar 2006 (C)</a>). </p> <section id="CD009666-sec-0093"> <h4 class="title">Allocation</h4> <section id="CD009666-sec-0094"> <h5 class="title">Sequence generation</h5> <p>In four trials, the method for generation of random sequence was unclear (<a href="./references#CD009666-bbs2-0002" title="KemmerTM , OmerPS , Gidvani‐DiazVK , CoelloM . Acceptance and effect of ferrous fumarate containing micronutrient sprinkles on anemia, iron deficiency and anthropometrics in Honduran children. In: SilverbergDS editor(s). Anemia. Rijeka (Croatia): InTech, 2012. [DOI: 10.5772/30987] ">Kemmer 2012 (C)</a>; <a href="./references#CD009666-bbs2-0009" title="SharieffW , YinSA , WuM , YangQ , SchauerC , TomlinsonG , et al. Short‐term daily or weekly administration of micronutrient Sprinkles has high compliance and does not cause iron overload in Chinese schoolchildren: a cluster‐randomized trial. Public Health Nutrition2006;9(3):336‐44. [PUBMED: 16684385] ZlotkinS [pers comm] . Regards and question ‐ Sharieff 2006. Email to: JP Peña‐Rosas 2 November 2011. ">Sharieff 2006 (C)</a>; <a href="./references#CD009666-bbs2-0010" title="TroeschB [pers comm] . Regards and question on Troesch et al 2011. Email to: JP Peña‐Rosas 1 November 2011. TroeschB , vanStuijvenbergME , SmutsCM , KrugerHS , BiebingerR , HurrellRF , et al. A micronutrient powder with low doses of highly absorbable iron and zinc reduces iron and zinc deficiency and improves weight‐for‐age Z‐scores in South African children. Journal of Nutrition2011;141(2):237‐42. [DOI: 10.3945/jn.110.129247; PUBMED: 21178093] ">Troesch 2011b</a>; <a href="./references#CD009666-bbs2-0013" title="VinodkumarM , RajagopalanS . Efficacy of fortification of school meals with ferrous glycine phosphate and riboflavin against anemia and angular stomatitis in schoolchildren. Food and Nutrition Bulletin2009;30(3):260‐4. [DOI: 10.1177/156482650903000307; PUBMED: 19927606] ">Vinodkumar 2009 (C)</a>). We judged the remaining nine trials at low risk of bias on this domain. <a href="./references#CD009666-bbs2-0001" title="InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Combined intensive nutrition education and micronutrient powder supplementation improved nutritional status of mildly wasted children on Nias Island, Indonesia. Asia Pacific Journal of Clinical Nutrition2012;21(3):361‐73. [PUBMED: 22705425] InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Improved nutrition knowledge and practice through intensive nutrition education: a study among caregivers of mildly wasted children on Nias Island, Indonesia. Food and Nutrition Bulletin2012;33(2):117‐27. [DOI: 10.1177/156482651203300205; PUBMED: 22908693] PurwestriRC , ScherbaumV , InayatiDA , WirawanNN , SuryantanJ , BloemMA , et al. Supplementary feeding with locally‐produced ready‐to‐use food (RUF) for mildly wasted children on Nias Island, Indonesia: comparison of daily and weekly programme outcomes. Asia Pacific Journal of Clinical Nutrition2012;21(3):374‐9. [PUBMED: 22705426] ScherbaumV [pers comm] . Your paper on MNP. Email to: LM De‐Regil 5 February 2013. ">Inayati 2012 (C)</a>; <a href="./references#CD009666-bbs2-0011" title="VarmaJL , DasS , SankarR , MannarMG , LevinsonFJ , HamerDH . Community‐level micronutrient fortification of a food supplement in India: a controlled trial in preschool children aged 36‐66 mo. American Journal of Clinical Nutrition2007;85(4):1127‐33. [PUBMED: 17413115] ">Varma 2007 (C)</a>; and <a href="./references#CD009666-bbs2-0012" title="VinodkumarM , RajagopalanS . Impact of a multiple‐micronutrient food supplement on the nutritional status of schoolchildren. Food and Nutrition Bulletin2006;27(3):203‐10. [DOI: 10.1177/156482650602700302; PUBMED: 17542110] ">Vinodkumar 2006 (C)</a> used random tables for sequence generation. <a href="./references#CD009666-bbs2-0003" title="KounnavongS , SunaharaT , Mascie‐TaylorCG , HashizumeM , OkumuraJ , MojiK , et al. Effect of daily versus weekly home fortification with multiple micronutrient powder on haemoglobin concentration of young children in a rural area, Lao People's Democratic Republic: a randomised trial. Nutrition Journal2011;10(129):1‐11. [DOI: 10.1186/1475‐2891‐10‐129; PMC3266642; PUBMED: 22111770] ">Kounnavong 2011 (C)</a> and <a href="./references#CD009666-bbs2-0006" title="JerlingJ [pers comm] . Regards and question on Ogundale et al 2011 vir Cochrane review. Email to: JP Pena‐Rosas 3 November 2011. OgunladeAO , KrugerHS , JerlingJC , SmutsCM , CovicN , HanekomSM , et al. Point‐of‐use micronutrient fortification: lessons learned in implementing a preschool‐based pilot trial in South Africa. International Journal of Food Sciences and Nutrition2011;62(1):1‐16. [DOI: 10.3109/09637486.2010.495710; PUBMED: 20701549] ">Ogunlade 2011</a> used computer‐generated random numbers. <a href="./references#CD009666-bbs2-0004" title="LundeenE [pers comm] . Kyrgyz Republic MNP data for children 24‐36 months. Email to: M Jefferds 3 November 2011. LundeenE , SchuethT , ToktobaevN , ZlotkinS , HyderSM , HouserR . Daily use of Sprinkles micronutrient powder for 2 months reduces anemia among children 6 to 36 months of age in the Kyrgyz Republic: a cluster‐randomized trial. Food and Nutrition Bulletin2010;31(3):446‐60. [DOI: 10.1177/156482651003100307; PUBMED: 20973465] ">Lundeen 2010 (C)</a> and <a href="./references#CD009666-bbs2-0008" title="OseiAK , HouserRF , BulusuS , HamerDH . Acceptability of micronutrient fortified school meals by schoolchildren in rural Himalayan villages of India. Journal of Food Science2008;73(7):S354‐8. [DOI: 10.1111/j.1750‐3841.2008.00878.x; PUBMED: 18803728] OseiAK , RosenbergIH , HouserRF , BulusuS , MathewsM , HamerDH . Community‐level micronutrient fortification of school lunch meals improved vitamin A, folate, and iron status of schoolchildren in Himalayan villages of India. Journal of Nutrition2010;140(6):1146‐54. [DOI: 10.3945/jn.109.114751; PUBMED: 20410083] ">Osei 2008 (C)</a> used shuffling cards to generate the random sequence. <a href="./references#CD009666-bbs2-0007" title="OrozcoJ , VargasC , RojasML , HerreraAM , MontoyaL , SánchezJG , et al. The effect of powdered micronutrients on the hematologic values and nutritional status of healthy preschoolers. Medellín, 2013 [Efecto de los micronutrientes en polvo en el estado nutricional y en los valores hemáticos de preescolares sanos. Medellín, 2013]. Revista Facultad Nacional de Salud Pública2015;33(2):161‐70. [DOI: 10.17533/udea.rfnsp.v33n2a03] ">Orozco 2015 (C)</a> reported using random blocks of variable length. <a href="./references#CD009666-bbs2-0005" title="Macharia‐MutieCW , MorettiD , Van denBrielN , OmusundiAM , MwangiAM , KokFJ , et al. Maize porridge enriched with a micronutrient powder containing low‐dose iron as NaFeEDTA but not amaranth grain flour reduces anemia and iron deficiency in Kenyan preschool children. Journal of Nutrition2012;142(9):1756‐63. [DOI: 10.3945/jn.112.157578; PUBMED: 22810982] Macharia‐MutieCW , OmusundiAM , MwaiJM , MwangiAM , BrouwerID . Simulation of the effect of maize porridge fortified with grain amaranth or micronutrient powder containing NaFeEDTA on iron intake and status in Kenyan children. Public Health Nutrition2013;16(9):1605‐13. [DOI: 10.1017/S1368980012005174; PUBMED: 23218415] ">Macharia‐Mutie 2012</a> used block randomisation by age and sex generated with Excel (Microsoft) by one investigator not involved in recruitment and data collection. </p> </section> <section id="CD009666-sec-0095"> <h5 class="title">Allocation concealment</h5> <p>In one trial, allocation concealment was unclear (<a href="./references#CD009666-bbs2-0009" title="SharieffW , YinSA , WuM , YangQ , SchauerC , TomlinsonG , et al. Short‐term daily or weekly administration of micronutrient Sprinkles has high compliance and does not cause iron overload in Chinese schoolchildren: a cluster‐randomized trial. Public Health Nutrition2006;9(3):336‐44. [PUBMED: 16684385] ZlotkinS [pers comm] . Regards and question ‐ Sharieff 2006. Email to: JP Peña‐Rosas 2 November 2011. ">Sharieff 2006 (C)</a>), while another did not conceal allocation and thus was rated at high risk of bias (<a href="./references#CD009666-bbs2-0003" title="KounnavongS , SunaharaT , Mascie‐TaylorCG , HashizumeM , OkumuraJ , MojiK , et al. Effect of daily versus weekly home fortification with multiple micronutrient powder on haemoglobin concentration of young children in a rural area, Lao People's Democratic Republic: a randomised trial. Nutrition Journal2011;10(129):1‐11. [DOI: 10.1186/1475‐2891‐10‐129; PMC3266642; PUBMED: 22111770] ">Kounnavong 2011 (C)</a>). We judged the remaining 11 trials at low risk of bias (<a href="./references#CD009666-bbs2-0001" title="InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Combined intensive nutrition education and micronutrient powder supplementation improved nutritional status of mildly wasted children on Nias Island, Indonesia. Asia Pacific Journal of Clinical Nutrition2012;21(3):361‐73. [PUBMED: 22705425] InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Improved nutrition knowledge and practice through intensive nutrition education: a study among caregivers of mildly wasted children on Nias Island, Indonesia. Food and Nutrition Bulletin2012;33(2):117‐27. [DOI: 10.1177/156482651203300205; PUBMED: 22908693] PurwestriRC , ScherbaumV , InayatiDA , WirawanNN , SuryantanJ , BloemMA , et al. Supplementary feeding with locally‐produced ready‐to‐use food (RUF) for mildly wasted children on Nias Island, Indonesia: comparison of daily and weekly programme outcomes. Asia Pacific Journal of Clinical Nutrition2012;21(3):374‐9. [PUBMED: 22705426] ScherbaumV [pers comm] . Your paper on MNP. Email to: LM De‐Regil 5 February 2013. ">Inayati 2012 (C)</a>; <a href="./references#CD009666-bbs2-0002" title="KemmerTM , OmerPS , Gidvani‐DiazVK , CoelloM . Acceptance and effect of ferrous fumarate containing micronutrient sprinkles on anemia, iron deficiency and anthropometrics in Honduran children. In: SilverbergDS editor(s). Anemia. Rijeka (Croatia): InTech, 2012. [DOI: 10.5772/30987] ">Kemmer 2012 (C)</a>; <a href="./references#CD009666-bbs2-0004" title="LundeenE [pers comm] . Kyrgyz Republic MNP data for children 24‐36 months. Email to: M Jefferds 3 November 2011. LundeenE , SchuethT , ToktobaevN , ZlotkinS , HyderSM , HouserR . Daily use of Sprinkles micronutrient powder for 2 months reduces anemia among children 6 to 36 months of age in the Kyrgyz Republic: a cluster‐randomized trial. Food and Nutrition Bulletin2010;31(3):446‐60. [DOI: 10.1177/156482651003100307; PUBMED: 20973465] ">Lundeen 2010 (C)</a>; <a href="./references#CD009666-bbs2-0005" title="Macharia‐MutieCW , MorettiD , Van denBrielN , OmusundiAM , MwangiAM , KokFJ , et al. Maize porridge enriched with a micronutrient powder containing low‐dose iron as NaFeEDTA but not amaranth grain flour reduces anemia and iron deficiency in Kenyan preschool children. Journal of Nutrition2012;142(9):1756‐63. [DOI: 10.3945/jn.112.157578; PUBMED: 22810982] Macharia‐MutieCW , OmusundiAM , MwaiJM , MwangiAM , BrouwerID . Simulation of the effect of maize porridge fortified with grain amaranth or micronutrient powder containing NaFeEDTA on iron intake and status in Kenyan children. Public Health Nutrition2013;16(9):1605‐13. [DOI: 10.1017/S1368980012005174; PUBMED: 23218415] ">Macharia‐Mutie 2012</a>; <a href="./references#CD009666-bbs2-0006" title="JerlingJ [pers comm] . Regards and question on Ogundale et al 2011 vir Cochrane review. Email to: JP Pena‐Rosas 3 November 2011. OgunladeAO , KrugerHS , JerlingJC , SmutsCM , CovicN , HanekomSM , et al. Point‐of‐use micronutrient fortification: lessons learned in implementing a preschool‐based pilot trial in South Africa. International Journal of Food Sciences and Nutrition2011;62(1):1‐16. [DOI: 10.3109/09637486.2010.495710; PUBMED: 20701549] ">Ogunlade 2011</a>; <a href="./references#CD009666-bbs2-0007" title="OrozcoJ , VargasC , RojasML , HerreraAM , MontoyaL , SánchezJG , et al. The effect of powdered micronutrients on the hematologic values and nutritional status of healthy preschoolers. Medellín, 2013 [Efecto de los micronutrientes en polvo en el estado nutricional y en los valores hemáticos de preescolares sanos. Medellín, 2013]. Revista Facultad Nacional de Salud Pública2015;33(2):161‐70. [DOI: 10.17533/udea.rfnsp.v33n2a03] ">Orozco 2015 (C)</a>; <a href="./references#CD009666-bbs2-0008" title="OseiAK , HouserRF , BulusuS , HamerDH . Acceptability of micronutrient fortified school meals by schoolchildren in rural Himalayan villages of India. Journal of Food Science2008;73(7):S354‐8. [DOI: 10.1111/j.1750‐3841.2008.00878.x; PUBMED: 18803728] OseiAK , RosenbergIH , HouserRF , BulusuS , MathewsM , HamerDH . Community‐level micronutrient fortification of school lunch meals improved vitamin A, folate, and iron status of schoolchildren in Himalayan villages of India. Journal of Nutrition2010;140(6):1146‐54. [DOI: 10.3945/jn.109.114751; PUBMED: 20410083] ">Osei 2008 (C)</a>; <a href="./references#CD009666-bbs2-0010" title="TroeschB [pers comm] . Regards and question on Troesch et al 2011. Email to: JP Peña‐Rosas 1 November 2011. TroeschB , vanStuijvenbergME , SmutsCM , KrugerHS , BiebingerR , HurrellRF , et al. A micronutrient powder with low doses of highly absorbable iron and zinc reduces iron and zinc deficiency and improves weight‐for‐age Z‐scores in South African children. Journal of Nutrition2011;141(2):237‐42. [DOI: 10.3945/jn.110.129247; PUBMED: 21178093] ">Troesch 2011b</a>; <a href="./references#CD009666-bbs2-0011" title="VarmaJL , DasS , SankarR , MannarMG , LevinsonFJ , HamerDH . Community‐level micronutrient fortification of a food supplement in India: a controlled trial in preschool children aged 36‐66 mo. American Journal of Clinical Nutrition2007;85(4):1127‐33. [PUBMED: 17413115] ">Varma 2007 (C)</a>; <a href="./references#CD009666-bbs2-0012" title="VinodkumarM , RajagopalanS . Impact of a multiple‐micronutrient food supplement on the nutritional status of schoolchildren. Food and Nutrition Bulletin2006;27(3):203‐10. [DOI: 10.1177/156482650602700302; PUBMED: 17542110] ">Vinodkumar 2006 (C)</a>; <a href="./references#CD009666-bbs2-0013" title="VinodkumarM , RajagopalanS . Efficacy of fortification of school meals with ferrous glycine phosphate and riboflavin against anemia and angular stomatitis in schoolchildren. Food and Nutrition Bulletin2009;30(3):260‐4. [DOI: 10.1177/156482650903000307; PUBMED: 19927606] ">Vinodkumar 2009 (C)</a>) </p> </section> </section> <section id="CD009666-sec-0096"> <h4 class="title">Blinding</h4> <section id="CD009666-sec-0097"> <h5 class="title">Blinding of participants and personnel</h5> <p>One trial had unclear blinding of participants (<a href="./references#CD009666-bbs2-0007" title="OrozcoJ , VargasC , RojasML , HerreraAM , MontoyaL , SánchezJG , et al. The effect of powdered micronutrients on the hematologic values and nutritional status of healthy preschoolers. Medellín, 2013 [Efecto de los micronutrientes en polvo en el estado nutricional y en los valores hemáticos de preescolares sanos. Medellín, 2013]. Revista Facultad Nacional de Salud Pública2015;33(2):161‐70. [DOI: 10.17533/udea.rfnsp.v33n2a03] ">Orozco 2015 (C)</a>. We rated eight trials at high risk of bias as they did not blind the intervention to the participants and personnel (<a href="./references#CD009666-bbs2-0001" title="InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Combined intensive nutrition education and micronutrient powder supplementation improved nutritional status of mildly wasted children on Nias Island, Indonesia. Asia Pacific Journal of Clinical Nutrition2012;21(3):361‐73. [PUBMED: 22705425] InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Improved nutrition knowledge and practice through intensive nutrition education: a study among caregivers of mildly wasted children on Nias Island, Indonesia. Food and Nutrition Bulletin2012;33(2):117‐27. [DOI: 10.1177/156482651203300205; PUBMED: 22908693] PurwestriRC , ScherbaumV , InayatiDA , WirawanNN , SuryantanJ , BloemMA , et al. Supplementary feeding with locally‐produced ready‐to‐use food (RUF) for mildly wasted children on Nias Island, Indonesia: comparison of daily and weekly programme outcomes. Asia Pacific Journal of Clinical Nutrition2012;21(3):374‐9. [PUBMED: 22705426] ScherbaumV [pers comm] . Your paper on MNP. Email to: LM De‐Regil 5 February 2013. ">Inayati 2012 (C)</a>; <a href="./references#CD009666-bbs2-0002" title="KemmerTM , OmerPS , Gidvani‐DiazVK , CoelloM . Acceptance and effect of ferrous fumarate containing micronutrient sprinkles on anemia, iron deficiency and anthropometrics in Honduran children. In: SilverbergDS editor(s). Anemia. Rijeka (Croatia): InTech, 2012. [DOI: 10.5772/30987] ">Kemmer 2012 (C)</a>; <a href="./references#CD009666-bbs2-0003" title="KounnavongS , SunaharaT , Mascie‐TaylorCG , HashizumeM , OkumuraJ , MojiK , et al. Effect of daily versus weekly home fortification with multiple micronutrient powder on haemoglobin concentration of young children in a rural area, Lao People's Democratic Republic: a randomised trial. Nutrition Journal2011;10(129):1‐11. [DOI: 10.1186/1475‐2891‐10‐129; PMC3266642; PUBMED: 22111770] ">Kounnavong 2011 (C)</a>; <a href="./references#CD009666-bbs2-0004" title="LundeenE [pers comm] . Kyrgyz Republic MNP data for children 24‐36 months. Email to: M Jefferds 3 November 2011. LundeenE , SchuethT , ToktobaevN , ZlotkinS , HyderSM , HouserR . Daily use of Sprinkles micronutrient powder for 2 months reduces anemia among children 6 to 36 months of age in the Kyrgyz Republic: a cluster‐randomized trial. Food and Nutrition Bulletin2010;31(3):446‐60. [DOI: 10.1177/156482651003100307; PUBMED: 20973465] ">Lundeen 2010 (C)</a>; <a href="./references#CD009666-bbs2-0005" title="Macharia‐MutieCW , MorettiD , Van denBrielN , OmusundiAM , MwangiAM , KokFJ , et al. Maize porridge enriched with a micronutrient powder containing low‐dose iron as NaFeEDTA but not amaranth grain flour reduces anemia and iron deficiency in Kenyan preschool children. Journal of Nutrition2012;142(9):1756‐63. [DOI: 10.3945/jn.112.157578; PUBMED: 22810982] Macharia‐MutieCW , OmusundiAM , MwaiJM , MwangiAM , BrouwerID . Simulation of the effect of maize porridge fortified with grain amaranth or micronutrient powder containing NaFeEDTA on iron intake and status in Kenyan children. Public Health Nutrition2013;16(9):1605‐13. [DOI: 10.1017/S1368980012005174; PUBMED: 23218415] ">Macharia‐Mutie 2012</a>; <a href="./references#CD009666-bbs2-0009" title="SharieffW , YinSA , WuM , YangQ , SchauerC , TomlinsonG , et al. Short‐term daily or weekly administration of micronutrient Sprinkles has high compliance and does not cause iron overload in Chinese schoolchildren: a cluster‐randomized trial. Public Health Nutrition2006;9(3):336‐44. [PUBMED: 16684385] ZlotkinS [pers comm] . Regards and question ‐ Sharieff 2006. Email to: JP Peña‐Rosas 2 November 2011. ">Sharieff 2006 (C)</a>; <a href="./references#CD009666-bbs2-0012" title="VinodkumarM , RajagopalanS . Impact of a multiple‐micronutrient food supplement on the nutritional status of schoolchildren. Food and Nutrition Bulletin2006;27(3):203‐10. [DOI: 10.1177/156482650602700302; PUBMED: 17542110] ">Vinodkumar 2006 (C)</a>; <a href="./references#CD009666-bbs2-0013" title="VinodkumarM , RajagopalanS . Efficacy of fortification of school meals with ferrous glycine phosphate and riboflavin against anemia and angular stomatitis in schoolchildren. Food and Nutrition Bulletin2009;30(3):260‐4. [DOI: 10.1177/156482650903000307; PUBMED: 19927606] ">Vinodkumar 2009 (C)</a>). We judged the remaining four trials at low risk of bias (<a href="./references#CD009666-bbs2-0006" title="JerlingJ [pers comm] . Regards and question on Ogundale et al 2011 vir Cochrane review. Email to: JP Pena‐Rosas 3 November 2011. OgunladeAO , KrugerHS , JerlingJC , SmutsCM , CovicN , HanekomSM , et al. Point‐of‐use micronutrient fortification: lessons learned in implementing a preschool‐based pilot trial in South Africa. International Journal of Food Sciences and Nutrition2011;62(1):1‐16. [DOI: 10.3109/09637486.2010.495710; PUBMED: 20701549] ">Ogunlade 2011</a>: <a href="./references#CD009666-bbs2-0008" title="OseiAK , HouserRF , BulusuS , HamerDH . Acceptability of micronutrient fortified school meals by schoolchildren in rural Himalayan villages of India. Journal of Food Science2008;73(7):S354‐8. [DOI: 10.1111/j.1750‐3841.2008.00878.x; PUBMED: 18803728] OseiAK , RosenbergIH , HouserRF , BulusuS , MathewsM , HamerDH . Community‐level micronutrient fortification of school lunch meals improved vitamin A, folate, and iron status of schoolchildren in Himalayan villages of India. Journal of Nutrition2010;140(6):1146‐54. [DOI: 10.3945/jn.109.114751; PUBMED: 20410083] ">Osei 2008 (C)</a>; <a href="./references#CD009666-bbs2-0010" title="TroeschB [pers comm] . Regards and question on Troesch et al 2011. Email to: JP Peña‐Rosas 1 November 2011. TroeschB , vanStuijvenbergME , SmutsCM , KrugerHS , BiebingerR , HurrellRF , et al. A micronutrient powder with low doses of highly absorbable iron and zinc reduces iron and zinc deficiency and improves weight‐for‐age Z‐scores in South African children. Journal of Nutrition2011;141(2):237‐42. [DOI: 10.3945/jn.110.129247; PUBMED: 21178093] ">Troesch 2011b</a>; <a href="./references#CD009666-bbs2-0011" title="VarmaJL , DasS , SankarR , MannarMG , LevinsonFJ , HamerDH . Community‐level micronutrient fortification of a food supplement in India: a controlled trial in preschool children aged 36‐66 mo. American Journal of Clinical Nutrition2007;85(4):1127‐33. [PUBMED: 17413115] ">Varma 2007 (C)</a>). </p> </section> <section id="CD009666-sec-0098"> <h5 class="title">Blinding of outcome assessors</h5> <p>Five trials had unclear blinding of outcome assessment (<a href="./references#CD009666-bbs2-0002" title="KemmerTM , OmerPS , Gidvani‐DiazVK , CoelloM . Acceptance and effect of ferrous fumarate containing micronutrient sprinkles on anemia, iron deficiency and anthropometrics in Honduran children. In: SilverbergDS editor(s). Anemia. Rijeka (Croatia): InTech, 2012. [DOI: 10.5772/30987] ">Kemmer 2012 (C)</a>; <a href="./references#CD009666-bbs2-0008" title="OseiAK , HouserRF , BulusuS , HamerDH . Acceptability of micronutrient fortified school meals by schoolchildren in rural Himalayan villages of India. Journal of Food Science2008;73(7):S354‐8. [DOI: 10.1111/j.1750‐3841.2008.00878.x; PUBMED: 18803728] OseiAK , RosenbergIH , HouserRF , BulusuS , MathewsM , HamerDH . Community‐level micronutrient fortification of school lunch meals improved vitamin A, folate, and iron status of schoolchildren in Himalayan villages of India. Journal of Nutrition2010;140(6):1146‐54. [DOI: 10.3945/jn.109.114751; PUBMED: 20410083] ">Osei 2008 (C)</a>; <a href="./references#CD009666-bbs2-0010" title="TroeschB [pers comm] . Regards and question on Troesch et al 2011. Email to: JP Peña‐Rosas 1 November 2011. TroeschB , vanStuijvenbergME , SmutsCM , KrugerHS , BiebingerR , HurrellRF , et al. A micronutrient powder with low doses of highly absorbable iron and zinc reduces iron and zinc deficiency and improves weight‐for‐age Z‐scores in South African children. Journal of Nutrition2011;141(2):237‐42. [DOI: 10.3945/jn.110.129247; PUBMED: 21178093] ">Troesch 2011b</a>; <a href="./references#CD009666-bbs2-0011" title="VarmaJL , DasS , SankarR , MannarMG , LevinsonFJ , HamerDH . Community‐level micronutrient fortification of a food supplement in India: a controlled trial in preschool children aged 36‐66 mo. American Journal of Clinical Nutrition2007;85(4):1127‐33. [PUBMED: 17413115] ">Varma 2007 (C)</a>; <a href="./references#CD009666-bbs2-0013" title="VinodkumarM , RajagopalanS . Efficacy of fortification of school meals with ferrous glycine phosphate and riboflavin against anemia and angular stomatitis in schoolchildren. Food and Nutrition Bulletin2009;30(3):260‐4. [DOI: 10.1177/156482650903000307; PUBMED: 19927606] ">Vinodkumar 2009 (C)</a>). Five trials did not blind the intervention and were at high risk of bias (<a href="./references#CD009666-bbs2-0001" title="InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Combined intensive nutrition education and micronutrient powder supplementation improved nutritional status of mildly wasted children on Nias Island, Indonesia. Asia Pacific Journal of Clinical Nutrition2012;21(3):361‐73. [PUBMED: 22705425] InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Improved nutrition knowledge and practice through intensive nutrition education: a study among caregivers of mildly wasted children on Nias Island, Indonesia. Food and Nutrition Bulletin2012;33(2):117‐27. [DOI: 10.1177/156482651203300205; PUBMED: 22908693] PurwestriRC , ScherbaumV , InayatiDA , WirawanNN , SuryantanJ , BloemMA , et al. Supplementary feeding with locally‐produced ready‐to‐use food (RUF) for mildly wasted children on Nias Island, Indonesia: comparison of daily and weekly programme outcomes. Asia Pacific Journal of Clinical Nutrition2012;21(3):374‐9. [PUBMED: 22705426] ScherbaumV [pers comm] . Your paper on MNP. Email to: LM De‐Regil 5 February 2013. ">Inayati 2012 (C)</a>; <a href="./references#CD009666-bbs2-0004" title="LundeenE [pers comm] . Kyrgyz Republic MNP data for children 24‐36 months. Email to: M Jefferds 3 November 2011. LundeenE , SchuethT , ToktobaevN , ZlotkinS , HyderSM , HouserR . Daily use of Sprinkles micronutrient powder for 2 months reduces anemia among children 6 to 36 months of age in the Kyrgyz Republic: a cluster‐randomized trial. Food and Nutrition Bulletin2010;31(3):446‐60. [DOI: 10.1177/156482651003100307; PUBMED: 20973465] ">Lundeen 2010 (C)</a>; <a href="./references#CD009666-bbs2-0005" title="Macharia‐MutieCW , MorettiD , Van denBrielN , OmusundiAM , MwangiAM , KokFJ , et al. Maize porridge enriched with a micronutrient powder containing low‐dose iron as NaFeEDTA but not amaranth grain flour reduces anemia and iron deficiency in Kenyan preschool children. Journal of Nutrition2012;142(9):1756‐63. [DOI: 10.3945/jn.112.157578; PUBMED: 22810982] Macharia‐MutieCW , OmusundiAM , MwaiJM , MwangiAM , BrouwerID . Simulation of the effect of maize porridge fortified with grain amaranth or micronutrient powder containing NaFeEDTA on iron intake and status in Kenyan children. Public Health Nutrition2013;16(9):1605‐13. [DOI: 10.1017/S1368980012005174; PUBMED: 23218415] ">Macharia‐Mutie 2012</a>; <a href="./references#CD009666-bbs2-0009" title="SharieffW , YinSA , WuM , YangQ , SchauerC , TomlinsonG , et al. Short‐term daily or weekly administration of micronutrient Sprinkles has high compliance and does not cause iron overload in Chinese schoolchildren: a cluster‐randomized trial. Public Health Nutrition2006;9(3):336‐44. [PUBMED: 16684385] ZlotkinS [pers comm] . Regards and question ‐ Sharieff 2006. Email to: JP Peña‐Rosas 2 November 2011. ">Sharieff 2006 (C)</a>; <a href="./references#CD009666-bbs2-0012" title="VinodkumarM , RajagopalanS . Impact of a multiple‐micronutrient food supplement on the nutritional status of schoolchildren. Food and Nutrition Bulletin2006;27(3):203‐10. [DOI: 10.1177/156482650602700302; PUBMED: 17542110] ">Vinodkumar 2006 (C)</a>). We judged the three remaining trials at low risk of detection bias (<a href="./references#CD009666-bbs2-0003" title="KounnavongS , SunaharaT , Mascie‐TaylorCG , HashizumeM , OkumuraJ , MojiK , et al. Effect of daily versus weekly home fortification with multiple micronutrient powder on haemoglobin concentration of young children in a rural area, Lao People's Democratic Republic: a randomised trial. Nutrition Journal2011;10(129):1‐11. [DOI: 10.1186/1475‐2891‐10‐129; PMC3266642; PUBMED: 22111770] ">Kounnavong 2011 (C)</a>; <a href="./references#CD009666-bbs2-0006" title="JerlingJ [pers comm] . Regards and question on Ogundale et al 2011 vir Cochrane review. Email to: JP Pena‐Rosas 3 November 2011. OgunladeAO , KrugerHS , JerlingJC , SmutsCM , CovicN , HanekomSM , et al. Point‐of‐use micronutrient fortification: lessons learned in implementing a preschool‐based pilot trial in South Africa. International Journal of Food Sciences and Nutrition2011;62(1):1‐16. [DOI: 10.3109/09637486.2010.495710; PUBMED: 20701549] ">Ogunlade 2011</a>; <a href="./references#CD009666-bbs2-0007" title="OrozcoJ , VargasC , RojasML , HerreraAM , MontoyaL , SánchezJG , et al. The effect of powdered micronutrients on the hematologic values and nutritional status of healthy preschoolers. Medellín, 2013 [Efecto de los micronutrientes en polvo en el estado nutricional y en los valores hemáticos de preescolares sanos. Medellín, 2013]. Revista Facultad Nacional de Salud Pública2015;33(2):161‐70. [DOI: 10.17533/udea.rfnsp.v33n2a03] ">Orozco 2015 (C)</a>). </p> </section> </section> <section id="CD009666-sec-0099"> <h4 class="title">Incomplete outcome data</h4> <p>We judged that trials with more than 20% loss to follow‐up, or with imbalanced loss to follow‐up in different arms of trials, were inadequate in terms of completeness of outcome data. Three trials were at high levels of attrition, or loss was not balanced across groups and may have occurred for reasons associated with treatment (<a href="./references#CD009666-bbs2-0002" title="KemmerTM , OmerPS , Gidvani‐DiazVK , CoelloM . Acceptance and effect of ferrous fumarate containing micronutrient sprinkles on anemia, iron deficiency and anthropometrics in Honduran children. In: SilverbergDS editor(s). Anemia. Rijeka (Croatia): InTech, 2012. [DOI: 10.5772/30987] ">Kemmer 2012 (C)</a>; <a href="./references#CD009666-bbs2-0006" title="JerlingJ [pers comm] . Regards and question on Ogundale et al 2011 vir Cochrane review. Email to: JP Pena‐Rosas 3 November 2011. OgunladeAO , KrugerHS , JerlingJC , SmutsCM , CovicN , HanekomSM , et al. Point‐of‐use micronutrient fortification: lessons learned in implementing a preschool‐based pilot trial in South Africa. International Journal of Food Sciences and Nutrition2011;62(1):1‐16. [DOI: 10.3109/09637486.2010.495710; PUBMED: 20701549] ">Ogunlade 2011</a>; <a href="./references#CD009666-bbs2-0011" title="VarmaJL , DasS , SankarR , MannarMG , LevinsonFJ , HamerDH . Community‐level micronutrient fortification of a food supplement in India: a controlled trial in preschool children aged 36‐66 mo. American Journal of Clinical Nutrition2007;85(4):1127‐33. [PUBMED: 17413115] ">Varma 2007 (C)</a>). With <a href="./references#CD009666-bbs2-0002" title="KemmerTM , OmerPS , Gidvani‐DiazVK , CoelloM . Acceptance and effect of ferrous fumarate containing micronutrient sprinkles on anemia, iron deficiency and anthropometrics in Honduran children. In: SilverbergDS editor(s). Anemia. Rijeka (Croatia): InTech, 2012. [DOI: 10.5772/30987] ">Kemmer 2012 (C)</a>, 31% of participants did not have Hb measurements. In <a href="./references#CD009666-bbs2-0006" title="JerlingJ [pers comm] . Regards and question on Ogundale et al 2011 vir Cochrane review. Email to: JP Pena‐Rosas 3 November 2011. OgunladeAO , KrugerHS , JerlingJC , SmutsCM , CovicN , HanekomSM , et al. Point‐of‐use micronutrient fortification: lessons learned in implementing a preschool‐based pilot trial in South Africa. International Journal of Food Sciences and Nutrition2011;62(1):1‐16. [DOI: 10.3109/09637486.2010.495710; PUBMED: 20701549] ">Ogunlade 2011</a>, attrition of the intervention group was 17.1% while attrition in the control group was 9.3%. For <a href="./references#CD009666-bbs2-0011" title="VarmaJL , DasS , SankarR , MannarMG , LevinsonFJ , HamerDH . Community‐level micronutrient fortification of a food supplement in India: a controlled trial in preschool children aged 36‐66 mo. American Journal of Clinical Nutrition2007;85(4):1127‐33. [PUBMED: 17413115] ">Varma 2007 (C)</a>, both intervention and control arms had 20% or more loss to follow‐up. </p> <p>We judged the remaining 10 trials at low risk of attrition bias (<a href="./references#CD009666-bbs2-0001" title="InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Combined intensive nutrition education and micronutrient powder supplementation improved nutritional status of mildly wasted children on Nias Island, Indonesia. Asia Pacific Journal of Clinical Nutrition2012;21(3):361‐73. [PUBMED: 22705425] InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Improved nutrition knowledge and practice through intensive nutrition education: a study among caregivers of mildly wasted children on Nias Island, Indonesia. Food and Nutrition Bulletin2012;33(2):117‐27. [DOI: 10.1177/156482651203300205; PUBMED: 22908693] PurwestriRC , ScherbaumV , InayatiDA , WirawanNN , SuryantanJ , BloemMA , et al. Supplementary feeding with locally‐produced ready‐to‐use food (RUF) for mildly wasted children on Nias Island, Indonesia: comparison of daily and weekly programme outcomes. Asia Pacific Journal of Clinical Nutrition2012;21(3):374‐9. [PUBMED: 22705426] ScherbaumV [pers comm] . Your paper on MNP. Email to: LM De‐Regil 5 February 2013. ">Inayati 2012 (C)</a>; <a href="./references#CD009666-bbs2-0003" title="KounnavongS , SunaharaT , Mascie‐TaylorCG , HashizumeM , OkumuraJ , MojiK , et al. Effect of daily versus weekly home fortification with multiple micronutrient powder on haemoglobin concentration of young children in a rural area, Lao People's Democratic Republic: a randomised trial. Nutrition Journal2011;10(129):1‐11. [DOI: 10.1186/1475‐2891‐10‐129; PMC3266642; PUBMED: 22111770] ">Kounnavong 2011 (C)</a>; <a href="./references#CD009666-bbs2-0004" title="LundeenE [pers comm] . Kyrgyz Republic MNP data for children 24‐36 months. Email to: M Jefferds 3 November 2011. LundeenE , SchuethT , ToktobaevN , ZlotkinS , HyderSM , HouserR . Daily use of Sprinkles micronutrient powder for 2 months reduces anemia among children 6 to 36 months of age in the Kyrgyz Republic: a cluster‐randomized trial. Food and Nutrition Bulletin2010;31(3):446‐60. [DOI: 10.1177/156482651003100307; PUBMED: 20973465] ">Lundeen 2010 (C)</a>; <a href="./references#CD009666-bbs2-0005" title="Macharia‐MutieCW , MorettiD , Van denBrielN , OmusundiAM , MwangiAM , KokFJ , et al. Maize porridge enriched with a micronutrient powder containing low‐dose iron as NaFeEDTA but not amaranth grain flour reduces anemia and iron deficiency in Kenyan preschool children. Journal of Nutrition2012;142(9):1756‐63. [DOI: 10.3945/jn.112.157578; PUBMED: 22810982] Macharia‐MutieCW , OmusundiAM , MwaiJM , MwangiAM , BrouwerID . Simulation of the effect of maize porridge fortified with grain amaranth or micronutrient powder containing NaFeEDTA on iron intake and status in Kenyan children. Public Health Nutrition2013;16(9):1605‐13. [DOI: 10.1017/S1368980012005174; PUBMED: 23218415] ">Macharia‐Mutie 2012</a>; <a href="./references#CD009666-bbs2-0007" title="OrozcoJ , VargasC , RojasML , HerreraAM , MontoyaL , SánchezJG , et al. The effect of powdered micronutrients on the hematologic values and nutritional status of healthy preschoolers. Medellín, 2013 [Efecto de los micronutrientes en polvo en el estado nutricional y en los valores hemáticos de preescolares sanos. Medellín, 2013]. Revista Facultad Nacional de Salud Pública2015;33(2):161‐70. [DOI: 10.17533/udea.rfnsp.v33n2a03] ">Orozco 2015 (C)</a>; <a href="./references#CD009666-bbs2-0008" title="OseiAK , HouserRF , BulusuS , HamerDH . Acceptability of micronutrient fortified school meals by schoolchildren in rural Himalayan villages of India. Journal of Food Science2008;73(7):S354‐8. [DOI: 10.1111/j.1750‐3841.2008.00878.x; PUBMED: 18803728] OseiAK , RosenbergIH , HouserRF , BulusuS , MathewsM , HamerDH . Community‐level micronutrient fortification of school lunch meals improved vitamin A, folate, and iron status of schoolchildren in Himalayan villages of India. Journal of Nutrition2010;140(6):1146‐54. [DOI: 10.3945/jn.109.114751; PUBMED: 20410083] ">Osei 2008 (C)</a>; <a href="./references#CD009666-bbs2-0009" title="SharieffW , YinSA , WuM , YangQ , SchauerC , TomlinsonG , et al. Short‐term daily or weekly administration of micronutrient Sprinkles has high compliance and does not cause iron overload in Chinese schoolchildren: a cluster‐randomized trial. Public Health Nutrition2006;9(3):336‐44. [PUBMED: 16684385] ZlotkinS [pers comm] . Regards and question ‐ Sharieff 2006. Email to: JP Peña‐Rosas 2 November 2011. ">Sharieff 2006 (C)</a>; <a href="./references#CD009666-bbs2-0010" title="TroeschB [pers comm] . Regards and question on Troesch et al 2011. Email to: JP Peña‐Rosas 1 November 2011. TroeschB , vanStuijvenbergME , SmutsCM , KrugerHS , BiebingerR , HurrellRF , et al. A micronutrient powder with low doses of highly absorbable iron and zinc reduces iron and zinc deficiency and improves weight‐for‐age Z‐scores in South African children. Journal of Nutrition2011;141(2):237‐42. [DOI: 10.3945/jn.110.129247; PUBMED: 21178093] ">Troesch 2011b</a>; <a href="./references#CD009666-bbs2-0012" title="VinodkumarM , RajagopalanS . Impact of a multiple‐micronutrient food supplement on the nutritional status of schoolchildren. Food and Nutrition Bulletin2006;27(3):203‐10. [DOI: 10.1177/156482650602700302; PUBMED: 17542110] ">Vinodkumar 2006 (C)</a>; <a href="./references#CD009666-bbs2-0013" title="VinodkumarM , RajagopalanS . Efficacy of fortification of school meals with ferrous glycine phosphate and riboflavin against anemia and angular stomatitis in schoolchildren. Food and Nutrition Bulletin2009;30(3):260‐4. [DOI: 10.1177/156482650903000307; PUBMED: 19927606] ">Vinodkumar 2009 (C)</a>). </p> </section> <section id="CD009666-sec-0100"> <h4 class="title">Selective reporting</h4> <p>In 11 trials, it was impossible to judge selective reporting (<a href="./references#CD009666-bbs2-0002" title="KemmerTM , OmerPS , Gidvani‐DiazVK , CoelloM . Acceptance and effect of ferrous fumarate containing micronutrient sprinkles on anemia, iron deficiency and anthropometrics in Honduran children. In: SilverbergDS editor(s). Anemia. Rijeka (Croatia): InTech, 2012. [DOI: 10.5772/30987] ">Kemmer 2012 (C)</a>; <a href="./references#CD009666-bbs2-0003" title="KounnavongS , SunaharaT , Mascie‐TaylorCG , HashizumeM , OkumuraJ , MojiK , et al. Effect of daily versus weekly home fortification with multiple micronutrient powder on haemoglobin concentration of young children in a rural area, Lao People's Democratic Republic: a randomised trial. Nutrition Journal2011;10(129):1‐11. [DOI: 10.1186/1475‐2891‐10‐129; PMC3266642; PUBMED: 22111770] ">Kounnavong 2011 (C)</a>; <a href="./references#CD009666-bbs2-0004" title="LundeenE [pers comm] . Kyrgyz Republic MNP data for children 24‐36 months. Email to: M Jefferds 3 November 2011. LundeenE , SchuethT , ToktobaevN , ZlotkinS , HyderSM , HouserR . Daily use of Sprinkles micronutrient powder for 2 months reduces anemia among children 6 to 36 months of age in the Kyrgyz Republic: a cluster‐randomized trial. Food and Nutrition Bulletin2010;31(3):446‐60. [DOI: 10.1177/156482651003100307; PUBMED: 20973465] ">Lundeen 2010 (C)</a>; <a href="./references#CD009666-bbs2-0005" title="Macharia‐MutieCW , MorettiD , Van denBrielN , OmusundiAM , MwangiAM , KokFJ , et al. Maize porridge enriched with a micronutrient powder containing low‐dose iron as NaFeEDTA but not amaranth grain flour reduces anemia and iron deficiency in Kenyan preschool children. Journal of Nutrition2012;142(9):1756‐63. [DOI: 10.3945/jn.112.157578; PUBMED: 22810982] Macharia‐MutieCW , OmusundiAM , MwaiJM , MwangiAM , BrouwerID . Simulation of the effect of maize porridge fortified with grain amaranth or micronutrient powder containing NaFeEDTA on iron intake and status in Kenyan children. Public Health Nutrition2013;16(9):1605‐13. [DOI: 10.1017/S1368980012005174; PUBMED: 23218415] ">Macharia‐Mutie 2012</a>; <a href="./references#CD009666-bbs2-0007" title="OrozcoJ , VargasC , RojasML , HerreraAM , MontoyaL , SánchezJG , et al. The effect of powdered micronutrients on the hematologic values and nutritional status of healthy preschoolers. Medellín, 2013 [Efecto de los micronutrientes en polvo en el estado nutricional y en los valores hemáticos de preescolares sanos. Medellín, 2013]. Revista Facultad Nacional de Salud Pública2015;33(2):161‐70. [DOI: 10.17533/udea.rfnsp.v33n2a03] ">Orozco 2015 (C)</a>, <a href="./references#CD009666-bbs2-0008" title="OseiAK , HouserRF , BulusuS , HamerDH . Acceptability of micronutrient fortified school meals by schoolchildren in rural Himalayan villages of India. Journal of Food Science2008;73(7):S354‐8. [DOI: 10.1111/j.1750‐3841.2008.00878.x; PUBMED: 18803728] OseiAK , RosenbergIH , HouserRF , BulusuS , MathewsM , HamerDH . Community‐level micronutrient fortification of school lunch meals improved vitamin A, folate, and iron status of schoolchildren in Himalayan villages of India. Journal of Nutrition2010;140(6):1146‐54. [DOI: 10.3945/jn.109.114751; PUBMED: 20410083] ">Osei 2008 (C)</a>; <a href="./references#CD009666-bbs2-0009" title="SharieffW , YinSA , WuM , YangQ , SchauerC , TomlinsonG , et al. Short‐term daily or weekly administration of micronutrient Sprinkles has high compliance and does not cause iron overload in Chinese schoolchildren: a cluster‐randomized trial. Public Health Nutrition2006;9(3):336‐44. [PUBMED: 16684385] ZlotkinS [pers comm] . Regards and question ‐ Sharieff 2006. Email to: JP Peña‐Rosas 2 November 2011. ">Sharieff 2006 (C)</a>; <a href="./references#CD009666-bbs2-0010" title="TroeschB [pers comm] . Regards and question on Troesch et al 2011. Email to: JP Peña‐Rosas 1 November 2011. TroeschB , vanStuijvenbergME , SmutsCM , KrugerHS , BiebingerR , HurrellRF , et al. A micronutrient powder with low doses of highly absorbable iron and zinc reduces iron and zinc deficiency and improves weight‐for‐age Z‐scores in South African children. Journal of Nutrition2011;141(2):237‐42. [DOI: 10.3945/jn.110.129247; PUBMED: 21178093] ">Troesch 2011b</a>; <a href="./references#CD009666-bbs2-0011" title="VarmaJL , DasS , SankarR , MannarMG , LevinsonFJ , HamerDH . Community‐level micronutrient fortification of a food supplement in India: a controlled trial in preschool children aged 36‐66 mo. American Journal of Clinical Nutrition2007;85(4):1127‐33. [PUBMED: 17413115] ">Varma 2007 (C)</a>; <a href="./references#CD009666-bbs2-0012" title="VinodkumarM , RajagopalanS . Impact of a multiple‐micronutrient food supplement on the nutritional status of schoolchildren. Food and Nutrition Bulletin2006;27(3):203‐10. [DOI: 10.1177/156482650602700302; PUBMED: 17542110] ">Vinodkumar 2006 (C)</a>; <a href="./references#CD009666-bbs2-0013" title="VinodkumarM , RajagopalanS . Efficacy of fortification of school meals with ferrous glycine phosphate and riboflavin against anemia and angular stomatitis in schoolchildren. Food and Nutrition Bulletin2009;30(3):260‐4. [DOI: 10.1177/156482650903000307; PUBMED: 19927606] ">Vinodkumar 2009 (C)</a>). One trial had a high risk of bias because they excluded from analysis children with adherence lower than 60% (<a href="./references#CD009666-bbs2-0006" title="JerlingJ [pers comm] . Regards and question on Ogundale et al 2011 vir Cochrane review. Email to: JP Pena‐Rosas 3 November 2011. OgunladeAO , KrugerHS , JerlingJC , SmutsCM , CovicN , HanekomSM , et al. Point‐of‐use micronutrient fortification: lessons learned in implementing a preschool‐based pilot trial in South Africa. International Journal of Food Sciences and Nutrition2011;62(1):1‐16. [DOI: 10.3109/09637486.2010.495710; PUBMED: 20701549] ">Ogunlade 2011</a>). We judged one study at low risk of reporting bias (<a href="./references#CD009666-bbs2-0001" title="InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Combined intensive nutrition education and micronutrient powder supplementation improved nutritional status of mildly wasted children on Nias Island, Indonesia. Asia Pacific Journal of Clinical Nutrition2012;21(3):361‐73. [PUBMED: 22705425] InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Improved nutrition knowledge and practice through intensive nutrition education: a study among caregivers of mildly wasted children on Nias Island, Indonesia. Food and Nutrition Bulletin2012;33(2):117‐27. [DOI: 10.1177/156482651203300205; PUBMED: 22908693] PurwestriRC , ScherbaumV , InayatiDA , WirawanNN , SuryantanJ , BloemMA , et al. Supplementary feeding with locally‐produced ready‐to‐use food (RUF) for mildly wasted children on Nias Island, Indonesia: comparison of daily and weekly programme outcomes. Asia Pacific Journal of Clinical Nutrition2012;21(3):374‐9. [PUBMED: 22705426] ScherbaumV [pers comm] . Your paper on MNP. Email to: LM De‐Regil 5 February 2013. ">Inayati 2012 (C)</a>). </p> </section> <section id="CD009666-sec-0101"> <h4 class="title">Other potential sources of bias</h4> <p>We rated three studies at high risk of other potential sources of bias (<a href="./references#CD009666-bbs2-0003" title="KounnavongS , SunaharaT , Mascie‐TaylorCG , HashizumeM , OkumuraJ , MojiK , et al. Effect of daily versus weekly home fortification with multiple micronutrient powder on haemoglobin concentration of young children in a rural area, Lao People's Democratic Republic: a randomised trial. Nutrition Journal2011;10(129):1‐11. [DOI: 10.1186/1475‐2891‐10‐129; PMC3266642; PUBMED: 22111770] ">Kounnavong 2011 (C)</a>; <a href="./references#CD009666-bbs2-0007" title="OrozcoJ , VargasC , RojasML , HerreraAM , MontoyaL , SánchezJG , et al. The effect of powdered micronutrients on the hematologic values and nutritional status of healthy preschoolers. Medellín, 2013 [Efecto de los micronutrientes en polvo en el estado nutricional y en los valores hemáticos de preescolares sanos. Medellín, 2013]. Revista Facultad Nacional de Salud Pública2015;33(2):161‐70. [DOI: 10.17533/udea.rfnsp.v33n2a03] ">Orozco 2015 (C)</a>; <a href="./references#CD009666-bbs2-0013" title="VinodkumarM , RajagopalanS . Efficacy of fortification of school meals with ferrous glycine phosphate and riboflavin against anemia and angular stomatitis in schoolchildren. Food and Nutrition Bulletin2009;30(3):260‐4. [DOI: 10.1177/156482650903000307; PUBMED: 19927606] ">Vinodkumar 2009 (C)</a>). <a href="./references#CD009666-bbs2-0003" title="KounnavongS , SunaharaT , Mascie‐TaylorCG , HashizumeM , OkumuraJ , MojiK , et al. Effect of daily versus weekly home fortification with multiple micronutrient powder on haemoglobin concentration of young children in a rural area, Lao People's Democratic Republic: a randomised trial. Nutrition Journal2011;10(129):1‐11. [DOI: 10.1186/1475‐2891‐10‐129; PMC3266642; PUBMED: 22111770] ">Kounnavong 2011 (C)</a> and <a href="./references#CD009666-bbs2-0013" title="VinodkumarM , RajagopalanS . Efficacy of fortification of school meals with ferrous glycine phosphate and riboflavin against anemia and angular stomatitis in schoolchildren. Food and Nutrition Bulletin2009;30(3):260‐4. [DOI: 10.1177/156482650903000307; PUBMED: 19927606] ">Vinodkumar 2009 (C)</a> had imbalanced Hb levels among intervention and control arms at baseline. <a href="./references#CD009666-bbs2-0007" title="OrozcoJ , VargasC , RojasML , HerreraAM , MontoyaL , SánchezJG , et al. The effect of powdered micronutrients on the hematologic values and nutritional status of healthy preschoolers. Medellín, 2013 [Efecto de los micronutrientes en polvo en el estado nutricional y en los valores hemáticos de preescolares sanos. Medellín, 2013]. Revista Facultad Nacional de Salud Pública2015;33(2):161‐70. [DOI: 10.17533/udea.rfnsp.v33n2a03] ">Orozco 2015 (C)</a> reported that, at the start of the study, the overall mean age of preschool‐age children was 4.8 years (SD 0.3), with a minimum age of 3.8 years and a maximum age of 5.2 years, with statistical differences between the two groups. Also, 71.1% of participants presented an adequate nutritional status, compared to 25.6% who had malnutrition due to excess (15.6% were overweight and 10% were obese). There were significant differences in the nutritional status between the groups at the beginning of the study. </p> <p>With the remainder of the trials, there was insufficient information to permit judgement (<a href="./references#CD009666-bbs2-0001" title="InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Combined intensive nutrition education and micronutrient powder supplementation improved nutritional status of mildly wasted children on Nias Island, Indonesia. Asia Pacific Journal of Clinical Nutrition2012;21(3):361‐73. [PUBMED: 22705425] InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Improved nutrition knowledge and practice through intensive nutrition education: a study among caregivers of mildly wasted children on Nias Island, Indonesia. Food and Nutrition Bulletin2012;33(2):117‐27. [DOI: 10.1177/156482651203300205; PUBMED: 22908693] PurwestriRC , ScherbaumV , InayatiDA , WirawanNN , SuryantanJ , BloemMA , et al. Supplementary feeding with locally‐produced ready‐to‐use food (RUF) for mildly wasted children on Nias Island, Indonesia: comparison of daily and weekly programme outcomes. Asia Pacific Journal of Clinical Nutrition2012;21(3):374‐9. [PUBMED: 22705426] ScherbaumV [pers comm] . Your paper on MNP. Email to: LM De‐Regil 5 February 2013. ">Inayati 2012 (C)</a>; <a href="./references#CD009666-bbs2-0002" title="KemmerTM , OmerPS , Gidvani‐DiazVK , CoelloM . Acceptance and effect of ferrous fumarate containing micronutrient sprinkles on anemia, iron deficiency and anthropometrics in Honduran children. In: SilverbergDS editor(s). Anemia. Rijeka (Croatia): InTech, 2012. [DOI: 10.5772/30987] ">Kemmer 2012 (C)</a>; <a href="./references#CD009666-bbs2-0005" title="Macharia‐MutieCW , MorettiD , Van denBrielN , OmusundiAM , MwangiAM , KokFJ , et al. Maize porridge enriched with a micronutrient powder containing low‐dose iron as NaFeEDTA but not amaranth grain flour reduces anemia and iron deficiency in Kenyan preschool children. Journal of Nutrition2012;142(9):1756‐63. [DOI: 10.3945/jn.112.157578; PUBMED: 22810982] Macharia‐MutieCW , OmusundiAM , MwaiJM , MwangiAM , BrouwerID . Simulation of the effect of maize porridge fortified with grain amaranth or micronutrient powder containing NaFeEDTA on iron intake and status in Kenyan children. Public Health Nutrition2013;16(9):1605‐13. [DOI: 10.1017/S1368980012005174; PUBMED: 23218415] ">Macharia‐Mutie 2012</a>; <a href="./references#CD009666-bbs2-0008" title="OseiAK , HouserRF , BulusuS , HamerDH . Acceptability of micronutrient fortified school meals by schoolchildren in rural Himalayan villages of India. Journal of Food Science2008;73(7):S354‐8. [DOI: 10.1111/j.1750‐3841.2008.00878.x; PUBMED: 18803728] OseiAK , RosenbergIH , HouserRF , BulusuS , MathewsM , HamerDH . Community‐level micronutrient fortification of school lunch meals improved vitamin A, folate, and iron status of schoolchildren in Himalayan villages of India. Journal of Nutrition2010;140(6):1146‐54. [DOI: 10.3945/jn.109.114751; PUBMED: 20410083] ">Osei 2008 (C)</a>; <a href="./references#CD009666-bbs2-0009" title="SharieffW , YinSA , WuM , YangQ , SchauerC , TomlinsonG , et al. Short‐term daily or weekly administration of micronutrient Sprinkles has high compliance and does not cause iron overload in Chinese schoolchildren: a cluster‐randomized trial. Public Health Nutrition2006;9(3):336‐44. [PUBMED: 16684385] ZlotkinS [pers comm] . Regards and question ‐ Sharieff 2006. Email to: JP Peña‐Rosas 2 November 2011. ">Sharieff 2006 (C)</a>), or other potential bias was unlikely (<a href="./references#CD009666-bbs2-0004" title="LundeenE [pers comm] . Kyrgyz Republic MNP data for children 24‐36 months. Email to: M Jefferds 3 November 2011. LundeenE , SchuethT , ToktobaevN , ZlotkinS , HyderSM , HouserR . Daily use of Sprinkles micronutrient powder for 2 months reduces anemia among children 6 to 36 months of age in the Kyrgyz Republic: a cluster‐randomized trial. Food and Nutrition Bulletin2010;31(3):446‐60. [DOI: 10.1177/156482651003100307; PUBMED: 20973465] ">Lundeen 2010 (C)</a>; <a href="./references#CD009666-bbs2-0006" title="JerlingJ [pers comm] . Regards and question on Ogundale et al 2011 vir Cochrane review. Email to: JP Pena‐Rosas 3 November 2011. OgunladeAO , KrugerHS , JerlingJC , SmutsCM , CovicN , HanekomSM , et al. Point‐of‐use micronutrient fortification: lessons learned in implementing a preschool‐based pilot trial in South Africa. International Journal of Food Sciences and Nutrition2011;62(1):1‐16. [DOI: 10.3109/09637486.2010.495710; PUBMED: 20701549] ">Ogunlade 2011</a>; <a href="./references#CD009666-bbs2-0010" title="TroeschB [pers comm] . Regards and question on Troesch et al 2011. Email to: JP Peña‐Rosas 1 November 2011. TroeschB , vanStuijvenbergME , SmutsCM , KrugerHS , BiebingerR , HurrellRF , et al. A micronutrient powder with low doses of highly absorbable iron and zinc reduces iron and zinc deficiency and improves weight‐for‐age Z‐scores in South African children. Journal of Nutrition2011;141(2):237‐42. [DOI: 10.3945/jn.110.129247; PUBMED: 21178093] ">Troesch 2011b</a>; <a href="./references#CD009666-bbs2-0011" title="VarmaJL , DasS , SankarR , MannarMG , LevinsonFJ , HamerDH . Community‐level micronutrient fortification of a food supplement in India: a controlled trial in preschool children aged 36‐66 mo. American Journal of Clinical Nutrition2007;85(4):1127‐33. [PUBMED: 17413115] ">Varma 2007 (C)</a>; <a href="./references#CD009666-bbs2-0012" title="VinodkumarM , RajagopalanS . Impact of a multiple‐micronutrient food supplement on the nutritional status of schoolchildren. Food and Nutrition Bulletin2006;27(3):203‐10. [DOI: 10.1177/156482650602700302; PUBMED: 17542110] ">Vinodkumar 2006 (C)</a>). </p> </section> </section> <section id="CD009666-sec-0102"> <h3 class="title" id="CD009666-sec-0102">Effects of interventions</h3> <p>See: <a href="./full#CD009666-tbl-0001"><b>Summary of findings for the main comparison</b> Point‐of‐use fortification of foods with micronutrients powders (MNP) compared to no intervention or placebo in preschool and school‐age children</a> </p> <p>We included data from 13 trials, involving 5810 participants, in this review; for trials that included more than two treatment arms, we may not have included all arms in our analyses. We have organised the summary of results by comparisons and by primary and secondary outcomes. Most of the included trials focused on haematological indices and few reported on any of the other outcomes prespecified in the review protocol (<a href="./references#CD009666-bbs2-0132" title="De‐RegilLM , JefferdsMED , Peña‐RosasJP . Point‐of‐use fortification of foods with micronutrient powders containing iron in children of preschool and school age. Cochrane Database of Systematic Reviews2012, Issue 2. [DOI: 10.1002/14651858.CD009666] ">De‐Regil 2012</a>). Many of the findings showed heterogeneity that could not be explained by standard sensitivity analyses or subgroup analysis, including quality assessment, and so we used a random‐effects model to analyse the results. </p> <p>See the <a href="./references#CD009666-sec-0150" title="">Data and analyses</a> section for detailed results on primary and secondary outcomes. </p> <p>For those outcomes that included data from cluster‐randomised trials, the number included is the effective sample size; that is, sample sizes and event rates have been adjusted for cluster‐trials to take account of the design effect. </p> <section id="CD009666-sec-0103"> <h4 class="title">Comparison 1. Point‐of‐use fortification of foods with MNP versus no intervention or placebo </h4> <p>We included 13 trials that compared point‐of‐use fortification of foods with MNP versus no intervention/placebo. </p> <section id="CD009666-sec-0104"> <h5 class="title">Primary outcomes  </h5> <section id="CD009666-sec-0105"> <h6 class="title">Anaemia</h6> <p>Ten trials involving 2448 children evaluated anaemia. Children receiving multiple MNP for point‐of‐use fortification of foods were significantly less likely to have anaemia at follow‐up than children receiving no intervention or placebo (RR 0.66, 95% CI 0.49 to 0.88, P = 0.005; Tau<sup>2</sup> = 0.13, Chi<sup>2</sup> = 32.91, I<sup>2</sup> = 73%; <a href="./references#CD009666-fig-0005" title="">Analysis 1.1</a>). We rated the quality of this evidence as moderate; most studies showed a positive effect of MNP but had no blinding and high heterogeneity. See <a href="./full#CD009666-tbl-0001">summary of findings Table for the main comparison</a>. Among the trials, nine were conducted with participants with unreported or mixed anaemia status at the start of the intervention and of these, one excluded participants with severe anaemia (Hb less than 70 g/L) at participant selection (<a href="./references#CD009666-bbs2-0003" title="KounnavongS , SunaharaT , Mascie‐TaylorCG , HashizumeM , OkumuraJ , MojiK , et al. Effect of daily versus weekly home fortification with multiple micronutrient powder on haemoglobin concentration of young children in a rural area, Lao People's Democratic Republic: a randomised trial. Nutrition Journal2011;10(129):1‐11. [DOI: 10.1186/1475‐2891‐10‐129; PMC3266642; PUBMED: 22111770] ">Kounnavong 2011 (C)</a>). One study was conducted among non‐anaemic children (<a href="./references#CD009666-bbs2-0002" title="KemmerTM , OmerPS , Gidvani‐DiazVK , CoelloM . Acceptance and effect of ferrous fumarate containing micronutrient sprinkles on anemia, iron deficiency and anthropometrics in Honduran children. In: SilverbergDS editor(s). Anemia. Rijeka (Croatia): InTech, 2012. [DOI: 10.5772/30987] ">Kemmer 2012 (C)</a>). See <a href="./references#CD009666-fig-0006" title="">Analysis 1.2</a>. </p> <p>The subgroup analysis test showed that there were no significant differences in the effect by age at the start of intervention (i.e. the effect was no longer significant for those participants aged 60 months or older) (<a href="./references#CD009666-fig-0007" title="">Analysis 1.3</a>; test for subgroup differences P = 0.67); frequency of provision (<a href="./references#CD009666-fig-0009" title="">Analysis 1.5</a>; test for subgroup differences P = 0.15); duration of the intervention (<a href="./references#CD009666-fig-0010" title="">Analysis 1.6</a>; test for subgroup differences P = 0.21); number of nutrients in addition to iron (<a href="./references#CD009666-fig-0013" title="">Analysis 1.9</a>; test for subgroup differences P = 0.07; ); but there were significant differences for malaria status of study site (<a href="./references#CD009666-fig-0008" title="">Analysis 1.4</a>; test for subgroup differences P = 0.02), iron content (<a href="./references#CD009666-fig-0011" title="">Analysis 1.7</a>; test for subgroup differences P = 0.002), type of iron compound (<a href="./references#CD009666-fig-0012" title="">Analysis 1.8</a>; test for subgroup differences P = 0.03) and micronutrient composition (<a href="./references#CD009666-fig-0014" title="">Analysis 1.10</a>; test for subgroup differences P = 0.002). However, these results must be interpreted with caution as heterogeneity was high. </p> </section> <section id="CD009666-sec-0106"> <h6 class="title">Haemoglobin</h6> <p>Eleven included trials with 2746 children evaluated Hb. Compared to children receiving no intervention or placebo, children receiving multiple MNP had more Hb at follow‐up (MD 3.37 g/L, 95% CI 0.94 to 5.80, P = 0.006; Tau<sup>2</sup> = 14.42, Chi<sup>2</sup> = 134.09, I<sup>2</sup> = 93%; <a href="./references#CD009666-fig-0015" title="">Analysis 1.11</a>). We rated the quality of this evidence as low; most studies showed a positive effect of MNP but had no blinding and high heterogeneity. See <a href="./full#CD009666-tbl-0001">summary of findings Table for the main comparison</a>. </p> <p>The analysis by subgroups by anaemia status at the start of the intervention was not estimable as all studies contributing data were of mixed anaemia status (<a href="./references#CD009666-fig-0016" title="">Analysis 1.12</a>). There were differences for subgroups by frequency of provision (<a href="./references#CD009666-fig-0019" title="">Analysis 1.15</a>; test for subgroup differences P = 0.04), type of iron compound (<a href="./references#CD009666-fig-0022" title="">Analysis 1.18</a>; test for subgroup differences P &lt; 0.00001), number of nutrients in addition to iron (<a href="./references#CD009666-fig-0023" title="">Analysis 1.19</a>; test for subgroup differences P = 0.003) and micronutrient composition (<a href="./references#CD009666-fig-0024" title="">Analysis 1.20</a>; test for subgroup differences P = 0.02). </p> <p>There were no subgroup differences by age of the participants (<a href="./references#CD009666-fig-0017" title="">Analysis 1.13</a>; test for subgroup differences P = 0.21), malaria status of the study site (<a href="./references#CD009666-fig-0018" title="">Analysis 1.14</a>; test for subgroup differences P = 0.56), duration of the intervention (<a href="./references#CD009666-fig-0020" title="">Analysis 1.16</a>; test for subgroup differences P = 0.59) and iron content of the product (<a href="./references#CD009666-fig-0021" title="">Analysis 1.17</a>; test for subgroup differences P = 0.54). </p> <p>There was no indication of publication bias through assessment of the funnel plot (<a href="#CD009666-fig-0004">Figure 4</a>). When we analysed the results only with studies that compared provision of MNP versus placebo (i.e. we excluded those providing no intervention), the estimate changed to MD 1.29 g/L (95% CI ‐0.69 to 3.28, 4 studies, 1086 participants; analyses not shown). </p> <div class="figure" id="CD009666-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Point‐of‐use fortification of foods with micronutrients powders versus no intervention/placebo, outcome: 1.11 Haemoglobin (g/L)." data-id="CD009666-fig-0004" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Point‐of‐use fortification of foods with micronutrients powders versus no intervention/placebo, outcome: 1.11 Haemoglobin (g/L). </p> </div> </div> </div> </section> <section id="CD009666-sec-0107"> <h6 class="title">Iron deficiency</h6> <p>Five trials with 1364 children evaluated iron deficiency (<a href="./references#CD009666-bbs2-0005" title="Macharia‐MutieCW , MorettiD , Van denBrielN , OmusundiAM , MwangiAM , KokFJ , et al. Maize porridge enriched with a micronutrient powder containing low‐dose iron as NaFeEDTA but not amaranth grain flour reduces anemia and iron deficiency in Kenyan preschool children. Journal of Nutrition2012;142(9):1756‐63. [DOI: 10.3945/jn.112.157578; PUBMED: 22810982] Macharia‐MutieCW , OmusundiAM , MwaiJM , MwangiAM , BrouwerID . Simulation of the effect of maize porridge fortified with grain amaranth or micronutrient powder containing NaFeEDTA on iron intake and status in Kenyan children. Public Health Nutrition2013;16(9):1605‐13. [DOI: 10.1017/S1368980012005174; PUBMED: 23218415] ">Macharia‐Mutie 2012</a>; <a href="./references#CD009666-bbs2-0008" title="OseiAK , HouserRF , BulusuS , HamerDH . Acceptability of micronutrient fortified school meals by schoolchildren in rural Himalayan villages of India. Journal of Food Science2008;73(7):S354‐8. [DOI: 10.1111/j.1750‐3841.2008.00878.x; PUBMED: 18803728] OseiAK , RosenbergIH , HouserRF , BulusuS , MathewsM , HamerDH . Community‐level micronutrient fortification of school lunch meals improved vitamin A, folate, and iron status of schoolchildren in Himalayan villages of India. Journal of Nutrition2010;140(6):1146‐54. [DOI: 10.3945/jn.109.114751; PUBMED: 20410083] ">Osei 2008 (C)</a>; <a href="./references#CD009666-bbs2-0009" title="SharieffW , YinSA , WuM , YangQ , SchauerC , TomlinsonG , et al. Short‐term daily or weekly administration of micronutrient Sprinkles has high compliance and does not cause iron overload in Chinese schoolchildren: a cluster‐randomized trial. Public Health Nutrition2006;9(3):336‐44. [PUBMED: 16684385] ZlotkinS [pers comm] . Regards and question ‐ Sharieff 2006. Email to: JP Peña‐Rosas 2 November 2011. ">Sharieff 2006 (C)</a>; <a href="./references#CD009666-bbs2-0010" title="TroeschB [pers comm] . Regards and question on Troesch et al 2011. Email to: JP Peña‐Rosas 1 November 2011. TroeschB , vanStuijvenbergME , SmutsCM , KrugerHS , BiebingerR , HurrellRF , et al. A micronutrient powder with low doses of highly absorbable iron and zinc reduces iron and zinc deficiency and improves weight‐for‐age Z‐scores in South African children. Journal of Nutrition2011;141(2):237‐42. [DOI: 10.3945/jn.110.129247; PUBMED: 21178093] ">Troesch 2011b</a>; <a href="./references#CD009666-bbs2-0011" title="VarmaJL , DasS , SankarR , MannarMG , LevinsonFJ , HamerDH . Community‐level micronutrient fortification of a food supplement in India: a controlled trial in preschool children aged 36‐66 mo. American Journal of Clinical Nutrition2007;85(4):1127‐33. [PUBMED: 17413115] ">Varma 2007 (C)</a>). Children receiving multiple MNP for point‐of‐use fortification of foods were significantly less likely to have iron deficiency at follow‐up than those children receiving no intervention or placebo (RR 0.35, 95% CI 0.27 to 0.47, P = 0.001; Tau<sup>2</sup> = 0.00, Chi<sup>2</sup> = 0.65, I<sup>2</sup> = 0%; <a href="./references#CD009666-fig-0025" title="">Analysis 1.21</a>). We rated the quality of this evidence as moderate; there was no heterogeneity and most studies showed a positive effect of MNP but they lacked blinding. See <a href="./full#CD009666-tbl-0001">summary of findings Table for the main comparison</a>. </p> <p>All five trials were conducted with participants with unreported or mixed anaemia status at start of the intervention. The subgroups analysis tests were either not significant or not estimable for the characteristics evaluated (see <a href="./references#CD009666-fig-0026" title="">Analysis 1.22</a>; <a href="./references#CD009666-fig-0027" title="">Analysis 1.23</a>; <a href="./references#CD009666-fig-0028" title="">Analysis 1.24</a>; <a href="./references#CD009666-fig-0029" title="">Analysis 1.25</a>; <a href="./references#CD009666-fig-0030" title="">Analysis 1.26</a>; <a href="./references#CD009666-fig-0031" title="">Analysis 1.27</a>; <a href="./references#CD009666-fig-0032" title="">Analysis 1.28</a>; <a href="./references#CD009666-fig-0033" title="">Analysis 1.29</a>; <a href="./references#CD009666-fig-0034" title="">Analysis 1.30</a>). </p> </section> <section id="CD009666-sec-0108"> <h6 class="title">Ferritin</h6> <p>Three trials, involving 1066 children, provided information on ferritin concentrations (reported as arithmetic means) (<a href="./references#CD009666-bbs2-0008" title="OseiAK , HouserRF , BulusuS , HamerDH . Acceptability of micronutrient fortified school meals by schoolchildren in rural Himalayan villages of India. Journal of Food Science2008;73(7):S354‐8. [DOI: 10.1111/j.1750‐3841.2008.00878.x; PUBMED: 18803728] OseiAK , RosenbergIH , HouserRF , BulusuS , MathewsM , HamerDH . Community‐level micronutrient fortification of school lunch meals improved vitamin A, folate, and iron status of schoolchildren in Himalayan villages of India. Journal of Nutrition2010;140(6):1146‐54. [DOI: 10.3945/jn.109.114751; PUBMED: 20410083] ">Osei 2008 (C)</a>; <a href="./references#CD009666-bbs2-0009" title="SharieffW , YinSA , WuM , YangQ , SchauerC , TomlinsonG , et al. Short‐term daily or weekly administration of micronutrient Sprinkles has high compliance and does not cause iron overload in Chinese schoolchildren: a cluster‐randomized trial. Public Health Nutrition2006;9(3):336‐44. [PUBMED: 16684385] ZlotkinS [pers comm] . Regards and question ‐ Sharieff 2006. Email to: JP Peña‐Rosas 2 November 2011. ">Sharieff 2006 (C)</a>; <a href="./references#CD009666-bbs2-0011" title="VarmaJL , DasS , SankarR , MannarMG , LevinsonFJ , HamerDH . Community‐level micronutrient fortification of a food supplement in India: a controlled trial in preschool children aged 36‐66 mo. American Journal of Clinical Nutrition2007;85(4):1127‐33. [PUBMED: 17413115] ">Varma 2007 (C)</a>). On average, it was uncertain whether children receiving multiple MNP had any difference in ferritin at follow‐up compared to children receiving no intervention or placebo (SMD 0.42 μg/L, 95% CI ‐4.36 to 5.19, Tau<sup>2</sup> = 17.76, Chi<sup>2</sup> = 1139.30, I<sup>2</sup> = 100%; <a href="./references#CD009666-fig-0035" title="">Analysis 1.31</a>), as the quality of the evidence has been assessed as very low. Most studies had no or unclear blinding, and there was 100% heterogeneity with most inconsistency in the direction of the effect. See <a href="./full#CD009666-tbl-0001">summary of findings Table for the main comparison</a>. </p> </section> <section id="CD009666-sec-0109"> <h6 class="title">All‐cause mortality: single study results</h6> <p>One trial with 115 participants reported on all‐cause mortality (<a href="./references#CD009666-bbs2-0001" title="InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Combined intensive nutrition education and micronutrient powder supplementation improved nutritional status of mildly wasted children on Nias Island, Indonesia. Asia Pacific Journal of Clinical Nutrition2012;21(3):361‐73. [PUBMED: 22705425] InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Improved nutrition knowledge and practice through intensive nutrition education: a study among caregivers of mildly wasted children on Nias Island, Indonesia. Food and Nutrition Bulletin2012;33(2):117‐27. [DOI: 10.1177/156482651203300205; PUBMED: 22908693] PurwestriRC , ScherbaumV , InayatiDA , WirawanNN , SuryantanJ , BloemMA , et al. Supplementary feeding with locally‐produced ready‐to‐use food (RUF) for mildly wasted children on Nias Island, Indonesia: comparison of daily and weekly programme outcomes. Asia Pacific Journal of Clinical Nutrition2012;21(3):374‐9. [PUBMED: 22705426] ScherbaumV [pers comm] . Your paper on MNP. Email to: LM De‐Regil 5 February 2013. ">Inayati 2012 (C)</a>). There were no deaths reported during this trial (<a href="./references#CD009666-fig-0036" title="">Analysis 1.32</a>). We rated the quality of this evidence as low as only one low‐risk trial reported all‐cause mortality. See <a href="./full#CD009666-tbl-0001">summary of findings Table for the main comparison</a>. </p> </section> <section id="CD009666-sec-0110"> <h6 class="title">Diarrhoea</h6> <p>Two trials with 366 participants reported data on diarrhoea (<a href="./references#CD009666-bbs2-0001" title="InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Combined intensive nutrition education and micronutrient powder supplementation improved nutritional status of mildly wasted children on Nias Island, Indonesia. Asia Pacific Journal of Clinical Nutrition2012;21(3):361‐73. [PUBMED: 22705425] InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Improved nutrition knowledge and practice through intensive nutrition education: a study among caregivers of mildly wasted children on Nias Island, Indonesia. Food and Nutrition Bulletin2012;33(2):117‐27. [DOI: 10.1177/156482651203300205; PUBMED: 22908693] PurwestriRC , ScherbaumV , InayatiDA , WirawanNN , SuryantanJ , BloemMA , et al. Supplementary feeding with locally‐produced ready‐to‐use food (RUF) for mildly wasted children on Nias Island, Indonesia: comparison of daily and weekly programme outcomes. Asia Pacific Journal of Clinical Nutrition2012;21(3):374‐9. [PUBMED: 22705426] ScherbaumV [pers comm] . Your paper on MNP. Email to: LM De‐Regil 5 February 2013. ">Inayati 2012 (C)</a>; <a href="./references#CD009666-bbs2-0008" title="OseiAK , HouserRF , BulusuS , HamerDH . Acceptability of micronutrient fortified school meals by schoolchildren in rural Himalayan villages of India. Journal of Food Science2008;73(7):S354‐8. [DOI: 10.1111/j.1750‐3841.2008.00878.x; PUBMED: 18803728] OseiAK , RosenbergIH , HouserRF , BulusuS , MathewsM , HamerDH . Community‐level micronutrient fortification of school lunch meals improved vitamin A, folate, and iron status of schoolchildren in Himalayan villages of India. Journal of Nutrition2010;140(6):1146‐54. [DOI: 10.3945/jn.109.114751; PUBMED: 20410083] ">Osei 2008 (C)</a>. Children receiving multiple MNP for point‐of‐use fortification of foods were as likely to have diarrhoea at follow‐up than those children receiving no intervention or placebo (RR 0.97, 95% CI 0.53 to 1.78, P = 0.93; Tau<sup>2</sup> = 0.00, Chi<sup>2</sup> = 0.42, I<sup>2</sup> = 0%; <a href="./references#CD009666-fig-0037" title="">Analysis 1.33</a>). We rated the quality of this evidence as low; two low‐risk trials reported diarrhoea and there was no heterogeneity, with both studies showing no difference between the intervention and comparison groups. See <a href="./full#CD009666-tbl-0001">summary of findings Table for the main comparison</a>. </p> </section> <section id="CD009666-sec-0111"> <h6 class="title">Adverse effects: single study results</h6> <p>One trial involving 90 children reported adverse effects (<a href="./references#CD009666-bbs2-0007" title="OrozcoJ , VargasC , RojasML , HerreraAM , MontoyaL , SánchezJG , et al. The effect of powdered micronutrients on the hematologic values and nutritional status of healthy preschoolers. Medellín, 2013 [Efecto de los micronutrientes en polvo en el estado nutricional y en los valores hemáticos de preescolares sanos. Medellín, 2013]. Revista Facultad Nacional de Salud Pública2015;33(2):161‐70. [DOI: 10.17533/udea.rfnsp.v33n2a03] ">Orozco 2015 (C)</a>). In this study, authors reported that, overall, four children (4.4%) reported adverse effects that consisted of abdominal pain and nausea. Two preschool‐age children (4.7%) in the MNP group and two children (4.3%) in the control group presented with nausea and abdominal pain (RR 1.09, 95% CI 0.16 to 7.42; <a href="./references#CD009666-fig-0038" title="">Analysis 1.34</a>). It is important to note that none of the participants required medical attention for the adverse effects attributed to the intervention; for this reason, none were withdrawn from the study. We rated the quality of this evidence as moderate. See <a href="./full#CD009666-tbl-0001">summary of findings Table for the main comparison</a>. </p> </section> </section> <section id="CD009666-sec-0112"> <h5 class="title">Secondary outcomes  </h5> <section id="CD009666-sec-0113"> <h6 class="title">Iron deficiency anaemia</h6> <p>Three trials with 918 participants reported on iron deficiency anaemia (<a href="./references#CD009666-bbs2-0005" title="Macharia‐MutieCW , MorettiD , Van denBrielN , OmusundiAM , MwangiAM , KokFJ , et al. Maize porridge enriched with a micronutrient powder containing low‐dose iron as NaFeEDTA but not amaranth grain flour reduces anemia and iron deficiency in Kenyan preschool children. Journal of Nutrition2012;142(9):1756‐63. [DOI: 10.3945/jn.112.157578; PUBMED: 22810982] Macharia‐MutieCW , OmusundiAM , MwaiJM , MwangiAM , BrouwerID . Simulation of the effect of maize porridge fortified with grain amaranth or micronutrient powder containing NaFeEDTA on iron intake and status in Kenyan children. Public Health Nutrition2013;16(9):1605‐13. [DOI: 10.1017/S1368980012005174; PUBMED: 23218415] ">Macharia‐Mutie 2012</a>; <a href="./references#CD009666-bbs2-0008" title="OseiAK , HouserRF , BulusuS , HamerDH . Acceptability of micronutrient fortified school meals by schoolchildren in rural Himalayan villages of India. Journal of Food Science2008;73(7):S354‐8. [DOI: 10.1111/j.1750‐3841.2008.00878.x; PUBMED: 18803728] OseiAK , RosenbergIH , HouserRF , BulusuS , MathewsM , HamerDH . Community‐level micronutrient fortification of school lunch meals improved vitamin A, folate, and iron status of schoolchildren in Himalayan villages of India. Journal of Nutrition2010;140(6):1146‐54. [DOI: 10.3945/jn.109.114751; PUBMED: 20410083] ">Osei 2008 (C)</a>; <a href="./references#CD009666-bbs2-0011" title="VarmaJL , DasS , SankarR , MannarMG , LevinsonFJ , HamerDH . Community‐level micronutrient fortification of a food supplement in India: a controlled trial in preschool children aged 36‐66 mo. American Journal of Clinical Nutrition2007;85(4):1127‐33. [PUBMED: 17413115] ">Varma 2007 (C)</a>. Children receiving multiple MNP for point‐of‐use fortification of foods were as likely to have iron deficiency anaemia as children receiving no intervention or placebo (RR 0.28, 95% CI 0.07 to 1.10, P = 0.07; Tau<sup>2</sup> = 0.97, Chi<sup>2</sup> = 5.90, I<sup>2</sup> = 66%; <a href="./references#CD009666-fig-0039" title="">Analysis 1.35</a>). </p> </section> <section id="CD009666-sec-0114"> <h6 class="title">Cognitive development and school performance: single study results</h6> <p>One trial reported on cognitive development and school performance, but the information could not be extracted (<a href="./references#CD009666-bbs2-0006" title="JerlingJ [pers comm] . Regards and question on Ogundale et al 2011 vir Cochrane review. Email to: JP Pena‐Rosas 3 November 2011. OgunladeAO , KrugerHS , JerlingJC , SmutsCM , CovicN , HanekomSM , et al. Point‐of‐use micronutrient fortification: lessons learned in implementing a preschool‐based pilot trial in South Africa. International Journal of Food Sciences and Nutrition2011;62(1):1‐16. [DOI: 10.3109/09637486.2010.495710; PUBMED: 20701549] ">Ogunlade 2011</a>). </p> </section> <section id="CD009666-sec-0115"> <h6 class="title">Motor development and physical capacity</h6> <p>No trials reported motor development and physical capacity.</p> </section> <section id="CD009666-sec-0116"> <h6 class="title">All‐cause morbidity</h6> <p>Three trials with 538 participants reported on all‐cause morbidity (<a href="./references#CD009666-bbs2-0001" title="InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Combined intensive nutrition education and micronutrient powder supplementation improved nutritional status of mildly wasted children on Nias Island, Indonesia. Asia Pacific Journal of Clinical Nutrition2012;21(3):361‐73. [PUBMED: 22705425] InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Improved nutrition knowledge and practice through intensive nutrition education: a study among caregivers of mildly wasted children on Nias Island, Indonesia. Food and Nutrition Bulletin2012;33(2):117‐27. [DOI: 10.1177/156482651203300205; PUBMED: 22908693] PurwestriRC , ScherbaumV , InayatiDA , WirawanNN , SuryantanJ , BloemMA , et al. Supplementary feeding with locally‐produced ready‐to‐use food (RUF) for mildly wasted children on Nias Island, Indonesia: comparison of daily and weekly programme outcomes. Asia Pacific Journal of Clinical Nutrition2012;21(3):374‐9. [PUBMED: 22705426] ScherbaumV [pers comm] . Your paper on MNP. Email to: LM De‐Regil 5 February 2013. ">Inayati 2012 (C)</a>; <a href="./references#CD009666-bbs2-0003" title="KounnavongS , SunaharaT , Mascie‐TaylorCG , HashizumeM , OkumuraJ , MojiK , et al. Effect of daily versus weekly home fortification with multiple micronutrient powder on haemoglobin concentration of young children in a rural area, Lao People's Democratic Republic: a randomised trial. Nutrition Journal2011;10(129):1‐11. [DOI: 10.1186/1475‐2891‐10‐129; PMC3266642; PUBMED: 22111770] ">Kounnavong 2011 (C)</a>; <a href="./references#CD009666-bbs2-0008" title="OseiAK , HouserRF , BulusuS , HamerDH . Acceptability of micronutrient fortified school meals by schoolchildren in rural Himalayan villages of India. Journal of Food Science2008;73(7):S354‐8. [DOI: 10.1111/j.1750‐3841.2008.00878.x; PUBMED: 18803728] OseiAK , RosenbergIH , HouserRF , BulusuS , MathewsM , HamerDH . Community‐level micronutrient fortification of school lunch meals improved vitamin A, folate, and iron status of schoolchildren in Himalayan villages of India. Journal of Nutrition2010;140(6):1146‐54. [DOI: 10.3945/jn.109.114751; PUBMED: 20410083] ">Osei 2008 (C)</a>). Children receiving multiple MNP for point‐of‐use fortification of foods were as likely to have all‐cause morbidity as children receiving no intervention or placebo (RR 0.96, 95% CI 0.74 to 1.23, P = 0.72; Tau<sup>2</sup> = 0.00, Chi<sup>2</sup> = 0.83, I<sup>2</sup> = 0%; <a href="./references#CD009666-fig-0040" title="">Analysis 1.36</a>). </p> </section> <section id="CD009666-sec-0117"> <h6 class="title">Acute respiratory infection: single study results</h6> <p>Only one trial with 115 participants reported on acute respiratory infection (<a href="./references#CD009666-bbs2-0001" title="InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Combined intensive nutrition education and micronutrient powder supplementation improved nutritional status of mildly wasted children on Nias Island, Indonesia. Asia Pacific Journal of Clinical Nutrition2012;21(3):361‐73. [PUBMED: 22705425] InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Improved nutrition knowledge and practice through intensive nutrition education: a study among caregivers of mildly wasted children on Nias Island, Indonesia. Food and Nutrition Bulletin2012;33(2):117‐27. [DOI: 10.1177/156482651203300205; PUBMED: 22908693] PurwestriRC , ScherbaumV , InayatiDA , WirawanNN , SuryantanJ , BloemMA , et al. Supplementary feeding with locally‐produced ready‐to‐use food (RUF) for mildly wasted children on Nias Island, Indonesia: comparison of daily and weekly programme outcomes. Asia Pacific Journal of Clinical Nutrition2012;21(3):374‐9. [PUBMED: 22705426] ScherbaumV [pers comm] . Your paper on MNP. Email to: LM De‐Regil 5 February 2013. ">Inayati 2012 (C)</a>). Participants who received the iron‐containing MNP for point‐of‐use fortification were less likely to have an acute respiratory infection than participants receiving no intervention or placebo (RR 0.58, 95% CI 0.37 to 0.90, P = 0.01; see the illustrative forest plot in <a href="./references#CD009666-fig-0041" title="">Analysis 1.37</a>). </p> </section> <section id="CD009666-sec-0118"> <h6 class="title">Growth (height‐for‐age Z‐score)</h6> <p>Four trials with 617 participants reported on growth (HAZ) (<a href="./references#CD009666-bbs2-0001" title="InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Combined intensive nutrition education and micronutrient powder supplementation improved nutritional status of mildly wasted children on Nias Island, Indonesia. Asia Pacific Journal of Clinical Nutrition2012;21(3):361‐73. [PUBMED: 22705425] InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Improved nutrition knowledge and practice through intensive nutrition education: a study among caregivers of mildly wasted children on Nias Island, Indonesia. Food and Nutrition Bulletin2012;33(2):117‐27. [DOI: 10.1177/156482651203300205; PUBMED: 22908693] PurwestriRC , ScherbaumV , InayatiDA , WirawanNN , SuryantanJ , BloemMA , et al. Supplementary feeding with locally‐produced ready‐to‐use food (RUF) for mildly wasted children on Nias Island, Indonesia: comparison of daily and weekly programme outcomes. Asia Pacific Journal of Clinical Nutrition2012;21(3):374‐9. [PUBMED: 22705426] ScherbaumV [pers comm] . Your paper on MNP. Email to: LM De‐Regil 5 February 2013. ">Inayati 2012 (C)</a>; <a href="./references#CD009666-bbs2-0002" title="KemmerTM , OmerPS , Gidvani‐DiazVK , CoelloM . Acceptance and effect of ferrous fumarate containing micronutrient sprinkles on anemia, iron deficiency and anthropometrics in Honduran children. In: SilverbergDS editor(s). Anemia. Rijeka (Croatia): InTech, 2012. [DOI: 10.5772/30987] ">Kemmer 2012 (C)</a>; <a href="./references#CD009666-bbs2-0003" title="KounnavongS , SunaharaT , Mascie‐TaylorCG , HashizumeM , OkumuraJ , MojiK , et al. Effect of daily versus weekly home fortification with multiple micronutrient powder on haemoglobin concentration of young children in a rural area, Lao People's Democratic Republic: a randomised trial. Nutrition Journal2011;10(129):1‐11. [DOI: 10.1186/1475‐2891‐10‐129; PMC3266642; PUBMED: 22111770] ">Kounnavong 2011 (C)</a>; <a href="./references#CD009666-bbs2-0006" title="JerlingJ [pers comm] . Regards and question on Ogundale et al 2011 vir Cochrane review. Email to: JP Pena‐Rosas 3 November 2011. OgunladeAO , KrugerHS , JerlingJC , SmutsCM , CovicN , HanekomSM , et al. Point‐of‐use micronutrient fortification: lessons learned in implementing a preschool‐based pilot trial in South Africa. International Journal of Food Sciences and Nutrition2011;62(1):1‐16. [DOI: 10.3109/09637486.2010.495710; PUBMED: 20701549] ">Ogunlade 2011</a>). There were no significant differences between children receiving MNPs and children receiving no intervention or placebo, although children receiving MNP were slightly shorter at follow‐up (MD ‐0.02, 95% CI ‐0.20 to 0.17, P = 0.86; Tau<sup>2</sup> = 0.00, Chi<sup>2</sup> = 0.25, I<sup>2</sup> = 0%; <a href="./references#CD009666-fig-0042" title="">Analysis 1.38</a>). </p> </section> <section id="CD009666-sec-0119"> <h6 class="title">Growth (weight‐for‐age Z‐score)</h6> <p>Three trials with 502 participants reported on growth (WAZ) (<a href="./references#CD009666-bbs2-0002" title="KemmerTM , OmerPS , Gidvani‐DiazVK , CoelloM . Acceptance and effect of ferrous fumarate containing micronutrient sprinkles on anemia, iron deficiency and anthropometrics in Honduran children. In: SilverbergDS editor(s). Anemia. Rijeka (Croatia): InTech, 2012. [DOI: 10.5772/30987] ">Kemmer 2012 (C)</a>; <a href="./references#CD009666-bbs2-0003" title="KounnavongS , SunaharaT , Mascie‐TaylorCG , HashizumeM , OkumuraJ , MojiK , et al. Effect of daily versus weekly home fortification with multiple micronutrient powder on haemoglobin concentration of young children in a rural area, Lao People's Democratic Republic: a randomised trial. Nutrition Journal2011;10(129):1‐11. [DOI: 10.1186/1475‐2891‐10‐129; PMC3266642; PUBMED: 22111770] ">Kounnavong 2011 (C)</a>; <a href="./references#CD009666-bbs2-0006" title="JerlingJ [pers comm] . Regards and question on Ogundale et al 2011 vir Cochrane review. Email to: JP Pena‐Rosas 3 November 2011. OgunladeAO , KrugerHS , JerlingJC , SmutsCM , CovicN , HanekomSM , et al. Point‐of‐use micronutrient fortification: lessons learned in implementing a preschool‐based pilot trial in South Africa. International Journal of Food Sciences and Nutrition2011;62(1):1‐16. [DOI: 10.3109/09637486.2010.495710; PUBMED: 20701549] ">Ogunlade 2011</a>). There were no significant differences between children receiving MNPs and children receiving no intervention or placebo, although children receiving MNP were slightly thinner for their age at follow‐up (MD ‐0.01, 95% CI ‐0.09 to 0.07 P = 0.85; Tau<sup>2</sup> = 0.00, Chi<sup>2</sup> = 0.89, I<sup>2</sup> = 0%; <a href="./references#CD009666-fig-0043" title="">Analysis 1.39</a>). </p> </section> <section id="CD009666-sec-0120"> <h6 class="title">Growth (weight‐for‐height Z‐score)</h6> <p>Two trials with 287 participants reported on growth (WHZ) (<a href="./references#CD009666-bbs2-0001" title="InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Combined intensive nutrition education and micronutrient powder supplementation improved nutritional status of mildly wasted children on Nias Island, Indonesia. Asia Pacific Journal of Clinical Nutrition2012;21(3):361‐73. [PUBMED: 22705425] InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Improved nutrition knowledge and practice through intensive nutrition education: a study among caregivers of mildly wasted children on Nias Island, Indonesia. Food and Nutrition Bulletin2012;33(2):117‐27. [DOI: 10.1177/156482651203300205; PUBMED: 22908693] PurwestriRC , ScherbaumV , InayatiDA , WirawanNN , SuryantanJ , BloemMA , et al. Supplementary feeding with locally‐produced ready‐to‐use food (RUF) for mildly wasted children on Nias Island, Indonesia: comparison of daily and weekly programme outcomes. Asia Pacific Journal of Clinical Nutrition2012;21(3):374‐9. [PUBMED: 22705426] ScherbaumV [pers comm] . Your paper on MNP. Email to: LM De‐Regil 5 February 2013. ">Inayati 2012 (C)</a>; <a href="./references#CD009666-bbs2-0003" title="KounnavongS , SunaharaT , Mascie‐TaylorCG , HashizumeM , OkumuraJ , MojiK , et al. Effect of daily versus weekly home fortification with multiple micronutrient powder on haemoglobin concentration of young children in a rural area, Lao People's Democratic Republic: a randomised trial. Nutrition Journal2011;10(129):1‐11. [DOI: 10.1186/1475‐2891‐10‐129; PMC3266642; PUBMED: 22111770] ">Kounnavong 2011 (C)</a>). Children receiving multiple MNP were heavier for their height at follow‐up in comparison to children receiving no intervention or placebo (MD 0.09, 95% CI 0.00 to 0.19, P = 0.04; Tau<sup>2</sup> = 0.00, Chi<sup>2</sup> = 0.15, I<sup>2</sup> = 0%; <a href="./references#CD009666-fig-0044" title="">Analysis 1.40</a>). </p> </section> <section id="CD009666-sec-0121"> <h6 class="title">Adherence: single study results</h6> <p>One trial with 131 participants reported on adherence (<a href="./references#CD009666-bbs2-0006" title="JerlingJ [pers comm] . Regards and question on Ogundale et al 2011 vir Cochrane review. Email to: JP Pena‐Rosas 3 November 2011. OgunladeAO , KrugerHS , JerlingJC , SmutsCM , CovicN , HanekomSM , et al. Point‐of‐use micronutrient fortification: lessons learned in implementing a preschool‐based pilot trial in South Africa. International Journal of Food Sciences and Nutrition2011;62(1):1‐16. [DOI: 10.3109/09637486.2010.495710; PUBMED: 20701549] ">Ogunlade 2011</a>). Children receiving multiple MNP for point‐of‐use fortification of foods were as likely to adhere to the intervention as children receiving no intervention or placebo (RR 1.00, 95% CI 0.87 to 1.16, P = 0.95; see the illustrative forest plot in <a href="./references#CD009666-fig-0045" title="">Analysis 1.41</a>). </p> </section> <section id="CD009666-sec-0122"> <h6 class="title">Red blood cell folate</h6> <p>No trials reported red blood cell folate.</p> </section> <section id="CD009666-sec-0123"> <h6 class="title">Serum/plasma retinol</h6> <p>Two trials with 547 participants reported serum/plasma retinol (<a href="./references#CD009666-bbs2-0011" title="VarmaJL , DasS , SankarR , MannarMG , LevinsonFJ , HamerDH . Community‐level micronutrient fortification of a food supplement in India: a controlled trial in preschool children aged 36‐66 mo. American Journal of Clinical Nutrition2007;85(4):1127‐33. [PUBMED: 17413115] ">Varma 2007 (C)</a>; <a href="./references#CD009666-bbs2-0012" title="VinodkumarM , RajagopalanS . Impact of a multiple‐micronutrient food supplement on the nutritional status of schoolchildren. Food and Nutrition Bulletin2006;27(3):203‐10. [DOI: 10.1177/156482650602700302; PUBMED: 17542110] ">Vinodkumar 2006 (C)</a>). It was uncertain whether the intervention made any change in serum/plasma retinol concentration at follow‐up (MD 10.08 mmol/L, 95% CI ‐10.72 to 30.88, P = 0.34; Tau<sup>2</sup> = 214.16, Chi<sup>2</sup> = 19.44, I<sup>2</sup> = 95%; <a href="./references#CD009666-fig-0046" title="">Analysis 1.42</a>). </p> </section> <section id="CD009666-sec-0124"> <h6 class="title">Serum/plasma zinc concentrations: single study results</h6> <p>One trial with 288 participants reported serum/plasma zinc concentrations (<a href="./references#CD009666-bbs2-0008" title="OseiAK , HouserRF , BulusuS , HamerDH . Acceptability of micronutrient fortified school meals by schoolchildren in rural Himalayan villages of India. Journal of Food Science2008;73(7):S354‐8. [DOI: 10.1111/j.1750‐3841.2008.00878.x; PUBMED: 18803728] OseiAK , RosenbergIH , HouserRF , BulusuS , MathewsM , HamerDH . Community‐level micronutrient fortification of school lunch meals improved vitamin A, folate, and iron status of schoolchildren in Himalayan villages of India. Journal of Nutrition2010;140(6):1146‐54. [DOI: 10.3945/jn.109.114751; PUBMED: 20410083] ">Osei 2008 (C)</a>). There were no differences between groups. It was uncertain whether the intervention made any difference in serum/plasma zinc concentration at follow‐up (MD ‐0.10 mmol/L, 95% CI ‐0.79 to 0.59, P = 0.78; see the illustrative forest plot in <a href="./references#CD009666-fig-0047" title="">Analysis 1.43</a>). </p> </section> </section> <section id="CD009666-sec-0125"> <h5 class="title">Non‐prespecified outcomes</h5> <p>Studies reported several non‐prespecified outcomes for indicators of vitamin and mineral status, growth and other health outcomes. </p> <section id="CD009666-sec-0126"> <h6 class="title">Iron status: single study results</h6> <p>One study with 288 children reported total iron binding capacity (MD 22.90 µmol/kg, 95% CI 22.55 to 23.25, P &lt; 0.001; <a href="./references#CD009666-fig-0048" title="">Analysis 1.44</a>) and serum transferrin receptors (MD ‐0.10 mg/L, 95% CI ‐0.44 to 0.24, P = 0.56; see the illustrative forest plot in <a href="./references#CD009666-fig-0049" title="">Analysis 1.45</a>) (<a href="./references#CD009666-bbs2-0008" title="OseiAK , HouserRF , BulusuS , HamerDH . Acceptability of micronutrient fortified school meals by schoolchildren in rural Himalayan villages of India. Journal of Food Science2008;73(7):S354‐8. [DOI: 10.1111/j.1750‐3841.2008.00878.x; PUBMED: 18803728] OseiAK , RosenbergIH , HouserRF , BulusuS , MathewsM , HamerDH . Community‐level micronutrient fortification of school lunch meals improved vitamin A, folate, and iron status of schoolchildren in Himalayan villages of India. Journal of Nutrition2010;140(6):1146‐54. [DOI: 10.3945/jn.109.114751; PUBMED: 20410083] ">Osei 2008 (C)</a>). However, we are uncertain whether the intervention makes any difference in these outcomes. </p> </section> <section id="CD009666-sec-0127"> <h6 class="title">Serum vitamin E: single study results</h6> <p>One study with 66 children reported serum vitamin E (<a href="./references#CD009666-bbs2-0012" title="VinodkumarM , RajagopalanS . Impact of a multiple‐micronutrient food supplement on the nutritional status of schoolchildren. Food and Nutrition Bulletin2006;27(3):203‐10. [DOI: 10.1177/156482650602700302; PUBMED: 17542110] ">Vinodkumar 2006 (C)</a>). It found no evidence of effect of multiple MNP in comparison with a placebo (MD 27.45 µg/dL, 95% CI ‐213.28 to 268.18, P = 0.82; see the illustrative forest plot in <a href="./references#CD009666-fig-0050" title="">Analysis 1.46</a>). </p> </section> <section id="CD009666-sec-0128"> <h6 class="title">Serum vitamin B<sub>12</sub> </h6> <p>Two studies with 329 children reported serum vitamin B<sub>12</sub> (<a href="./references#CD009666-bbs2-0008" title="OseiAK , HouserRF , BulusuS , HamerDH . Acceptability of micronutrient fortified school meals by schoolchildren in rural Himalayan villages of India. Journal of Food Science2008;73(7):S354‐8. [DOI: 10.1111/j.1750‐3841.2008.00878.x; PUBMED: 18803728] OseiAK , RosenbergIH , HouserRF , BulusuS , MathewsM , HamerDH . Community‐level micronutrient fortification of school lunch meals improved vitamin A, folate, and iron status of schoolchildren in Himalayan villages of India. Journal of Nutrition2010;140(6):1146‐54. [DOI: 10.3945/jn.109.114751; PUBMED: 20410083] ">Osei 2008 (C)</a>; <a href="./references#CD009666-bbs2-0012" title="VinodkumarM , RajagopalanS . Impact of a multiple‐micronutrient food supplement on the nutritional status of schoolchildren. Food and Nutrition Bulletin2006;27(3):203‐10. [DOI: 10.1177/156482650602700302; PUBMED: 17542110] ">Vinodkumar 2006 (C)</a>). There was no evidence of effect among children who consumed multiple MNP in comparison with children who received no intervention or placebo (MD 241.16 pg/mL, 95% CI ‐258.70 to 741.02, P = 0.34; Tau<sup>2</sup> = 99511.92, Chi<sup>2</sup> = 3.27, I<sup>2</sup> = 69%; <a href="./references#CD009666-fig-0051" title="">Analysis 1.47</a>). </p> </section> <section id="CD009666-sec-0129"> <h6 class="title">Zinc deficiency: single study results</h6> <p>One study with 192 children reported zinc deficiency (<a href="./references#CD009666-bbs2-0010" title="TroeschB [pers comm] . Regards and question on Troesch et al 2011. Email to: JP Peña‐Rosas 1 November 2011. TroeschB , vanStuijvenbergME , SmutsCM , KrugerHS , BiebingerR , HurrellRF , et al. A micronutrient powder with low doses of highly absorbable iron and zinc reduces iron and zinc deficiency and improves weight‐for‐age Z‐scores in South African children. Journal of Nutrition2011;141(2):237‐42. [DOI: 10.3945/jn.110.129247; PUBMED: 21178093] ">Troesch 2011b</a>). It found that multiple MNP significantly reduced zinc deficiency (serum zinc less than 6.5 µg/L) compared to no intervention or placebo (RR 0.64, 95% CI 0.45 to 0.93, P = 0.02; see the illustrative forest plot in <a href="./references#CD009666-fig-0052" title="">Analysis 1.48</a>). </p> </section> <section id="CD009666-sec-0130"> <h6 class="title">Vitamin A deficiency: single study results</h6> <p>One study with 481 children reported vitamin A deficiency (serum retinol less than 0.70 µg/L) (<a href="./references#CD009666-bbs2-0011" title="VarmaJL , DasS , SankarR , MannarMG , LevinsonFJ , HamerDH . Community‐level micronutrient fortification of a food supplement in India: a controlled trial in preschool children aged 36‐66 mo. American Journal of Clinical Nutrition2007;85(4):1127‐33. [PUBMED: 17413115] ">Varma 2007 (C)</a>). We were uncertain of effect among children who consumed multiple MNP in comparison with children who received no intervention or placebo (RR 1.31, 95% CI 0.69 to 2.48, P = 0.41; see the illustrative forest plot in <a href="./references#CD009666-fig-0053" title="">Analysis 1.49</a>). </p> </section> <section id="CD009666-sec-0131"> <h6 class="title">Serum folate</h6> <p>Two studies with 329 children reported serum folate (<a href="./references#CD009666-bbs2-0008" title="OseiAK , HouserRF , BulusuS , HamerDH . Acceptability of micronutrient fortified school meals by schoolchildren in rural Himalayan villages of India. Journal of Food Science2008;73(7):S354‐8. [DOI: 10.1111/j.1750‐3841.2008.00878.x; PUBMED: 18803728] OseiAK , RosenbergIH , HouserRF , BulusuS , MathewsM , HamerDH . Community‐level micronutrient fortification of school lunch meals improved vitamin A, folate, and iron status of schoolchildren in Himalayan villages of India. Journal of Nutrition2010;140(6):1146‐54. [DOI: 10.3945/jn.109.114751; PUBMED: 20410083] ">Osei 2008 (C)</a>; <a href="./references#CD009666-bbs2-0012" title="VinodkumarM , RajagopalanS . Impact of a multiple‐micronutrient food supplement on the nutritional status of schoolchildren. Food and Nutrition Bulletin2006;27(3):203‐10. [DOI: 10.1177/156482650602700302; PUBMED: 17542110] ">Vinodkumar 2006 (C)</a>). Children who consumed multiple MNP had higher serum folate concentrations in comparison with children who received no intervention or placebo (MD 2.16 ng/mL, 95% CI 0.76 to 3.56, P = 0.002; Tau<sup>2</sup> = 0.36, Chi<sup>2</sup> = 1.45, I<sup>2</sup> = 31%; <a href="./references#CD009666-fig-0054" title="">Analysis 1.50</a>). </p> </section> <section id="CD009666-sec-0132"> <h6 class="title">Height</h6> <p>Two studies with 182 children reported height (<a href="./references#CD009666-bbs2-0001" title="InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Combined intensive nutrition education and micronutrient powder supplementation improved nutritional status of mildly wasted children on Nias Island, Indonesia. Asia Pacific Journal of Clinical Nutrition2012;21(3):361‐73. [PUBMED: 22705425] InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Improved nutrition knowledge and practice through intensive nutrition education: a study among caregivers of mildly wasted children on Nias Island, Indonesia. Food and Nutrition Bulletin2012;33(2):117‐27. [DOI: 10.1177/156482651203300205; PUBMED: 22908693] PurwestriRC , ScherbaumV , InayatiDA , WirawanNN , SuryantanJ , BloemMA , et al. Supplementary feeding with locally‐produced ready‐to‐use food (RUF) for mildly wasted children on Nias Island, Indonesia: comparison of daily and weekly programme outcomes. Asia Pacific Journal of Clinical Nutrition2012;21(3):374‐9. [PUBMED: 22705426] ScherbaumV [pers comm] . Your paper on MNP. Email to: LM De‐Regil 5 February 2013. ">Inayati 2012 (C)</a>; <a href="./references#CD009666-bbs2-0012" title="VinodkumarM , RajagopalanS . Impact of a multiple‐micronutrient food supplement on the nutritional status of schoolchildren. Food and Nutrition Bulletin2006;27(3):203‐10. [DOI: 10.1177/156482650602700302; PUBMED: 17542110] ">Vinodkumar 2006 (C)</a>). There was no evidence of effect among children who consumed multiple MNP in comparison with children who received no intervention or placebo (MD 0.05 cm, 95% CI ‐3.71 to 3.82, P = 0.98; Tau<sup>2</sup> = 3.45, Chi<sup>2</sup> = 1.86, I<sup>2</sup> = 46%; <a href="./references#CD009666-fig-0055" title="">Analysis 1.51</a>). </p> </section> <section id="CD009666-sec-0133"> <h6 class="title">Weight</h6> <p>Three studies with 313 children reported weight (<a href="./references#CD009666-bbs2-0001" title="InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Combined intensive nutrition education and micronutrient powder supplementation improved nutritional status of mildly wasted children on Nias Island, Indonesia. Asia Pacific Journal of Clinical Nutrition2012;21(3):361‐73. [PUBMED: 22705425] InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Improved nutrition knowledge and practice through intensive nutrition education: a study among caregivers of mildly wasted children on Nias Island, Indonesia. Food and Nutrition Bulletin2012;33(2):117‐27. [DOI: 10.1177/156482651203300205; PUBMED: 22908693] PurwestriRC , ScherbaumV , InayatiDA , WirawanNN , SuryantanJ , BloemMA , et al. Supplementary feeding with locally‐produced ready‐to‐use food (RUF) for mildly wasted children on Nias Island, Indonesia: comparison of daily and weekly programme outcomes. Asia Pacific Journal of Clinical Nutrition2012;21(3):374‐9. [PUBMED: 22705426] ScherbaumV [pers comm] . Your paper on MNP. Email to: LM De‐Regil 5 February 2013. ">Inayati 2012 (C)</a>; <a href="./references#CD009666-bbs2-0006" title="JerlingJ [pers comm] . Regards and question on Ogundale et al 2011 vir Cochrane review. Email to: JP Pena‐Rosas 3 November 2011. OgunladeAO , KrugerHS , JerlingJC , SmutsCM , CovicN , HanekomSM , et al. Point‐of‐use micronutrient fortification: lessons learned in implementing a preschool‐based pilot trial in South Africa. International Journal of Food Sciences and Nutrition2011;62(1):1‐16. [DOI: 10.3109/09637486.2010.495710; PUBMED: 20701549] ">Ogunlade 2011</a>; <a href="./references#CD009666-bbs2-0012" title="VinodkumarM , RajagopalanS . Impact of a multiple‐micronutrient food supplement on the nutritional status of schoolchildren. Food and Nutrition Bulletin2006;27(3):203‐10. [DOI: 10.1177/156482650602700302; PUBMED: 17542110] ">Vinodkumar 2006 (C)</a>). There was no evidence of an effect among children who consumed multiple MNP in comparison with children who received no intervention or placebo (MD ‐0.02 kg, 95% CI ‐0.59 to 0.55, P = 0.94; Tau<sup>2</sup> = 0.00, Chi<sup>2</sup> = 1.85, I<sup>2</sup> = 0%; <a href="./references#CD009666-fig-0056" title="">Analysis 1.52</a>). </p> </section> <section id="CD009666-sec-0134"> <h6 class="title">Fever: single study results</h6> <p>One study with 115 children reported fever (<a href="./references#CD009666-bbs2-0001" title="InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Combined intensive nutrition education and micronutrient powder supplementation improved nutritional status of mildly wasted children on Nias Island, Indonesia. Asia Pacific Journal of Clinical Nutrition2012;21(3):361‐73. [PUBMED: 22705425] InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Improved nutrition knowledge and practice through intensive nutrition education: a study among caregivers of mildly wasted children on Nias Island, Indonesia. Food and Nutrition Bulletin2012;33(2):117‐27. [DOI: 10.1177/156482651203300205; PUBMED: 22908693] PurwestriRC , ScherbaumV , InayatiDA , WirawanNN , SuryantanJ , BloemMA , et al. Supplementary feeding with locally‐produced ready‐to‐use food (RUF) for mildly wasted children on Nias Island, Indonesia: comparison of daily and weekly programme outcomes. Asia Pacific Journal of Clinical Nutrition2012;21(3):374‐9. [PUBMED: 22705426] ScherbaumV [pers comm] . Your paper on MNP. Email to: LM De‐Regil 5 February 2013. ">Inayati 2012 (C)</a>). We were uncertain of any effect among children who consumed multiple MNP in comparison with children who received no intervention or placebo (RR 0.82, 95% CI 0.45 to 1.48, P = 0.50; <a href="./references#CD009666-fig-0057" title="">Analysis 1.53</a>). </p> </section> <section id="CD009666-sec-0135"> <h6 class="title">Stunting</h6> <p>Two studies with 654 children reported stunting (HAZ‐2 SD) (<a href="./references#CD009666-bbs2-0002" title="KemmerTM , OmerPS , Gidvani‐DiazVK , CoelloM . Acceptance and effect of ferrous fumarate containing micronutrient sprinkles on anemia, iron deficiency and anthropometrics in Honduran children. In: SilverbergDS editor(s). Anemia. Rijeka (Croatia): InTech, 2012. [DOI: 10.5772/30987] ">Kemmer 2012 (C)</a>; <a href="./references#CD009666-bbs2-0008" title="OseiAK , HouserRF , BulusuS , HamerDH . Acceptability of micronutrient fortified school meals by schoolchildren in rural Himalayan villages of India. Journal of Food Science2008;73(7):S354‐8. [DOI: 10.1111/j.1750‐3841.2008.00878.x; PUBMED: 18803728] OseiAK , RosenbergIH , HouserRF , BulusuS , MathewsM , HamerDH . Community‐level micronutrient fortification of school lunch meals improved vitamin A, folate, and iron status of schoolchildren in Himalayan villages of India. Journal of Nutrition2010;140(6):1146‐54. [DOI: 10.3945/jn.109.114751; PUBMED: 20410083] ">Osei 2008 (C)</a>). There was no evidence of an effect among children who consumed multiple MNP in comparison with children who received no intervention or placebo (RR 0.91, 95% CI 0.66 to 1.25, P = 0.56; Tau<sup>2</sup> = 0.04, Chi<sup>2</sup> = 3.90, I<sup>2</sup> = 74%; <a href="./references#CD009666-fig-0058" title="">Analysis 1.54</a>). </p> </section> <section id="CD009666-sec-0136"> <h6 class="title">Angular stomatitis</h6> <p>Two studies with 236 children reported angular stomatitis (<a href="./references#CD009666-bbs2-0012" title="VinodkumarM , RajagopalanS . Impact of a multiple‐micronutrient food supplement on the nutritional status of schoolchildren. Food and Nutrition Bulletin2006;27(3):203‐10. [DOI: 10.1177/156482650602700302; PUBMED: 17542110] ">Vinodkumar 2006 (C)</a>; <a href="./references#CD009666-bbs2-0013" title="VinodkumarM , RajagopalanS . Efficacy of fortification of school meals with ferrous glycine phosphate and riboflavin against anemia and angular stomatitis in schoolchildren. Food and Nutrition Bulletin2009;30(3):260‐4. [DOI: 10.1177/156482650903000307; PUBMED: 19927606] ">Vinodkumar 2009 (C)</a>). Children who received placebo had a higher risk of having angular stomatitis compared with children who received multiple MNP (RR 0.04, 95% CI 0.01 to 0.29, P = 0.001; Tau<sup>2</sup> = 0.00, Chi<sup>2</sup> = 0.39, I<sup>2</sup> = 0%; <a href="./references#CD009666-fig-0059" title="">Analysis 1.55</a>). </p> </section> </section> </section> <section id="CD009666-sec-0137"> <h4 class="title">Comparison 2. Point‐of‐use fortification of foods with MNP versus iron‐only supplement</h4> <p>We found no trials comparing point‐of‐use fortification of foods with MNP versus iron‐only supplement. </p> </section> <section id="CD009666-sec-0138"> <h4 class="title">Comparison 3. Point‐of‐use fortification of foods with MNP versus iron and folic acid supplements </h4> <p>We found no trials comparing point‐of‐use fortification of foods with MNP versus iron and folic acid supplements. </p> </section> <section id="CD009666-sec-0139"> <h4 class="title">Comparison 4. Point‐of‐use fortification of foods with MNP versus same micronutrients in supplements </h4> <p>We found no trials comparing point‐of‐use fortification of foods with MNP versus same micronutrients in supplements. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD009666-sec-0140" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD009666-sec-0140"></div> <section id="CD009666-sec-0141"> <h3 class="title" id="CD009666-sec-0141">Summary of main results</h3> <p>We included 13 trials, involving 5810 participants from nine countries in Latin America, Africa and Asia, in this review. We excluded 38 trials and six trials are ongoing or are unpublished. All trials assessed the provision of MNP for point‐of‐use fortification to no intervention or placebo. None of the trials evaluated the other comparisons of interest. </p> <p>The sample sizes in the included trials ranged from 90 to 2193 participants. The age range of the participants was six months to 15 years. Six trials included participants aged six to 59 months, four included children aged 60 months or older and three trials included children both younger and older than 59 months of age. Two trials did not report the sex of the participants. The composition of the MNP in the trials varied: three trials used a formulation with 14 vitamins and minerals, two trials used a formulation with six vitamin and minerals, and the other eight trials provided MNP with different formulations ranging from two to 18 vitamins and minerals. </p> <p>The iron compound and dose also varied in the included trials: one trial provided 30 mg of elemental iron, one trial provided 28 mg of elemental iron, one trial provided 14 mg of elemental iron, three trials provided 12.5 mg of elemental iron, four trials provided 10 mg of elemental iron, one trial provided 2.86 mg of elemental iron and two trials provided 2.5 mg of elemental iron. Seven trials used encapsulated ferrous fumarate (<a href="./references#CD009666-bbs2-0001" title="InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Combined intensive nutrition education and micronutrient powder supplementation improved nutritional status of mildly wasted children on Nias Island, Indonesia. Asia Pacific Journal of Clinical Nutrition2012;21(3):361‐73. [PUBMED: 22705425] InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Improved nutrition knowledge and practice through intensive nutrition education: a study among caregivers of mildly wasted children on Nias Island, Indonesia. Food and Nutrition Bulletin2012;33(2):117‐27. [DOI: 10.1177/156482651203300205; PUBMED: 22908693] PurwestriRC , ScherbaumV , InayatiDA , WirawanNN , SuryantanJ , BloemMA , et al. Supplementary feeding with locally‐produced ready‐to‐use food (RUF) for mildly wasted children on Nias Island, Indonesia: comparison of daily and weekly programme outcomes. Asia Pacific Journal of Clinical Nutrition2012;21(3):374‐9. [PUBMED: 22705426] ScherbaumV [pers comm] . Your paper on MNP. Email to: LM De‐Regil 5 February 2013. ">Inayati 2012 (C)</a>; <a href="./references#CD009666-bbs2-0002" title="KemmerTM , OmerPS , Gidvani‐DiazVK , CoelloM . Acceptance and effect of ferrous fumarate containing micronutrient sprinkles on anemia, iron deficiency and anthropometrics in Honduran children. In: SilverbergDS editor(s). Anemia. Rijeka (Croatia): InTech, 2012. [DOI: 10.5772/30987] ">Kemmer 2012 (C)</a>; <a href="./references#CD009666-bbs2-0003" title="KounnavongS , SunaharaT , Mascie‐TaylorCG , HashizumeM , OkumuraJ , MojiK , et al. Effect of daily versus weekly home fortification with multiple micronutrient powder on haemoglobin concentration of young children in a rural area, Lao People's Democratic Republic: a randomised trial. Nutrition Journal2011;10(129):1‐11. [DOI: 10.1186/1475‐2891‐10‐129; PMC3266642; PUBMED: 22111770] ">Kounnavong 2011 (C)</a>; <a href="./references#CD009666-bbs2-0004" title="LundeenE [pers comm] . Kyrgyz Republic MNP data for children 24‐36 months. Email to: M Jefferds 3 November 2011. LundeenE , SchuethT , ToktobaevN , ZlotkinS , HyderSM , HouserR . Daily use of Sprinkles micronutrient powder for 2 months reduces anemia among children 6 to 36 months of age in the Kyrgyz Republic: a cluster‐randomized trial. Food and Nutrition Bulletin2010;31(3):446‐60. [DOI: 10.1177/156482651003100307; PUBMED: 20973465] ">Lundeen 2010 (C)</a>, <a href="./references#CD009666-bbs2-0007" title="OrozcoJ , VargasC , RojasML , HerreraAM , MontoyaL , SánchezJG , et al. The effect of powdered micronutrients on the hematologic values and nutritional status of healthy preschoolers. Medellín, 2013 [Efecto de los micronutrientes en polvo en el estado nutricional y en los valores hemáticos de preescolares sanos. Medellín, 2013]. Revista Facultad Nacional de Salud Pública2015;33(2):161‐70. [DOI: 10.17533/udea.rfnsp.v33n2a03] ">Orozco 2015 (C)</a>, <a href="./references#CD009666-bbs2-0009" title="SharieffW , YinSA , WuM , YangQ , SchauerC , TomlinsonG , et al. Short‐term daily or weekly administration of micronutrient Sprinkles has high compliance and does not cause iron overload in Chinese schoolchildren: a cluster‐randomized trial. Public Health Nutrition2006;9(3):336‐44. [PUBMED: 16684385] ZlotkinS [pers comm] . Regards and question ‐ Sharieff 2006. Email to: JP Peña‐Rosas 2 November 2011. ">Sharieff 2006 (C)</a>, <a href="./references#CD009666-bbs2-0011" title="VarmaJL , DasS , SankarR , MannarMG , LevinsonFJ , HamerDH . Community‐level micronutrient fortification of a food supplement in India: a controlled trial in preschool children aged 36‐66 mo. American Journal of Clinical Nutrition2007;85(4):1127‐33. [PUBMED: 17413115] ">Varma 2007 (C)</a>); four trials used iron as NaFeEDTA (<a href="./references#CD009666-bbs2-0005" title="Macharia‐MutieCW , MorettiD , Van denBrielN , OmusundiAM , MwangiAM , KokFJ , et al. Maize porridge enriched with a micronutrient powder containing low‐dose iron as NaFeEDTA but not amaranth grain flour reduces anemia and iron deficiency in Kenyan preschool children. Journal of Nutrition2012;142(9):1756‐63. [DOI: 10.3945/jn.112.157578; PUBMED: 22810982] Macharia‐MutieCW , OmusundiAM , MwaiJM , MwangiAM , BrouwerID . Simulation of the effect of maize porridge fortified with grain amaranth or micronutrient powder containing NaFeEDTA on iron intake and status in Kenyan children. Public Health Nutrition2013;16(9):1605‐13. [DOI: 10.1017/S1368980012005174; PUBMED: 23218415] ">Macharia‐Mutie 2012</a>; <a href="./references#CD009666-bbs2-0006" title="JerlingJ [pers comm] . Regards and question on Ogundale et al 2011 vir Cochrane review. Email to: JP Pena‐Rosas 3 November 2011. OgunladeAO , KrugerHS , JerlingJC , SmutsCM , CovicN , HanekomSM , et al. Point‐of‐use micronutrient fortification: lessons learned in implementing a preschool‐based pilot trial in South Africa. International Journal of Food Sciences and Nutrition2011;62(1):1‐16. [DOI: 10.3109/09637486.2010.495710; PUBMED: 20701549] ">Ogunlade 2011</a>, <a href="./references#CD009666-bbs2-0008" title="OseiAK , HouserRF , BulusuS , HamerDH . Acceptability of micronutrient fortified school meals by schoolchildren in rural Himalayan villages of India. Journal of Food Science2008;73(7):S354‐8. [DOI: 10.1111/j.1750‐3841.2008.00878.x; PUBMED: 18803728] OseiAK , RosenbergIH , HouserRF , BulusuS , MathewsM , HamerDH . Community‐level micronutrient fortification of school lunch meals improved vitamin A, folate, and iron status of schoolchildren in Himalayan villages of India. Journal of Nutrition2010;140(6):1146‐54. [DOI: 10.3945/jn.109.114751; PUBMED: 20410083] ">Osei 2008 (C)</a>, <a href="./references#CD009666-bbs2-0010" title="TroeschB [pers comm] . Regards and question on Troesch et al 2011. Email to: JP Peña‐Rosas 1 November 2011. TroeschB , vanStuijvenbergME , SmutsCM , KrugerHS , BiebingerR , HurrellRF , et al. A micronutrient powder with low doses of highly absorbable iron and zinc reduces iron and zinc deficiency and improves weight‐for‐age Z‐scores in South African children. Journal of Nutrition2011;141(2):237‐42. [DOI: 10.3945/jn.110.129247; PUBMED: 21178093] ">Troesch 2011b</a>), one trial used chelated ferrous sulphate (<a href="./references#CD009666-bbs2-0012" title="VinodkumarM , RajagopalanS . Impact of a multiple‐micronutrient food supplement on the nutritional status of schoolchildren. Food and Nutrition Bulletin2006;27(3):203‐10. [DOI: 10.1177/156482650602700302; PUBMED: 17542110] ">Vinodkumar 2006 (C)</a>), one trial used ferrous glycine phosphate (<a href="./references#CD009666-bbs2-0013" title="VinodkumarM , RajagopalanS . Efficacy of fortification of school meals with ferrous glycine phosphate and riboflavin against anemia and angular stomatitis in schoolchildren. Food and Nutrition Bulletin2009;30(3):260‐4. [DOI: 10.1177/156482650903000307; PUBMED: 19927606] ">Vinodkumar 2009 (C)</a>). </p> <p>In comparison with receiving no intervention or placebo, children receiving iron‐containing MNP for point‐of‐use fortification of foods had a lower risk of anaemia and iron deficiency and a higher Hb concentration. We were unable to ascertain any effect on all‐cause mortality, as only one study with no reported deaths contributed data for this outcome. Two trials reported diarrhoea, with mixed results. </p> <p>Nine of the 13 trials reported that participants had mixed anaemia status at baseline; this limited our ability to examine risk among non‐anaemic or anaemic populations. The effect on anaemia did not vary significantly by age of participants at the start of the intervention, frequency of provision or duration of intervention. There appears to be differences in the subgroups by the number of additional nutrients added, although the effect differed by the malaria risk in the trial setting, iron compound and iron content in the formulation. The magnitude of effects on Hb concentrations differed according to the frequency of the intervention, type of iron compound and number of nutrients, although heterogeneity in the subgroups was high. </p> <p>As no included trials compared MNP to iron supplementation, which is the standard of care, we were unable to examine whether MNPs were as efficacious or safer than iron supplements (as drops, tablets or syrup). </p> </section> <section id="CD009666-sec-0142"> <h3 class="title" id="CD009666-sec-0142">Overall completeness and applicability of evidence</h3> <p>This review included 13 trials with 5810 children and all the trials were published after 2005. We only included RCTs and quasi‐RCTs in this review. This may have limited the inclusion of programme evaluation trials without control groups, which could have potentially provided additional evidence about the effectiveness of this intervention in programme settings (<a href="./references#CD009666-bbs2-0083" title="HirveS , MartiniE , JuvekarSK , AgarwalD , BavdekarA , SariM , et al. Delivering Sprinkles Plus through the integrated child development services (ICDS) to reduce anemia in pre‐school children in India. Indian Journal of Pediatrics2013;80(12):990‐5. [DOI: 10.1007/s12098‐013‐1063‐2; PUBMED: 23723079] ">Hirve 2013</a>; <a href="./references#CD009666-bbs2-0129" title="World VisionMongolia . Effectiveness of home‐based fortification with Sprinkles in an integrated nutrition program to address rickets and anemia. Ulaanbaatar, Mongolia: World Vision Mongolia2005. ">World Vision Mongolia 2005</a>). The included trials only examined MNP versus no intervention or placebo and did not examine other comparisons of interest, including MNP versus iron‐only supplements, versus iron and folic acid supplements and versus the same micronutrients in supplements. The current review cannot compare the efficacy, adherence or adverse effects for these three interventions, which may be important for decision‐making by country programme managers and policy makers. The lack of trials comparing MNP to iron‐containing supplements is an important gap, as existing WHO guidelines currently recommend either daily or intermittent supplementation with iron for children younger than 12 years of age (<a href="./references#CD009666-bbs2-0116" title="World Health Organization. Iron Deficiency Anaemia Assessment Prevention and Control: a Guide for Programme Managers. Geneva (Switzerland): World Health Organization, 2001:132. ">WHO 2001</a>; <a href="./references#CD009666-bbs2-0122" title="World Health Organization. Guideline: intermittent iron supplementation in preschool and school‐age children. Geneva (Switzerland): World Health Organization, 2011. ">WHO 2011c</a>), and researchers suggest that MNP consumed with food is safer than iron supplements (<a href="./references#CD009666-bbs2-0085" title="HurrellR . Iron and malaria: absorption, efficacy and safety. International Journal of Vitamin Nutrition Research2010;80(4‐5):279‐92. [DOI: 10.1024/0300‐9831/a000035; PUBMED: 21462111] ">Hurrell 2010</a>). With the exception of anaemia, Hb and iron status outcomes, there were insufficient trials to examine most of the primary and secondary outcomes of interest and by subgroups. </p> <p>Eight of the 13 trials took place in Asia (<a href="./references#CD009666-bbs2-0001" title="InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Combined intensive nutrition education and micronutrient powder supplementation improved nutritional status of mildly wasted children on Nias Island, Indonesia. Asia Pacific Journal of Clinical Nutrition2012;21(3):361‐73. [PUBMED: 22705425] InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Improved nutrition knowledge and practice through intensive nutrition education: a study among caregivers of mildly wasted children on Nias Island, Indonesia. Food and Nutrition Bulletin2012;33(2):117‐27. [DOI: 10.1177/156482651203300205; PUBMED: 22908693] PurwestriRC , ScherbaumV , InayatiDA , WirawanNN , SuryantanJ , BloemMA , et al. Supplementary feeding with locally‐produced ready‐to‐use food (RUF) for mildly wasted children on Nias Island, Indonesia: comparison of daily and weekly programme outcomes. Asia Pacific Journal of Clinical Nutrition2012;21(3):374‐9. [PUBMED: 22705426] ScherbaumV [pers comm] . Your paper on MNP. Email to: LM De‐Regil 5 February 2013. ">Inayati 2012 (C)</a>; <a href="./references#CD009666-bbs2-0003" title="KounnavongS , SunaharaT , Mascie‐TaylorCG , HashizumeM , OkumuraJ , MojiK , et al. Effect of daily versus weekly home fortification with multiple micronutrient powder on haemoglobin concentration of young children in a rural area, Lao People's Democratic Republic: a randomised trial. Nutrition Journal2011;10(129):1‐11. [DOI: 10.1186/1475‐2891‐10‐129; PMC3266642; PUBMED: 22111770] ">Kounnavong 2011 (C)</a>; <a href="./references#CD009666-bbs2-0004" title="LundeenE [pers comm] . Kyrgyz Republic MNP data for children 24‐36 months. Email to: M Jefferds 3 November 2011. LundeenE , SchuethT , ToktobaevN , ZlotkinS , HyderSM , HouserR . Daily use of Sprinkles micronutrient powder for 2 months reduces anemia among children 6 to 36 months of age in the Kyrgyz Republic: a cluster‐randomized trial. Food and Nutrition Bulletin2010;31(3):446‐60. [DOI: 10.1177/156482651003100307; PUBMED: 20973465] ">Lundeen 2010 (C)</a>; <a href="./references#CD009666-bbs2-0008" title="OseiAK , HouserRF , BulusuS , HamerDH . Acceptability of micronutrient fortified school meals by schoolchildren in rural Himalayan villages of India. Journal of Food Science2008;73(7):S354‐8. [DOI: 10.1111/j.1750‐3841.2008.00878.x; PUBMED: 18803728] OseiAK , RosenbergIH , HouserRF , BulusuS , MathewsM , HamerDH . Community‐level micronutrient fortification of school lunch meals improved vitamin A, folate, and iron status of schoolchildren in Himalayan villages of India. Journal of Nutrition2010;140(6):1146‐54. [DOI: 10.3945/jn.109.114751; PUBMED: 20410083] ">Osei 2008 (C)</a>; <a href="./references#CD009666-bbs2-0009" title="SharieffW , YinSA , WuM , YangQ , SchauerC , TomlinsonG , et al. Short‐term daily or weekly administration of micronutrient Sprinkles has high compliance and does not cause iron overload in Chinese schoolchildren: a cluster‐randomized trial. Public Health Nutrition2006;9(3):336‐44. [PUBMED: 16684385] ZlotkinS [pers comm] . Regards and question ‐ Sharieff 2006. Email to: JP Peña‐Rosas 2 November 2011. ">Sharieff 2006 (C)</a>; <a href="./references#CD009666-bbs2-0011" title="VarmaJL , DasS , SankarR , MannarMG , LevinsonFJ , HamerDH . Community‐level micronutrient fortification of a food supplement in India: a controlled trial in preschool children aged 36‐66 mo. American Journal of Clinical Nutrition2007;85(4):1127‐33. [PUBMED: 17413115] ">Varma 2007 (C)</a>; <a href="./references#CD009666-bbs2-0012" title="VinodkumarM , RajagopalanS . Impact of a multiple‐micronutrient food supplement on the nutritional status of schoolchildren. Food and Nutrition Bulletin2006;27(3):203‐10. [DOI: 10.1177/156482650602700302; PUBMED: 17542110] ">Vinodkumar 2006 (C)</a>; <a href="./references#CD009666-bbs2-0013" title="VinodkumarM , RajagopalanS . Efficacy of fortification of school meals with ferrous glycine phosphate and riboflavin against anemia and angular stomatitis in schoolchildren. Food and Nutrition Bulletin2009;30(3):260‐4. [DOI: 10.1177/156482650903000307; PUBMED: 19927606] ">Vinodkumar 2009 (C)</a>), three in Africa (<a href="./references#CD009666-bbs2-0005" title="Macharia‐MutieCW , MorettiD , Van denBrielN , OmusundiAM , MwangiAM , KokFJ , et al. Maize porridge enriched with a micronutrient powder containing low‐dose iron as NaFeEDTA but not amaranth grain flour reduces anemia and iron deficiency in Kenyan preschool children. Journal of Nutrition2012;142(9):1756‐63. [DOI: 10.3945/jn.112.157578; PUBMED: 22810982] Macharia‐MutieCW , OmusundiAM , MwaiJM , MwangiAM , BrouwerID . Simulation of the effect of maize porridge fortified with grain amaranth or micronutrient powder containing NaFeEDTA on iron intake and status in Kenyan children. Public Health Nutrition2013;16(9):1605‐13. [DOI: 10.1017/S1368980012005174; PUBMED: 23218415] ">Macharia‐Mutie 2012</a>; <a href="./references#CD009666-bbs2-0006" title="JerlingJ [pers comm] . Regards and question on Ogundale et al 2011 vir Cochrane review. Email to: JP Pena‐Rosas 3 November 2011. OgunladeAO , KrugerHS , JerlingJC , SmutsCM , CovicN , HanekomSM , et al. Point‐of‐use micronutrient fortification: lessons learned in implementing a preschool‐based pilot trial in South Africa. International Journal of Food Sciences and Nutrition2011;62(1):1‐16. [DOI: 10.3109/09637486.2010.495710; PUBMED: 20701549] ">Ogunlade 2011</a>; <a href="./references#CD009666-bbs2-0010" title="TroeschB [pers comm] . Regards and question on Troesch et al 2011. Email to: JP Peña‐Rosas 1 November 2011. TroeschB , vanStuijvenbergME , SmutsCM , KrugerHS , BiebingerR , HurrellRF , et al. A micronutrient powder with low doses of highly absorbable iron and zinc reduces iron and zinc deficiency and improves weight‐for‐age Z‐scores in South African children. Journal of Nutrition2011;141(2):237‐42. [DOI: 10.3945/jn.110.129247; PUBMED: 21178093] ">Troesch 2011b</a>), and two in Latin America and the Caribbean (<a href="./references#CD009666-bbs2-0002" title="KemmerTM , OmerPS , Gidvani‐DiazVK , CoelloM . Acceptance and effect of ferrous fumarate containing micronutrient sprinkles on anemia, iron deficiency and anthropometrics in Honduran children. In: SilverbergDS editor(s). Anemia. Rijeka (Croatia): InTech, 2012. [DOI: 10.5772/30987] ">Kemmer 2012 (C)</a>; <a href="./references#CD009666-bbs2-0007" title="OrozcoJ , VargasC , RojasML , HerreraAM , MontoyaL , SánchezJG , et al. The effect of powdered micronutrients on the hematologic values and nutritional status of healthy preschoolers. Medellín, 2013 [Efecto de los micronutrientes en polvo en el estado nutricional y en los valores hemáticos de preescolares sanos. Medellín, 2013]. Revista Facultad Nacional de Salud Pública2015;33(2):161‐70. [DOI: 10.17533/udea.rfnsp.v33n2a03] ">Orozco 2015 (C)</a>). A 2011 global assessment of home fortification interventions identified 14 projects currently distributing MNP in Latin America and the Caribbean, including five programmes delivering MNP through early childhood development (ECD) centres (<a href="./references#CD009666-bbs2-0113" title="UNICEF/CDC . Global Assessment of Home Fortification Interventions 2011. Geneva (Switzerland): Home Fortification Technical Advisory Group, 2013. ">UNICEF/CDC 2013</a>), but no trials included in this review were from ECD or school settings in Latin America and the Caribbean. Furthermore, none of the 13 trials took place in high‐income countries, and it is unknown if the results of trials would differ in high‐income countries. One trial conducted in the US among low‐income infants aged five to seven months documented lower intake adherence with MNP compared to iron drops (<a href="./references#CD009666-bbs2-0021" title="GeltmanPL , HironakaLK , MehtaSD , PadillaP , RodriguesP , MeyersAF , et al. Iron supplementation of low‐income infants: a randomized clinical trial of adherence with ferrous fumarate sprinkles versus ferrous sulfate drops. Journal of Pediatrics2009;154(5):738‐43. ">Geltman 2009</a>; excluded as age range outside the scope of this review). </p> <p>Most trials included both boys and girls. Some of the trials included children younger than 24 months of age. One trial provided the original data sets so the information included in this review could be limited to the participants aged 24 months or older (<a href="./references#CD009666-bbs2-0004" title="LundeenE [pers comm] . Kyrgyz Republic MNP data for children 24‐36 months. Email to: M Jefferds 3 November 2011. LundeenE , SchuethT , ToktobaevN , ZlotkinS , HyderSM , HouserR . Daily use of Sprinkles micronutrient powder for 2 months reduces anemia among children 6 to 36 months of age in the Kyrgyz Republic: a cluster‐randomized trial. Food and Nutrition Bulletin2010;31(3):446‐60. [DOI: 10.1177/156482651003100307; PUBMED: 20973465] ">Lundeen 2010 (C)</a>), but other trials were included because at least 50% of the sample was older than 24 months of age (<a href="./references#CD009666-bbs2-0001" title="InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Combined intensive nutrition education and micronutrient powder supplementation improved nutritional status of mildly wasted children on Nias Island, Indonesia. Asia Pacific Journal of Clinical Nutrition2012;21(3):361‐73. [PUBMED: 22705425] InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Improved nutrition knowledge and practice through intensive nutrition education: a study among caregivers of mildly wasted children on Nias Island, Indonesia. Food and Nutrition Bulletin2012;33(2):117‐27. [DOI: 10.1177/156482651203300205; PUBMED: 22908693] PurwestriRC , ScherbaumV , InayatiDA , WirawanNN , SuryantanJ , BloemMA , et al. Supplementary feeding with locally‐produced ready‐to‐use food (RUF) for mildly wasted children on Nias Island, Indonesia: comparison of daily and weekly programme outcomes. Asia Pacific Journal of Clinical Nutrition2012;21(3):374‐9. [PUBMED: 22705426] ScherbaumV [pers comm] . Your paper on MNP. Email to: LM De‐Regil 5 February 2013. ">Inayati 2012 (C)</a>; <a href="./references#CD009666-bbs2-0003" title="KounnavongS , SunaharaT , Mascie‐TaylorCG , HashizumeM , OkumuraJ , MojiK , et al. Effect of daily versus weekly home fortification with multiple micronutrient powder on haemoglobin concentration of young children in a rural area, Lao People's Democratic Republic: a randomised trial. Nutrition Journal2011;10(129):1‐11. [DOI: 10.1186/1475‐2891‐10‐129; PMC3266642; PUBMED: 22111770] ">Kounnavong 2011 (C)</a>; <a href="./references#CD009666-bbs2-0005" title="Macharia‐MutieCW , MorettiD , Van denBrielN , OmusundiAM , MwangiAM , KokFJ , et al. Maize porridge enriched with a micronutrient powder containing low‐dose iron as NaFeEDTA but not amaranth grain flour reduces anemia and iron deficiency in Kenyan preschool children. Journal of Nutrition2012;142(9):1756‐63. [DOI: 10.3945/jn.112.157578; PUBMED: 22810982] Macharia‐MutieCW , OmusundiAM , MwaiJM , MwangiAM , BrouwerID . Simulation of the effect of maize porridge fortified with grain amaranth or micronutrient powder containing NaFeEDTA on iron intake and status in Kenyan children. Public Health Nutrition2013;16(9):1605‐13. [DOI: 10.1017/S1368980012005174; PUBMED: 23218415] ">Macharia‐Mutie 2012</a>). As the prevalence of anaemia, and iron and other micronutrient deficiencies tend to be higher among children younger than 24 months compared to children older than 24 months, and there is typically an inverse relationship between deficiency and response to treatment, the inclusion of these younger children in the review might suggest a stronger effect of MNP programmes than would occur in programme settings with older children. </p> <p>One trial excluded anaemic participants at baseline (<a href="./references#CD009666-bbs2-0002" title="KemmerTM , OmerPS , Gidvani‐DiazVK , CoelloM . Acceptance and effect of ferrous fumarate containing micronutrient sprinkles on anemia, iron deficiency and anthropometrics in Honduran children. In: SilverbergDS editor(s). Anemia. Rijeka (Croatia): InTech, 2012. [DOI: 10.5772/30987] ">Kemmer 2012 (C)</a>) and two trials did not report anaemia prevalence at baseline (<a href="./references#CD009666-bbs2-0009" title="SharieffW , YinSA , WuM , YangQ , SchauerC , TomlinsonG , et al. Short‐term daily or weekly administration of micronutrient Sprinkles has high compliance and does not cause iron overload in Chinese schoolchildren: a cluster‐randomized trial. Public Health Nutrition2006;9(3):336‐44. [PUBMED: 16684385] ZlotkinS [pers comm] . Regards and question ‐ Sharieff 2006. Email to: JP Peña‐Rosas 2 November 2011. ">Sharieff 2006 (C)</a>; <a href="./references#CD009666-bbs2-0012" title="VinodkumarM , RajagopalanS . Impact of a multiple‐micronutrient food supplement on the nutritional status of schoolchildren. Food and Nutrition Bulletin2006;27(3):203‐10. [DOI: 10.1177/156482650602700302; PUBMED: 17542110] ">Vinodkumar 2006 (C)</a>). All other trials included populations with different anaemia prevalence ranging from 7.25% to 92.1% across trials (or arms) at baseline. The predominance of trials with mixed anaemia status at baseline makes it impossible to examine risk among non‐anaemic populations or anaemic populations, and thus we cannot assess the efficacy of MNP with iron for the prevention or treatment of anaemia, exclusively. </p> <p>For implementation projects or programmes, MNP are delivered to participants using multiple distribution platforms, including health systems through routine services and scheduled health facility events, community‐based distribution, general food distribution, ECD centre meals, school meals and market‐based approaches (<a href="./references#CD009666-bbs2-0113" title="UNICEF/CDC . Global Assessment of Home Fortification Interventions 2011. Geneva (Switzerland): Home Fortification Technical Advisory Group, 2013. ">UNICEF/CDC 2013</a>). The 13 trials in this review also used multiple approaches to deliver MNP, including distributions through schools, feeding centres and communities, although these did not reflect all the delivery platforms currently in use in some settings. Nine of the trials were delivered through institutional settings (schools and a feeding centre), and with one exception (<a href="./references#CD009666-bbs2-0009" title="SharieffW , YinSA , WuM , YangQ , SchauerC , TomlinsonG , et al. Short‐term daily or weekly administration of micronutrient Sprinkles has high compliance and does not cause iron overload in Chinese schoolchildren: a cluster‐randomized trial. Public Health Nutrition2006;9(3):336‐44. [PUBMED: 16684385] ZlotkinS [pers comm] . Regards and question ‐ Sharieff 2006. Email to: JP Peña‐Rosas 2 November 2011. ">Sharieff 2006 (C)</a>), the MNP was added at a central level to the meals prior to serving them to the children. This provides evidence for the emerging use of MNP in settings where the caretakers or participants do not necessarily have an active role in the point‐of‐use fortification, with preparing and adding the MNP to food prior to consumption, which could result in higher micronutrient intakes among children who regularly attend these institutions. Increased intake adherence and lower adverse effects are two of the proposed benefits for the use of MNP instead of iron supplements, but trials did not report adherence and adverse effects consistently and some trials did not report them. Lack of information about adverse effects and potential morbidities is an important gap, as some studies have suggested a small but significant increase in the incidence of diarrhoea with MNP intake among very young children (<a href="./references#CD009666-bbs2-0042" title="SoofiS , CousensS , IqbalSP , AkhundT , KhanJ , AhmedI , et al. Effect of provision of daily zinc and iron with several micronutrients on growth and morbidity among young children in Pakistan: a cluster‐randomised trial. Lancet2013;382(9886):29‐40. [DOI: 10.1016/S0140‐6736(13)60437‐7; PUBMED: 23602230] ">Soofi 2013</a>), and documented changes in the gut microbiome among Kenyan children aged six months consuming MNP with iron (<a href="./references#CD009666-bbs2-0027" title="Barth‐JaeggiT , MorettiD , KvalsvigJ , HoldingPA , NjengaJ , MwangiA , et al. In‐home fortification with 2.5 mg iron as NaFeEDTA does not reduce anaemia but increases weight gain: a randomised controlled trial in Kenyan infants. Maternal &amp; Child Nutrition2015;11(Suppl 4):151‐62. [DOI: 10.1111/mcn.12163; PUBMED: 25420455] JaeggiT , KortmanGA , MorettiD , ChassardC , HoldingP , DostalA , et al. Iron fortification adversely affects the gut microbiome, increases pathogen abundance and induces intestinal inflammation in Kenyan infants. Gut2015;64(5):731‐42. [DOI: 10.1136/gutjnl‐2014‐307720; PUBMED: 25143342] ZimmermannM , KvalsvigJ . Changes in microbiota and iron status after iron fortification of complementary foods. clinicaltrials.gov/ct2/show/NCT01111864 Date first received: 23 April 2010. ">Jaeggi 2015</a>). </p> <p>Most of the 13 trials distributed MNP for daily intake (or daily when school was in session). The exceptions involved two trials with arms recommending intake twice a week (<a href="./references#CD009666-bbs2-0003" title="KounnavongS , SunaharaT , Mascie‐TaylorCG , HashizumeM , OkumuraJ , MojiK , et al. Effect of daily versus weekly home fortification with multiple micronutrient powder on haemoglobin concentration of young children in a rural area, Lao People's Democratic Republic: a randomised trial. Nutrition Journal2011;10(129):1‐11. [DOI: 10.1186/1475‐2891‐10‐129; PMC3266642; PUBMED: 22111770] ">Kounnavong 2011 (C)</a>) or weekly (<a href="./references#CD009666-bbs2-0009" title="SharieffW , YinSA , WuM , YangQ , SchauerC , TomlinsonG , et al. Short‐term daily or weekly administration of micronutrient Sprinkles has high compliance and does not cause iron overload in Chinese schoolchildren: a cluster‐randomized trial. Public Health Nutrition2006;9(3):336‐44. [PUBMED: 16684385] ZlotkinS [pers comm] . Regards and question ‐ Sharieff 2006. Email to: JP Peña‐Rosas 2 November 2011. ">Sharieff 2006 (C)</a>). Other micronutrient intake schedules reported in projects include every other day, five days a week and flexible intake (with no suggested intake schedule other than no more than one dose a day and consuming all the MNP within a specific time frame) (<a href="./references#CD009666-bbs2-0113" title="UNICEF/CDC . Global Assessment of Home Fortification Interventions 2011. Geneva (Switzerland): Home Fortification Technical Advisory Group, 2013. ">UNICEF/CDC 2013</a>). The micronutrient formulation, quantity of iron and iron compound varied across the 13 trials. The number of nutrients included in MNP formulations across the trials ranged from two to 18. One trial also included amylase‐rich, light malted barley flour with the micronutrient mix (<a href="./references#CD009666-bbs2-0006" title="JerlingJ [pers comm] . Regards and question on Ogundale et al 2011 vir Cochrane review. Email to: JP Pena‐Rosas 3 November 2011. OgunladeAO , KrugerHS , JerlingJC , SmutsCM , CovicN , HanekomSM , et al. Point‐of‐use micronutrient fortification: lessons learned in implementing a preschool‐based pilot trial in South Africa. International Journal of Food Sciences and Nutrition2011;62(1):1‐16. [DOI: 10.3109/09637486.2010.495710; PUBMED: 20701549] ">Ogunlade 2011</a>), and one trial included phytase (<a href="./references#CD009666-bbs2-0010" title="TroeschB [pers comm] . Regards and question on Troesch et al 2011. Email to: JP Peña‐Rosas 1 November 2011. TroeschB , vanStuijvenbergME , SmutsCM , KrugerHS , BiebingerR , HurrellRF , et al. A micronutrient powder with low doses of highly absorbable iron and zinc reduces iron and zinc deficiency and improves weight‐for‐age Z‐scores in South African children. Journal of Nutrition2011;141(2):237‐42. [DOI: 10.3945/jn.110.129247; PUBMED: 21178093] ">Troesch 2011b</a>). Most existing programmes use a standard formulation of five or 15 micronutrients (<a href="./references#CD009666-bbs2-0113" title="UNICEF/CDC . Global Assessment of Home Fortification Interventions 2011. Geneva (Switzerland): Home Fortification Technical Advisory Group, 2013. ">UNICEF/CDC 2013</a>). The trials included iron in the form of encapsulated ferrous fumarate, NaFeEDTA, chelated ferrous sulphate and ferrous glycine phosphate, and the iron doses ranged from 10 mg to 30 mg for ferrous fumarate, 2.5 mg to 10 mg for NaFeEDTA, 10 mg for chelated ferrous sulphate and 28 mg for ferrous glycine phosphate. </p> <p>Some additional information about organoleptic properties of MNP mixed into foods (such as the food changed colour or consistency) came from direct communications with the authors (<a href="./references#CD009666-bbs2-0005" title="Macharia‐MutieCW , MorettiD , Van denBrielN , OmusundiAM , MwangiAM , KokFJ , et al. Maize porridge enriched with a micronutrient powder containing low‐dose iron as NaFeEDTA but not amaranth grain flour reduces anemia and iron deficiency in Kenyan preschool children. Journal of Nutrition2012;142(9):1756‐63. [DOI: 10.3945/jn.112.157578; PUBMED: 22810982] Macharia‐MutieCW , OmusundiAM , MwaiJM , MwangiAM , BrouwerID . Simulation of the effect of maize porridge fortified with grain amaranth or micronutrient powder containing NaFeEDTA on iron intake and status in Kenyan children. Public Health Nutrition2013;16(9):1605‐13. [DOI: 10.1017/S1368980012005174; PUBMED: 23218415] ">Macharia‐Mutie 2012</a>; <a href="./references#CD009666-bbs2-0006" title="JerlingJ [pers comm] . Regards and question on Ogundale et al 2011 vir Cochrane review. Email to: JP Pena‐Rosas 3 November 2011. OgunladeAO , KrugerHS , JerlingJC , SmutsCM , CovicN , HanekomSM , et al. Point‐of‐use micronutrient fortification: lessons learned in implementing a preschool‐based pilot trial in South Africa. International Journal of Food Sciences and Nutrition2011;62(1):1‐16. [DOI: 10.3109/09637486.2010.495710; PUBMED: 20701549] ">Ogunlade 2011</a>). It is unknown if other trials experienced organoleptic issues not included in the final published documents. These changes could potentially influence the blinding of trials, or acceptability of the intervention to participants. </p> <p>While the trials routinely reported Hb, anaemia and iron status indicators, most did not assess the status of other micronutrients in MNP or functional outcomes. The lack of information about functional outcomes is an especially important gap as these are the expected longer‐term health benefits that justify investment in this intervention. Similarly, there appears to be paucity of data on potential adverse health effects, which is important considering ongoing debates. </p> </section> <section id="CD009666-sec-0143"> <h3 class="title" id="CD009666-sec-0143">Quality of the evidence</h3> <p>We considered nine of the 13 trials at low risk of bias (<a href="./references#CD009666-bbs2-0001" title="InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Combined intensive nutrition education and micronutrient powder supplementation improved nutritional status of mildly wasted children on Nias Island, Indonesia. Asia Pacific Journal of Clinical Nutrition2012;21(3):361‐73. [PUBMED: 22705425] InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Improved nutrition knowledge and practice through intensive nutrition education: a study among caregivers of mildly wasted children on Nias Island, Indonesia. Food and Nutrition Bulletin2012;33(2):117‐27. [DOI: 10.1177/156482651203300205; PUBMED: 22908693] PurwestriRC , ScherbaumV , InayatiDA , WirawanNN , SuryantanJ , BloemMA , et al. Supplementary feeding with locally‐produced ready‐to‐use food (RUF) for mildly wasted children on Nias Island, Indonesia: comparison of daily and weekly programme outcomes. Asia Pacific Journal of Clinical Nutrition2012;21(3):374‐9. [PUBMED: 22705426] ScherbaumV [pers comm] . Your paper on MNP. Email to: LM De‐Regil 5 February 2013. ">Inayati 2012 (C)</a>; <a href="./references#CD009666-bbs2-0003" title="KounnavongS , SunaharaT , Mascie‐TaylorCG , HashizumeM , OkumuraJ , MojiK , et al. Effect of daily versus weekly home fortification with multiple micronutrient powder on haemoglobin concentration of young children in a rural area, Lao People's Democratic Republic: a randomised trial. Nutrition Journal2011;10(129):1‐11. [DOI: 10.1186/1475‐2891‐10‐129; PMC3266642; PUBMED: 22111770] ">Kounnavong 2011 (C)</a>; <a href="./references#CD009666-bbs2-0004" title="LundeenE [pers comm] . Kyrgyz Republic MNP data for children 24‐36 months. Email to: M Jefferds 3 November 2011. LundeenE , SchuethT , ToktobaevN , ZlotkinS , HyderSM , HouserR . Daily use of Sprinkles micronutrient powder for 2 months reduces anemia among children 6 to 36 months of age in the Kyrgyz Republic: a cluster‐randomized trial. Food and Nutrition Bulletin2010;31(3):446‐60. [DOI: 10.1177/156482651003100307; PUBMED: 20973465] ">Lundeen 2010 (C)</a>; <a href="./references#CD009666-bbs2-0005" title="Macharia‐MutieCW , MorettiD , Van denBrielN , OmusundiAM , MwangiAM , KokFJ , et al. Maize porridge enriched with a micronutrient powder containing low‐dose iron as NaFeEDTA but not amaranth grain flour reduces anemia and iron deficiency in Kenyan preschool children. Journal of Nutrition2012;142(9):1756‐63. [DOI: 10.3945/jn.112.157578; PUBMED: 22810982] Macharia‐MutieCW , OmusundiAM , MwaiJM , MwangiAM , BrouwerID . Simulation of the effect of maize porridge fortified with grain amaranth or micronutrient powder containing NaFeEDTA on iron intake and status in Kenyan children. Public Health Nutrition2013;16(9):1605‐13. [DOI: 10.1017/S1368980012005174; PUBMED: 23218415] ">Macharia‐Mutie 2012</a>; <a href="./references#CD009666-bbs2-0006" title="JerlingJ [pers comm] . Regards and question on Ogundale et al 2011 vir Cochrane review. Email to: JP Pena‐Rosas 3 November 2011. OgunladeAO , KrugerHS , JerlingJC , SmutsCM , CovicN , HanekomSM , et al. Point‐of‐use micronutrient fortification: lessons learned in implementing a preschool‐based pilot trial in South Africa. International Journal of Food Sciences and Nutrition2011;62(1):1‐16. [DOI: 10.3109/09637486.2010.495710; PUBMED: 20701549] ">Ogunlade 2011</a>; <a href="./references#CD009666-bbs2-0007" title="OrozcoJ , VargasC , RojasML , HerreraAM , MontoyaL , SánchezJG , et al. The effect of powdered micronutrients on the hematologic values and nutritional status of healthy preschoolers. Medellín, 2013 [Efecto de los micronutrientes en polvo en el estado nutricional y en los valores hemáticos de preescolares sanos. Medellín, 2013]. Revista Facultad Nacional de Salud Pública2015;33(2):161‐70. [DOI: 10.17533/udea.rfnsp.v33n2a03] ">Orozco 2015 (C)</a>; <a href="./references#CD009666-bbs2-0008" title="OseiAK , HouserRF , BulusuS , HamerDH . Acceptability of micronutrient fortified school meals by schoolchildren in rural Himalayan villages of India. Journal of Food Science2008;73(7):S354‐8. [DOI: 10.1111/j.1750‐3841.2008.00878.x; PUBMED: 18803728] OseiAK , RosenbergIH , HouserRF , BulusuS , MathewsM , HamerDH . Community‐level micronutrient fortification of school lunch meals improved vitamin A, folate, and iron status of schoolchildren in Himalayan villages of India. Journal of Nutrition2010;140(6):1146‐54. [DOI: 10.3945/jn.109.114751; PUBMED: 20410083] ">Osei 2008 (C)</a>; <a href="./references#CD009666-bbs2-0011" title="VarmaJL , DasS , SankarR , MannarMG , LevinsonFJ , HamerDH . Community‐level micronutrient fortification of a food supplement in India: a controlled trial in preschool children aged 36‐66 mo. American Journal of Clinical Nutrition2007;85(4):1127‐33. [PUBMED: 17413115] ">Varma 2007 (C)</a>; <a href="./references#CD009666-bbs2-0012" title="VinodkumarM , RajagopalanS . Impact of a multiple‐micronutrient food supplement on the nutritional status of schoolchildren. Food and Nutrition Bulletin2006;27(3):203‐10. [DOI: 10.1177/156482650602700302; PUBMED: 17542110] ">Vinodkumar 2006 (C)</a>). In most studies, the main limitation was the lack of blinding at all levels: participants, personnel and outcome assessors. In one study, authors attempted to blind the intervention to the participants and the personnel, but the powders changed the consistency of the porridge and made it slightly darker and lighter compared to the original maize porridge, unmasking the intervention (<a href="./references#CD009666-bbs2-0005" title="Macharia‐MutieCW , MorettiD , Van denBrielN , OmusundiAM , MwangiAM , KokFJ , et al. Maize porridge enriched with a micronutrient powder containing low‐dose iron as NaFeEDTA but not amaranth grain flour reduces anemia and iron deficiency in Kenyan preschool children. Journal of Nutrition2012;142(9):1756‐63. [DOI: 10.3945/jn.112.157578; PUBMED: 22810982] Macharia‐MutieCW , OmusundiAM , MwaiJM , MwangiAM , BrouwerID . Simulation of the effect of maize porridge fortified with grain amaranth or micronutrient powder containing NaFeEDTA on iron intake and status in Kenyan children. Public Health Nutrition2013;16(9):1605‐13. [DOI: 10.1017/S1368980012005174; PUBMED: 23218415] ">Macharia‐Mutie 2012</a>). </p> <p>We judged the overall quality of the evidence for the provision of multiple MNP versus no intervention or placebo as moderate for anaemia, iron deficiency and adverse effects. We judged the evidence as low quality for Hb, all‐cause mortality and diarrhoea, and very low‐quality for ferritin (See <a href="./full#CD009666-tbl-0001">summary of findings Table for the main comparison</a>). </p> </section> <section id="CD009666-sec-0144"> <h3 class="title" id="CD009666-sec-0144">Potential biases in the review process</h3> <p>We were aware of the possibility of introducing bias at every stage of the reviewing process. In this review, we tried to minimise bias in a number of ways; two review authors assessed eligibility for inclusion, carried out data extraction and assessed risk of bias. Each worked independently. Nevertheless, the process of assessing risk of bias, for example, is not an exact science and includes many personal judgements. Further, the process of reviewing research trials is known to be affected by prior beliefs and attitudes. It is difficult to control for this type of bias in the reviewing process. </p> <p>While we designed our search strategies to be as inclusive as possible (<a href="./appendices#CD009666-sec-0152">Appendix 1</a>), the literature that we identified was predominantly written in English and published in North American and European journals. Although we did attempt to assess reporting bias, constraints of time meant that this assessment largely relied on information available in the published trial reports and thus, reporting bias was not usually apparent. </p> <p>We included a 'Summary of findings' table in this review (<a href="./full#CD009666-tbl-0001">summary of findings Table for the main comparison</a>). Assessing the quality of the evidence relating to specific outcomes is a difficult process, but we attempted to produce the table using a transparent process. Two review authors (LD‐R, MJ) independently assessed the evidence for each outcome for each quality domain and discussed any disagreements. </p> </section> <section id="CD009666-sec-0145"> <h3 class="title" id="CD009666-sec-0145">Agreements and disagreements with other studies or reviews</h3> <p>One non‐Cochrane review assessed the effects of MNP in women and children (<a href="./references#CD009666-bbs2-0102" title="SalamRA , MacPhailC , DasJK , BhuttaZA . Effectiveness of micronutrient powders (MNP) in women and children. BMC Public Health2013;13 Suppl 3:S22. [DOI: 10.1186/1471‐2458‐13‐S3‐S22] ">Salam 2013</a>). Two reviews examined the effects and safety of MNP among younger children (aged six to 23 months) in the complementary feeding period (<a href="./references#CD009666-bbs2-0073" title="De‐RegilLM , SuchdevPS , VistGE , WalleserS , Peña‐RosasJP . Home fortification of foods with multiple micronutrient powders for health and nutrition in children under two years of age. Cochrane Database of Systematic Reviews2011, Issue 9. [DOI: 10.1002/14651858.CD008959.pub2] ">De‐Regil 2011b</a>; <a href="./references#CD009666-bbs2-0076" title="DeweyKG , YangZ , BoyE . Systematic review and meta‐analysis of home fortification of complementary foods. Maternal &amp; Child Nutrition2009;5(4):283‐321. [DOI: 10.1111/j.1740‐8709.2009.00190.x] ">Dewey 2009</a>). </p> <p><a href="./references#CD009666-bbs2-0102" title="SalamRA , MacPhailC , DasJK , BhuttaZA . Effectiveness of micronutrient powders (MNP) in women and children. BMC Public Health2013;13 Suppl 3:S22. [DOI: 10.1186/1471‐2458‐13‐S3‐S22] ">Salam 2013</a> carried out a systematic review of 16 MNP trials that took place in Asia, Africa and Haiti. Trials were included if they had MNP formulations with a minimum of two micronutrients, and otherwise could be consumed in the home or other settings, at any dosage and duration. While they aimed to examine the impact of MNP on women and children, they did not identify any studies among women that met their inclusion criteria. The final trials included in the review were all from low‐ and middle‐income countries and compared to no intervention or control. All the trial formulations included iron and the children were aged between six months and 11 years. <a href="./references#CD009666-bbs2-0102" title="SalamRA , MacPhailC , DasJK , BhuttaZA . Effectiveness of micronutrient powders (MNP) in women and children. BMC Public Health2013;13 Suppl 3:S22. [DOI: 10.1186/1471‐2458‐13‐S3‐S22] ">Salam 2013</a> found MNP reduced the prevalence of anaemia, iron deficiency anaemia and vitamin A deficiency, and improved Hb concentrations. There were no significant effects on ferritin concentrations, zinc deficiency or anthropometric indicators. Four studies with morbidity outcome data showed a small but significant increase in the incidence of diarrhoea, and no significant effects on recurrent diarrhoea or upper respiratory illness. </p> <p><a href="./references#CD009666-bbs2-0073" title="De‐RegilLM , SuchdevPS , VistGE , WalleserS , Peña‐RosasJP . Home fortification of foods with multiple micronutrient powders for health and nutrition in children under two years of age. Cochrane Database of Systematic Reviews2011, Issue 9. [DOI: 10.1002/14651858.CD008959.pub2] ">De‐Regil 2011b</a> included eight RCTs and quasi‐RCTs of apparently healthy children (aged six to 23 months) from Asia, Africa and the Caribbean. The review only included trials using MNP formulations with at least iron, zinc and vitamin A. The results of six trials compared MNP to no intervention or placebo, and two trials compared MNP to iron supplements. MNPs were found to reduce anaemia and iron deficiency when compared to no intervention or placebo, but had no effects on growth. These findings were consistent across the trials regardless of intervention duration or the prevalences of anaemia and malaria at baseline. The two trials that compared MNP to iron supplementation drops suggested there were no differences for anaemia or Hb concentrations, but the authors advised caution due to the limited number of trials included in this comparison. There was insufficient information to assess adverse effects or other functional outcomes. </p> <p><a href="./references#CD009666-bbs2-0076" title="DeweyKG , YangZ , BoyE . Systematic review and meta‐analysis of home fortification of complementary foods. Maternal &amp; Child Nutrition2009;5(4):283‐321. [DOI: 10.1111/j.1740‐8709.2009.00190.x] ">Dewey 2009</a> carried out a systematic review and meta‐analysis of 16 trials of home fortification of complementary foods using MNP, crushable tablets, and lipid‐based or soy‐based products. Of the 16 included trials, five were defined as treatment and all involved MNP. Of the remaining 11 trials defined as prevention, eight included arms with MNP. <a href="./references#CD009666-bbs2-0076" title="DeweyKG , YangZ , BoyE . Systematic review and meta‐analysis of home fortification of complementary foods. Maternal &amp; Child Nutrition2009;5(4):283‐321. [DOI: 10.1111/j.1740‐8709.2009.00190.x] ">Dewey 2009</a> did not specify any minimum formulation criteria for the MNP (or other home fortification products), but all trials with MNP contained iron. <a href="./references#CD009666-bbs2-0076" title="DeweyKG , YangZ , BoyE . Systematic review and meta‐analysis of home fortification of complementary foods. Maternal &amp; Child Nutrition2009;5(4):283‐321. [DOI: 10.1111/j.1740‐8709.2009.00190.x] ">Dewey 2009</a> also included a trial not eligible for inclusion in the current review, which only compared MNP with iron to MNP with iron and zinc. The treatment trials showed no differences in the effects on Hb and ferritin between MNP and iron supplementation drops, which we were unable to assess in the current review due to a lack of trials examining this comparison. For the prevention trials, the overall effect size for ferritin and Hb concentrations include trials involving all the home fortification products and were not limited to MNP; they showed that home fortification improved ferritin and Hb concentrations reducing iron deficiency and anaemia. </p> <p>There were several differences between our review and the above‐mentioned reviews. Compared to <a href="./references#CD009666-bbs2-0073" title="De‐RegilLM , SuchdevPS , VistGE , WalleserS , Peña‐RosasJP . Home fortification of foods with multiple micronutrient powders for health and nutrition in children under two years of age. Cochrane Database of Systematic Reviews2011, Issue 9. [DOI: 10.1002/14651858.CD008959.pub2] ">De‐Regil 2011b</a>; <a href="./references#CD009666-bbs2-0076" title="DeweyKG , YangZ , BoyE . Systematic review and meta‐analysis of home fortification of complementary foods. Maternal &amp; Child Nutrition2009;5(4):283‐321. [DOI: 10.1111/j.1740‐8709.2009.00190.x] ">Dewey 2009</a>; and <a href="./references#CD009666-bbs2-0102" title="SalamRA , MacPhailC , DasJK , BhuttaZA . Effectiveness of micronutrient powders (MNP) in women and children. BMC Public Health2013;13 Suppl 3:S22. [DOI: 10.1186/1471‐2458‐13‐S3‐S22] ">Salam 2013</a>, our review only required the MNP formulation to include at least iron, whereas <a href="./references#CD009666-bbs2-0102" title="SalamRA , MacPhailC , DasJK , BhuttaZA . Effectiveness of micronutrient powders (MNP) in women and children. BMC Public Health2013;13 Suppl 3:S22. [DOI: 10.1186/1471‐2458‐13‐S3‐S22] ">Salam 2013</a> required a minimum of two micronutrients, <a href="./references#CD009666-bbs2-0073" title="De‐RegilLM , SuchdevPS , VistGE , WalleserS , Peña‐RosasJP . Home fortification of foods with multiple micronutrient powders for health and nutrition in children under two years of age. Cochrane Database of Systematic Reviews2011, Issue 9. [DOI: 10.1002/14651858.CD008959.pub2] ">De‐Regil 2011b</a> required iron, zinc and vitamin A, and <a href="./references#CD009666-bbs2-0076" title="DeweyKG , YangZ , BoyE . Systematic review and meta‐analysis of home fortification of complementary foods. Maternal &amp; Child Nutrition2009;5(4):283‐321. [DOI: 10.1111/j.1740‐8709.2009.00190.x] ">Dewey 2009</a> had no minimum formulation criteria. Compared to this review, which focused on children aged 24 months to 12 years and included trials with children up to 15 years of age, <a href="./references#CD009666-bbs2-0073" title="De‐RegilLM , SuchdevPS , VistGE , WalleserS , Peña‐RosasJP . Home fortification of foods with multiple micronutrient powders for health and nutrition in children under two years of age. Cochrane Database of Systematic Reviews2011, Issue 9. [DOI: 10.1002/14651858.CD008959.pub2] ">De‐Regil 2011b</a> and <a href="./references#CD009666-bbs2-0076" title="DeweyKG , YangZ , BoyE . Systematic review and meta‐analysis of home fortification of complementary foods. Maternal &amp; Child Nutrition2009;5(4):283‐321. [DOI: 10.1111/j.1740‐8709.2009.00190.x] ">Dewey 2009</a> focused on children younger than 24 months of age. <a href="./references#CD009666-bbs2-0102" title="SalamRA , MacPhailC , DasJK , BhuttaZA . Effectiveness of micronutrient powders (MNP) in women and children. BMC Public Health2013;13 Suppl 3:S22. [DOI: 10.1186/1471‐2458‐13‐S3‐S22] ">Salam 2013</a> included children up to 11 years of age, but 10 trials included only children younger than 36 months of age and four included children older than five years of age; in this review, seven trials included children aged five years or older. None of the trials included in <a href="./references#CD009666-bbs2-0073" title="De‐RegilLM , SuchdevPS , VistGE , WalleserS , Peña‐RosasJP . Home fortification of foods with multiple micronutrient powders for health and nutrition in children under two years of age. Cochrane Database of Systematic Reviews2011, Issue 9. [DOI: 10.1002/14651858.CD008959.pub2] ">De‐Regil 2011b</a> or <a href="./references#CD009666-bbs2-0076" title="DeweyKG , YangZ , BoyE . Systematic review and meta‐analysis of home fortification of complementary foods. Maternal &amp; Child Nutrition2009;5(4):283‐321. [DOI: 10.1111/j.1740‐8709.2009.00190.x] ">Dewey 2009</a> involved distribution and use of MNP through schools or other institutional settings. <a href="./references#CD009666-bbs2-0102" title="SalamRA , MacPhailC , DasJK , BhuttaZA . Effectiveness of micronutrient powders (MNP) in women and children. BMC Public Health2013;13 Suppl 3:S22. [DOI: 10.1186/1471‐2458‐13‐S3‐S22] ">Salam 2013</a> included trials distributing outside the home but did not report which studies did so, and, in the current review eight of the 13 trials distributed through school or other institutional settings. Our review also had little information on intake adherence, which is a primary rationale for the use of MNP over iron supplementation. </p> <p>Similar to <a href="./references#CD009666-bbs2-0102" title="SalamRA , MacPhailC , DasJK , BhuttaZA . Effectiveness of micronutrient powders (MNP) in women and children. BMC Public Health2013;13 Suppl 3:S22. [DOI: 10.1186/1471‐2458‐13‐S3‐S22] ">Salam 2013</a> and <a href="./references#CD009666-bbs2-0073" title="De‐RegilLM , SuchdevPS , VistGE , WalleserS , Peña‐RosasJP . Home fortification of foods with multiple micronutrient powders for health and nutrition in children under two years of age. Cochrane Database of Systematic Reviews2011, Issue 9. [DOI: 10.1002/14651858.CD008959.pub2] ">De‐Regil 2011b</a>, the current review found MNP reduced anaemia and iron deficiency, and increased mean Hb values when compared to no intervention or placebo. <a href="./references#CD009666-bbs2-0102" title="SalamRA , MacPhailC , DasJK , BhuttaZA . Effectiveness of micronutrient powders (MNP) in women and children. BMC Public Health2013;13 Suppl 3:S22. [DOI: 10.1186/1471‐2458‐13‐S3‐S22] ">Salam 2013</a> reported three morbidity outcomes related to diarrhoea and upper respiratory infection, but, similar to <a href="./references#CD009666-bbs2-0073" title="De‐RegilLM , SuchdevPS , VistGE , WalleserS , Peña‐RosasJP . Home fortification of foods with multiple micronutrient powders for health and nutrition in children under two years of age. Cochrane Database of Systematic Reviews2011, Issue 9. [DOI: 10.1002/14651858.CD008959.pub2] ">De‐Regil 2011b</a> and <a href="./references#CD009666-bbs2-0076" title="DeweyKG , YangZ , BoyE . Systematic review and meta‐analysis of home fortification of complementary foods. Maternal &amp; Child Nutrition2009;5(4):283‐321. [DOI: 10.1111/j.1740‐8709.2009.00190.x] ">Dewey 2009</a>, data in the current review were limited for adverse effects and functional outcomes, and variable outcome definitions limited some analyses. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD009666-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD009666-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/full#CD009666-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included trials." data-id="CD009666-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included trials. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/full#CD009666-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD009666-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/full#CD009666-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Point‐of‐use fortification of foods with micronutrients powders versus no intervention/placebo, outcome: 1.11 Haemoglobin (g/L)." data-id="CD009666-fig-0004" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Point‐of‐use fortification of foods with micronutrients powders versus no intervention/placebo, outcome: 1.11 Haemoglobin (g/L). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/full#CD009666-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 1 Anaemia." data-id="CD009666-fig-0005" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 1 Anaemia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 2 Anaemia by anaemic status of participants at start of intervention." data-id="CD009666-fig-0006" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 2 Anaemia by anaemic status of participants at start of intervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 3 Anaemia by age of children at start of intervention." data-id="CD009666-fig-0007" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 3 Anaemia by age of children at start of intervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 4 Anaemia by malaria status of study site at time of trial." data-id="CD009666-fig-0008" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 4 Anaemia by malaria status of study site at time of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 5 Anaemia by frequency." data-id="CD009666-fig-0009" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 5 Anaemia by frequency. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 6 Anaemia by duration of intervention." data-id="CD009666-fig-0010" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 6 Anaemia by duration of intervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 7 Anaemia by iron content of product." data-id="CD009666-fig-0011" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 7 Anaemia by iron content of product. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 8 Anaemia by type of iron compound." data-id="CD009666-fig-0012" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 8 Anaemia by type of iron compound. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 9 Anaemia by number of nutrients accompanying iron." data-id="CD009666-fig-0013" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 9 Anaemia by number of nutrients accompanying iron. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 10 Anaemia by micronutrient composition." data-id="CD009666-fig-0014" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 10 Anaemia by micronutrient composition. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-11.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 11 Haemoglobin (g/L)." data-id="CD009666-fig-0015" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 11 Haemoglobin (g/L). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 12 Haemoglobin by anaemic status of participants at start of intervention (g/L)." data-id="CD009666-fig-0016" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 12 Haemoglobin by anaemic status of participants at start of intervention (g/L). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 13 Haemoglobin by age of children at start of intervention." data-id="CD009666-fig-0017" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 13 Haemoglobin by age of children at start of intervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 14 Haemoglobin by malaria status of study site at time of trial." data-id="CD009666-fig-0018" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 14 Haemoglobin by malaria status of study site at time of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 15 Haemoglobin by frequency (g/L)." data-id="CD009666-fig-0019" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 15 Haemoglobin by frequency (g/L). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 16 Haemoglobin by duration of intervention." data-id="CD009666-fig-0020" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 16 Haemoglobin by duration of intervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 17 Haemoglobin by iron content of product." data-id="CD009666-fig-0021" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 17 Haemoglobin by iron content of product. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 18 Haemoglobin by type of iron compound (g/L)." data-id="CD009666-fig-0022" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.18</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 18 Haemoglobin by type of iron compound (g/L). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 19 Haemoglobin by number of nutrients accompanying iron (g/L)." data-id="CD009666-fig-0023" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.19</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 19 Haemoglobin by number of nutrients accompanying iron (g/L). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 20 Haemoglobin by micronutrient composition (g/L)." data-id="CD009666-fig-0024" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.20</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 20 Haemoglobin by micronutrient composition (g/L). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 21 Iron deficiency." data-id="CD009666-fig-0025" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.21</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 21 Iron deficiency. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-22.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 22 Iron deficiency by anaemia status at start of intervention." data-id="CD009666-fig-0026" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.22</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 22 Iron deficiency by anaemia status at start of intervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-23" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-23.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 23 Iron deficiency by age of children at start of intervention." data-id="CD009666-fig-0027" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-23.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.23</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 23 Iron deficiency by age of children at start of intervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-23.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-24" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-24.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 24 Iron deficiency by malaria status of study site at time of trial." data-id="CD009666-fig-0028" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-24.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.24</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 24 Iron deficiency by malaria status of study site at time of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-24.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-25" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-25.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 25 Iron deficiency by frequency." data-id="CD009666-fig-0029" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-25.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.25</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 25 Iron deficiency by frequency. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-25.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-26" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-26.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 26 Iron deficiency by duration of intervention." data-id="CD009666-fig-0030" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-26.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.26</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 26 Iron deficiency by duration of intervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-26.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-27" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-27.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 27 Iron deficiency by iron content of product." data-id="CD009666-fig-0031" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-27.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.27</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 27 Iron deficiency by iron content of product. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-27.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-28" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-28.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 28 Iron deficiency by type of iron compound." data-id="CD009666-fig-0032" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-28.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.28</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 28 Iron deficiency by type of iron compound. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-28.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-29" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-29.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 29 Iron deficiency by number of nutrients accompanying iron." data-id="CD009666-fig-0033" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-29.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.29</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 29 Iron deficiency by number of nutrients accompanying iron. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-29.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-30" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-30.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 30 Iron deficiency by micronutrient composition." data-id="CD009666-fig-0034" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-30.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.30</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 30 Iron deficiency by micronutrient composition. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-30.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-31" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-31.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 31 Ferritin (μg/L)." data-id="CD009666-fig-0035" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-31.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.31</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 31 Ferritin (μg/L). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-31.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-32" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-32.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 32 All‐cause mortality." data-id="CD009666-fig-0036" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-32.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.32</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 32 All‐cause mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-32.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-33" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-33.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 33 Diarrhoea." data-id="CD009666-fig-0037" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-33.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.33</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 33 Diarrhoea. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-33.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-34" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-34.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 34 Adverse effects." data-id="CD009666-fig-0038" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-34.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.34</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 34 Adverse effects. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-34.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-35" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-35.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 35 Iron deficiency anaemia." data-id="CD009666-fig-0039" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-35.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.35</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 35 Iron deficiency anaemia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-35.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-36" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-36.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 36 All‐cause morbidity." data-id="CD009666-fig-0040" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-36.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.36</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 36 All‐cause morbidity. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-36.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-37" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-37.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 37 Acute respiratory infection." data-id="CD009666-fig-0041" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-37.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.37</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 37 Acute respiratory infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-37.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-38" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-38.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 38 Growth (height‐for‐age Z‐score)." data-id="CD009666-fig-0042" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-38.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.38</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 38 Growth (height‐for‐age Z‐score). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-38.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-39" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-39.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 39 Growth (weight‐for‐age Z‐score)." data-id="CD009666-fig-0043" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-39.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.39</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 39 Growth (weight‐for‐age Z‐score). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-39.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-40" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-40.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 40 Growth (weight‐for‐height Z‐score)." data-id="CD009666-fig-0044" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-40.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.40</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 40 Growth (weight‐for‐height Z‐score). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-40.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-41" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-41.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 41 Adherence." data-id="CD009666-fig-0045" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-41.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.41</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 41 Adherence. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-41.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-42" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-42.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 42 Serum/plasma retinol (mmol/L)." data-id="CD009666-fig-0046" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-42.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.42</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 42 Serum/plasma retinol (mmol/L). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-42.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-43" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-43.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 43 Serum/plasma zinc concentrations (mmol/L)." data-id="CD009666-fig-0047" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-43.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.43</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 43 Serum/plasma zinc concentrations (mmol/L). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-43.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-44" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-44.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 44 Iron status (iron‐binding capacity) (non‐prespecified) (µmol/kg)." data-id="CD009666-fig-0048" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-44.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.44</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 44 Iron status (iron‐binding capacity) (non‐prespecified) (µmol/kg). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-44.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-45" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-45.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 45 Iron status (serum‐transferrin receptors; non‐prespecified) (mg/L)." data-id="CD009666-fig-0049" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-45.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.45</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 45 Iron status (serum‐transferrin receptors; non‐prespecified) (mg/L). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-45.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-46" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-46.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 46 Serum vitamin E (non‐prespecified) (µg/dL)." data-id="CD009666-fig-0050" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-46.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.46</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 46 Serum vitamin E (non‐prespecified) (µg/dL). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-46.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-47" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-47.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 47 Serum vitamin B12 (non‐prespecified) (pg/mL)." data-id="CD009666-fig-0051" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-47.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.47</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 47 Serum vitamin B<sub>12</sub> (non‐prespecified) (pg/mL). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-47.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-48" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-48.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 48 Zinc deficiency (non‐prespecified)." data-id="CD009666-fig-0052" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-48.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.48</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 48 Zinc deficiency (non‐prespecified). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-48.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0053"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-49" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-49.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 49 Vitamin A deficiency (non‐prespecified)." data-id="CD009666-fig-0053" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-49.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.49</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 49 Vitamin A deficiency (non‐prespecified). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0053">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-49.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0054"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-50" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-50.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 50 Serum folate concentration (ng/mL)." data-id="CD009666-fig-0054" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-50.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.50</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 50 Serum folate concentration (ng/mL). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0054">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-50.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0055"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-51" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-51.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 51 Height (non‐prespecified) (cm)." data-id="CD009666-fig-0055" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-51.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.51</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 51 Height (non‐prespecified) (cm). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0055">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-51.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0056"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-52" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-52.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 52 Weight (non‐prespecified) (kg)." data-id="CD009666-fig-0056" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-52.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.52</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 52 Weight (non‐prespecified) (kg). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0056">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-52.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0057"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-53" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-53.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 53 Fever (non‐prespecified)." data-id="CD009666-fig-0057" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-53.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.53</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 53 Fever (non‐prespecified). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0057">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-53.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0058"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-54" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-54.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 54 Stunting (non‐prespecified)." data-id="CD009666-fig-0058" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-54.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.54</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 54 Stunting (non‐prespecified). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0058">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-54.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009666-fig-0059"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/urn:x-wiley:14651858:media:CD009666:CD009666-CMP-001-55" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_t/tCD009666-CMP-001-55.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 55 Angular stomatitis (non‐prespecified)." data-id="CD009666-fig-0059" src="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-55.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.55</div> <div class="figure-caption"> <p>Comparison 1 Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo, Outcome 55 Angular stomatitis (non‐prespecified). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-fig-0059">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/media/CDSR/CD009666/image_n/nCD009666-CMP-001-55.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD009666-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Point‐of‐use fortification of foods with micronutrients powders (MNP) compared to no intervention or placebo in preschool and school‐age children</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Point‐of‐use fortification of foods with MNP compared to no intervention or placebo in preschool and school‐age children</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> preschool and school‐age children </p> <p><b>Setting:</b> all settings </p> <p><b>Intervention:</b> point‐of‐use fortification of foods with MNP </p> <p><b>Comparison:</b> no intervention or placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with no intervention or placebo</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with point‐of‐use fortification of foods with MNP</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Anaemia</b> (defined as haemoglobin &lt; 110 g/L for children aged 24‐59 months and &lt; 115 g/L for children aged 5‐11.9 years, adjusted by altitude where appropriate)* </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.66</b> <br/> (0.49 to 0.88) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2448<br/> (10 RCTs) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Included studies: <a href="./references#CD009666-bbs2-0001" title="InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Combined intensive nutrition education and micronutrient powder supplementation improved nutritional status of mildly wasted children on Nias Island, Indonesia. Asia Pacific Journal of Clinical Nutrition2012;21(3):361‐73. [PUBMED: 22705425] InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Improved nutrition knowledge and practice through intensive nutrition education: a study among caregivers of mildly wasted children on Nias Island, Indonesia. Food and Nutrition Bulletin2012;33(2):117‐27. [DOI: 10.1177/156482651203300205; PUBMED: 22908693] PurwestriRC , ScherbaumV , InayatiDA , WirawanNN , SuryantanJ , BloemMA , et al. Supplementary feeding with locally‐produced ready‐to‐use food (RUF) for mildly wasted children on Nias Island, Indonesia: comparison of daily and weekly programme outcomes. Asia Pacific Journal of Clinical Nutrition2012;21(3):374‐9. [PUBMED: 22705426] ScherbaumV [pers comm] . Your paper on MNP. Email to: LM De‐Regil 5 February 2013. ">Inayati 2012 (C)</a>; <a href="./references#CD009666-bbs2-0002" title="KemmerTM , OmerPS , Gidvani‐DiazVK , CoelloM . Acceptance and effect of ferrous fumarate containing micronutrient sprinkles on anemia, iron deficiency and anthropometrics in Honduran children. In: SilverbergDS editor(s). Anemia. Rijeka (Croatia): InTech, 2012. [DOI: 10.5772/30987] ">Kemmer 2012 (C)</a>; <a href="./references#CD009666-bbs2-0003" title="KounnavongS , SunaharaT , Mascie‐TaylorCG , HashizumeM , OkumuraJ , MojiK , et al. Effect of daily versus weekly home fortification with multiple micronutrient powder on haemoglobin concentration of young children in a rural area, Lao People's Democratic Republic: a randomised trial. Nutrition Journal2011;10(129):1‐11. [DOI: 10.1186/1475‐2891‐10‐129; PMC3266642; PUBMED: 22111770] ">Kounnavong 2011 (C)</a>; <a href="./references#CD009666-bbs2-0004" title="LundeenE [pers comm] . Kyrgyz Republic MNP data for children 24‐36 months. Email to: M Jefferds 3 November 2011. LundeenE , SchuethT , ToktobaevN , ZlotkinS , HyderSM , HouserR . Daily use of Sprinkles micronutrient powder for 2 months reduces anemia among children 6 to 36 months of age in the Kyrgyz Republic: a cluster‐randomized trial. Food and Nutrition Bulletin2010;31(3):446‐60. [DOI: 10.1177/156482651003100307; PUBMED: 20973465] ">Lundeen 2010 (C)</a>; <a href="./references#CD009666-bbs2-0005" title="Macharia‐MutieCW , MorettiD , Van denBrielN , OmusundiAM , MwangiAM , KokFJ , et al. Maize porridge enriched with a micronutrient powder containing low‐dose iron as NaFeEDTA but not amaranth grain flour reduces anemia and iron deficiency in Kenyan preschool children. Journal of Nutrition2012;142(9):1756‐63. [DOI: 10.3945/jn.112.157578; PUBMED: 22810982] Macharia‐MutieCW , OmusundiAM , MwaiJM , MwangiAM , BrouwerID . Simulation of the effect of maize porridge fortified with grain amaranth or micronutrient powder containing NaFeEDTA on iron intake and status in Kenyan children. Public Health Nutrition2013;16(9):1605‐13. [DOI: 10.1017/S1368980012005174; PUBMED: 23218415] ">Macharia‐Mutie 2012</a>; <a href="./references#CD009666-bbs2-0006" title="JerlingJ [pers comm] . Regards and question on Ogundale et al 2011 vir Cochrane review. Email to: JP Pena‐Rosas 3 November 2011. OgunladeAO , KrugerHS , JerlingJC , SmutsCM , CovicN , HanekomSM , et al. Point‐of‐use micronutrient fortification: lessons learned in implementing a preschool‐based pilot trial in South Africa. International Journal of Food Sciences and Nutrition2011;62(1):1‐16. [DOI: 10.3109/09637486.2010.495710; PUBMED: 20701549] ">Ogunlade 2011</a>; <a href="./references#CD009666-bbs2-0008" title="OseiAK , HouserRF , BulusuS , HamerDH . Acceptability of micronutrient fortified school meals by schoolchildren in rural Himalayan villages of India. Journal of Food Science2008;73(7):S354‐8. [DOI: 10.1111/j.1750‐3841.2008.00878.x; PUBMED: 18803728] OseiAK , RosenbergIH , HouserRF , BulusuS , MathewsM , HamerDH . Community‐level micronutrient fortification of school lunch meals improved vitamin A, folate, and iron status of schoolchildren in Himalayan villages of India. Journal of Nutrition2010;140(6):1146‐54. [DOI: 10.3945/jn.109.114751; PUBMED: 20410083] ">Osei 2008 (C)</a>; <a href="./references#CD009666-bbs2-0010" title="TroeschB [pers comm] . Regards and question on Troesch et al 2011. Email to: JP Peña‐Rosas 1 November 2011. TroeschB , vanStuijvenbergME , SmutsCM , KrugerHS , BiebingerR , HurrellRF , et al. A micronutrient powder with low doses of highly absorbable iron and zinc reduces iron and zinc deficiency and improves weight‐for‐age Z‐scores in South African children. Journal of Nutrition2011;141(2):237‐42. [DOI: 10.3945/jn.110.129247; PUBMED: 21178093] ">Troesch 2011b</a>; <a href="./references#CD009666-bbs2-0011" title="VarmaJL , DasS , SankarR , MannarMG , LevinsonFJ , HamerDH . Community‐level micronutrient fortification of a food supplement in India: a controlled trial in preschool children aged 36‐66 mo. American Journal of Clinical Nutrition2007;85(4):1127‐33. [PUBMED: 17413115] ">Varma 2007 (C)</a>; <a href="./references#CD009666-bbs2-0013" title="VinodkumarM , RajagopalanS . Efficacy of fortification of school meals with ferrous glycine phosphate and riboflavin against anemia and angular stomatitis in schoolchildren. Food and Nutrition Bulletin2009;30(3):260‐4. [DOI: 10.1177/156482650903000307; PUBMED: 19927606] ">Vinodkumar 2009 (C)</a>. </p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>375 per 1000</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>247 per 1000</b> <br/> (184 to 330) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Haemoglobin</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean haemoglobin score in control groups ranged from 103.50 g/L to 128.00 g/L</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean haemoglobin score in intervention groups was, on average, <b>3.37 g/L higher</b> (0.94 g/L higher to 5.80 g/L higher) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2746<br/> (11 RCTs) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Included studies: <a href="./references#CD009666-bbs2-0001" title="InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Combined intensive nutrition education and micronutrient powder supplementation improved nutritional status of mildly wasted children on Nias Island, Indonesia. Asia Pacific Journal of Clinical Nutrition2012;21(3):361‐73. [PUBMED: 22705425] InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Improved nutrition knowledge and practice through intensive nutrition education: a study among caregivers of mildly wasted children on Nias Island, Indonesia. Food and Nutrition Bulletin2012;33(2):117‐27. [DOI: 10.1177/156482651203300205; PUBMED: 22908693] PurwestriRC , ScherbaumV , InayatiDA , WirawanNN , SuryantanJ , BloemMA , et al. Supplementary feeding with locally‐produced ready‐to‐use food (RUF) for mildly wasted children on Nias Island, Indonesia: comparison of daily and weekly programme outcomes. Asia Pacific Journal of Clinical Nutrition2012;21(3):374‐9. [PUBMED: 22705426] ScherbaumV [pers comm] . Your paper on MNP. Email to: LM De‐Regil 5 February 2013. ">Inayati 2012 (C)</a>; <a href="./references#CD009666-bbs2-0002" title="KemmerTM , OmerPS , Gidvani‐DiazVK , CoelloM . Acceptance and effect of ferrous fumarate containing micronutrient sprinkles on anemia, iron deficiency and anthropometrics in Honduran children. In: SilverbergDS editor(s). Anemia. Rijeka (Croatia): InTech, 2012. [DOI: 10.5772/30987] ">Kemmer 2012 (C)</a>; <a href="./references#CD009666-bbs2-0003" title="KounnavongS , SunaharaT , Mascie‐TaylorCG , HashizumeM , OkumuraJ , MojiK , et al. Effect of daily versus weekly home fortification with multiple micronutrient powder on haemoglobin concentration of young children in a rural area, Lao People's Democratic Republic: a randomised trial. Nutrition Journal2011;10(129):1‐11. [DOI: 10.1186/1475‐2891‐10‐129; PMC3266642; PUBMED: 22111770] ">Kounnavong 2011 (C)</a>; <a href="./references#CD009666-bbs2-0004" title="LundeenE [pers comm] . Kyrgyz Republic MNP data for children 24‐36 months. Email to: M Jefferds 3 November 2011. LundeenE , SchuethT , ToktobaevN , ZlotkinS , HyderSM , HouserR . Daily use of Sprinkles micronutrient powder for 2 months reduces anemia among children 6 to 36 months of age in the Kyrgyz Republic: a cluster‐randomized trial. Food and Nutrition Bulletin2010;31(3):446‐60. [DOI: 10.1177/156482651003100307; PUBMED: 20973465] ">Lundeen 2010 (C)</a>; <a href="./references#CD009666-bbs2-0005" title="Macharia‐MutieCW , MorettiD , Van denBrielN , OmusundiAM , MwangiAM , KokFJ , et al. Maize porridge enriched with a micronutrient powder containing low‐dose iron as NaFeEDTA but not amaranth grain flour reduces anemia and iron deficiency in Kenyan preschool children. Journal of Nutrition2012;142(9):1756‐63. [DOI: 10.3945/jn.112.157578; PUBMED: 22810982] Macharia‐MutieCW , OmusundiAM , MwaiJM , MwangiAM , BrouwerID . Simulation of the effect of maize porridge fortified with grain amaranth or micronutrient powder containing NaFeEDTA on iron intake and status in Kenyan children. Public Health Nutrition2013;16(9):1605‐13. [DOI: 10.1017/S1368980012005174; PUBMED: 23218415] ">Macharia‐Mutie 2012</a>; <a href="./references#CD009666-bbs2-0006" title="JerlingJ [pers comm] . Regards and question on Ogundale et al 2011 vir Cochrane review. Email to: JP Pena‐Rosas 3 November 2011. OgunladeAO , KrugerHS , JerlingJC , SmutsCM , CovicN , HanekomSM , et al. Point‐of‐use micronutrient fortification: lessons learned in implementing a preschool‐based pilot trial in South Africa. International Journal of Food Sciences and Nutrition2011;62(1):1‐16. [DOI: 10.3109/09637486.2010.495710; PUBMED: 20701549] ">Ogunlade 2011</a>; <a href="./references#CD009666-bbs2-0008" title="OseiAK , HouserRF , BulusuS , HamerDH . Acceptability of micronutrient fortified school meals by schoolchildren in rural Himalayan villages of India. Journal of Food Science2008;73(7):S354‐8. [DOI: 10.1111/j.1750‐3841.2008.00878.x; PUBMED: 18803728] OseiAK , RosenbergIH , HouserRF , BulusuS , MathewsM , HamerDH . Community‐level micronutrient fortification of school lunch meals improved vitamin A, folate, and iron status of schoolchildren in Himalayan villages of India. Journal of Nutrition2010;140(6):1146‐54. [DOI: 10.3945/jn.109.114751; PUBMED: 20410083] ">Osei 2008 (C)</a>; <a href="./references#CD009666-bbs2-0009" title="SharieffW , YinSA , WuM , YangQ , SchauerC , TomlinsonG , et al. Short‐term daily or weekly administration of micronutrient Sprinkles has high compliance and does not cause iron overload in Chinese schoolchildren: a cluster‐randomized trial. Public Health Nutrition2006;9(3):336‐44. [PUBMED: 16684385] ZlotkinS [pers comm] . Regards and question ‐ Sharieff 2006. Email to: JP Peña‐Rosas 2 November 2011. ">Sharieff 2006 (C)</a>; <a href="./references#CD009666-bbs2-0011" title="VarmaJL , DasS , SankarR , MannarMG , LevinsonFJ , HamerDH . Community‐level micronutrient fortification of a food supplement in India: a controlled trial in preschool children aged 36‐66 mo. American Journal of Clinical Nutrition2007;85(4):1127‐33. [PUBMED: 17413115] ">Varma 2007 (C)</a>; <a href="./references#CD009666-bbs2-0012" title="VinodkumarM , RajagopalanS . Impact of a multiple‐micronutrient food supplement on the nutritional status of schoolchildren. Food and Nutrition Bulletin2006;27(3):203‐10. [DOI: 10.1177/156482650602700302; PUBMED: 17542110] ">Vinodkumar 2006 (C)</a>; <a href="./references#CD009666-bbs2-0013" title="VinodkumarM , RajagopalanS . Efficacy of fortification of school meals with ferrous glycine phosphate and riboflavin against anemia and angular stomatitis in schoolchildren. Food and Nutrition Bulletin2009;30(3):260‐4. [DOI: 10.1177/156482650903000307; PUBMED: 19927606] ">Vinodkumar 2009 (C)</a>. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Iron deficiency</b> (defined by using ferritin concentrations less than 15 µg/L) </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.35</b> <br/> (0.27 to 0.47) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1364<br/> (5 RCTs) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Included studies: <a href="./references#CD009666-bbs2-0005" title="Macharia‐MutieCW , MorettiD , Van denBrielN , OmusundiAM , MwangiAM , KokFJ , et al. Maize porridge enriched with a micronutrient powder containing low‐dose iron as NaFeEDTA but not amaranth grain flour reduces anemia and iron deficiency in Kenyan preschool children. Journal of Nutrition2012;142(9):1756‐63. [DOI: 10.3945/jn.112.157578; PUBMED: 22810982] Macharia‐MutieCW , OmusundiAM , MwaiJM , MwangiAM , BrouwerID . Simulation of the effect of maize porridge fortified with grain amaranth or micronutrient powder containing NaFeEDTA on iron intake and status in Kenyan children. Public Health Nutrition2013;16(9):1605‐13. [DOI: 10.1017/S1368980012005174; PUBMED: 23218415] ">Macharia‐Mutie 2012</a>; <a href="./references#CD009666-bbs2-0008" title="OseiAK , HouserRF , BulusuS , HamerDH . Acceptability of micronutrient fortified school meals by schoolchildren in rural Himalayan villages of India. Journal of Food Science2008;73(7):S354‐8. [DOI: 10.1111/j.1750‐3841.2008.00878.x; PUBMED: 18803728] OseiAK , RosenbergIH , HouserRF , BulusuS , MathewsM , HamerDH . Community‐level micronutrient fortification of school lunch meals improved vitamin A, folate, and iron status of schoolchildren in Himalayan villages of India. Journal of Nutrition2010;140(6):1146‐54. [DOI: 10.3945/jn.109.114751; PUBMED: 20410083] ">Osei 2008 (C)</a>; <a href="./references#CD009666-bbs2-0009" title="SharieffW , YinSA , WuM , YangQ , SchauerC , TomlinsonG , et al. Short‐term daily or weekly administration of micronutrient Sprinkles has high compliance and does not cause iron overload in Chinese schoolchildren: a cluster‐randomized trial. Public Health Nutrition2006;9(3):336‐44. [PUBMED: 16684385] ZlotkinS [pers comm] . Regards and question ‐ Sharieff 2006. Email to: JP Peña‐Rosas 2 November 2011. ">Sharieff 2006 (C)</a>; <a href="./references#CD009666-bbs2-0010" title="TroeschB [pers comm] . Regards and question on Troesch et al 2011. Email to: JP Peña‐Rosas 1 November 2011. TroeschB , vanStuijvenbergME , SmutsCM , KrugerHS , BiebingerR , HurrellRF , et al. A micronutrient powder with low doses of highly absorbable iron and zinc reduces iron and zinc deficiency and improves weight‐for‐age Z‐scores in South African children. Journal of Nutrition2011;141(2):237‐42. [DOI: 10.3945/jn.110.129247; PUBMED: 21178093] ">Troesch 2011b</a>; <a href="./references#CD009666-bbs2-0011" title="VarmaJL , DasS , SankarR , MannarMG , LevinsonFJ , HamerDH . Community‐level micronutrient fortification of a food supplement in India: a controlled trial in preschool children aged 36‐66 mo. American Journal of Clinical Nutrition2007;85(4):1127‐33. [PUBMED: 17413115] ">Varma 2007 (C)</a>. </p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>220 per 1000</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>77 per 1000</b> <br/> (59 to 104) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Ferritin</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The standardised mean ferritin score in intervention groups was, on average, <b>0.42 μg/L higher</b> (4.36 μg/L lower to 5.19 μg/L higher) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1066<br/> (3 RCTs) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>d,e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Included studies: <a href="./references#CD009666-bbs2-0008" title="OseiAK , HouserRF , BulusuS , HamerDH . Acceptability of micronutrient fortified school meals by schoolchildren in rural Himalayan villages of India. Journal of Food Science2008;73(7):S354‐8. [DOI: 10.1111/j.1750‐3841.2008.00878.x; PUBMED: 18803728] OseiAK , RosenbergIH , HouserRF , BulusuS , MathewsM , HamerDH . Community‐level micronutrient fortification of school lunch meals improved vitamin A, folate, and iron status of schoolchildren in Himalayan villages of India. Journal of Nutrition2010;140(6):1146‐54. [DOI: 10.3945/jn.109.114751; PUBMED: 20410083] ">Osei 2008 (C)</a>; <a href="./references#CD009666-bbs2-0009" title="SharieffW , YinSA , WuM , YangQ , SchauerC , TomlinsonG , et al. Short‐term daily or weekly administration of micronutrient Sprinkles has high compliance and does not cause iron overload in Chinese schoolchildren: a cluster‐randomized trial. Public Health Nutrition2006;9(3):336‐44. [PUBMED: 16684385] ZlotkinS [pers comm] . Regards and question ‐ Sharieff 2006. Email to: JP Peña‐Rosas 2 November 2011. ">Sharieff 2006 (C)</a>; <a href="./references#CD009666-bbs2-0011" title="VarmaJL , DasS , SankarR , MannarMG , LevinsonFJ , HamerDH . Community‐level micronutrient fortification of a food supplement in India: a controlled trial in preschool children aged 36‐66 mo. American Journal of Clinical Nutrition2007;85(4):1127‐33. [PUBMED: 17413115] ">Varma 2007 (C)</a>. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>All‐cause mortality</b> (number of deaths during trial) </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Not estimable</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>115<br/> (1 RCT) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>f</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Included study: <a href="./references#CD009666-bbs2-0001" title="InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Combined intensive nutrition education and micronutrient powder supplementation improved nutritional status of mildly wasted children on Nias Island, Indonesia. Asia Pacific Journal of Clinical Nutrition2012;21(3):361‐73. [PUBMED: 22705425] InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Improved nutrition knowledge and practice through intensive nutrition education: a study among caregivers of mildly wasted children on Nias Island, Indonesia. Food and Nutrition Bulletin2012;33(2):117‐27. [DOI: 10.1177/156482651203300205; PUBMED: 22908693] PurwestriRC , ScherbaumV , InayatiDA , WirawanNN , SuryantanJ , BloemMA , et al. Supplementary feeding with locally‐produced ready‐to‐use food (RUF) for mildly wasted children on Nias Island, Indonesia: comparison of daily and weekly programme outcomes. Asia Pacific Journal of Clinical Nutrition2012;21(3):374‐9. [PUBMED: 22705426] ScherbaumV [pers comm] . Your paper on MNP. Email to: LM De‐Regil 5 February 2013. ">Inayati 2012 (C)</a>. </p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b> <br/> (0 to 0) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Diarrhoea</b> (≥ 3 liquid stools per day) </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.97</b> <br/> (0.53 to 1.78) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>366<br/> (2 RCTs) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>g</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Included studies: <a href="./references#CD009666-bbs2-0001" title="InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Combined intensive nutrition education and micronutrient powder supplementation improved nutritional status of mildly wasted children on Nias Island, Indonesia. Asia Pacific Journal of Clinical Nutrition2012;21(3):361‐73. [PUBMED: 22705425] InayatiDA , ScherbaumV , PurwestriRC , WirawanNN , SuryantanJ , HartonoS , et al. Improved nutrition knowledge and practice through intensive nutrition education: a study among caregivers of mildly wasted children on Nias Island, Indonesia. Food and Nutrition Bulletin2012;33(2):117‐27. [DOI: 10.1177/156482651203300205; PUBMED: 22908693] PurwestriRC , ScherbaumV , InayatiDA , WirawanNN , SuryantanJ , BloemMA , et al. Supplementary feeding with locally‐produced ready‐to‐use food (RUF) for mildly wasted children on Nias Island, Indonesia: comparison of daily and weekly programme outcomes. Asia Pacific Journal of Clinical Nutrition2012;21(3):374‐9. [PUBMED: 22705426] ScherbaumV [pers comm] . Your paper on MNP. Email to: LM De‐Regil 5 February 2013. ">Inayati 2012 (C)</a>; <a href="./references#CD009666-bbs2-0008" title="OseiAK , HouserRF , BulusuS , HamerDH . Acceptability of micronutrient fortified school meals by schoolchildren in rural Himalayan villages of India. Journal of Food Science2008;73(7):S354‐8. [DOI: 10.1111/j.1750‐3841.2008.00878.x; PUBMED: 18803728] OseiAK , RosenbergIH , HouserRF , BulusuS , MathewsM , HamerDH . Community‐level micronutrient fortification of school lunch meals improved vitamin A, folate, and iron status of schoolchildren in Himalayan villages of India. Journal of Nutrition2010;140(6):1146‐54. [DOI: 10.3945/jn.109.114751; PUBMED: 20410083] ">Osei 2008 (C)</a>. </p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>96 per 1000</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>93 per 1000</b> <br/> (51 to 170) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse effects</b> (any, as defined by trialists) </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.09</b> <br/> (0.16 to 7.42) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>90<br/> (1 RCT) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Included study: <a href="./references#CD009666-bbs2-0007" title="OrozcoJ , VargasC , RojasML , HerreraAM , MontoyaL , SánchezJG , et al. The effect of powdered micronutrients on the hematologic values and nutritional status of healthy preschoolers. Medellín, 2013 [Efecto de los micronutrientes en polvo en el estado nutricional y en los valores hemáticos de preescolares sanos. Medellín, 2013]. Revista Facultad Nacional de Salud Pública2015;33(2):161‐70. [DOI: 10.17533/udea.rfnsp.v33n2a03] ">Orozco 2015 (C)</a>. </p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>43 per 1000</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>46 per 1000</b> <br/> (7 to 316) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>MD: m</b> ean difference; <b>MNP:</b> micronutrient powder; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Most studies had no blinding. High heterogeneity (72%) with most studies showing a positive effect of MNP.<br/> <sup>b</sup>Most studies had no blinding. High heterogeneity (93%) with most studies showing a positive effect of MNP.<br/> <sup>c</sup>Most studies had no blinding. No heterogeneity with most studies showing a positive effect of MNP.<br/> <sup>d</sup>All the studies had no or unclear blinding.<br/> <sup>e</sup>100% heterogeneity with most inconsistency in direction of effect.<br/> <sup>f</sup>Only one low‐risk trial reported all‐cause mortality.<br/> <sup>g</sup>Two low‐risk trials reported diarrhoea. No heterogeneity with both studies showing no difference between intervention and comparison group. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Point‐of‐use fortification of foods with micronutrients powders (MNP) compared to no intervention or placebo in preschool and school‐age children</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/full#CD009666-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009666-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Unused methods archived for use in future updates of this review</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Method</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Approach</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unit of analysis issues</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cross‐over trials</b> </p> <p>We planned to only include the first period of a randomised cross‐over trial prior to the washout period or to a change in the sequence of treatments. We planned to treat them as parallel randomised controlled trials. </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Unused methods archived for use in future updates of this review</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/full#CD009666-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009666-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Anaemia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2448</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [0.49, 0.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Anaemia by anaemic status of participants at start of intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2448</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [0.49, 0.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Anaemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Non‐anaemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>199</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.49 [0.74, 3.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Mixed/unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2249</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.45, 0.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Anaemia by age of children at start of intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2249</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.45, 0.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Aged 24‐59 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [0.44, 0.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Aged 60 months or older</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>543</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.53 [0.25, 1.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Anaemia by malaria status of study site at time of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2249</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.45, 0.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>934</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.29, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1252</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.62, 0.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.21, 0.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Anaemia by frequency <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2249</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.62 [0.46, 0.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Daily</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2163</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.43, 0.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Weekly</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>86</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.50, 2.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 Flexible</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Anaemia by duration of intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2249</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.45, 0.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Less than 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>867</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.63, 0.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 3 months or longer</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1382</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.51 [0.31, 0.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Anaemia by iron content of product <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2249</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.45, 0.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 12.5 mg elemental iron or less</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1705</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.65, 0.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 More than 12.5 mg elemental iron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>544</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.26 [0.14, 0.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Anaemia by type of iron compound <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2249</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.45, 0.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Iron EDTA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>797</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.56, 1.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 Encapsulated ferrous fumarate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1389</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.35, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3 Other</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.21, 0.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Anaemia by number of nutrients accompanying iron <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2249</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.45, 0.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 1‐4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1185</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.37 [0.16, 0.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 5‐9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.3 10‐15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1064</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.65, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Anaemia by micronutrient composition <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2249</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.45, 0.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 Iron alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2 Iron + vitamin A + zinc</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1705</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.65, 0.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.3 Iron + other combinations</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>544</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.26 [0.14, 0.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Haemoglobin (g/L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2746</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.37 [0.94, 5.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Haemoglobin by anaemic status of participants at start of intervention (g/L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2547</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.70 [1.08, 6.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 Anaemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.2 Non‐anaemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.3 Mixed/unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2547</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.70 [1.08, 6.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Haemoglobin by age of children at start of intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2547</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.70 [1.08, 6.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 Aged 24‐59 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2023</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.02 [‐0.87, 4.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.2 Aged 60 months or older</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>524</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.86 [‐0.76, 16.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Haemoglobin by malaria status of study site at time of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2547</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.70 [1.08, 6.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.1 Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>954</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.68 [1.15, 4.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.2 No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1060</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.31 [‐2.84, 7.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.3 Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>533</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.51 [‐1.22, 16.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Haemoglobin by frequency (g/L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2547</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.27 [0.84, 5.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.1 Daily</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2315</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.84 [1.07, 6.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.2 Weekly</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>232</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.25 [‐3.07, 2.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.3 Flexible</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Haemoglobin by duration of intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2547</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.70 [1.08, 6.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.1 Less than 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>887</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.14 [‐5.04, 9.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.2 3 months or longer</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1660</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.26 [1.23, 7.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Haemoglobin by iron content of product <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2547</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.70 [1.08, 6.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.1 12.5 mg elemental iron or less</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.05 [‐0.20, 6.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.2 More than 12.5 mg elemental iron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>841</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.33 [‐1.23, 11.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Haemoglobin by type of iron compound (g/L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2547</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.70 [1.08, 6.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.1 Iron EDTA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>605</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.51 [‐0.99, 2.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.2 Encapsulated ferrous fumarate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.81 [‐0.77, 6.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.3 Other</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>236</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>11.42 [8.81, 14.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Haemoglobin by number of nutrients accompanying iron (g/L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2547</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.70 [1.08, 6.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.1 + 1‐4 micronutrients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1185</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.11 [3.70, 12.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.2 + 5‐9 micronutrients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>470</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.85 [‐5.73, 15.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.3 + 10‐15 micronutrients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>892</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.35, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Haemoglobin by micronutrient composition (g/L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2547</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.70 [1.08, 6.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.1 Iron alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.2 Iron + vitamin A + zinc</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1830</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.53 [‐0.88, 3.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.3 Iron + other combinations</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>717</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.95 [3.42, 14.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 Iron deficiency <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1364</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.27, 0.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 Iron deficiency by anaemia status at start of intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1364</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.27, 0.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>22.1 Anaemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>22.2 Non‐anaemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>22.3 Mixed/unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1364</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.27, 0.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">23 Iron deficiency by age of children at start of intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1364</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.27, 0.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>23.1 Aged 24‐59 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>884</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.22, 0.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>23.2 Aged 60 months or older</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>480</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [0.26, 0.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">24 Iron deficiency by malaria status of study site at time of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1364</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.27, 0.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>24.1 Yes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>667</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.22, 0.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>24.2 No</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>480</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [0.26, 0.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>24.3 Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>217</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [0.03, 2.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">25 Iron deficiency by frequency <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1364</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.27, 0.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>25.1 Daily</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>25.2 Weekly</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1364</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.27, 0.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>25.3 Flexible</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">26 Iron deficiency by duration of intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1364</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.27, 0.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>26.1 Less than 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>26.2 3 months or longer</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1364</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.27, 0.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">27 Iron deficiency by iron content of product <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1364</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.27, 0.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>27.1 12.5 mg elemental iron or less</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>666</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.26, 0.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>27.2 More than 12.5 mg elemental iron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>698</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.21, 0.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">28 Iron deficiency by type of iron compound <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1364</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.27, 0.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>28.1 Iron EDTA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>666</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.26, 0.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>28.2 Encapsulated ferrous fumarate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>698</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.21, 0.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>28.3 Other</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">29 Iron deficiency by number of nutrients accompanying iron <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1364</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.27, 0.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>29.1 + 1‐4 micronutrients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>481</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.21, 0.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>29.2 + 5‐9 micronutrients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>29.3 + 10‐15 micronutrients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>883</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.37 [0.25, 0.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">30 Iron deficiency by micronutrient composition <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1364</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.27, 0.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>30.1 Iron alone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>30.2 Iron + vitamin A + zinc</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>883</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.37 [0.25, 0.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>30.3 Iron + other combinations</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>481</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.21, 0.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">31 Ferritin (μg/L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1066</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [‐4.36, 5.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">32 All‐cause mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">33 Diarrhoea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>366</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.53, 1.78]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">34 Adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">35 Iron deficiency anaemia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>918</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.28 [0.07, 1.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">36 All‐cause morbidity <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>538</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.74, 1.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">37 Acute respiratory infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">38 Growth (height‐for‐age Z‐score) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>617</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.02 [‐0.20, 0.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">39 Growth (weight‐for‐age Z‐score) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>502</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.09, 0.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">40 Growth (weight‐for‐height Z‐score) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>287</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [0.00, 0.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">41 Adherence <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">42 Serum/plasma retinol (mmol/L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>547</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>10.08 [‐10.72, 30.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">43 Serum/plasma zinc concentrations (mmol/L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">44 Iron status (iron‐binding capacity) (non‐prespecified) (µmol/kg) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">45 Iron status (serum‐transferrin receptors; non‐prespecified) (mg/L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">46 Serum vitamin E (non‐prespecified) (µg/dL) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">47 Serum vitamin B<sub>12</sub> (non‐prespecified) (pg/mL) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>329</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>241.16 [‐258.70, 741.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">48 Zinc deficiency (non‐prespecified) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">49 Vitamin A deficiency (non‐prespecified) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">50 Serum folate concentration (ng/mL) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>329</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.16 [0.76, 3.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">51 Height (non‐prespecified) (cm) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>182</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.05 [‐3.71, 3.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">52 Weight (non‐prespecified) (kg) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>313</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.02 [‐0.59, 0.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">53 Fever (non‐prespecified) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">54 Stunting (non‐prespecified) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>654</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.66, 1.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">55 Angular stomatitis (non‐prespecified) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>236</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.04 [0.01, 0.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Point‐of‐use fortification of foods with micronutrients powders (MNP) versus no intervention or placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009666.pub2/references#CD009666-tbl-0003">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD009666.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD009666-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD009666-note-0004">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD009666-note-0005">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD009666-note-0002">Français</a> </li> <li class="section-language"> <a class="" href="pl#CD009666-note-0003">Polski</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD009666-note-0010">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009666\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009666\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009666\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009666\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009666\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009666\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009666\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009666\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009666\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009666\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009666\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009666\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009666\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009666\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009666\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009666\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009666\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009666\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=18M35a5z&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009666.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009666.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD009666.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD009666.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009666.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740727328820"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009666.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740727328824"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009666.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ea9613bd59377',t:'MTc0MDcyNzMyOS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 